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Abstract 
The age for optimal women’s childbearing, with the best chance of delivering a healthy 
baby, is generally considered to be when aged in their 20s years. Some researchers 
propose that fertility declines occurs from 32 years of age. After this age women have a 
decreasing chance of conception attributed primarily to age-related chromosomal changes 
in their oocytes. Midlife intending mothers (women aged 35 and older) are the largest 
users of Assisted Reproductive Technology (ART) in Australia. Whatever the aetiology of 
infertility, age-related changes in their oocytes increase the chance of spontaneous 
miscarriage and decrease the chance of a live healthy baby. In 2013 the overall live birth 
rate per initiated ART cycle for Australian women of all ages was 18.2%. A breakdown into 
age groups shows per initiated cycle for those aged; 35–39 years was 16.3%, 40–44 years 
5.9%, and 45 years or older 1.2%. Women unaware of this low success rate of ART may 
experience involuntary childlessness.  
This research investigates perceptions of women’s fertility decline and ART success from 
a group of women who had used ART, and from men and women in the community who 
may not have used ART. Women who had used ART and a community cohort were 
surveyed.  Responses from these two groups were analysed separately and compared. 
Women who had used ART were asked about their experiences at their clinic, and if 
treatment had social or psychological repercussions. Participants asked about their 
perceptions of media portrayal of ART success for women aged 35 and older. The concept 
that ART has become commodified, where commodification is the transformation of 
services or entities into a commodity, is explored. Those who had used ART suggested 
recommendations for younger women about childbearing.  
A mixed-methods approach was utilised. Data were gathered from three cohorts of 
participants. Quantitative and qualitative data were gathered from an in-vitro fertilisation 
(IVF) support group (N = 68) and qualitative data from an interview group of IVF users 
(N=6) who had engaged with ART treatment either currently or recently. Some had 
conceived and some were still having treatment. The community group (N= 1243) 
comprised men and women over 18 years of age who participated in a Queensland-wide 
telephone survey. Quantitative data gathered from the support group and the community 
were analysed using SPSS. Qualitative data were explored via thematic analysis.  
Thematic findings from the interview group supported findings of the support group. Most 
women knew the benefits and risks of delaying childbearing and made an informed choice 
   ii 
to use ART. Most were aware that fertility declined from the age of 35, yet this age group 
is the major consumer of ART. Most women younger than 40 years believed they would 
get pregnant and have a healthy baby. Only half of the women aged 40 years and older 
had that confidence. However, this insight may have been gained after using ART. Women 
found their experience physiologically and psychologically challenging and those who 
didn’t conceive, found making the decision to stop treatment confronting. Some were 
confused on the published success rates, and expectations elevated from overall rather 
than age specific pregnancy not birth rates.  
Support group and interview participants felt delayed childbearing was mainly due to lack 
of a relationship partner whereas community members believed career or work 
aspirations. Both he support group and community group agreed that women’s fertility 
declined from the age of 35 years but significantly more community members, and 
significantly more men than women, thought that some women were fertile when aged in 
their 40s. Similarly, community members had much higher expectations that ART would 
achieve a pregnancy and a live birth for older women than the support group. Most 
participants believed media and clinic marketing portrayed ART as successful for older 
women and did not accurately depict the stories of many women. Some women felt that 
ART was commodified.  
Findings highlight that women are delaying childbearing, despite some awareness that 
fertility declines from midlife. This knowledge was tempered by faith that ART is a 
successful technology. This research highlights the quandary women may experience in 
making decisions on timing of childbearing. Further research using a larger sample cohort 
would expand the findings of this study. 
Public funding by Medicare for unlimited ART cycles for women aged over 40 years, or for 
women with little chance of success, requires review. Psychological support is needed for 
women who have difficulty stopping treatment. 
Lack of a coherent body of knowledge on age-related infertility and success rates amongst 
the general public is of public heath interest. Information needs to be accurate and 
disseminated by an independent body. Primary health providers could better inform 
younger women about age-related fertility decline. Overall, the message that ART is not a 
reliable “fall-back” option could be promoted by media and primary health providers. 
Accurate information on the limits of women’s fertility and success rates of ART for women 
of all ages allows women to make informed decisions on the timing of their childbearing. 
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Glossary 
ACCC: Australian Competition and Consumer Commission 
Aetiology: The cause, set of causes, or manner of causation of a disease or 
condition  
Aneuploidy: Refers to any number of chromosomes that is not euploid, and 
for constitutional chromosome disorders, usually refers to an extra copy of a single 
chromosome (trisomy) or absence of a single chromosome (monosomy). 
ANZARD:  Australian and New Zealand Assisted Reproductive 
Databases. An initiative of the Fertility Society of Australia (FSA) is to provide 
a joint data collection for both the NPESU and the Reproductive Technology 
Accreditation Committee (RTAC) of the FSA. The purpose of the ANZARD 
collection is to monitor the perinatal outcomes of assisted reproduction and to 
assess the effectiveness of ART treatments in Australian and New Zealand 
fertility clinics. 
Apoptosis: Programmed cell death. 
ART: Assisted Reproductive Technology ART encapsulates a range of 
treatments or procedures that involve the in vitro handling of human oocytes and 
sperm or embryos for the purposes of establishing a pregnancy. ART is non-coital, 
technically assisted reproduction that does not include artificial insemination. 
AS: Angelmann Syndrome. 
Atresia: Ovarian follicle atresia is the periodic process in which immature 
ovarian follicles degenerate and are subsequently re-absorbed during the follicular 
phase of the menstrual cycle. 
Autologous cycle: An autologous cycle is an ART treatment cycle in which a 
woman intends to use, or uses her own oocytes.  
BWS: Beckwith-Wiedmann Syndrome. 
Blastocyst: An embryo comprising approximately 100 cells usually developed 
by the 5th or 6th day after fertilisation. 
CGH: Comparative genetic hybridization is a micro-array technique that 
permits the detection of chromosomal copy number changes without the need to 
culture the cells.  
Cleavage stage embryo: An embryo containing approximately 8 cells usually 
developed by the 2nd or 3rd day after fertilisation. 
   xxii 
Clinical pregnancy: Ongoing pregnancy confirmed by elevated levels of hCG 
or evidence by ultrasound of one or more gestational sacs (with or without a foetal 
heart), or examination of the products of conception with chorionic villi present, or 
ectopic pregnancy diagnosed by ultrasound or definitive clinical signs of pregnancy. 
Clomiphene Citrate (Clomid/Serophene): Stimulates the secretion of FSH 
and LH. Use to regulate irregular ovulation, stimulates ovulation, and increases 
oocyte production.  
Controlled ovarian hyperstimulation: Pharmaceutical treatment to induce the 
development of multiple ovarian follicles in order to obtain multiple oocytes at 
oocyte pick-up (OPU). 
Cumulative pregnancy rate (CPR): The calculation of success of a ART 
program where a pregnancy is achieved after one or two IVF/ICSI cycles, including 
the use of any "spare" frozen embryos 
Donation cycle: ART treatment cycle in which a woman intends to donate, or 
donates her oocytes to others. A donation cycle may result in the donation of either 
oocytes or embryos to a recipient woman. 
Ectopic pregnancy: A pregnancy in which implantation occurs outside the 
uterine cavity most commonly in the fallopian tube. 
Embryo: An egg that has been fertilised by a sperm and has undergone one 
or more divisions. 
Embryo transfer: The transfer of one or more embryos, selected from a larger 
cohort of viable embryos.  
Epigenetic: Changes in gene expression caused by molecular mechanisms 
other than the mutations in the DNA sequence itself. 
Euploid: The number of chromosomes in a normal haploid gamete.  
Fallopian tube: One fallopian tube is attached to each ovary and after 
fertilisation the embryo travels down the tube to the uterus.  
Fecundity: The ability to reproduce. 
Fertility intentions: The number of biological children a woman aspires to 
have in her lifetime. 
Fertilisation: The penetration of the ovum by the spermatozoon and 
combination of genetic material resulting in the formation of a zygote. 
Foetus: The product of fertilisation from the completion of embryonic 
development at eight weeks after fertilisation until abortion or birth.  
   xxiii 
Fresh cycle: An ART treatment cycle that intends to use, or uses embryo(s) 
that have not been cryopreserved (frozen). 
FSH: Follicular stimulation hormone is produced by the pituitary gland and 
controls the production of oestrogen by the ovaries. 
Genomic imprinting: Mechanism of DNA methylation controls which genes 
are expressed in certain cell types. Many imprinted genes play an important role in 
embryonic growth, placental function and neuro-behavorial processes. Certain 
genes are expressed in a parent of origin in a specific manner. If an allele inherited 
from one parent is imprinted it is silenced and only the allele from the other parent is 
expressed.  
ICSI:  Intracytoplasmic sperm injection was developed in 1990 for male factor 
infertility. ICSI technique injects a single spermatozoon into an oocyte cytoplasm. 
Implantation: The attachment and subsequent penetration by the zona-free 
blastocyst that starts five to seven days after fertilisation. 
Infertility: Failure to achieve a clinical pregnancy after 12 months or more of 
regular unprotected intercourse. 
In vitro fertilisation: IVF is a procedure within ART that involves 
extracorporeal fertilisation. Fertilisation occurs outside the body. 
LH:  Luteinising hormone is produced by the pituitary gland and controls the 
length and sequence of a menstrual cycle. A midcycle surge of LH triggers 
ovulation.  
Live birth: A live birth is defined as a birth past 20 weeks gestation and the 
babies survival for longer than 28 days. 
Low birth weight: A birth weight of less than 2,500 grams. 
Karyotype: The number and visual appearance of the chromosomes in the 
cell nuclei of an organism.  
Midlife intending mothers: A term used in this research describing women 
aged 35 years or older using ART to conceive. 
Miscarriage: A pregnancy with a gestational sac that fails to progress past 20 
weeks of gestation. Miscarriage frequently occurs in the first trimester but can occur 
within the first few weeks of conception. 
Monosomy: A chromosome is missing. 
Neonatal death: Death of live born infants within 28 days of birth. 
NPESU: National Perinatal Epidemiology and Statistics Unit. 
Nulliparous: Woman who has not carried a pregnancy beyond 20 weeks.  
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Oocyte: A female reproductive cell. 
Oogenesis: The creation of a single ovum (egg cell)  
OHSS: Ovarian hyperstimulation syndrome is an adverse complication of 
ovulation stimulation therapy, after the administration of follicle stimulating hormone 
(FSH). OHSS symptoms include abdominal distension, ovarian enlargement, and 
respiratory, haemodynamic, and metabolic complications.  
Ovarian follicles: A granulose cavity or recess in an ovary containing a 
mature ovum surrounded by cells. 
Oviduct: Passageway from the ovaries to the uterus where the ovulated 
oocyte travels to potential fertilisation. Also known as the fallopian tube. 
Parity: The classification of a woman in terms of the number of pregnancies 
that have reached 20 weeks or longer gestation. 
Parous: A woman who has delivered a viable baby after at least of 20 weeks 
gestation. 
Partnering: A significant relationship with a male, but not necessarily in a 
legal marriage. 
PBS: Pharmaceutical Benefits Scheme. 
PGD: Preimplantation genetic diagnosis involves testing for specific genetic 
conditions in an embryo created using ART to identify conditions of risk prior to 
transferring it to the uterus. 
PGS: Preimplantation genetic screening involves screening for many genetic 
conditions in an embryo created using ART to identify conditions of risk prior to 
transferring it to the uterus. 
Perinatal death: Foetal or neonatal deaths (stillbirths) occurring during late 
pregnancy (at 20 weeks gestation or later), during childbirth or up to 28 days after 
birth.  
Primary infertility: Never conceived. 
QFG: Queensland Fertility Group. 
Secondary infertility: Subfertility after a pregnancy. 
RTAC: Reproductive Technology Accreditation Committee of the 
Fertility Society of Australia. 
Recipient cycle: An ART treatment cycle in which a woman receives oocytes 
or embryos from another woman. 
SGA: Small for gestational age. 
   xxv 
Spontaneous miscarriage: The spontaneous loss of a clinical pregnancy 
before gestational age of 20 weeks or the loss of an embryo/foetus of less than 
400g. 
Trophectoderm: Outermost layer of cells in the mammalian blastodermic 
vesicle, which will make contact with the endometrium and take part in establishing 
the embryo's means of receiving nutrition; the cell layer from which the trophoblast 
differentiates. 
Trisomy: Chromosomal disorder caused by the presence of all, or part of, an 
extra chromosome. Three copies of chromosome results in a total chromosome 
number of 47 instead of 46. 
Zona pellucida: The extracellular coat that forms around an ovum as it 
develops in an ovary. It has a vital role during oogenesis, fertilisation and 
preimplantation development. A sperm needs to penetrate the zona pellucida for 
fertilisation to occur.  
Zygote: A diploid cell formed after fertilisation between a sperm and oocyte 
and is the earliest developmental stage of an embryo. 
   1 
Chapter 1: Assisted Reproductive Technology for women in midlife 
The aim of this research is to investigate beliefs and expectations along with social 
reasons for women delaying childbearing, and perceptions of the success of Assisted 
Reproductive Technology (ART). In addition, it seeks to explore the experiences of women 
who have undertaken ART. This research was designed to fill a gap in the body of 
knowledge about the use of ART services by women in midlife through two Australian 
infertility clinics. The evaluation of beliefs and expectations are viewed from a public health 
perspective. 
Chapter One provides an introduction to the research. It includes the significance and 
rationale of the study, an introduction to the medical procedures of ART, including 
Australia’s role in ART, a review of research undertaken into Australian women’s beliefs 
about, and engagement with, ART and an outline of the research.  
1.1 Rationale 
In the Australian context, there is limited research on women undertaking ART, particularly 
women in midlife when their fertility is substantially waning. Little is known about the 
perceptions and expectations of these women about ART, the factors that have informed 
their expectations, and how these expectations may change when they engage with 
infertility treatment. The research compares the beliefs and understandings of the general 
public with those of female patients of an infertility clinic.  
Women in Australia are having children at an age later than in previous years (Australian 
Bureau of Statistics, 2012b). While female fertility has been postulated to decline from as 
young as 32 years of age, 35 years of age is accepted as the period of significant decline 
(American Society of Reproductive Medicine, 2014). Older women have age-related 
infertility that arises from chromosomal changes in their oocytes. Childbearing for midlife 
intending mothers has health implications for the mother and baby (Baart et al., 2006). 
Midlife intending mothers also have an increased risk of adverse maternal, foetal or infant 
outcomes, smaller family size than desired, higher chance of miscarriage, as well as 
involuntary childlessness (Daniluk & Koert, 2015). It has been documented that older 
women have higher rates of instrument birth, neonatal complications, caesarean delivery, 
gestational diabetes, and low birthweight babies. Information on the increased risks for 
women who delay childbearing or use ART is not widely understood in the community.  
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Women delaying childbearing may believe that ART can overcome age-related infertility 
and seek to use it as a fall-back option (Hashiloni-Dolev, Kaplan, & Shkedi-Rafis, 2011; 
Weston, Qu, Parker, & Alexander, 2004). Some women may be unaware of age-related 
fertility decline or have unrealistic expectations of ART and experience involuntary 
childlessness or fewer children than anticipated. To make informed decisions it is 
imperative women have a substantial understanding of the risks of delaying pregnancy  
Widespread access to contraception frees women to decide when to have children; some 
delay childbearing based on social factors or personal beliefs. Australian women’s 
childbearing intentions and reasons for having children in later life have been explored. 
Some influences include: not being in a partnered relationship, educational pursuits, and 
career or work aspirations. Influences may be shaped by circumstances and may not have 
been well-considered (Holton, Fisher, & Rowe, 2011a). The medical profession 
understands the evidence that normal ageing impacts upon likelihood of a conception. 
However, the proposition exists that this is not fully understood within the community.  
ART-conceived babies accounted for 4.1% of Australian births (Li, Zeki, Hilder, & Sullivan, 
2012). In the reproductive context, this is important, as an increasing number of women 
are delaying childbearing until midlife (Billari et al., 2011). This is an age when they are 
unlikely to conceive without fertility treatment and thus risk involuntary childlessness 
(Leridon, 2008). Women need reliable and accurate knowledge of the success and risks of 
ART to make decisions about childbearing. Information about age-related fertility decline, 
ART procedures, costs and success rates (reported in a manner able to be comprehended 
by non-experts) should be freely available. Women may believe they are informed but may 
not be fully informed, and become aware of risks only when pregnant. Those who are 
informed may also choose to delay childbearing (Cooke, 2010). A lack of awareness of the 
cause of decline in fertility may influence some women to delay childbearing until they are 
unwittingly reliant on medical intervention. Women may not be aware of health risks when 
undertaking ART. Some, aware of the danger of delaying childbearing, may take the 
chance, perhaps buoyed by the perception, through the media, that medical technology 
will circumvent problems. However, this confidence may be unjustified.  
A lack of knowledge of infertility and success rates of ART are a problem for Australian 
women. The number of women accessing ART is increasing annually and the age of 
women requiring ART is rising. More needs to be known about the needs and expectations 
of this group. Determining the level of knowledge surrounding these issues can benefit 
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young women in the community. Exploring the experiences of women who have used ART 
can provide insight and knowledge to improve IVF services. An understanding of the 
limitations of female fertility may encourage women to start their families before their 
fertility declines. Fewer women with age-related infertility requiring ART and achieving their 
personal childbearing aspirations is in the public interest.  
Growth in the number of women aged 35 years or older using ART has increased 
expenditure in the Australian healthcare system. In the context of age-related infertility, the 
chance of pregnancy is small, particularly for women with declining fertility. Johri and 
Lehoux (2003) argue that ART reflects a dilemma by using expensive medical 
technologies that benefit a small number of people. Neumann (1997) suggests that 
resources for ART should be allocated to couples with a higher chance of success from 
clinics with high success rates. A health technology assessment of the social value versus 
the cost of ART is difficult as the interpretation of value is different from a societal value 
compared with personal desire for a child (Johri & Lehoux, 2003). Within the Australian 
context, ART could be interpreted as an expensive technology for a few beneficiaries (van 
Gool, Savage, Viney, Haas, & Anderson, 2009). 
1.2 Background 
In this research, midlife intending mothers are defined as women giving birth or trying to 
conceive when aged 35 years or older (Berryman & Windbridge, 1997). This group have a 
higher risk of age-related chromosomal changes in their oocytes and a higher reliance on 
ART compared with younger women. 
The research sought to obtain the personal stories and beliefs of women who have used 
ART. Data were sought regarding women’s optimal age for childbearing, perceptions 
about their ART experience, prior expectations, the success rate of ART and whether their 
beliefs are shaped by preconceptions gained from media or marketing. The community, 
who in the majority would not have used ART, were also questioned about their views of 
the optimal age for women to have children, beliefs on the success of ART, and whether 
media has influenced their views. The research also examines whether environmental 
influences have impacted the childbearing intentions of Australian women. 
The study seeks to provide insight and extend the body of knowledge about the 
phenomena of midlife intending mothers and community beliefs regarding ART. Views of 
Queensland women aged 35–52 years who had engaged with ART and men and women 
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aged 18–82 years in the Queensland community were compared. Data on women 
accessing ART is available through perinatal statistics compiled from the Australian and 
New Zealand Assisted Reproductive Databases (ANZARD). ANZARD data includes; 
the age of women having ART, number of cycles, pregnancy rates, birth rates, miscarriage 
rates, birth outcomes and other data pertaining to ART cycles (Macaldowie, Lee, & 
Chambers, 2015). However, empirical data lacks social perspectives and social research 
surrounding ART is limited due to privacy issues and limited researcher access to patients 
in private clinics. Some women find the psychological consequences of infertility and ART 
treatment taxing and can be reluctant to discuss their personal stories.  
Women may not fully grasp the fertility implications of delaying childbearing and chances 
of conceiving with ART and may be denying themselves the opportunity for motherhood. 
As Lord Robert Winston notes “infertility is not a disease but a natural process” and “in 
vitro fertilisation (IVF) cannot cure infertility” (McLaren, 2014). This statement may be 
perceived as controversial as some causes of infertility may be due, for example, to 
blocked fallopian tubes or genetic conditions (Khetarpal & Singh, 2012); however, it is 
important to note that ART cannot cure age-related chromosomal changes in oocytes (Lim 
& Tsakok, 1997). Perceptions of the success of ART for midlife intending mothers can be 
unrealistically elevated through media and marketing. As medical advances are made in 
reproductive technology, women’s expectations of the success of ART may be elevated. 
However, the power of marketing by infertility clinics and pharmaceutical companies, and 
media’s tendency to overestimate the capability of ART has lead to global misinformation 
that overrides the limitations of ART (Zoll & Tsigdinos, 2013). Australian women may 
perceive ART as a fall-back option (Norman, 2007; Weston & Qu, 2005). Consequently, 
women who believed they would have children may have unintentional childlessness. 
Awareness of the relationship between increasing maternal age and decreasing 
childbearing potential allows women to make informed choices about childbearing. 
ART is an expensive medical procedure and is available mainly in privately owned clinics. 
Australian women can undertake unlimited ART cycles provided they fund the out-of-
pocket expenses of treatment. The cost of ART is subsidised through Medicare and the 
Pharmaceutical Benefits Scheme (PBS) and the out-of-pocket expense per treatment 
cycle is considerable (Chambers & Sullivan, 2005). Despite the availability of unlimited 
funded cycles, Australian research into cumulative live birth rates shows there is little 
chance of pregnancy after the fifth cycle of ART regardless of a woman’s age 
(Macaldowie, Wang, Chambers, & Sullivan, 2013). Live birth per ART cycle rate indicates 
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that less than one in five women aged 35 years or older will conceive (Macaldowie, Wang, 
Chughtai, & Chambers, 2014; Weston et al., 2004). Unlimited Medicare-funded cycles for 
women who have a marginal chance of birth are problematic for Australian health care 
funding.  
Australian infertility clinics are private companies; some owned by venture capital 
companies and listed on the Australian stock exchange and some privately owned 
(Gardner, 2014a, 2014b, 2014c). The research questions whether infertility has become 
commodified and how this impacts on patient care. The Australian Financial Review, on 
August 20th, 2015 (Whyte, 2015), cites discontent within medical practitioners and 
embryologists with an IVF clinic, which was purchased by a venture capital company in 
2009. Clinicians and embryologists were concerned that the company was moving away 
from the core values of the clinic leading to a lack of clinician input into patient care, rising 
treatment costs, and hiring of new IVF specialists. As smaller infertility clinics become 
absorbed into larger clinics, questions arise regarding the potential for compromised 
patient care arising via corporatisation.  
1.3 Barriers to Conception 
Infertility can have multiple aetiologies, either male or female, or a combination of both. In 
2013, of the more than 70,000 initiated autologous (using a women’s own oocytes) and 
recipient cycles (using donated oocytes or embryos), 20.9% involved male infertility only, 
27.9% female factors, and 13.3% a combination of male and female factors with 22% 
idiopathic and 15.6% from unknown factors (Macaldowie et al., 2015). Reduced semen 
parameters are an important factor in couples attending infertility clinics; however, for this 
research, female age-related infertility is the focus.  
Women are increasingly delaying their age of childbearing compared with their mothers 
and grandmothers. In Australia, the average maternal age is 30.1 years of age, the 
average age of first time mothers is 28.6 years of age, and 22% of first time mothers are 
aged 35 years or older (Li, Hilder, & Sullivan, 2015). The average age of women 
undergoing ART autologous cycles in 2013 was 35.9 years and 26.8% of women were 
aged 40 and older, an age when fertility is significantly compromised (Macaldowie et al., 
2015).  
Women may be delaying childbearing for many reasons and there is no consensus for this 
trend. For many women, social factors combined with a lack of understanding of age-
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related fertility decline can lead to involuntary childlessness (Van Balen & Inhorn, 2002). 
Australian research indicates that social reasons such as career and educational goals, 
desire for financial security, and volatility of parenting relationships may be significant 
factors for women contemplating childbearing in midlife (Weston & Qu, 2005). To have a 
90% chance of a single naturally conceived birth, women should commence childbearing 
before the age of 35 years. However to have two naturally conceived children, women 
should start their families at age 31 years, and for three children, 28 years. These age 
limits may be unknown in the community (Habbema, Eijkemans, Leirdon, & te Velde, 
2015)   
Many women who delay childbearing have a reduced chance of conception, a higher 
chance of pregnancy loss, and increased health risks for themselves and their baby. 
Midlife intending mothers are more susceptible to miscarriage or having a baby born with a 
significant chromosomal impediment (Baart et al., 2006). Irrespective of the initial infertility 
aetiology, maternal age affects oocyte quality and quantity, and age is the most important 
factor influencing the success or failure of ART (Damario, Davis, & Rosenwaks, 1999; 
Handyside et al., 2012; Harton et al., 2013; Krey, Zhang, & Gfiro, 2001; Sauer, 2015). 
Because women are born with their lifetime complement of oocytes and age-related 
changes are caused by chromosomal variations, increasing maternal age is associated 
with detrimental changes. 
1.4 ART  
The Fertility Society of Australia’s website (Fertility Society of Australia, 2005) defines 
infertility as “the inability of a couple to achieve conception after a year of unprotected 
intercourse, or the failure to carry pregnancies to a live birth.” The World Health 
Organization’s website (World Health Organization, 2016) defines infertility as “a disease 
of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 
months or more of regular unprotected sexual intercourse”. ART was developed to bypass 
biological impediments to conception (Wang, Chambers, Dieng, & Sullivan, 2009) by 
manipulation of reproductive cycles, oocytes, embryos and semen to aid conception 
(Reed, 2001). In in-vitro fertilisation (IVF), the fertilisation of egg by sperm occurs outside 
the body (in vitro) and a fertilised embryo is transferred to the uterus (Rowell & Braude, 
2003). It may assist idiopathic (unexplained) infertility or at least reveal the impediments to 
conception (Rowell & Braude, 2003; Sandelowski, Holditch-Davis, & Harris, 1990). ART is 
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an expensive and invasive treatment. It generally does not cure infertility but attempts to 
circumvent obstacles to conception (McLaren, 2014). 
In Australia, one in six couples are unable to conceive spontaneously after a year of timed, 
unprotected intercourse and may seek medical advice from infertility clinics (Australian 
Broadcasting Corporation, 2014; Fertility Society of Australia, 2005; Kersten et al., 2015a). 
Herbert, Lucke and Dobson (2012) discuss the term “subfertility” and suggest that many 
women may self-diagnose infertility when they are subfertile and may conceive without 
intervention, although a conception may take longer than 12 months. However, this option 
may not be suitable for older women, as waiting may be detrimental to oocyte quality.  
In a natural cycle, the ovary releases an oocyte into the fallopian tube at ovulation. For a 
natural conception, sperm and oocyte must mix in the oviduct, a sperm penetrates through 
the zona pellicuda (the outside of the oocyte), and fertilisation occurs (Rijinders et al., 
1996). The fertilised zygote passes down the fallopian tube to the uterus for implantation 
into the uterine wall.  
In ART, a women’s reproductive cycle is artificially manipulated to produce multiple 
oocytes in a cycle. The natural ovarian function is shut down at the pituitary level from day 
20 of the preceding cycle with nafarelin acetate or from day 2 of the current cycle with 
leuprolide acetate. Down-regulation of the pituitary gland is required to prevent the surge 
of luteinising hormone and to block the accidental release of the oocyte from the ovaries 
before surgical oocyte collection (Rowell & Braude, 2003). Follicle growth is stimulated by 
subcutaneous injections of follicle-stimulating hormone (FSH) analogues. Oestradiol levels 
are monitored daily by blood tests. Typically, about ten days of FSH injections will be 
required before oocyte collection. Ultrasounds monitor follicular growth and human 
chorionic gonadotropin (hCG) is administered to initiate oocyte maturation. A transvaginal 
retrieval procedure, which requires a general anaesthetic, is scheduled approximately 36 
hours after the hCG injection to recover oocytes from the ovarian follicle. However, not all 
stimulated cycles will proceed to oocyte collection because of inadequate response to the 
ovarian stimulation and lack of oocyte maturation (Braude & Rowell, 2003a, 2003b; 
Templeton, Ashok, Bhattacharya, Gazvani, & Hamilton, 2000). 
The oocyte then completes a secondary meiotic division to form a mature oocyte, which is 
then capable of being fertilised by sperm. Oocytes are placed into a culture medium to 
promote cell division, and sperm is mixed with the oocytes in a petri dish or a single sperm 
may be injected into the oocyte via Intracytoplasmic Sperm Injection (ICSI). The 
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appearance of two pronuclei after 24 hours indicates that fertilisation has occurred and the 
embryo is dividing. Embryo viability is graded and either two-to three-day-old embryos 
(containing six–eight cells), or blastocysts (embryos five days after collection) are 
transferred to the uterus through the cervix using a catheter (Jansen, 2003). Hormonal 
support in the form of supplementary progesterone assists the implantation of the embryo 
into the uterus (Braude & Rowell, 2003a, 2003b; Hartshorne, 1999). If a menstrual period 
has not occurred within two weeks after embryo transfer, a blood test showing elevated 
levels of beta hCG indicates a biochemical pregnancy. Detection of a foetal heartbeat at 
six weeks gestation confirms a clinical pregnancy (Braude & Rowell, 2003a, 2003b; 
Templeton et al., 2000).  
There are two narratives of the outcome of ART – either “happy” or “hopeless”. The happy 
narratives are for the much-anticipated baby born to a grateful mother but happy stories 
are problematic for those women who do not conceive, which is the majority of older 
women (Franklin, 1990). Hopeless narratives are not openly discussed or embraced by 
media, compared with success stories. Some childless women place the burden of blame 
and guilt upon themselves and happy perceptions perpetuate women’s sense of failure 
(McLaren, 2014; Sandelowski et al., 1990).  
Most research into infertility, involuntary childlessness and ART relate to women within a 
high-income context where motivations for having children may arise from the search for 
personal happiness or goals, yet the motivation of continuity and care for parents in old 
age are less frequently mentioned than in non-Western societies (Van Balen, Verdurmen, 
& Ketting, 1995). Low-income societies have different social and economic reasons for 
having children such as for social security by financial or labour contributions of offspring, 
social powers sources for women in patriarchal societies, or social perpetuity or kinship 
reasons (Inhorn, 2006). Low-income societies do not always view having children as a 
lifestyle option, but necessary for social support. 
1.5 Evolution of ART in Australia 
Australian scientists have been at the forefront of ART research and although the birth of 
the first ART baby occurred in the UK (Steptoe & Edwards, 1978), the race for that first 
pregnancy was strongly contested by Australian medical teams (Brisden, 2009). In the 
1970s, Drs. Carl Wood and Alex Lopata attempted an IVF cycle but the oocytes failed to 
fertilise (Dawson, 1994). Candice Reed was born in 1980, and was the third baby in the 
world to be born through ART and Australia’s first ART baby. In 1980, Monash IVF had an 
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ART breakthrough by initiating stimulated cycles, which increased the number of oocytes 
produced, thus improving the pregnancy rate from 2% to 18% per cycle. Australian clinics 
achieved the first ART twins in 1981, triplets in 1983, and quadruplets in 1984 (Dawson, 
1994; Rowland, 1992). Melbourne scientist Alan Trounson developed cryoprotectants, 
which prevented ice crystals forming in cells causing rupture of the cell membrane, and 
slow-rate freezing protocols to allow storage of surplus embryos that improved success 
rates (Cohen, Trounson, Dawson, & Jones, 2005). The technique of frozen embryo 
transfer (FET) enabled excess embryos to be transferred in subsequent cycles without the 
need for ovarian stimulation and resulted in the world first live birth from FET (Dawson, 
1994). Chambers, Illingworth and Sullivan (2011) suggest that Australian infertility clinics 
work to increase success rates by improving culture media and techniques. However, a 
systematic review of randomised controlled trials on the effect of culture media on success 
rates for IVF/ICSI has not determined a significant improvement (Mantikou et al., 2013).  
There are no restrictions on the number of ART cycles that Medicare will fund, and 
Australia is the only Western country without cycle limitations. Many infertility clinics have 
transformed from small clinician run practices to large multi-site clinics and some run by 
venture capital companies and listed on the stock market (McCullough, 2010; Thompson & 
Connors, 2011). The ART business is very profitable and encompasses a high percentage 
of the Medicare budget for only a small number of patients compared with other Medicare 
funded services such as general practitioner consultations (van Gool et al., 2009).  
In 2013 in Australia and New Zealand, over 37,000 women undertook treatment cycles, 
with 23.8% resulting in pregnancies and 18.2% proceeding to a live birth for women of all 
ages (Macaldowie et al., 2015). ANZARD annual data shows variation in success rates 
between clinics, with some more successful than others. Many clinics publish cumulative 
data results giving the impression of a higher success rate overall compared to per-cycle 
success rates. The complexity of the data and being able to compare published success 
rates between clinics can be confusing for the consumer and is currently being reviewed 
by the Australian Competition and Consumer Commission (Whyte, 2015). 
1.6 An overview of previous Australian research into older women and ART 
Previous Australian researchers in this area have previously focused on quantitative 
research on women and childbearing rates. There has been minimal research into the 
social issues around midlife intending mothers accessing ART, particularly from a 
qualitative perspective. Key Australian researchers who have evaluated women’s 
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childbearing intentions are Cannold, Hammarberg, Kimberley-Smith and Weston. The 
thesis builds on research initiated by these researchers by further examining the views of a 
broader section of the community along with consumers of ART. A study by Hammarberg 
and co-authors (2001) researched past clients of an infertility clinic and a group of women 
undertaking ART (Hammarberg & Clarke, 2005). Hammarberg, Setter, Norman, Holden, 
Michelmore and Johnson (2013) examined men and women about their beliefs in the age 
of fertility decline. Cannold’s (2000) 35 participants from North America and Australia had 
not all received ART treatment and Cannold investigated how childlessness is experienced 
and understood. Weston and colleagues (Weston & Parker, 2002; Weston & Qu, 2001, 
2005; Weston et al., 2004; Weston, Stanton, Qu, & Soriano, 2001) surveyed a sample of 
the general population about their attitudes to childbearing, and Kimberley-Smith 
(Kimberley-Smith 2003) surveyed undergraduate students.  
Leslie Cannold (2000, 2005) is an Australian researcher who has undertaken qualitative 
research on women’s views on childbearing and childlessness. Her research suggests that 
women may have reasons for delaying childbearing that extend beyond their control and 
may be contrary to their desires and aspirations for parenthood. Cannold (2000, 2005) 
stressed the importance of relationship stability in relation to women’s intentions to have 
children and reported that stability in career, relationships and financial security were seen 
to be important issues for women before they had children. Women who chose to pursue 
their education and career when aged in their 30s may not be able to find a suitable 
partner when they feel ready to have children. If they do not wish to be a sole parent, they 
may then find themselves becoming childless through circumstance and not by choice.   
One of the Australian studies involving women attending an infertility clinic was a study of 
women attending a clinic in Melbourne (Hammarberg & Clarke, 2005). Of 152 female 
participants, 18% were unaware that the chances of having children was age-dependent, 
and 50% cited lack of a relationship as their prime reason for delaying childbearing. The 
study found that women might desire career, financial, or partnering relationships before 
they started a family or have health issues which precluded them from conceiving without 
difficulty.  
Kimberley-Smith (2003) found a lack of knowledge about biological limitations on women’s 
fertility amongst young female Australian university students. Most were confident that 
ovulating women could achieve a pregnancy regardless of age as long as they are were 
menstruating. Students believed that, if women delayed childbearing and subsequently 
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had trouble conceiving, ART would be able to help them achieve a pregnancy. This study 
suggested that young women’s expectations of ART at the time were strong and positive. 
This was a prospective study involving young Australians and participants were selected 
from a narrow population. Consequently, generalisation of their beliefs and opinions to the 
broader population and to women already experiencing infertility would benefit from further 
investigation. 
Other researchers have reported the many reasons why more Australian women appear to 
be delaying their childbearing compared with previous generations (Merlo, 1995; Merlo & 
Rowland, 2000; Qu, Weston, & Kilmartin, 2000; Weston & Qu, 2001; Weston et al., 2004). 
Researchers have investigated social reasons for women approaching motherhood in 
midlife (Rindfuss & St.John, 1983; Stolka & Barnett, 1969; Summers, 2003; Weston et al., 
2004). Educational attainment, lack of partnering relationship (Cannold, 2000; Weston et 
al., 2004) and financial costs of raising children (Qu et al., 2000), were found to be some 
reasons for delaying motherhood. Research findings indicate that younger women (aged 
20–29 years) were more likely than older women (30 years of age or older) to emphasise 
the importance of being able to provide a secure financial upbringing for a family before 
having children (Weston et al., 2004). Younger women may choose to postpone 
childbearing to fulfil these expectations. Living in an urban or rural region in Australia has 
also been identified as relevant to childbearing decisions because women in capital cities 
are having their first child two years later than are women from regional areas (Australian 
Bureau of Statistics, 2000).  
Some studies with the general community have been undertaken such as Weston and Qu 
(2005) who used a telephone survey to investigate the opinions of Australian men and 
women aged 20–39 years of age about the use of ART. Respondents were childless and 
not using ART at the time. They found more than 40% of the participants anticipated they 
would use ART if they had problems conceiving. Men had greater expectations of success 
than women. Women aged in their late 30s were just as likely to have hopes of achieving a 
pregnancy with ART, as younger women. The authors suggested that, because many 
believed they would have success using ART, such optimism might strengthen beliefs that 
childbearing could be postponed. The researcher prior to candidature at the University of 
Queensland Medical School presented the study overview at the XV International 
Congress of the International Society of the Psychosomatics Obstetrics and Gynecology 
Conference in Kyoto, Japan in 2007 (Hayward 2007a,b). A poster was presented at the 
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Population Health Congress - A global world-practical action for health and wellbeing in 
Brisbane in 2008 (Hayward, 2008). 
These studies support further investigation into women’s expectations of ART.  
1.7 Significance Of The Problem 
In the Australian context, there has been limited research on women undertaking ART, 
particularly women in midlife when their fertility is substantially waning. Little is known 
within this context about the beliefs and expectations these women have of ART, the 
social factors that have informed their expectations, and how these expectations may 
change in the period during which they engage with ART. This research looks into women 
of an age that leads them to be users of ART treatment which, in Australia, is a public 
health concern. This research compares the beliefs and understandings of the general 
public with those of female patients of infertility clinics. Two clinics were chosen to avoid 
too much emphasis on the culture of a single institution.  
ART conceived babies accounted for 4.1% of Australian births (Li et al., 2012). As this is 
an age when they are unlikely to conceive without fertility treatment and thus risk 
involuntary childlessness (Leridon, 2008). Childbearing for midlife intending mothers has 
health implications for the mother and baby (Baart et al., 2006), and older women have 
higher rates of instrument births, neonatal complications, caesarean delivery, gestational 
diabetes, and low birth weights babies. Delaying childbearing has health risk implications 
for mother and child, even more so for ART-conceived pregnancies (Becker, 2000; 
Cnattingius, Berendes, & Forman, 1993; Gilbert, Nesbitt, & Danielsen, 1999; Hollander, 
1999; Snijders, Sebire, & Nicholaides, 1995; Viot, Epelboin, & Olivennes, 2010). Increased 
risks for women who delay childbearing or use ART is not widely appreciated in the 
general community. 
Some of the influences for delaying childbearing include: not being in a partnered 
relationship, educational pursuits, and career or work aspirations. These factors have been 
explored in the Australian context (Cannold, 2000; Hammarberg & Clarke, 2005; Weston & 
Qu, 2001). Women’s childbearing intentions may be shaped by such influences and may 
not be a rational decision as demonstrated in Holton’s (2011a) study which showed that 
80% of Australian women aged 30-34 years had fewer children than desired.  
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Based on the relevant literature, this thesis presumes, that some women of childbearing 
age may make informed or uninformed decisions on the timing of childbearing. Women 
may believe they are informed on the risks associated with delaying motherhood, (Cooke, 
2010). A lack of awareness of the cause of the decline in fertility may influence some 
women to delay their childbearing until they are reliant on medical intervention by ART as 
the only way to conceive a child. Women may not be aware of health risks for women 
undertaking ART and their babies. Some women are also aware of the danger of delaying 
childbearing but take the chance, maybe buoyed by the perception through the media that 
medical technology will circumvent these problems, however, this confidence may be 
unjustified.  
 Johri and Lehoux (2003) argue that ART reflects a dilemma between expensive medical 
technologies which benefit a small number of people against the benefit it gives for the 
users of the technology. Some health insurers in the USA argue that infertility is not 
medically necessary to preserve health and limit the medical coverage of ART while others 
accept that it is a disease of the reproductive system. Neumann (1997) suggests that 
resources for ART should be allocated to couples with a higher chance of success and 
using clinics with higher success rates. A health technology assessment of the social value 
versus the cost of ART is difficult as the interpretation of the value is different from a 
societal value compared with the individual value of yearning for a child (Johri & Lehoux, 
2003). Within the Australian healthcare context, ART could be interpreted as an expensive 
technology with few beneficiaries (van Gool et al., 2009). 
The growth in the numbers of women accessing ART has resulted in an increase in 
expenditure to the Australian healthcare system as infertility treatment is funded through 
Medicare. Although the desire for a child is emotive, in reality ART has does not guarantee 
success, and in the context of age-related infertility, the chance of pregnancy is small. The 
increasing demand for ART services has implications for expenditure in the public health 
system and ongoing formation of public health policies and education about fertility 
limitations. An understanding of influences on delaying childbearing, experiences, and 
success rates can provide data for health educational programs and social strategic 
initiatives.  
1.8 Organisation Of The Thesis 
This study aims to ascertain whether the community holds accurate beliefs about infertility 
and its treatment and questions whether media or clinic marketing information influences 
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community perceptions. It explores these concepts among women who had engaged in 
ART along with their experiences.  
Chapter 2 presents the theoretical framework for the study and introduces the idea of 
medicalisation and of infertility, where commodification is the transformation of services or 
entities into a commodity. The theory of anticipated decision regret is proposed as it 
relates to decisions to discontinue treatment.  
Chapter 3 presents a literature review of childbearing in Australia. This chapter reviews 
childbearing practices, beliefs and social factors that influence or limit women’s 
childbearing decisions. 
Chapter 4 is an overview of the ART industry in Australia. ART success rates and medical 
risks for midlife intending mothers and babies from either natural or ART-assisted 
pregnancies are detailed. The medical literature on physiological changes attributed to 
genetic changes in women’s oocytes because of biological aging is reviewed. 
Psychological aspects of undertaking ART are discussed within the context of infertility 
clinics who are marketing hope for a woman to start a family. The history of public funding 
for ART and lack of restrictions on cycles is described.  
Chapter 5 outlines the research methodology, including methods of data collection and 
analysis. Qualitative and quantitative data were collected from three sources; two infertility 
clinics and community members in Queensland.  
The subsequent four chapters present the research data and its analysis.  
Chapter 6 evaluates survey data collected from women who had used ART using an 
online questionnaire investigating key measures linked to the research questions.  
Chapter 7 evaluates survey data collected by telephone survey from 1243 men and 
women in the community. The group was asked five key questions, and their overall 
responses are analysed according to gender and age group.  
Chapter 8 explicitly compares and contrasts five key questions from survey data in 
Chapters 6 and 7.  
Chapter 9 presents analysed qualitative data gathered from six women who participated in 
face-to-face interviews. Common themes arising from the analysis of their views, 
expectations, and experiences are discussed. 
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Chapter 10 includes the conclusions and recommendations arising from the research. This 
chapter also reviews the limitations of the investigation and presents recommendations for 
further study based on findings from this study.  
Chapter 11 outlines recommendations to younger women in the community based on data 
from the research. 
1.9 Research Questions 
The following eight questions were investigated in this research.  
1. What are the views of women who have engaged with ART about their clinic 
experience? 
2. What were women’s expectations of the success of ART?  
3. What are the views of women involved with ART on women’s age-related 
fertility decline, childbearing decisions, the success of ART and impact of media 
and marketing on childbearing decisions? 
4. What are the beliefs of the community towards women’s age-related fertility 
decline, childbearing decisions, success of ART and impact of media and 
marketing on childbearing decisions? 
5. Do social factors such as; career and work, educational attainment, financial 
security, health or partnering relationship influence women’s childbearing 
intentions? 
6. Is there a perception among the general population and consumers of ART that 
infertility is medicalised and its treatment commodified? 
7. What are the social and psychological impacts for women using ART? 
8. Do women who have engaged with ART have recommendations for women in 
the community regarding the timing of childbearing and ART? 
1.10 Summary 
This research attempts to build upon and extend existing Australian research 
and findings from other Western cultures. It examines the experiences, 
expectations of ART, and knowledge of age-related infertility and ART for midlife 
intending mothers in Queensland. It compared this with beliefs about and 
knowledge of age-related infertility and its treatment within the general community.  
Accurate information on age-related decline in women’s fertility and a realistic 
understanding of chances of a baby using ART are important issues. Such 
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information allows individuals to make considered decisions on timing of 
childbearing. Women able to conceive spontaneously do not incur the physical, 
psychological, and financial challenges of ART. 
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Chapter 2:  Theoretical framework of the research  
2.1 Overview 
This chapter introduces several themes supporting the research. These are the 
medicalisation of healthcare and ART, concepts of disease and technology mongering, the 
commodification of ART, and the theory of anticipated decision regret. The idea of 
medicalisation applies when health or social issues are reclassified as medical conditions 
thus requiring medical intervention (Conrad, 2004). As a consequence of medicalisation, 
health care becomes commodified, with positive fiscal outcomes for pharmaceutical 
companies and medical practitioners. This chapter examines the rise of over-
medicalisation in high-income societies. The medicalisation and commodification of 
infertility within the Australian context is discussed. Tymstra’s theory of anticipated 
decision regret (Tymstra, 1989, 2007) is considered in relation to the difficulty of some 
women to discontinue ART treatment without experiencing regret.   
2.2 Medicalisation 
In simple terms, medicalisation narrows the definition of health and widens the definition of 
sickness (Conrad, 2004). Conrad suggests that medicalisation encompasses “defining a 
medical condition in medical terms, usually as an illness or disorder, or using medical 
intervention to treat it” (Conrad, 2005:3). Similarly, medicalisation occurs when human 
experiences and conditions are defined as medical problems, and there is a tendency to 
classify some non-medical social issues as medical conditions (Australian Broadcasting 
Corporation, 2014; Becker & Nachtingall, 1992; Conrad, 1992; Hassan, 2006; Williams & 
Calnan, 1996a; Zola, 1972). Medicalisation operates with the framework of the medical 
model based on empirical data and without reference to social factors (Brennan, Eagle, & 
Rice, 2010; Filc, 2004; Lupton, 1997; Nettleton & Gustafsson, 2002) and has implications 
for social control, power and liberty (McGann & Conrad, 2007). It is proposed “growth in 
the number of medical conditions reflects the dominance of medicine and the significance 
of illness in defining social deviance” (Abraham, 2010:290). Medicalisation can also 
emerge after “health scares” which lead to social anxiety as “events in which the health of 
a population or a significant subpopulation is at risk to an uncertain and potentially 
devastating degree” (Hooker, 2010:8).  
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Whereas the concept of medicalisation was originally associated with the medical 
dominance of the medical profession, this is changing in the postmodern era. Today 
medical consumers have access to online medical information, and as a consequence, are 
more informed and able to access peer-reviewed research (Cline & Haynes, 2001). As the 
dominance and power of the medical profession declines, consumers can choose to resist 
or embrace medicalisation (Ballard & Elston, 2005).  
There are three primary progenitors of medicalisation. The first is conceptual in which a 
biomedical framework is used to define a problem that was once considered non-medical. 
The second is institutional in which organisations prefer medical rather than non-medical 
approaches to treating a problem. The third is interactional in which a socially linked factor 
is treated with medical intervention (Brennan et al., 2010; Conrad, 2005; Moynihan, Heath, 
& Henry, 2002). In recent times the medical profession has become closely aligned with 
those who profit from the marketing of pharmaceuticals for new diseases or medical 
conditions, and can no longer be regarded as an objective agent (Godlee, 2010). 
Relationships can be fostered through informal alliances between; pharmaceutical 
companies, public relations companies, doctors groups, and patient advocate groups, 
which actively market through the media (Moynihan & Henry, 2006). Conrad (2004) 
believes that the push towards medicalisation comes more from the creation of medical 
markets for financial gain than from the medical profession wishing to expand its market 
professionally. 
The number of normal human conditions that are regarded as medical diseases is 
increasing. There is also an increase in pre-symptomatic conditions linked to a statistical 
likelihood where a medical condition (such as elevated cholesterol, mild diabetes or high 
blood pressure) may develop in future (Cassels, 2007; Greene, 2007). Tiefer (2006) 
suggests that the community finds medicalisation attractive as it presents understandable 
scientific solutions for medical conditions and there seems to be overinvestment in 
biological explanations of conditions and their interventions. Medicalisation also occurs if 
the public has a low tolerance of personal discomfort and refers to the medical profession 
for treatment by pharmaceuticals (Barsky & Boros, 1995).   
Some examples of medicalisation are documented in the literature, including restless leg 
syndrome (Woloshin & Schwartz, 2006), and male erectile dysfunction (Conrad, 2005). In 
particular, women’s natural reproductive functions of menstruation, pregnancy, childbirth 
and also mental illness have become routinely medicalised (Barker, 1998; Conrad & 
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Barker, 2010; Riessman, 1983). Menopause was medicalised from the 1970s as a 
deficiency disease, and consequently, oestrogen has been the fifth most commonly 
prescribed pharmaceutical in the USA (Ballard & Elston, 2005; Conrad, 2007; McCrea, 
1983). The medicalisation of obstetric practice has increased since the 1960s when control 
of birthing shifted from midwives to obstetricians (Macintyre, 2008; Riessman, 1983). The 
increasing number of instrumental births, hospital births, and use of anaesthesia show the 
medicalisation of childbearing. 
The growth of large pharmaceutical companies coexists with increases in the 
medicalisation of social conditions. Many major pharmaceutical breakthroughs occurred 
after World War II when large investment companies began funding marketing and 
research (Burton & Roell, 2003). Medicalisation generates further financial advantage to 
physicians, pharmaceutical and medical device industries (Heitman, 1999). The US market 
is the major profit centre for the world’s top ten global drug companies because of the 
higher numbers of FDA-approved drugs compared with other advanced countries (Angell, 
2004). In the USA in 2005 it was estimated that the cost of medicalisation (4% of USA 
national health expenditure) was greater than the spending on public health (3%) (Budetti, 
2008; Conrad, 2010). 
Pharmaceutical companies play a central role in the definition of disease and 
categorisation of illness. High expectations of a drug increase its market share (Moynihan, 
1998). Australian law prohibits direct advertising of prescription drugs to the public. To 
overcome this limitation, pharmaceutical companies provide grants to independent disease 
foundations that work in close collaboration with drug companies. Medical foundations and 
support groups receive sponsorships from pharmaceutical companies to advertise disease 
awareness campaigns while inclusively promoting awareness of a medical condition and 
the company’s advertising of the relevant pharmaceutical for that condition (Moynihan, 
1998). Australian medical educators hold concerns for medical students being influenced 
with pharmaceutical industry gifts and hospitality, impacting on future prescribing 
practices, despite such inducements being illegal (Rogers, Mansfield, Braunack-Mayer, & 
Jureidini, 2004). The marketing departments of major pharmaceutical companies 
underwrite disease-awareness campaigns to the public about medical conditions 
(Moynihan & Henry, 2006). As public awareness grows from the advocacy, patients ask 
their doctors to prescribe the company’s drug. The promotion of a condition in this way 
legitimises the condition and treatment requirement. 
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Medical professionals have societal status through membership in a respected profession, 
which is influential on health policy, and medical practitioners have jurisdiction of the 
categorisation of medical conditions (Freidson, 1970; Friedson, 1970; Riessman, 1983). 
However, the autonomous nature of the medical profession has declined in the past 50 
years while the power of the major pharmaceutical companies has grown (Greene, 2007). 
Zola (1972) suggests that the medicalisation of society also fulfils society’s faith in the 
effectiveness of medicine. It is the public’s faith in and expectations of medicine that 
makes possible the opportunity for the commodification of medicine by disease mongering. 
2.3 Disease Mongering 
Within this chapter, the definitions of medicalisation and disease mongering have some 
overlap. Medicalisation is a non-judgemental term that implies that a condition is given a 
medical name, whereas disease mongering suggests a deliberate move to frame a 
condition in a medical framework for the purposes of financial gain (Williams, Seale, 
Boden, Lowe, & Steinberg, 2008). Disease mongering demonstrates the widening of the 
boundaries of treatable illness to increase the range of treatable conditions (Moynihan & 
Henry, 2006) and the escalation of anxiety about future ill-health in healthy individuals 
(Mintzes, 2006). Payer (1992) originally defined disease mongering as convincing people 
who are well or asymptomatic that they have a medical condition of concern by widening 
of the boundaries of illness, and doctors and pharmaceutical companies use patients for 
financial gain. Doust (2013) uses the term overdiagnosis for conditions that would never 
cause harm, and thus exposes the patient to treatments where the benefits may not 
outweigh the harm of treatment. Moynihan, Heath and Henry (2002), describe disease 
mongering as a widening of the boundaries of treatable illness in order to expand markets 
for those who sell and deliver treatments and treating personal problems as medical 
concerns and seeing risk as disease. Disease mongering can be considered as an 
aggressive by-product of medicalisation.  
Woloshin and Schwartz (2006) suggest the definition of heath has narrowed.  Disease 
mongering may be fuelled by the need of corporations to fund drug research to satisfy 
shareholders by promoting the need for new drugs (Cassels, 2007). Pharmaceutical 
companies monger potential new markets by extending the definition of disease and 
illness (Goldacre, 2009; Moynihan, 1998). Pharmaceutical companies in the USA use a 
direct marketing process that encourages patients to discuss new products with their 
clinician with the potential to pressure clinicians to prescribe that drug (Applebaum, 2006). 
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Moynihan (2006) and others, suggest that disease mongering presents a global challenge 
in the public health area by increasing the marketing potential of pharmaceuticals that 
promote treatment (Collyer, 1999; Mintzes, 2006; Moynihan et al., 2002; Shankar & 
Subish, 2007). Moynihan suggests, for example, that lowering of the normal range of blood 
pressure is not a public health issue but a move by pharmaceutical companies to increase 
their market share of blood pressure lowering drugs (Australian Institute of Health and 
Welfare, 2011; Moynihan, 2010). Consequently, deviations from this norm are perceived 
as disease and pre-symptomatic conditions are medicalised.  
The marketing of Viagra by Pfizer for either medical or social erectile dysfunction 
demonstrates how drug companies have identified so called lifestyle drugs, as a growth 
market (Lexchin, 2006). Men initially used Viagra to alleviate erectile dysfunction caused 
by injury, diabetes or prostate surgery. Pfizer used carefully reported statistical research to 
construct a perception that many men have erectile problems and Viagra enhances sexual 
performance. In this way, companies can identify a lifestyle market for pharmaceuticals for 
non-life threatening but life-enhancing conditions (Lexchin, 2006).  
Pharmaceutical companies encourage disease mongering by sponsoring medical 
conferences and selecting medical practitioners as product promoters or key presenters. 
The pharmaceutical company Organon, part of Schering-Plough/Merck, manufactures 
drugs used for infertility treatment and sponsors reproductive medicine conferences. 
Platinum-level sponsors at conferences can recommend key speakers or themes to 
promote their product in Australia (Moynihan, 2008). According to a past president of the 
Australian Medical Association (Hambleton, 2012) in 2012, pharmaceutical companies 
spent $30 million wining and dining doctors and allied health professionals at educational 
sessions for marketing purposes. Such an alliance assists pharmaceutical companies to 
market their products and presents an ethical dilemma for medical clinicians who face a 
duality of interest between incentives and clinical practice (Australian Institute of Health 
and Welfare, 2011; Moynihan, 1998). Dualities of interest need to be publically declared 
and apparently transparent to patients within the clinical setting (Komesaroff & Kerridge, 
2002).  
2.4 The Medicalisation Of Infertility  
It is generally accepted that infertility is understood by the community to be a medical 
condition. However, infertility does not have to be cured, as it has no detrimental effects on 
wellbeing other than limiting the ability to have children. Infertility can remain undetected 
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until trying to conceive, and then infertility becomes an illness only by the virtue of one 
symptom, which is lack of a desired child (Sandelowski et al., 1990). Within the Australian 
context, infertility is seen as a medical condition requiring medical resources.  
Women’s lives are increasingly becoming medicalised particularly in the areas of 
reproduction, childbirth, menopause, and fertility (Inhorn, 2006). ART has medicalised 
conception (Smajdor, 2011). Healthy women who are struggling to conceive become 
patients within a medical environment in which human reproduction is the goal (Ferguson 
& Ragone, 1997:68). The medicalisation of infertility began in the 1960s with the 
introduction of fertility drugs such as clomiphene citrate (Clomid) (Glud, Kjaer, Troisi, & 
Brinton, 1998; Greil, 1991a). The use of ART for single women, same sex couples and 
women with age-related infertility demonstrates a social use of medical technology rather 
than for medical necessity (Conrad, 2004) because infertility is not considered a medical 
issue rather a “social fact based on marital and maternity norms in our society” (Roach, 
1988:164). Heitman (1999) suggests that IVF has itself contributed to the medicalisation of 
infertility and the imperative nature of ART despite its uncertain success rates. 
The social construction of infertility is based on the biomedical model, which creates a 
paradigm of normal childbearing and where deviations from the norm are considered 
abnormal. Barker (1998) suggests this normal–abnormal dichotomy legitimises diagnosis 
and medical treatment behaviour. Such a model is perpetuated in the popular press with 
midlife intending mothers seeking treatment for subfertility (Australian Institute of Health 
and Welfare, 2011; Becker & Nachtigall, 1994; Sandelowski, 1991; Woollett, 1996). Midlife 
intending mothers can become medicalised when their reason for attending a clinic is for 
medical assistance; as the cause of some infertility is socially constructed such as 
postponement of childbearing (Collyer, 1999; Van Balen, 2009).   
Infertility clinics found a ready market among educated women who can afford ART 
treatment to alleviate age-elated infertility (Heitman, 1999). The concept of infertility as a 
social problem is being challenged in some states of the USA, where consumers have 
mounted legal action against medical insurance providers who classified infertility is a 
disability and denied insurance coverage for ART, which constitutes discrimination under 
the Americans with Disabilities Act of 1990 (Conrad, 2004; Gilbert, 1996:44). Insurance 
companies counterclaimed that being unable to conceive is not a disease and ART 
treatment is elective and insurance covers only the small number of cases of medical 
infertility rather than social infertility (Conrad, 2004). In comparison, the Australian health 
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system does not discriminate between a medical or social cause of infertility for public or 
private health funding. 
Individuals unable to conceive can gain public recognition of the importance of the 
condition by grouping with people similarly afflicted. Medical consumers join support 
groups whose collective action medicalise conditions such as infertility, as individuals are 
eager for medical categorisation. Access Australia is an Australian infertility consumer 
support group associated with infertility clinics and lobbies on behalf of consumers for 
improvements to ART funding. 
Spiralling needs, expectations of technology and promises of technology are balanced 
against the increasing cost of the technology and the ability of health budgets to afford 
technology against limited health funding (More & More, 1994). However there are 
limitations to the capabilities of ART technology (Williams & Calnan, 1996b). Bhattacharya 
(2001:2078) suggests “assisted reproduction has been technologically driven rather than 
evidence based” and “treatment tends to be empirical, and existing evidence can be 
ignored for novel interventions”. Women may be vulnerable to unrealistic expectations of 
the technology during infertility treatment as they may not have the knowledge necessary 
to challenge the authority or decisions of their clinician regarding their care (Lupton, 1997). 
It is concerning that a misunderstanding of the age of fertility decline also exists amongst 
general medical practitioners who are the primary health contact for women (MacDougall, 
Beyene, & Nachtigal, 2013; Qu & Weston, 2005; Weston & Qu, 2005). Disease mongering 
may permit the perception that ART is likened to a safety net, which allows some women 
to believe that medical technology can bypass age-related limitations on fertility. However, 
diminished oocyte quality and quantity in midlife intending mothers cannot be reversed and 
ART should not be perceived as a fall-back option for women as it cannot guarantee a 
baby (MacDougall et al., 2013; Qu & Weston, 2005; Weston & Qu, 2005). 
Medicalisation may give authority to sections of the medical industry that seek to promote 
a particular agenda or to promote a financially lucrative industry such as infertility clinics 
and pharmaceuticals (Chambers & Sullivan, 2005; Williams, 2008). Kovacs proposed in 
the Medical Journal of Australia that the Australian public favours Medicare funding for 
ART; however, the author is an infertility clinician with shareholdings in an infertility clinic 
(Kovacs, Morgan, Wood, Forbes, & Howlett, 2003).   
The rush to use ART may be interpreted as medicalisation. In a study of 7,280 Australian 
women enrolled in the Australian Longitudinal Study on Women’s Health (ALSWH), born 
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between 1973 and 1978, 18.6% of participants reported a history of infertility. The 
aetiology of the infertility was not part of the study. Of the 1,376 women reporting a history 
of infertility, 574 women had used ART. 43.8% of women aged 28–36 years were classed 
as infertile and achieved a spontaneous conception. The research contrasted treated 
women with untreated women, and suggests that more than 40% of women aged 28-36 
years who were unable to conceive could achieve a live birth in time. Rushing to ART 
could be perceived as over-servicing as many women may take longer than 12 months of 
timed and unprotected intercourse to achieve a conception and may not fall into the strict 
guidelines of infertility (Herbert et al., 2012).  
A conflict of interest can exist between prescribing medical practitioners and large 
pharmaceutical companies regarding the marketing of a disease or treatment in the 
context of drugs used in Australian ART procedures. Padamsee (2011) established a link 
between Organon International and clinicians through an industry-produced quarterly 
magazine ORGYN. Published for fourteen years, ORGYN was distributed to 120,000 
obstetricians and gynaecologists and promotes Organon’s women’s health drugs in an 
easy-to-read format that describes Organon and clinicians working together in women’s 
reproductive health. ORGYN covered infertility articles with 95.9% of issues thematically 
framing age-related infertility as a disease. ORGYN portrayed a paternalistic account of 
the doctor-patient relationship, rewarding clinicians for using ART and depicting women as 
voiceless and passive objects of medical care (Padamsee, 2011). ORGYN illustrates the 
efforts taken by pharmaceutical companies to shape clinicians’ views and prescribing 
behaviour for reproductive issues.    
Infertility clinics medicialise by promoting social oocyte freezing with financial benefits for 
themselves and pharmaceutical companies (Heitman, 2002). Oocyte freezing as a growing 
market contributes to the medicalisation of infertility (Mohapatra, 2014). Evers (2013) 
suggests that introducing new infertility treatments without proper empirical evidence of 
benefit is an ethical issue because subfertile couples are open to exploitation. Robert 
Winston believes that women are being deceived, as by the time women aged 36 or older 
worry about their fertility it is too late to cryopreserve oocytes (Cohen, 2015). Cohen 
attended an Australian clinic information session on oocyte freezing and found the 
marketing information misleading. Clinicians did not discuss age-related birth rate 
predictions. Women were advised that they should preserve 10 oocytes to have a 
reasonable chance of pregnancy, costing around $10,000 per cycle. However, older 
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women would be unlikely to obtain 10 viable oocytes in one cycle and need to preserve at 
least 15–20 oocytes, as the chance of a pregnancy per oocyte is 5–7% (Cohen, 2015). 
Oocyte preservation is financially lucrative as clinics charge for freezing cycles, storage, 
and IVF cycles to use the oocytes in the future.  
2.5 Commodification In Medicine 
Commodification is the transformation of goods and services (or things that may not 
normally be regarded as property or services) into a commodity (Parrott, 2014; Polanyic, 
2004). Commodification exhibits certain key features: every commodity has a price, 
commodities are interchangeable with other goods of similar quality, and their value is 
measured by their ability to satisfy the owner’s desires (Kaveny, 1999). Health care can 
also be commodified where there is a cost to an individual for health services. If healthcare 
is to be considered a commodity, then it can be sold in the marketplace (as with other 
commodities) and it is desirable to create a demand for that product. Plato refers to 
doctors as ‘true physicians when they are healers first and money-makers second’ 
(Pellegrino, 1999). In the context of medicine, commodification occurs when a new 
disease or disorder is promoted to create markets for a new pharmaceutical regime. 
Medicalisation and commodification of new medical conditions are demonstrated by 
descriptions of prehypertension and prediabetes. Prehypertension describes individuals 
with blood pressure readings on the upper limit of the normal range, and prediabetic where 
the lower level for glucose intolerance is reduced. By altering the normal range of a 
condition, a new population is exposed and can be considered at possible risk for a 
medical condition, which may not develop but medication will be prescribed (Moynihan, 
2010: 484.). Side effects from medication for these conditions may do more harm than 
good, as individuals may not develop these conditions, and individuals could adopt a 
healthier lifestyle as a drug-free alternative (Greene, 2007). Changes to clinical thresholds 
may unnecessarily burden society in exchange for limited value to individuals and develop 
new markets for pharmaceutical companies (Yudkin & Montori, 2014). 
Clinicians in the UK and in the USA are being offered consultancy and sponsorship 
payments to recommend pharmaceutical products which Dyer (2014) suggests, is a 
conflict of interest and threatens the integrity of the medical profession and the quality of 
patient care. In the USA, between 2009 and 2012, there were US$4 billion dollars 
dispersed to health professionals by 17 pharmaceutical companies and their subsidiaries, 
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with details of the disclosure required by the Physician Payment Sunshine Act, a part of 
the 2010 Affordable Care Act. Genetech, Incorporated dispersed US$388 million dollars to 
1,892 doctors in that period (Sagara, Ornstein, Grochowski, & Merrill, 2013). Similarly, in 
the UK in 2013, £38.5 million was paid to 21,000 clinicians and healthcare professionals 
(Dyer, 2014). Since 2015, the ACCC requires Medicines Australia to report transfers of 
value such as speaking fees, advisory board fees, or sponsorships for conference 
attendance to ensure transparency in areas of possible conflict of interest (Australian 
Competition and Consumer Commission, 2015). Commodification also extends to the ART 
industry. 
2.6 Commodification Of Infertility 
Reproducers become consumers when they use bought services and goods such as ART 
to conceive and consume these services to become parents (Fletcher, 2006). 
Commodification has been described as “…not only the actual buying and selling, but also 
market rhetoric, the practice of thinking about interaction as if they were sale transactions” 
(Radin, 1987). Radin’s definition encompasses ART and other healthcare where, in 
principle, everything is a commodity because products are traded for money. Madeira 
(2015) argues from a legal and ethical perspective that ART is commodified. It is the 
normalising of ART practices that make commodification possible for gamete and embryo 
donation, surrogacy and ART (Widdows, 2009). The commodification of ART is not openly 
discussed in the media or medical field.  
Decisions on the timing of parenthood can be attributed to a lifestyle decision. Many 
aspects of motherhood or parenthood are commodified, including surrogacy and adoption. 
As ART becomes more of an acceptable social phenomenon, motherhood is becoming 
commodified. There are many commodities to trade in ART, as clearly the primary 
commodity for women is a baby and childbearing is a commodity to be targeted by “the 
new reproductive marketing” (Rothman, 2000). Patients have become consumers, and 
eggs, sperm and embryos have become commodities (van Dyck, 1995). Infertility clinics 
sell time mitigation, while medical, personal, and pharmaceutical interests drive ART as a 
commodity (Shanahan, 2012). The discussion surrounding the medical ethics of ART has 
shifted to a discussion of ART as a technology with power, commodification, and 
commercialisation implications (Dyson, 1995; Madiera, 2015). Infertility clinics’ marketing 
and advertising campaigns appear to promote commodification. 
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The costs of ART procedures are steadily increasing. The Australian ART pioneer, 
Professor Alan Trounson, suggests that the cost of ART does not reflect the outlay by 
clinics or specialists but the supply and demand of a commodity. He suggests that ART 
treatment could cost hundreds not thousands of dollars, but clinics do not want to charge 
less because the treatment costs are lucrative. They charge what the market will tolerate 
(Medew, 2014). From 2000 to 2005, Medicare released $584.6 million dollars for ART 
services and saw the costs to the Medical Benefits Scheme (MBS) rise from $50 million in 
2003 rising to $108.4 million in 2005 (Assisted Reproductive Technologies Review 
Committee, 2007; Dunlevy, 2007; Smith, 2006) and to $251.6 million in 2013–2014 fiscal 
year (Australian Government Department of Human Services, 2014). In the 2013–2014 
financial years, of the 24,934 Medicare rebateable services for ART, 14,489 were for 
women aged 35–44 years of age (Australian Government Department of Human Services, 
2014).  
The Extended Medicare Safety Net (EMSN) was introduced in March 2004 and designed 
to provide additional financial assistance for patient’s out-of-pocket costs when 
undertaking out-of-hospital services. It was designed to pay 80% of the out-of-pocket costs 
once the individual’s or family’s threshold had been reached. When introduced in 2004, the 
lower threshold was $300 for Commonwealth concession cardholders and for those who 
qualified for the Family Benefit Part A payment, the general threshold was $700 for 
families and individuals. In 2007, the EMSN distributed $324 million dollars to 790,000 
Australians (Savage & van Gool, 2009)  
Clinicians can independently increase the gap payment between the Medicare rebate and 
their fee. The Review report showed that for some services, such as obstetrics and ART, 
the EMSN had been used by specialist doctors to raise their fees, aware that the taxpayer 
would cover 80% of the fee rise. The EMSN benefit was intended to be a patient benefit; it 
was not intended to be a mechanism for doctors to increase their fees (Australian 
Government Department of Health and Aging, 2014). The Department of Health and Aging 
claimed that infertility clinics did not increase fees for relevant Medicare items 13200 and 
13209 while the Independent Review of Assisted Reproductive services was underway 
between 2005 and 2006. Then the average fee increased dramatically. As providers 
gained 52 cents and patients gained 48 cents of every dollar spent in the EMSN in 2008 
(Savage & van Gool, 2009) it was beneficial for the clinics to increase their fees and 
encourage patients to undertake multiple cycles  
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From 2004 to 2007 the EMSN funding of ART increased from $29 million to $72 million 
(Savage & van Gool, 2009). Following the introduction of the EMSN, infertility clinics 
increased fees for a stimulated cycle from $3269 to $4089 per cycle (Metherell, 2005). The 
government quoted figures for Medicare rebates for three stimulated cycles rising from 
$5,000 in 2003 to $10,000 in 2004 (Australian Broadcasting Corporation, 2005). In 2006, 
benefits for ART from 68 private infertility clinics comprised 22% of all benefits paid by the 
EMSN (Chambers, Hoang, Zhu, & Illingworth, 2012a). General practitioner consultations 
accounted for 40.7% of Medicare rebates and received 14.2% of total Medicare funding. 
However, ART comprised only 0.05% of Medicare rebate services and received 12.7% of 
total Medicare funding (van Gool et al., 2009). Changes to out-of-pocket fees were 
implemented in 2010 to rationalise EMSN’s spending on ART, which was estimated to 
provide savings of $69.4M annually but saved $84.2 M (Chambers et al., 2012a; 
Chambers, Van Phong, Zhu, & Illingworth, 2012b; Robotham, 2010). The changes 
resulted in a significant decline in the number of women having IVF cycles in particular 
among women 40 years or older (Chambers et al., 2012a). The 21–25% decrease in the 
number of women of all ages accessing IVF suggests that the additional out-of-pocket 
expense of approximately $2500 was financially prohibitive for many couples (Chambers, 
Hoang, & Illingworth, 2013b).  
In 2005, the government increased the out-of-pocket threshold expenditure and proposed 
a stimulated cycle limit of three cycles in a calendar year for women aged younger than 42 
years, and a total of three cycles in a lifetime for women aged over 42 (Dunlevy, 2007). 
The public outcry was so vehement that the proposal was dropped from the budget 
(Peatling, 2005). Lobbying by stakeholders from infertility clinics continues to advocate for 
increased Medicare funding for ART services. Professor Stephen Leeder of the Menzies 
Centre for Health Policy suggests that the government’s rational argument to limit public 
funding to older women accessing ART was difficult as ART is “protected territory” and 
both politically and ethically sensitive (Nogrady, 2008)  
Australian infertility clinics are a lucrative health sector business with fiscal growth up to 
10% annually (Thompson & Connors, 2011). Private equity fund managers predict that the 
$500 million a year ART industry will double in a few years because of the increase in 
social infertility (Medew & Baker, 2013b). The cost for a single fresh IVF cycle has 
increased by 18% from 2007 to 2012, which is three to four times the rate of health service 
inflation (Medew & Baker, 2013a). Interest in the ART industry includes; pharmaceutical 
companies, professional medical associations, and venture capital companies which 
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control the majority of infertility clinics in Australia (McCullough, 2010), international sperm 
banks that supply semen to Australian clinics (Becker, 2000), and independent Australian 
clinics. ABN AMRO purchased 53% of Monash IVF in 2007 which valued the group at 
$200 million, and Quadrant Private Equity paid $32.6 million for 10.9 million shares in IVF 
Australia (Nogrady, 2008). Virtus Health owns three of the most successful ART 
companies in Australia with estimated earnings of $50 million in 2010 and half yearly 
revenues in 2014 of $101 million. These companies acquire over half their income from 
Medicare rebates (Manning, 2014; Thompson & Connors, 2011), and their net profit for 
2013/2014 increased 17.2% to $32 million (Gardner, 2014a)  (Gardner, 2014c). Virtus 
justified the corporatisation of infertility clinics claiming the provision of secure finances 
funds research and hence better patient outcomes. However, some patients claim they 
have not seen any noticeable improvement in services between 2007 and 2012 (Medew & 
Baker, 2013a 2012). Clinicians are reported to hold 20% of Virtus and Monash IVF stock 
listed on the Australian stock market and valued at over $1 billion (Dingle, 2014). 
 Professor Geoff Driscoll, believes that prices in Australia will remain high because of the 
lack of competition between private equity groups who manage the major IVF groups. 
There is also no economic incentive to offer less costly treatments (Stark, 2011). Driscoll, 
who is on the board of the Low Cost IVF Foundation which aims to deliver affordable but 
effective ART to developing countries, claims that low cost IVF is not of interest to 
Australian ART clinics (Low Cost IVF Foundation, 2011). Virtus introduced a low cost 
subsidiary clinic for basic cycles with minimum out-of-pocket fees, and a low cost clinic 
operated by Primary Health has slashed the out-of-pocket expense from approximately 
$4000 to $500 per cycle (Gardner, 2014 a,b). 
Private lobbying endeavours to obtain Medicare rebates for new ART techniques are 
demonstrated in the infertility clinics’ campaign to receive a Medicare rebate for ICSI. ICSI 
involves injecting a single sperm into an oocyte to assist fertilisation. In 2004, ICSI was 
used over 12,000 times in Australia and New Zealand with Medicare rebates totalling 
around $4 million (Robotham, 2007). In 2007, a Medicare rebate of $380 per service was 
approved (Commonwealth of Australia, 2008), based on a capital cost of equipment, 
labour, and consumables. The rebate was estimated to cost $31 million per year based on 
the 1999 figures of 8,000 cycles per annum as clinics claimed that 8% of cycles would use 
ICSI (Commonwealth of Australia, 2008 :74; Wang, Chambers, & Sullivan, 2008a, 2010; 
Yudkin & Montori, 2014). After Medicare approval, in 2006, ICSI usage increased to 
almost 25,000 cycles and then to 32,800 cycles in 2010. In 2010, 67.3% of autologous 
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cycles used ICSI (Macaldowie, Wang, Chambers, & Sullivan, 2010). It is unclear if 
increased ICSI use reflects patient demand, decreased semen parameters, clinics wishing 
to boost conception rates, or a misconception allowing the Medicare rebate.  
Prior to the May 2009 budget the government reviewed Medicare rebates for ART with the 
out-of-pocket payment at around $3,000 (Dunlevy, 2009b). Proposed reductions to the 
EMSN would reimburse $257.9 million dollars. ART clinics had increased their fees, on 
average, by 290% when the EMSN was initiated (Australian Government Department of 
Health and Aging, 2009; Dunlevy, 2009b). A clinic director claimed there was a three-fold 
increase in cycles before the funding cuts to the EMSN before 1 January 2011(Dunlevy, 
2009a). Dunlevy noted that obstetricians (many obstetricians also practice ART) in 2009 
increased their fees by 20% compared to 5% in other specialities. Changes to the EMSN 
for ART in January in 2010 doubled the out-of-pocket expenses to $2,000 per stimulated 
cycle by reducing the number of cycles undertaken (Robotham, 2010). An ART clinician 
stated, “the thought of people not being able to achieve their dream of having a baby 
because of Medicare changes is saddening” (Wilkinson, 2010). Excessive increases in 
ART fees resulted the government reducing EMSN benefits (Wilkinson, 2010). Reductions 
to funding was opposed by clinics and Access Australia, which is partially financed by 
infertility clinics, and a concerted campaign against these changes was initiated emotively 
claiming that women would not be able to afford to have children as a consequence.  
Midlife intending mothers have a lower probability of conceiving than younger women but 
are the greatest consumers of ART services. Increasing numbers of older women 
accessing ART has seen the Medicare benefits for procedures double since the 2004 
estimates, with $11 million paid for ART for women aged 40 years and older (Chandler, 
2005). Westmead Fertility’s clinic manager stated that women aged over 43 years 
accessing ART had a “slim, slim chance” and “you are wasting your time and money to be 
totally realistic, and you are just stringing them [older female patients] along, giving them 
false hopes” (Bissett, 2008). Federal Treasurer Peter Costello stated “there is no point in 
giving treatments where there is a very, very low chance of success” (Chandler, 2005). 
Terry Barnes, a former health adviser to the Howard government, suggests that it is 
appropriate for the government as a subsidiser of ART to place limitations on the number 
of attempts that can be made (Dingle, 2014). Barnes suggested that the two companies 
that provide 80% of the ART services are listed on the ASX with a combined value of more 
than $1 billion, and 20% of their shareholders who are doctors and fertility specialists who 
directly profit from each ART procedure. Skekette (2005) writes that the aging of the 
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society and the increased demand for medical technology places pressure on 
governments to evaluate the cost-effectiveness of individual medical procedures and 
techniques.  
Costs for ART are both direct and indirect. Direct costs include medical consultations, 
pathology and laboratory testing, and hospital and treatment procedures. Indirect costs are 
costs arising from complications of ART procedures, disruption to employment and costs 
of multiple births (Chambers, Adamson, & Eijkemans, 2013a). One of the few economic 
appraisals of individual costs for ART demonstrates the greater fiscal costing for an older, 
compared with a younger, woman to have a baby. Women attending infertility clinics aged 
less than 30 years spent an average of $24,809 on ART per birth compared with women 
aged 42 or older who spend $97,884. If a women aged 42 is fortunate to have a child after 
ART, she will have spent on average $182,000 for that conception (Chambers & Sullivan, 
2005). Analysis of ANZARD data between 2002 and 2004 concluded the success rate for 
a live birth for women aged 45 and older, was less than 1% and the cost of each baby was 
more than $500,000 (Sullivan, Wang, Chapman, & Chambers, 2008). These economic 
data question the increasing negative cost-effectiveness of Medicare rebates for ART for 
women over the age of 35 years. 
There is no legal requirement for fertility specialists holding shares in the company to 
disclose to their patients their shareholding, which could be viewed as a conflict of interest. 
Full disclosure of a clinician’s commercial interests in infertility clinics should be provided 
to patients in light of possible influence by commercial interests (Coombes, 2014), 
particularly as most infertility clinics offer in-house pathology services that patients are 
required to use. Professor Robert Norman, a non-shareholding consultant to the 
Repromed clinic in South Australia, suggests that shareholding clinicians are guided by 
their governing venture capital company and may steer patients quickly into the high-cost 
IVF route rather than initiating low-intervention options (Gardner, 2014a, 2014c). Professor 
Seamark (Australian Broadcasting Corporation, 2014) expressed concern that profits from 
clinics that previously were for clinical research now were returned to shareholders. 
Associate Professor Beverley Vollenhoven commented that one of the main providers of 
ART was inflating success rates, reducing scientific research, and not consultative on 
staffing and treatment price increases (Cohen, 2015) and the clinic seemed to be moving 
from its core values (Whyte, 2015).  
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Demand for a commodity is achieved by increasing the awareness of the product. The 
Australian Medical Association does not favour the direct advertising of medical or 
infertility services because this may be perceived as persuasive or may exploit patient’s 
vulnerability or lack of medical knowledge (Australian Medical Association, 2006). 
Advertising blankets with narratives and signifies the position and the meaning of the 
commodity (ART) within non-commodified relations such as the images of a happy family. 
News articles can sensitise audiences with depictions of cutting-edge fertility treatments, 
and these visual images, when combined with ART success stories, can be persuasive 
(van Dyck, 1995). Van Dyck suggests the process of commodification of ART is achieved 
by telling a positive story to allow justification of the time, expenses, and efforts to use the 
technology. It is important that businesses marketing a positive ART story do not sell false 
hope by claiming success rates higher than those from accredited data such as ANZARD 
(Australian Broadcasting Corporation, 2014). Widdows (2009) suggests the “cute factor” of 
a new baby and the willingness of users of ART to accept the health, psychological, and 
medical risks of the technology overrides concerns. 
There exists a close relationship between the pharmaceutical companies who manufacture 
ART drugs and infertility clinics. The marketing practices of drug companies have an effect 
on clinicians’ prescribing behaviour, despite a belief to the contrary that inducements have 
no effect. This may arise because of the conscious or unconscious behaviour of 
indebtedness after an inducement (Orlowski & Wateska, 1992). Pharmaceuticals used for 
ART ensure large profits. In 2011, worldwide sales of Gonal-F, a recombinant hormone for 
ART, rose 7.2% to €130 million due to a high demand in Australia, Asia and Africa (Merck, 
2011). Pharmaceutical companies sponsor medical conferences focused on women’s 
health and infertility. They also sponsor clinicians’ attendance and speakers to these 
events, as they have a vested interest in the business of ART (Health, 2006). Benefits are 
offered as an incentive to use a product over the similar products of opposition companies 
even if there is parity between the costs of the products. 
Initially, Medicare covered a lifetime funding of six stimulated cycles per woman as it was 
postulated that 90% of women would conceive within four or fewer stimulated cycles. After 
six cycles, women had to fund the treatment costs themselves (Kovacs et al., 2003; Smith, 
2006). The six-cycle limit was abolished in 1999 due to public and clinic pressure with 
clinics defending the abolition when 1.5% of women went beyond six cycles (Cummings, 
2005). Governments are concerned about of rising health expenditure and its sustainability 
(van Gool et al., 2009). Medicare partially funds Australian citizens having ART but the 
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out-of-pocket expenses discriminate against women in low-socioeconomic groups who 
may find these costs prohibitive. This represents inequality in the Australian health system. 
Evaluating the cost-effectiveness of medical treatments is a challenge when health is a 
rising expenditure for governments (Mastenbroek & Repping, 2014).  
2.7 Technology Mongering 
 Hoffman (2006) suggests that technology has become a symbol of our culture. Humans, 
market forces and consumer requirements socially shape medical technology (MacKenzie 
& Wajcman, 1999). Technological imperative is created, as once a technology is 
underway, it is unstoppable and progress is inevitable (Hofmann, 2002). As when 
technology is introduced into a culture, what follows is the inevitable use of technology, 
which leads to further technological developments (Fuchs, 1968). Technology mongering 
describes the phenomenon by which individuals are influenced or compelled to use 
procedures that may be optional or experimental and may have unsubstantiated benefits. 
Innovations in medical technology present ethical dilemmas and challenge the boundary 
between health and illness (Lauritzen & Hyden, 2007). When ART was developed, it 
created a need that exceeded the initial indications of the technology, as the human action 
has shaped the continual development of technology (Heitman, 1999; MacKenzie & 
Wajcman, 1999).  
ART has become socially acceptable because people believe in medical technology as a 
symbol of our culture and progress (Hofmann, 2002). Australians have a high level of 
confidence in scientists, scientific institutions, and biological technologies (Farquharson & 
Critchley, 2004). ART embraces new technology - such as ICSI, preimplantation genetic 
diagnosis (PGD), preimplantation genetic screening (PGS), comparative genomic 
hybridisation (CGH), and oocyte freezing. The confidence in technology and its ability to 
achieve high success rates is often not comparable to published success rates. Women 
may feel that there is technological imperative to use new medical technology (Motluk, 
2011), as many women are eager to try new technology to have a child despite its 
effectiveness being unproven.  
Steures et al (2006), in a study of 253 couples, suggests that the use of technology should 
be evaluated for couples using ART, and that selection of couples best suited for 
insemination cycles be qualified. This eliminates the unnecessary use of technology and 
resources. A study of 9818 couples attending Dutch infertility clinics for idiopathic infertility 
suggested that overtreatment occurred in 36% of the participants, possibly exposing them 
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to unnecessary treatment (Kersten et al., 2015b). Some clinics promote success rates of 
30% to 40%, but some are as low as 8 to 15% (Hinde & Vogler, 2008). Hinde and Vogler 
(2008) claim that some clinics “massage” their marketing information for ART success rate 
by reporting pregnancies rather than a live births. Reporting early stage clinical pregnancy 
rates elevates the reported success rate when 10% of these pregnancies may not be 
viable or may not proceed to birth. Technology mongering can increase women’s 
expectations of achievement when clinics advertise success rates for younger women who 
have higher pregnancy and birth rates, rather than midlife intending mothers, who have 
lower success rates. 
The national infertility support organisation Access Australia, has a pharmaceutical 
supplier of ovulation drugs as a patron ($40,000 annually), and two infertility clinics which 
provided $20,000 and $10,000, respectively for annual support 
(http://www.access.org.au)(Michelle, 2007). In defence, Healy (2004) suggests that 
pharmaceutical companies support consumer patient groups as part of an intentional 
marketing strategy to lobby government assistance for increases to the PBS. As a 
consumer advocate group, Access Australia has been an energetic campaigner for 
Medicare rebate funding to remove the six funded-cycle limitations and the funding of ICSI 
by Medicare. Access Australia cannot objectively lobby for consumers due to its vested 
interests.  
A specific example of technology mongering in ART is the use of PGD or PGS, which is 
available in many Australian ART clinics. PGS can be used to screen embryos for 
chromosome aneuploidy (an embryonic chromosome imbalance with loss or gain of a 
whole or part of a chromosome). The American Society of Reproductive Medicine (ASRM) 
does not support PGS for common aneuploidy screening in older women or support that 
PGS leads to improved live-birth rates in women of advanced maternal age, (American 
Society for Reproductive Medicine, 2007; Medicine, 2008). Mastenbroek and Repping 
(Mastenbroek & Repping, 2014) suggest that clinicians who offer PGS are either unaware 
of such data or driven by other motives, as PGS is financially lucrative for infertility clinics. 
In some centres, PGS has been found to reduce rather than increase the chance of a 
successful pregnancy due to the potential of loss of the embryo after manipulation to 
remove a single cell for testing (Dondorp & de Wert, 2011). 
Zeiler (2004) found that women considering PGS perceived a technological imperative to 
use it if it is available. Selecting not to use PGS implies they were doing less than they 
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should to ensure the birth of a healthy child. PGS is promoted as a service than can lessen 
women’s anxiety because it screens out common aneuploidy-affected embryos. Zieler’s 
(2004) interviews indicated that for some women, the choice of PGS increased their 
trauma and could reduce their ability to make autonomous decisions. Some women 
perceive that infertility professionals have an unconscious vested financial interest in 
promoting PGS and alternative technologies, and procedures are not discussed sufficiently 
with the consumer (Zeiler, 2004). 
Some assert that clinics adopt new technologies without clear empirical data on its clinical 
success and individuals may select clinics which offer breaking technology (Mastenbroek 
& Repping, 2014). It is the clinician’s ultimate decision to use technology that has not 
undergone clinical trials, despite the patient giving consent. There is a possibility that 
infertility clinics may adopt or copy new technologies without undertaking research to 
evaluate clinical studies or the safety of the patient before offering it as a routine procedure 
(Dondorp & de Wert, 2011). 
Currently, science is unable to delay the biological aging of oocytes. Some midlife 
intending mothers are unable to conceive with their oocytes and require donated oocytes 
from younger women as their only chance of a pregnancy (Tarlatzis & Zepridis, 2003). 
Technology mongering is evident when clinics promote the concept of younger women 
taking out reproductive insurance by freezing oocytes if they wish to delay childbearing to 
an age when their fertility potential is compromised (Shkedi-Rafid & Hashiloni-Dolev, 
2011). Data for the success rate of oocyte preservation does not support marketing claims. 
Robert Winston (Cohen, 2015) suggests women are being given false hope of success as 
the IVF industry preys on the anxieties of women. Despite recent technological 
improvements, the implantation rate is 13.2% for women younger than 30 years reducing 
to 8.6% for women aged 40 years of age (Cil, Bang, & Oktay, 2013). Mohapatra (2014) 
suggests that the medicalisation of women’s reproduction, because of social constraints to 
have a child when younger, is ill advised. Oocyte freezing puts young women through ART 
oocyte collection cycles that carry potential medical risks. Future use of preserved oocytes 
is via ART with ongoing storage fees and treatment costs and with no guarantee of 
success. 
Woloshin (2006) suggests that the media overstates the benefit of IVF technology by 
telling stories of dramatic benefit and by minimising potential harms. Dr. Peter Illingworth, 
a clinician from IVF Australia, stated that “there’s a lot of emotional attachment to this 
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piece of frozen tissue, and six or seven years later it’s going to be a blow when it doesn’t 
thaw out” (Nowak, 2007). Women may have unjustified optimism and limited knowledge 
regarding the success of oocyte preservation and, hence, be open to technology 
mongering (Harwood, 2009). As McLeod (2002) suggests, women believe they are buying 
insurance against age-related infertility but may be inadequately informed of the possibility 
of preserved oocyte cycles failing when required in the future. Lord Robert Winston 
suggests that egg freezing is a “confidence trick” with fewer than ten percent of women 
who use their frozen eggs conceiving (Francis, 2014; McLaren, 2014), and over a five year 
period in the UK, data showed that each oocyte had a 1.5% of progressing to a birth 
(Cohen, 2015). Professor Gab Kovacs said “women should not be conned into thinking it 
offered a guaranteed family in the fridge” (Medew, 2011). Martin (2010) suggests this 
technology creates a new reality of anticipated infertility with healthy fertile women 
anticipating they will need ART in the future.  
Oocyte freezing for social reasons does not qualify for a Medicare rebate and each cycle 
costs approximately $10,000 out-of-pocket which could be cost prohibitive for women 
(Lemoine & Ravitsky, 2013). Women may need multiple cycles to harvest sufficient 
oocytes for future use because each cycle may yield fewer than ten oocytes and no clear 
guidelines exist to recommend the optimal number to freeze per anticipated child (Baldwin, 
Culley, Hudson , & Mitchell, 2014). The media uses phrases such as “reproductive 
insurance policies”, “social egg freezing” (Carrington, 2008) and “putting your reproductive 
future on ice” (Wildman, 2006) to depict this technology when the chances of a birth from 
stored oocytes are not guaranteed. Some women may wish to store oocytes when aged in 
their late 30s and 40s, when their fertility is declining (Baldwin et al., 2014). An Australian 
infertility clinic and companies Apple and Facebook, will subsidise oocyte freezing for its 
employees and suggest that this will assist women who are “time-trapped’ by social factors 
(Francis, 2014; McLaren, 2014). Lemione and Ravitsky (2013) suggest this does not 
improve reproductive autonomy but avoids improving workplace conditions to allow 
women to have children without detriment to their career.  
In 2013 the ASRM advised that there was insufficient data to recommend oocyte freezing 
for the sole purpose of circumventing reproductive aging in otherwise healthy women 
(American Society for Reproductive Medicine, 2013). In 2009, the Royal College of 
Obstetricians and Gynaecologists in the UK warned that woman should not look to oocyte 
freezing for nonmedical reasons (Motluk, 2011). There is no fall-back option for women if 
their frozen oocytes fail. Oocyte preservation moves ART from a therapy into an elective 
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social use of technology and into the realm of family planning and reproductive autonomy. 
Women need to be fully informed of the benefits and the drawbacks of reproductive 
technology from an independent authority, to ensure they are making the best decision in 
their circumstance.  
2.8 Anticipated Decision Regret 
The theory of anticipated decision regret proposes that an individual who wishes to avoid 
regret about a decision they are currently making may behave in ways to avoid regret (de 
Zoeten, Tymstra, & Alberta, 1987; Tymstra, 1989, 2007; Zeelenberg, 1999). This theory 
suggests that women could have their expectations raised about the capability of ART and 
consequently women may persevere with repeated ART cycles so they do not, in the 
future; regret the decision they may make to discontinue treatment.  
Individuals may have feelings associated with health decisions and then experience 
emotions more adverse than they initially anticipated. Decisions about health are made in 
the context of feelings and emotions, whereby individuals are not inclined to refuse to use 
a diagnostic or a treatment because that decision may be regretted at a later stage 
(Tymstra, 2007). Avoidance of decision regret is a driving force for women who have 
repeat ART cycles until they are successful. The avoidance of regret gives medical 
technology an imperative character (Tymstra, 1989). 
De Zoeten (1987) explored anticipated decision regret through a small study in a Dutch 
infertility clinic. Participants reported optimism that their treatment would be successful and 
that they would continue with treatment even if their chances of success were 2% because 
they did not wish to experience regret in the future. As Tymstra (2007) suggests, women 
should be informed of possible future regret and avoid self-blame for not embracing 
current medical technology.  
Women are postulated to start ART because the technology is available to them and that 
they may do so in order to avoid anticipated decision regret. Hofmann (2002) suggests 
that this is influenced by a technological imperative because women believe they have to 
participate in the most advanced level of technology available. In the developed world, 
women have the opportunity to access ART and may feel that they cannot refuse to use 
the available technology (de Zoeten et al., 1987; Sandelowski et al., 1990; Tymstra, 1989). 
De Lacey (2002) explores a lottery analogy (the next cycle will be a winner) within the 
Australian context and suggests that infertile women who persist with ART until they 
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succeed are predominantly represented in the popular media and rewarded for their 
persistence. 
Some couples undertaking ART find the process therapeutic even if the cycles are not 
successful, as they have tried the technology available to them. Zeiler (2004) suggests 
that some couples believed they could now relax as they had tried all available options and 
they did not have to make further decisions on treatment. 
2.9 Summary  
The use of medical technology, the rise and power of pharmaceutical companies and 
medicalisation have initiated contemporary debates about health care and, in particular, 
reproductive technology. Medicalisation is a descriptive term for the intention to take a 
human character or the extension of a mild human condition to create the impression that 
it is a medical disease requiring treatment. Some women undertaking ART may not 
understand that they are consumers of IVF technology and they are being medicalised and 
potentially commodified.  
Some women choose to use ART as they are unable to conceive naturally, and may have 
unrealistic expectations of the success rate of the technology. Marketing from infertility 
clinics and pharmaceutical companies portrays the technology as being quite successful, 
although actual success rates are rarely reported for the largest group, women aged over 
35 years, whose success rate is lower. Expectation of treatment success may be elevated 
by the publication of cumulative success rates, which will be higher than the initiated cycle 
rate or the live birth rate. 
Chapter 3 discusses influences on the childbearing age of women and the factors that 
influence the decision on the timing of childbearing. Women are tending to have children at 
a later age than their mothers, and this has implications for their ability to conceive and, if 
unsuccessful, their reliance on ART as a fall-back option (Gray, Qu, & Weston, 2008).  
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Chapter 3: The changing and contested nature of family in recent times 
and social factors in influencing women’s childbearing intentions 
3.1 Overview 
This chapter examines the place of the family in Australia, changes in the structure of 
families and partnering relationships, and social influences upon women’s childbearing 
intentions. The cost of rearing children with one parental income is offered as a reason for 
the decline in family size and anticipated family size (Bulatao, 2001). Social, biological and 
environmental factors such as relationships, career and employment, financial attainment, 
and educational aspirations shape women’s childbearing intentions; these may not always 
represent a rational voluntary decision (Holton et al., 2011a). 
3.2 The Family and Childbearing Trends in Australia  
Contemporary Australia reflects changes in the patterns of marriage, partnering, and 
family formation with stepfamilies, blended families, and sole parent families (Australian 
Bureau of Statistics, 2008b). Variations in birth rates correspond to social changes, and 
birth rates vary between developed and developing countries (de Vaus, 2002; Gray et al., 
2008). Women’s aspirations for the timing and the size of their families are influenced by 
external factors, which has ramifications on the timing of childbearing (Wang et al., 2008a). 
Australian parents indicate that economic and career factors, and the embodied 
experiences of parenthood influence family size and the age of childbearing (Newman, 
2004). The size of the family increased during the 1950s because of improvements in the 
economic climate, a lack of reliable contraception, and a boom in marriages in the post-
war period, which led to significant increases in the number of births to young Australian 
women, peaking at 3.55 births per female in 1961 (Australian Bureau of Statistics, 1994a; 
Hugo, 2002; Lesthaeghe, 1998; Weston et al., 2004). This was the era of the nuclear 
family comprising two biological parents and children. 
Family size decreased to 2.5 individuals per household in 2006 because of a decline in 
fertility rates and a change in household structure (de Vaus, 2008; Hugo, 2002). Lee and 
Gramotnev’s (2006) research suggests that most Australian women aged in their 20s plan 
to have children at some stage. There is an increasing trend for women to have their first 
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child and further children at a later stage of their life compared to women in previous 
generations (Wilkie, 1981).   
Contraception allows family planning and despite childlessness being more socially 
acceptable today than then in previous generations, 85% of married couples in developed 
countries choose to have children (McDaniel & Tepperman, 2000). The availability of 
female contraception and access to safe induced abortion influenced the timing of 
childbearing for women in Australia and has contributed to declining birth rates (Frejka & 
Jean-Paul, 2004; Jain & McDonald, 1997; Weston & Parker, 2002). Initially, mostly 
educated women embraced the contraceptive pill but, by 1971, it was accepted by women 
of all social classes (Gilding, 1997).   
3.3 Maternal Age In Relation To The Decline In Fertility  
There is direct relationship between increasing age and decreasing childbearing potential 
for women. Females have an optimal time to have a healthy baby. The theory that women 
have a finite reproductive period was initially posed in 1921 by Pearl (1921: 111) who 
published the biological doctrine that, “during the lifetime of an individual there neither is 
nor can be any increase in the number of primary oocytes beyond those originally laid 
down when the ovary was formed”. Many women’s fertility declines from the age of 35 
years (Leridon, 2004) and some researchers suggest fertility declines as early as 32 years 
of age (American Society of Reproductive Medicine, 2014). Jansen (2003) reported that 
women aged younger than 34 years require fewer cycles of ART to achieve a pregnancy 
and had a higher birth rate and lower miscarriage rate than older women. ANZARD data 
confirms that live birth rate per initiated cycle for ages; 30–34 years was 24.1%, 35-39 
years 16.3%, and 40-44 years 5.9% (Macaldowie et al., 2015). Research by Schwartz and 
Mayaux (1982) and Shenfield (1993) on fertile women’s access to donor semen, support 
the concept of age-related decline; i.e., women younger than 30 have four times the 
chance of achieving a pregnancy compared to women aged over 35 years (Klein & Sauer, 
2001; Shenfield, Doyle, Valentine, & Ton, 1993).  
Menopause, which for most women begins at around age 51 years (range from 40–60 
years), occurs when the number and quality of oocytes decreases below a certain 
threshold and is manifested by the absence of menstruation (Kline, Kinney, Levin, & 
Warburton, 2000). The menopause occurs 10–12 years after fertility starts to diminish 
during perimenopause and is the absolute end of fertility (Klein & Sauer, 2001; Tarlatzis & 
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Zepridis, 2003). The perimenopausal period manifests as a loss of oocyte quality and 
quantity.  
Perimenopause leads to a decline in oocyte numbers; this degeneration in the quality of 
oocytes has a variable age of onset amongst women (Klein & Sauer, 2001; Lim & Tsakok, 
1997) due to varying numbers of oocytes in individuals (Soules et al., 2001). Twin studies 
shows correlation between age of menarche and menopause within female members of a 
family, with a heritability of 63% (Snider, MacGregor, & Spector, 1998) and 31–53% 
(Treloar, Do, & Martin, 1998), respectively. If a woman’s mother or twin sister experiences 
early menopause, she has a higher risk of early menopause (de Bruin, Bovenhuis, van 
Noord, & Pearson, 2001).  
The progression towards menopause can be quantified according to the changes in the 
endocrine system. The gonadotropin follicle-stimulating hormone (FSH) causes the ovum 
to mature in the follicular phase, which gives a measurable indication of ovarian aging. As 
the hypothalamus ages, the FSH level increases, which shortens the menstrual cycle 
length and results in slower follicular growth, reduced follicle diameter, lower progesterone 
levels and a transition to menopause (Ebbiary, Lenton, Salt, Ward, & Cooke, 1994; 
Gosden & Faddy, 1994; teVelde & Pearson, 2002). Measuring the antral follicle count 
using ovarian ultrasound imaging can assess declining ovarian function. Turfan and 
Durmusoglu (2004) concluded, there is no abrupt decline in fertility but a gradual decline in 
the third decade of a woman’s life.  
Age is a significant factor in oocyte developmental competence. A woman is born with her 
lifetime complement of six–seven million ovarian follicles. Her ability to have children starts 
at puberty when fertility peaks with 300,000 to 400,000 follicles, after which atresia 
decreases the number of follicles each month of a woman’s post-pubescent life, which 
gradually decreases the chances of conception (Cooke & Nelson, 2011) because declining 
reproductive potential is a continuum (Klein & Sauer, 2001). Atresia is caused by 
apoptosis when the resting follicle number declines to less than 25,000, which is usually 
when a women is aged 37–38 years of age (Hughes, Steingrad, Persson, & Costello, 
2005). Once menopause is reached, 1000 or fewer follicles remain, which is an insufficient 
number to sustain the cyclic hormonal process necessary for conception (Faddy, Gosden, 
& Gougeon, 1992; Gardner & Sutherland, 2004). Oocyte degeneration proceeds with age 
and is reflected in age-related chromosomal abnormalities (Lim & Tsakok, 1997).   
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Oocyte degeneration is confirmed after PGS in IVF cycles (Battaglia, Goodwin, Klein, & 
Soules, 1996; Gianaroli et al., 1997; Krey et al., 2001). Franasiak et al.(2014) tested over 
15,000 trophectoderm biopsies from 2,701 patients in 3,392 cycles to determine by 
comprehensive chromosomal testing (CCS) to determine if they were euploid or aneuploid. 
Aneuploidy was lowest in women aged 26–38 years of age, confirming that aneuploidy 
increases with maternal age. Embryos from women aged 42 years had one-third aneuploid 
and those aged 44 years had half of their embryos aneuploid. After fertilisation, if the 
developing embryo has less or more genetic material than required (fewer or more than 46 
chromosomes) the embryo will stop developing and miscarry spontaneously or develop 
until term. If a chromosomally unbalanced embryo continues to birth, the baby may be 
born with significant physiological or developmental disabilities, and depending on whether 
monosomy, trisomy, or other chromosomal anomaly is present, this may not be compatible 
with life. Chromosomally abnormal embryos are responsible for a higher spontaneous 
abortion rate in older women (Fretts, Schmittdiel, Mclean, Usher, & Goldman, 1995; 
Gardner & Sutherland, 2004; Mueller & Young, 1996). Miscarriage rates for women aged 
30–34 years are 12%, rising to 18% for women aged 35–39 years to 34% for women aged 
40–44 years. The spontaneous miscarriage rate, for women aged 40 or older, approaches 
50% for each pregnancy (American Society for Reproductive Medicine, 2012; Holter, 
Anderheim, Berg, & Moller, 2006).  
Decreased ovarian reserve and age-related changes in oocyte are generally present in 
women aged 35 years and older, and 90% of spontaneous miscarriages in midlife 
intending mothers are likely to be caused by trisomies (Kline et al., 2000). An age-related 
increased risk of trisomies is attributed to age-related errors in meiosis (Kline et al., 2000) 
related to the decline in the functional competence of the meiotic spindle. These changes 
cause extra maternal chromosomal material to be present in the embryo (Battaglia et al., 
1996). Many trisomic pregnancies spontaneously miscarry during the pregnancy. 
Trisomies 13 (Patau syndrome), 18 (Edward’s syndrome) and 21 (Down syndrome), can 
progress to birth. From 10 weeks gestation, an estimated 83% of trisomy 13 and 86% of 
trisomy 18 pregnancies will miscarry spontaneously (Snijders et al., 1995). For trisomy 21, 
only 31% of pregnancies will miscarry spontaneously (Spencer, 2001). The risk of having a 
child born with Down syndrome is 1 in 430 births for women aged 34 years, 1 in 84 at age 
40 years and 1 in 45 at age of 45 years. Giving birth to a baby with chromosome 
abnormalities is more common in midlife intending mothers: 1 in 244 at age 34 years, 1 in 
64 at age 40 years and 1 in 19 at age 45 years, from the frequently cited research by Hook 
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(1981). Data for chromosomal abnormalities will reduce due to the uptake of non-invasive 
prenatal screening in early pregnancy. 
Women may be ignorant about their state of fertility. Some believe that as long as they 
have regular menses they still have ovarian function and can achieve a pregnancy. The 
study by MacDougall et al. (2013) of 61 American women aged over 40 years found that 
they did not have a clear understanding of age-related fertility decline. Surprisingly, close 
to half of participants were shocked to find that their chances of conception were lower 
than they had anticipated. Research by Hammarberg (2005) concurred with MacDougall’s 
study as 18% of the Australian women in the study were unaware of the link between 
maternal age and age-related fertility decline. Hammarberg et al. (2013) interviewed 462 
childless men and women aged 18–45 years of age on the age of fertility decline and 
established that one in four correctly identified that women’s fertility declined around the 
age of 35 years. Cooke and Nelson (2011) encapsulate the problem of measuring 
awareness, as because the main determinants of ART success are age and oocyte 
quality, ART cannot adequately compensate for women delaying childbearing. The 
transition period of perimenopause clearly signals the decline in reproductive capability, 
and some the general community may not be aware of this decline. 
3.4 Timing Of Childbearing 
The mean age of Australian women having their first child has increased from 27.3 years 
in 1985 to 28.3 years in 1994 to 29.8 years in 2006 and 30.1 years in 2012 (Australian 
Bureau of Statistics, 2005; Hilder, Zhichao, Parker, Jahan, & Chambers, 2014; Laws & 
Hilder, 2008). Proportion of all women giving birth shows the number women aged 20–24 
years having children has fallen from 17.1% to 14.6% from 1997 to 2006. Whereas rates 
for women 35 years or older have increased from 12.7% in 1994 to 18.8% in 2003 and to 
21.4% in 2006 (Laws & Hilder, 2008).  
Many women who try to start their family later in life will remain childless or have 
fewer children than they aspire (Barnes, 2001; Weston et al., 2004). More women are 
delaying childbearing to an age when they cannot conceive without fertility treatment and, 
thus, have an increased chance if involuntary childlessness (Leridon, 2008). As 
suggested:  
“women make their own reproductive choices, but they 
do not make them just as they please; they do not make them 
under conditions which they themselves create but under social 
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conditions and constraints which they, as mere individuals, are 
powerless to change” (Petchesky, 1980: 675). 
Women aged in their 30s and older often refer to their biological clock ticking which 
describes the process in woman’s reproductive life when fertility and conception may be 
difficult. Some women view their biological clock as an indicator for considerations on the 
timing of their childbearing (Friese, Becker, & Nachtigall, 2006; McKaughan, 1987). 
Women compare their decision to start a family relative to their peers, so the timing of 
childbearing may be based on the opinions of others. Women may normalise the timing of 
childbearing when reproduction is risky or difficult (Daly & Bewley, 2013).  
The age that women actually have children and the age considered an ideal age to 
conceive may differ. Weston et al. (2004) surveyed mothers and childless women aged 20 
to 39 years of age about the ideal age to have children and found that mothers nominated 
that age as 26 years compared with childless women, who nominated an age of 28.1 
years as the ideal age to have a child. Some women, due to their age, are having fewer 
children than their younger peers (MacDougall, Beyene, & Nachtigall, 2012) or fewer 
children than they imagined (Weston et al., 2004). A small cohort of men and women aged 
over 40 stated that later parenting was advantageous as financial security, careers, and 
relationships were established. On the other hand, conception was problematic; they 
would have fewer children, less energy, and fewer years to spend with offspring 
(MacDougall et al., 2012). 
Bolvin et al. (2009) suggests that parenting outcomes from midlife intending mothers is not 
associated with poorer outcomes for children in the psychosocial context. Older mothers 
are thought to have better parenting practices than younger women due to their maturity, 
life experiences, financial and social resources, experience, resilience and understanding 
(Bolvin et al., 2009; Bornstein, Putnick, Joan, Suwalsky, & Motti Gini, 2006; Ferguson & 
Woodward, 1999; McMahon et al., 2011). Older mothers also tend to have richer and more 
responsive communication with their infants and toddlers based on their greater life 
experience in communication (Rowe, Pan, & Ayoib, 2005).  
3.5 The Dilemma Of Motherhood Or Childlessness 
“Let’s face it, motherhood is a risk. You have no way of 
knowing if you’re going to like it until it’s too late. It’s the egg of 
life that can’t be unscrambled.” (Tuohy, 2011) 
   45 
Reproduction is a natural part of a woman’s life journey (Rowland, 1992). Views of 
motherhood are socially shaped by cultural meanings (McMahon, 2004) which define 
motherhood as central to the ways in which women are defined by others and to their 
perceptions of others (Phoenix & Woollett, 1991). Richardson (1993) suggests that women 
may feel a sense of importance and maturity when becoming a mother and women are 
strongly socialised to believe that marriage and motherhood are central to their lives and 
identity. 
The decision to become a mother is shaped by nature, social structure (McMahon, 2004) 
sociocultural context, and women’s personal views of motherhood (Ulrich & Weatherall, 
2000). Rewards of childbearing may encompass personal achievement, emotional 
fulfilment, sense of identity, family continuity, happiness, and life enhancement 
(Sarantakos, 1996). Motherhood has been reported to offer relationship stability and 
provide a sense of purpose by, fulfilment, and may offer physical, psychological, and social 
completeness (Phoenix & Wollett, 1983; Ulrich & Weatherall, 2000). The decision to 
become a mother is not always socially and emotionally centred on women’s lives 
(Badinter, 1981); however, motherhood is an achieved identity that, for some women, 
gives them strength and joy (McMahon, 2004). Infertility may be viewed as impairment, 
more so in low-income couples, as motherhood is an important role in Western societies 
(Phoenix & Wollett, 1983) and infertility as failure (Ulrich & Weatherall, 2000). 
Unfortunately, motherhood is not possible for every woman. Although ART can assist with 
male and female barriers to conception, oocyte age-related changes cannot be reversed.  
Before the development of ART, the only chance infertile couples had for a child for were 
adoption or childlessness. Adoptions are limited with few Australian children available to 
adopt, and couples source international adoptions. In 1971–72 there were almost 10,000 
adoptions in Australia, but this number had dropped to 317 in 2013-2014, and most were 
inter-country adoptions (Australian Institute of Health and Welfare, 2014a). Adoptions are 
complicated and by the time the adoption application is initiated applicants may be too old 
to qualify to become an adoptive parent.  
Not all women wish to be mothers (May, 1995), and developed societies are more 
accepting of a woman’s choice to be childless (Dyer, 2014). In 2006 in Australia, seven 
percent of women aged 35–44 years were childless and had never been in a live-in 
relationship; they accounted for 29% of all childless women of this age. The lifetime rate of 
childlessness for Australian women is 25% (Australian Bureau of Statistics, 2009a, 2009b). 
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Considerations such as; advanced age, lack of a partner, and health problems are 
suggested as being pivotal factors in this circumstance (Rowland, 1992). Personal reasons 
such as a dislike of children, financial or career reasons, lifestyle choices, or concerns 
about bringing children into the world are all reasons for voluntary childlessness (Weston 
et al., 2004).  
Haussenger (2005) challenges the perception that childlessness is socially acceptable; the 
fascination with childlessness is at fever pitch and underlies the uneasiness of women who 
are childless. Female identity is associated with motherhood, and childlessness is seen as 
a challenge to the societal norms because childless women are often stereotypically 
depicted as being personally unfulfilled (Morell, 2000). Involuntary childlessness is 
depicted as a failure to attain cultural norms, and this is seen to increase the 
medicalisation of childlessness (Nachtigall, Becker, & Wozny, 1992). Crowe (1987) as 
cited in (Ulrich & Weatherall, 2000) considers that many childless women have little choice 
but to seek medical intervention to avoid the stigmatisation associated with infertility.   
Some women are childless by circumstance and not by choice (Cannold, 2000, 2005). 
Women who are circumstantially childless fall into two groups; women who are committed 
to motherhood and wait for a suitable partner or use donor sperm, or the women who are 
thwarted from motherhood by fertility problems, relationship, or career barriers (2000, 
2005). Hewlett (2002) interviewed prominent women whose life circumstances had 
rendered them childless and she found that children were crowded out of their lives by 
high-maintenance careers and needy partners. A life without children may be by choice, 
chance, or by circumstance. 
3.6 Social Factors Influencing Women’s Childbearing Decisions – Childless By 
Circumstance Not By Choice 
“...people do not have enough control over their lives to plan exactly when they will 
have children” Das (2004: 4-5). 
Australian women may be delaying their childbearing past the age when their mothers and 
grandmothers had children for a number of reasons, and it is suggested that social 
reasons have triggered this delay (Qu et al., 2000). Some women, despite having 
intentions to have children, can be childless not by choice, as external factors have 
overridden earlier intentions (Cannold, 2000). The timing surrounding a woman’s first birth 
can be influenced by young adults who are postponing marriage and childbearing (Fussell, 
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2002). The availability of contraception along with expanded educational and occupational 
opportunities have empowered women to make choices about their lifestyle and 
childbearing decisions (Australian Bureau of Statistics, 2008a). Various factors such as 
socioeconomic status, education and employment, relationships, marital stability, health 
concerns and religion can influence pregnancy planning and the timing of childbearing 
(Baker, 2008; Holton, Rowe, & Fisher, 2011b; Weston et al., 2004; Wilkie, 1981). Cooke’s 
(2010) meta-synthesis suggests a primary concern is the need for a supportive 
relationship partner. Petersen et al. (2015) found in their study of cohabiting and single 
women in Denmark, that having a relationship partner was not their prime concern but that 
the access to childcare and being able to combine work and children was of greater 
importance before childbearing. 
The fertility rate in Australia as in developed countries is decreasing to below replacement 
rate (Baker, 2008). Advances in contraception, postponement of parenthood, and the 
development and promotion of ART are factors in delaying childbearing (Schritchfield, 
2009). Alterations in social structure and traditional values such as the formation and 
constitution of families, premarital and unmarried cohabitation and later age of marriage 
are shaping women’s intentions to have children and the number of children they aspire to 
have (Australian Bureau of Statistics, 1994b; Barber, 2000, 2001; Damario et al., 1999; 
Rindfuss & St.John, 1983; Weston et al., 2004). High costs of raising children, new 
economic roles for women, and improvements in gender equality are leading women to 
take on roles other than motherhood (Goldin, 2006; McDonald, 2000a, 2000b, 2001; 
Weston & Qu, 2001).  
3.7 Relationship Between Education Level And Women’s Childbearing Intentions. 
Research as early as 1969 indicated that women’s decisions about childbearing were 
influenced by educational and religious factors (Stolka & Barnett, 1969) and that women’s 
level of education changed the age at which they begin childbearing (Maxwell, 2007). 
Parity is lower for women who have higher levels of education (Barber, 2001; Rindfuss & 
St.John, 1983) and those professionals (such as doctors and lawyers) have the highest 
rates of childlessness of working women (Miranti, McNamara, Tanton, & Yap, 2009). In 
1970, three percent of working age Australians has higher education qualifications that 
increased to 25% in 2011, and of these 57% were females (Australian Bureau of Statistics, 
2012a). Women with non-school qualifications are more likely have a partnering 
relationship than women with higher education (Australian Bureau of Statistics, 2009b; 
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Birrell, 2004). Women with higher education and higher socioeconomic status are more 
likely to delay their childbearing and partnering, and have fewer children than women with 
lower socioeconomic status and less education, despite both groups having similar desires 
to have children (Australian Institute of Health and Welfare, 2011; Baker, 2008; Freeman-
Wang & Beski, 2002; McDonald, 2002; Weston et al., 2004). Zoll (2013) suggests some 
educated women fantasise that they can rely on science to overcome infertility and believe 
that women can have it all.  
3.8 Relationships Between Employment And Finances And Women’s Childbearing 
Intentions 
Societal changes such as work and family compatibility and the desire of women to return 
to the workplace, and the aspiration for personal economic security such as housing 
stability are social factors that influence childbearing decisions (Newman, 2004; Wilkie, 
1981) regardless of a women’s socioeconomic status (Steele, Giles, Davies, & Moore, 
2014). Some women postpone childbearing wishing to be financially secured before the 
financial demands of childrearing (Kravdal, 1994). Historically, benefits of having larger 
families waned when education policies legislated for compulsory childhood education 
rather than children contributing to household income (Baker, 2008). Women’s increasing 
workforce participation from the 1980s to the present day has been a factor in Australia’s 
low birth rate (Australian Bureau of Statistics, 2003a, 2012a). Women in the workforce 
contribute to later and less childbearing (Fussell, 2002; Gilding, 1997; Lesthaeghe, 1998; 
McDonald, 2000c, 2002). Women’s level of attachment to employment may influence their 
decisions on timing of childbearing (McDonald, 2001; McGann & Conrad, 2007). 
Some women may have difficulty balancing motherhood, paid employment, and marriage. 
Employers should provide maternity benefits during late pregnancy and after childbirth, 
and provide access to subsidised childcare to assist women returning to the workplace 
(Baker, 2008), with childcare essential for working mothers (Mahon, Bergqvist, & Brennan, 
2016). Interrupting a career may be a difficult decision for some women as they may be 
concerned about their ability to re-enter the workforce and lost earning capacity. 
 Maher, Dever, Curtin and Singleton (2004) interviewed 114 Victorian men and women 
about how reproductive choices related to career, personal, and relationship plans. Maher 
concluded that the decision to become a parent is often complicated, and the provision of 
paid parental leave, affordable and accessible childcare, and flexible working practices are 
important considerations. Some women place their job or their career on hold until they 
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achieve a pregnancy because a prolonged period of accessing ART treatment can 
interfere with paid employment (Baker, 2003). Women, unlike men, may have to choose 
between parenthood and employment, and if they want work, must fit within 
responsibilities of parenthood (Richardson, 1993). In contrast, Petersen et al. (2015) found 
in a study of cohabitating and single childless women aged 35–43 years, that career was 
not a significant factor in delaying childbearing.  
Women who predominately have casual employment are more likely to become a mother 
irrespective of socioeconomic status, relationship status, partner’s educational level, or 
parental birthplace (Steele et al., 2014). However, characterising childless women as 
choosing career over family fails to acknowledge that there may be other reasons for 
childlessness and serves to group these women as selfish and ambitious. Women may not 
plan to postpone childbearing, and the inference to depict some women who delay 
childbearing as reluctant to leave a high paying professional occupation, is challenged by 
many women (Graham & Rich, 2014). Coleman (1988) agrees that midlife intending 
mothers provide greater financial and social capital, relevant to parenting and family 
development compared to younger mothers. Thus, some mothers are better able to 
support children financially as they have established careers, a home, and saved capital 
before the arrival of children (Wilkie, 1981). It would appear that policymakers should 
consider strategies to support mothers who wish to remain in the workforce (Lee & 
Gramotnev, 2006). 
3.9 The Effects Of Personal Relationships On Women’s Childbearing Intentions 
Changing marriage rates and marriage longevity are key features of the changing nature 
of Australian families and are reflected in fertility and childbearing patterns. Having 
children is considered an extension of a couple’s relationship and a normal part of life 
(Sarantakos, 1996). For women in past generations, the purpose of marriage was for 
childbearing; however, current trends suggest that marriage and children are increasingly 
becoming a matter of personal choice. Women’s average age at marriage increased from 
21 in 1975 to 28 years of age in 2006 (Australian Bureau of Statistics, 1993, 2006a). The 
likelihood of marriage has decreased in recent decades and many young adults 
cohabitating will marry before or after children have entered the relationship (Australian 
Bureau of Statistics, 2007, 2009b; Birrell, 2004; Green, 2008). In 1971, 99% of 
cohabitating couples were married, which decreased by the year 2011 to 84% of 
cohabitating couples (Weston & Qu, 2013). 
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Relationship stability is declining with 33% of all marriages between 2000–2002 projected 
to end (Australian Bureau of Statistics, 2007). There appears to be an environment of 
relationship instability because of rising divorce rates; the divorce rate in 1995 was 12.0 
and in 2000, was 12.9 per 1000 marriages. Loss of permanent legal relationships and time 
taken to establish new relationships lessens a woman’s fertility options. Many women who 
divorce and remarry tend to be in the perimenopausal age group (mean age 38.6 years) 
and hence, at an age of diminishing fertility (Australian Bureau of Statistics, 2003a). Some 
Australians have multiple partnered relationships, and individuals aged 35–44 years can 
have multiple partnered relationships lasting a median of 6 years (Australian Bureau of 
Statistics, 2009b). As a consequence of relationship breakdown or instability, fewer 
children could be conceived. An absence of permanent relationships may lessen a 
woman’s opportunity to have children or as many children as they aspire to have due to 
maternal age (Weston et al., 2004). A Danish study of 340 women aged 35–43 years 
attending the Fertility Assessment and Counselling Clinic in Copenhagen determined that 
higher levels of cohabitation a stable relationship with a partner to share the responsibility 
of children were prerequisites to childbearing (Petersen et al., 2015). 
Before World War II, 15–24% of men did not marry and 10–17% of women aged in their 
40s did not marry. This trend has continued to increase after a recovery in the marriage 
rates in the 1970s (Hugo, 2002). 1991, the marriage rates were; 20.4% for women and 
27.6% for men aged 30–34 years, 11.1% for women and 14.9% for men aged 35–39 
years, and 14.8% for women and 20.3% for men aged older than 40 years. Twenty years 
later, marriage rates had increased to; 31% for women and 35.8% for men aged 30–34 
years, 14.8% for women and 19.3% for men aged 35–39 years, and 17% for women and 
23% for men aged older than 40 years (Australian Bureau of Statistics, 2011).  
Young adults are leaving home at an older age and forming partnering relationships later 
in life than in previous generations. Later relationships delay the age women may commit 
to a family (Australian Bureau of Statistics, 2003b; Fussell, 2002). Between 1979 and 
2000, the percentage of young adults aged 20–29 years living in the family home 
increased from 46% to 52%, with 57% of young women aged in their 20s residing in the 
parental home (Weston & Parker, 2002; Weston et al., 2004; Weston et al., 2001). 
3.10 Awareness Of Age Related Infertility 
 Myths and misconceptions can be perpetuated among women such as believing that 
childbearing later in life is possible and which can shape childbearing decisions.  
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Wyndham, Figueira and Patrizio (2012) suggest that the misconceptions women hold 
about their fertility is alarming. Hashiloni-Dolev et al.(2011) surveyed 400 young female 
students on their knowledge of age-related infertility. Students were aware that fertility 
declines with age and had expectations that a conception was likely even into women’s 
fourth decade. The authors suggest these myths are perpetuated by media coverage of 
older mothers and technological hype. Similarly, a Canadian study of 360 women aged 
18–42 years were surveyed using the Reproductive Health Survey. Findings showed that 
although most were aware of fertility decline, around half overestimated the chance of a 
conception. They were supportive of the belief that natural conception was possible. 
Despite knowledge of age-related fertility decline, this was not seen as a factor in their 
childbearing intentions. An earlier study established that some women lack knowledge of 
age-related infertility regardless of age or level of education (Bretherick, Fairbrother, Avila, 
Harbord, & Robinson, 2010; 2012). Daniluk ,Koert and Cheung (2012) studied 3,345 
childless women aged 20–50 years found a significant lack of knowledge by women of the 
consequences of age-related infertility, the availability and cost of ART, health risks 
associated with ART, and the age range of fertility decline. Kimberley-Smith’s (2003) 
female undergraduate participants believed that women aged under 35 years should not 
be concerned about fertility decline because advanced ART would assist them. 
MacDougall et al.(2013) participants aged 40 years and older also were alarmed to learn 
that their perceptions of age-related fertility decline were inaccurate despite the fact that 
many women were well educated.  
3.11 Knowledge And Health Behaviour Change 
Behaviour change can only occur with knowledge. In the case of infertility, 
knowledge of age-related infertility could be disseminated from primary health providers. 
Yu et al. (2016) studied obstetric and gynaecology residents and most agreed that such a 
speciality should initiate a discussion of age-related infertility with their patients. One-half 
overestimated the age of significant fertility decline and three-quarters overestimated the 
likelihood of ART success. However simplistic, with the assumption that ART can assist 
women who plan to delay childbearing by cryopreserving oocytes or embryos, or women 
who need ART for conception, the social pressures on women should be addressed as a 
health issue (Lemoine & Ravitsky, 2013). These studies suggest the need for an 
improvement in public education about the limits of women’s fertility and the limitations of 
ART for age-related infertility, as the awareness of an issue may not result in a change in 
behaviour. However, little research has been undertaken on the most efficient types of 
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public education programs for this problem. Knowledge of age-related fertility decline does 
not necessarily change women’s intentions as shown in a Canadian study of female 
undergraduates (Australian Bureau of Statistics, 2012a; Bretherick et al., 2010). 
3.12 Summary   
In Australia, in the past two decades, changes in partnering relationships, family 
composition, and women’s workplace participation have changed women’s childbearing. 
Some women wish to have children at a later age for personal reasons at a particular 
stage of their life. Changes in the rates of childlessness can be related to societal changes 
such the rates of marriages and partnering.  
Women who have postponed childbearing because of personal relationships are 
increasingly using ART as their only option. Consequently, for women, it seems that 
greater freedom of employment, reproductive choice, and changes in social boundaries 
are responsible for changes in the birth rate as women have greater control over these 
aspects of their lives.  
Chapter 4 will explore the relationship between women and ART in Australia. 
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Chapter 4: Midlife motherhood and ART 
This chapter explores women’s access to ART services in Australia. The number of midlife 
intending mothers attending infertility clinics is increasing, and there are many older 
women having ART. However, many women may not be aware of the health risks to the 
mother and/or child from this technology. Some risks are age related, and some are 
related to the technology, or the superovulatory drugs. ART cannot reverse the age-related 
decline in fertility and most midlife intending mothers using ART will not be successful. 
Medicare part-funds unlimited ART cycles for women of any age, which has assisted the 
expansion of infertility clinics.  
4.1 Number And Ages Of Women Accessing ART In Australia  
The number of women aged 35–44 years giving birth has doubled, younger women aged 
15–24 years are having fewer births, and birth rates for women aged 25–29 years are 
stable. Women entering an age of fertility decline are the fastest growing cohorts of 
mothers in Australia. Since ART started in Australia in 1978, the median age of women 
having their first child had increased by 3 years (Australian Bureau of Statistics, 2003a; 
Macaldowie et al., 2014). The average age at delivery of Australian women using ART is 
35.1 years, which is 5 years older than for women in the community in 2010 (Li, Zeki, 
Hilder, & Sullivan, 2010). 
The Fertility Society of Australia initiates an annual report from the Australian Institute of 
Health and Welfare (AIHW) compiled by the NPESU on ART cycles initiated in Australia 
and New Zealand. All infertility clinics, 80 in Australian and New Zealand in 2012, must 
supply cycle and outcome data to retain their clinic’s accreditation to practice (Macaldowie 
et al., 2014). AIHW data show an annual increase in the number of clinics, cycles and 
maternal age of women attending infertility clinics. The AIHW data show there were 28,797 
ART cycles in Australia and New Zealand in 2001 increasing to 67,980 autologous cycles 
in 2013 (Australian Institute of Health and Welfare, 2003; Macaldowie et al., 2015).  
The average age of women undertaking ART cycles using their own oocytes in 2013 was 
35.9 years, a slight increase from 35.5 years six years previously (Macaldowie et al., 2015; 
Wang, Healy, Black, & Sullivan, 2008b). Of all the ART cycles undertaken in 2012, women 
aged 35 and older undertook 64.1% of cycles, which represents an increase from 61% in 
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2008 (Macaldowie et al., 2014; Wang et al., 2010). One in four women aged 40 or older 
initiated autologous ART cycles, and the average age of women using donated oocytes or 
embryos was 40.7 years of age (Macaldowie et al., 2015). 
An increase in the Australian midlife intending mothers using ART correlates with 
increases reported from other Western countries such as the United Kingdom. The Human 
Fertilisation and Embryology Authority (HFEA) showed a 10-fold increase in the number of 
women aged 40 and older accessing ART clinics (Hamm, 2007). Women aged over 35 
years are twice as likely as younger women to present at infertility clinics with unexplained 
infertility (Maheshwari, Hamilton, & Bhattacharya, 2008; teVelde & Pearson, 2002).  
4.2 Success Rates For ART 
Fecundability (the ability to reproduce) is dependent on many factors, including the ages of 
the man and the women, their health, and timing of intercourse. Leridon (2004) suggests 
the natural conception rate per month of around 23% for women aged 20–30 years of age. 
The live birth rate is also dependent on the foetal loss rate per month which ranged from 
approximately 12% of conceptions for women aged 20 years to 35% for women aged 45 
years of age (Habbema et al., 2015). Success rates can be reported either as a 
conception or a live birth. ANZARD data and infertility clinic marketing may express ART 
success rates in a number of different ways that may include success per cycle, per 
oocyte retrieval, per embryo transfer, or cumulative success rate. Pregnancy rates will be 
higher than live birth rates as not all conceptions will proceed to term due to foetal loss. 
ANZARD data suggest that 21% of clinical ART pregnancies miscarried in 2013 
(Macaldowie et al., 2015). ANZARD define a pregnancy as either; ongoing at 20 weeks 
gestation, ultrasound detection of a intrauterine sac with or without a foetal sac, chorionic 
villi present in products of conception, or laparoscopic or ultrasound detection of an ectopic 
pregnancy (Macaldowie et al., 2015). There is around a 20% chance of a conception each 
month and, after trying for 12 months, up to 90% of healthy couples will conceive (Leridon, 
2004). In a study of 3011 women between 1998–2007 it was concluded that that ART can 
reach natural fertility rates but not exceed them (Gnoth et al., 2011). Women in midlife 
have fewer euploid embryos to transfer in an ART cycle compared with younger women 
because of age-related chromosomal changes (Harton et al., 2013). The chance of midlife 
mothers conceiving is half that of women 10 years younger (van Noord-Zaadstra et al., 
1991).  
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In 1989, the AIHW reported 4,799 live births from 22 clinics in Australia and from three 
clinics in New Zealand (Rutnam, 1991). Ten years later, this had increased to 13,114 live 
births from 70 clinics in Australia and seven clinics in New Zealand, a 780% increase since 
1987 (Wang, Macaldowie, Hayward, Chambers, & Sullivan, 2011b). Two per cent of 
babies born in Australia and New Zealand in 1998–1999 were ART conceived (Hurst & 
Lancaster, 2001); this increased to 3.1% in 2007, and 4.1% in 2012 (Li et al., 2015).   
In 2013, in Australia and New Zealand, 37,192 women undertook 71,516 treatment cycles, 
with 23.8% resulting in pregnancies and 18.2% proceeding to a live birth for women of all 
ages. Most women were nulliparous and averaged 1.8 cycles per woman (Macaldowie et 
al., 2015). Live birth rates have not markedly improved since 2001 when multiple embryos 
transfer was commonplace and the viable pregnancy rate was 20.6 %, (Australian Institute 
of Health and Welfare, 2003). In 2013, women on average undertook 1.8 fresh and or thaw 
cycles. 48.9% of Australian women had two or more autologous cycles and 9.5% had four 
or more cycles (Macaldowie et al., 2015). 
Success rates can also vary between the stage of the embryo transfer either cleavage or 
blastocyst stage. Cleavage stage embryos (with 4–8 cells) provide more embryos at 
transfer or to preserve compared with fewer embryos at a later stage blastocyst embryo 
transfer (up to 100 cells), as the embryos may not survive to the blastocyst stage. 
Blastocyst embryos have a higher implantation rate as they are more developed. Success 
rates for women from 2012 show that, for women of all ages, the birth rate for blastocyst 
stage embryos was 11.1% higher than that for cleavage stage embryos, and in 2013 the 
live delivery rate for women for all ages after blastocyst transfer was 28.4% (Macaldowie 
et al., 2015; Macaldowie et al., 2014). 
 Younger women have a higher success than older women. In 2013, the live birth rate per 
initiated cycle for women aged 35–39 years was 16.3%, per embryo cycle 23.1%, and per 
clinical pregnancy 74.8%. This compares with live birth rate per initiated cycle for women 
aged 40–44 years being 5.9%, per embryo cycle 9.2%, and per clinical pregnancy 58.5% 
(Macaldowie et al., 2015). Published ART success rates vary between different ART 
providers; live births rates for autologous cycles range from 19.8% to 29.0% for women 
aged younger than 35 years and from 9.6 to 15.7% for women aged over 35 year (Wang, 
Macaldowie, Hayward, Chambers, & Sullivan, 2011a). One reason for variations in 
success rates may be due to varying ages of women or different stages of embryo 
transfer.  
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Cumulative success rates can be based either on pregnancy or live birth rates. These 
rates include the initial stimulated cycle and subsequent transfer of any frozen embryos 
resulting from that stimulated cycle, and is the statistic frequently cited by infertility clinics. 
Cumulative success can give a higher rating than single cycle rates. In Australia between 
2009 and 2011, the overall cumulative pregnancy rate was 54.9% for age 35–39 years, 
29.4% for aged 40-44 years, and 3.5% for women aged 45 and older. The cumulative live 
birth rates were 40.7% for women aged 35–39 years and 16.4% for women aged 40–44 
years, and 1.7% for those aged 45 years or older (Macaldowie et al., 2013). Cumulative 
success rates may increase the expectation of success compared with the single cycle 
rates reported above. Daya (2005) suggests that cumulative success rates are not 
appropriate for ART, as the scale for measuring the time span for all treatment cycles and 
the variability between treatment types (i.e., fresh embryo transfer or frozen embryo) does 
not give a comparable measure. However, clinics prefer to publish Cumulative Pregnancy 
Rates (CPR) because they tend to overestimate of the efficacy of treatment. An infertility 
clinic marketed their CPR for women 35–39 years as 45.2% and women aged 40 and 
older as 19.3%, compared with the ANZARD cycle data for 2009 as 24.3% for age 35–39 
years and 10.9% for age 40 and older (Wang et al., 2011b). The cumulative live birth rate 
for all age groups was calculated as 21.1% after the first cycle, 31.1% after two cycles, 
36% after three cycles, 38.6% after four cycles, and 40% after five cycles. There is little 
chance of a pregnancy after the fifth round of ART regardless of a woman’s age, and the 
sixth cycle only increases the chance by 0.7% (Macaldowie et al., 2013). 
4.3 Health Issues For Conception And Birth For Midlife Intending Mothers  
Medical complications for both mother and baby are more frequent in midlife intending 
mothers. As discussed in this chapter, most women accessing ART are of an age that is 
an independent risk factor for certain adverse events in pregnancy (Jolly, Sebire, Harris, 
Robinson, & Regan, 2000). Younger women have less ante-partum and intra-partum 
complications than women aged over 35 years (Bewley, Foo, & Braude, 2011; Braat, 
Schutte, Bernadus, Mooij, & van Leewen, 2010). Increased risks of adverse health 
outcomes for children born to midlife intending mothers are established in the literature. 
4.4 Risks For Any Midlife Mother 
Midlife mothers have an independent risk for certain adverse events during pregnancy 
such as non-insulin-dependent diabetes mellitus, gestational diabetes, hypertension or 
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medical morbidity. Some of these conditions increase in occurrence with age and are of 
concern during pregnancy (Berkowitz, Skovron, Lapinski, & Berkowitz, 1990; Bianco, 
1996; O'Connor & Johnson, 2005; van Katwijk & Peeters, 1998; van Noord-Zaadstra et al., 
1991). Older mothers enter pregnancy with a higher incidence of pre-existing medical 
conditions, such as non insulin-dependent diabetes mellitus and hypertension (Bianco, 
1996). Gestational diabetes occurs more frequently in this group because pancreatic beta-
cell function and insulin sensitivity decrease with increasing age. Women entering 
pregnancy with a predisposition to non insulin-dependent diabetes mellitus are more likely 
to have an inadequate insulin response and increased insulin resistance than younger 
women (Jolly et al., 2000). There is a fivefold increase in gestational diabetes rates for 
women aged between 25–40 years with chronic hypertension is detected in 1.5% of these 
women (van Katwijk & Peeters, 1998).    
Midlife intending mothers have a higher chance of gestational complications such as 
ectopic pregnancy, prolonged labour, placenta praevia, low birth weight (LBW), birth 
asphyxia and foetal growth restriction, pre-term delivery and delivery by Lower Section 
Caesarean Section (LSCS) rather than spontaneous vaginal delivery (van Katwijk & 
Peeters, 1998). Labour is more complicated and more dysfunctional in older women, and 
clinicians are more likely to recommend a LSCS delivery to avoid possible complications. 
In Australian in 2011, one-third of deliveries were by LSCS, with 41% of women aged 35–
39 years, and 49% of those aged 40 years and older having a LSCS (Li.Z, Hilder, & 
Sullivan, 2013). 
Nulliparous (a woman who has never given birth to a viable or live infant) older women 
have an increased risk of a having a foetus with a chromosome abnormality, an ectopic 
pregnancy, miscarriage or a stillbirth than nulliparous younger women (Freeman-Wang & 
Beski, 2002; Prysak, Lorenz, & Kisley, 1995). Women who have their first child when aged 
35 or older have a significantly greater risk of complications of pregnancy and delivery 
compared with women of the same age who had already had at least one birth (Berkowitz 
et al., 1990; Nabukera, Wingate, Kirby, Owen, & Swaminathan, 2008; Pandian, 
Bhattacharya, & Templeton, 2001). The average miscarriage rate for women of all ages 
without an underlying chromosomal problem is 16.1% for women aged 35–39 years and 
this rate increases to 42.9% for women aged 40–44 years (Jansen, 2003). Midlife 
intending mothers have a risk of miscarrying a pregnancy, greater risks during pregnancy, 
and greater risk of a baby with congenital problems compared to younger women. 
However, despite the clinical risks, children of older mothers are shown to be at a lower 
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risk for behavioural and academic difficulties compared to women in their teens and 
twenties, conferring a protective maternal influence (Tearne, 2015). 
4.5 Risks In Using ART 
The rate of maternal death from medical complications in women aged 35–39 years of age 
is twice as high and for those aged 40 years and older is five times that of younger women 
(London, 2004), and most women using ART are aged 35 years and older. The numbers 
of initiated cycles for idiopathic infertility in the UK tripled between 2000 and 2011, 
whereas the number of cycles initiated for cycles for fallopian tubal problems decreased by 
one-third. Mol and Bhattacharya (2014) propose that the extended use of ART increases 
the risk of harm to babies because babies conceived through ART have more health 
concerns than naturally conceived babies.  
ART may expose women to health complications caused by hormonal hyperstimulation. 
Ovarian hyperstimulation syndrome (OHSS) results from an excessive response to 
superovulation drugs and manifests as high oestrogen levels, increased ovarian size and 
fluid imbalance. Severe cases involve pleural effusion and compromised cardiac, renal 
and liver functions. OHSS is potentially a fatal condition because of its thromboembolic 
phenomena (Akagbosu, 1999; Assisted Reproductive Technologies Review Committee, 
2006; Braude & Rowell, 2003a; Templeton, Morris, & Parslow, 1996). Bewley, Foo and 
Braude (2011) support notification of deaths from OHSS as required in Australia.  
Women with ART-conceived pregnancies had a higher rate of LSCS than natural 
conceptions: 50.7% of women aged 35–39 years and 66.2% in women aged 40–44 years 
with ART-conceptions compared to 41% of mothers aged 35–39 years and 49% of 
mothers aged 40 years or older (Australian Institute of Health and Welfare, 2014b; Laws & 
Hilder, 2010; Wang et al., 2009; Wang et al., 2011b).  
Handyside, Montag, Magli, Repping, Harper and Schmitzler (2012) suggest that the risks 
of advanced maternal age indicate a role for ovarian stimulation in perturbing meiosis in 
ageing oocyte. The use of superovulatory drugs to stimulate the ovaries of older women 
increases the chance of a chromosomally abnormal embryo. Handyside et al. (2012) used 
array comparative genomic hybridisation, which looks for chromosomal abnormalities in all 
22 pairs of chromosomes, and found multiple aneuploidies in ART conceived embryos. 
This shows that ART can damage the oocytes, lessen the chance of a normal embryo, and 
increase the chance of a chromosomally abnormal baby. Routine non-invasive prenatal 
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screening screens for only three trisomies and sex chromosome abnormalities, and 
abnormalities on other chromosomes could be missed by screening compared to 
diagnostic testing such as karyotyping. Handyside et al. (2012) found that for both 
spontaneous and ART conceived pregnancies, trisomies occur mainly in female meiosis 
and mostly in the first meiotic division. Analysis of ART conceived oocytes from women 
aged between 33–44 years found that pre-division caused a lack of cohesion is a major 
factor in loss which may be due to a higher level of ovarian stimulation on aging oocytes. 
On the other hand, Pendina et al.(2014) did not find a significant difference in women aged 
35 years or older. The Handyside study was conducted using comparative genomic 
hybridisation (CGH) and the Pendina study using standard karyotyping and as improved 
molecular techniques such as CGH or next generation sequencing improve, the question 
of whether ART has an adverse effect on oocytes will be clarified. Older women, whether 
using ART or not, should be aware of a greater chance of chromosomally aneuploid 
embryos and consider prenatal diagnostic sampling and karyotyping during early 
pregnancy (Handyside et al., 2012). Furthermore, as Kamphius et al (2014) demonstrates 
reviewing single embryo transfer with blastocyst transfer found an additional 50-70% risk 
of preterm and congenital malformation suggesting caution should be exhibited about 
using ART in couples where the benefit is questionable or there is a chance of a 
spontaneous conception. 
4.6 Risks To Babies Born To Midlife Intending Mothers And Women Using ART 
ART treatment contributes to a greater number of multiple births from multiple embryos 
transferred each cycle, with multiple pregnancies usually delivering before term. Multiple 
births are more likely than ART-conceived singletons to require neonatal care and have a 
LBW (Shieve et al., 2002). Perinatal outcomes for ART for either a singleton or multiple 
birth is reflected in greater usage of neonatal services and paediatric services for the first 
five years of life, which is a funding concern for health services (Chambers et al., 2013b). 
Reduction in multiple birth rates is occurring in Australia because of recommendations by 
the Fertility Society of Australia (FSA), which encourages single-embryo rather than 
multiple-embryos transfer per cycle (Fertility Society of Australia, 2005; Wang et al., 2009). 
The average gestational age for Australian ART-conceived pregnancies in 2013 was 37.9 
weeks (Macaldowie et al., 2015), which is shorter than the population average of 38.7 
weeks (Hilder et al., 2014). Australian data show that ART- conceived twins were born at 
34.8 weeks and overall Australian twin births averaged 35 weeks gestation (Hilder et al., 
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2014; Macaldowie et al., 2015). ART-conceived infants born between 22 and 26 weeks 
have a higher incidence of long-term moderate to severe functional disability than do those 
conceived spontaneously (Abdel-Latif, Bajuk, Ward, Oei, & Badawi, 2013).   
Preterm delivery usually results in LBW babies (World Health Organization, 1992). 
Singleton births for midlife intending mothers from ART-conceived pregnancies have 
significantly higher risk of LBW and in 2007 13% of Australian ART-conceived singleton 
babies had a LBW compared with 6.4% of Australian spontaneous-conception babies 
(Laws & Hilder, 2008; Shieve et al., 2002; Wang et al., 2011b). These differences are 
attributed to higher pre-term delivery rates for ART-conceived babies, although Marino 
(2014) suggests that the mode of ART, such as fresh-embryo transfer, results in a 250g 
reduction in birth weight. LBW contributes to 65–75% of neonatal deaths, and LBW ART-
conceived infants may have ongoing health problems, which are associated with higher 
rates of hospitalisation compared to their full-term peers, and a greater risk of neonatal 
death (Marino et al., 2014; Tough et al., 2002). Marino (2014) confirmed an increased risk 
of LBW and preterm birth in Australian ovulation-induced women.  
There is ongoing research indicating that girls born with a LBW or small for gestational age 
(SGA) have an increased risk of infertility in adulthood due to female fertility factor. Women 
with female factor infertility were twice as likely to have been born with LBW or SGA. In a 
Swedish study of 1206 births, babies with a LBW were 2.4 times and with SGA were 2.7 
times more frequent in women with female factor infertility than male or idiopathic 
diagnosis. As ART-conceived babies have a higher risk of LBW, those conceived by ART 
may go on to have difficulty in conceiving naturally themselves later in life (Vikstrom, 
Hammar, Josefsson, Bladh, & Sydsjo, 2014). 
ART pregnancies have an increased rate of stillbirth as confirmed by an Australian and a 
Danish study. A South Australian study between 1986–2002 of singletons conceived by 
ART compared to a state birth register showed that ART conceived singletons were more 
likely to be stillborn, and surviving babies had low birth weights and a higher chance of 
neonatal death compared with singletons conceived spontaneously (Marino et al., 2014). 
Research in Denmark has shown that ART conceptions have four times the chance of 
being stillborn compared to non-ART conceptions, (Wisborg, Ingerslev, & Henriksen, 
2010). The Australian rates of perinatal mortality for ART-conceived births in 2007 were 
1.4% (Laws & Hilder, 2008; Wang et al., 2009), which remains higher than the 1.03% for 
all Australian births in 2006.  
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Determining the risk of long-term health complications for ART-conceived babies is 
difficult, as health data can be difficult to obtain and environmental factors have to be 
excluded. Wilson and colleagues (2011) review article was unable to reach a conclusion 
about the likelihood of health problems for ART-conceived babies. Large longitudinal 
studies would assist these determinations. Smaller studies have shown that midlife 
intending mothers have an increased chance of delivering a baby with congenital defects 
that are genetically derived, and clinically present, with neonatal health problems 
(Nabukera et al., 2008). Older women can have children with increased health risks 
including higher rates of autistic spectrum disorder, cerebral palsy, cancer and mental 
retardation compared to women who are fertile (Blackburn-Starza, 2006; Croen, Najjar, 
Fireman, & Grether, 2007). Whereas, Halliday et al. (2014) researching ART-conceived 
offspring did not find an increase in occurrences of cognitive disability, autism or autism 
spectrum disorder in Australian young adults aged 18-28 years. Epidemiological data 
show that, regardless of age or family history, the population risk for any woman of having 
a child with congenital health anomalies is 3%. Katari, Turan, Bibikova, Erinle, Chalian and 
Foster (2009) found a 4–6% occurrence of congenital anomalies and Viot  (2010) found a 
rate of 4.24% for ART-conceived babies which is not markedly different from the general 
population. Some subtle genetic changes indicating possible precursors in adult life of 
hypertension, non-insulin-dependent diabetes mellitus and cancer possibly due to 
epigenetic changes at time of conception are found in ART-conceived babies (Katari et al., 
2009). Horwitz (2000) suggests that these epigenetic changes have been implicated in the 
development of obesity and non-insulin-dependent diabetes mellitus, and changes in gene 
expression have long-term effects on patterns of gene expression, which may manifest as 
health issues in future generations. Pontesilliet al. (2014) suggests that ART is responsible 
for babies having higher glucose levels which impacts on adverse cardiovascular and 
metabolic conditions during childhood compared to non-ART-conceived babies. Some of 
these studies have small sample sizes and long-term assessment of ART-conceived 
children is required to determine if clinical differences exist from such conceptions. 
Midlife intending mothers using ART are more likely to have chromosomally abnormal 
embryos. These genetic abnormalities are mainly congenital cardiac conditions, 
malformations of the urogenital tract, retinoblastoma and angioma. It has been suggested 
that these malformations arise from genetic errors that occur during the ART procedures 
(Viot et al., 2010). DNA methylation controls which genes are expressed in certain cell 
types, and errors in methylation disturb embryonic development and can manifest as 
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clinical syndromes (Chang et al., 2011; Moisse, 2010). Methylation of DNA occurs when 
there is an interaction between environmental factors, such as the interaction between 
fertility treatment and genetic expression, (Katari et al., 2009). It is proposed that either the 
gametes or the embryos from the parents have abnormal epigenetic markers or the 
process of ART has allowed the methylation to take place, which increases the risk of a 
child having severe health problems. These can include imprinting, when the expression of 
a gene is expressed either maternally or paternally non-equivalently.  
Some congenital genetic abnormalities involve imprinting genes for Angelmann Syndrome 
(AS), which manifests as intellectual disability and developmental delay, and Beckwith-
Wiedmann Syndrome (BWS), an overgrowth disorder with gigantism, macroglossia, and 
an elevated risk of kidney tumours (Halliday, Oke, Breheny, Algar, & Amor, 2004). In the 
case of AS, a maternally inherited microdeletion on chromosome 15q manifests as severe 
mental retardation and small stature (Gardner & Sutherland, 2004). AS occurs in 1 in 
15,000 to 20,000 births, but the risk increases to 1 in 4000 in ART-conceived children 
(Moisse, 2010). A 10–fold increase in BWS was observed in Canada with 1 in 1,300 ART 
conceived births compared to 1 in 13,000 in the general population with BWS (Blackwell, 
2011). Gosden (2003) reported BWS 3–4 times higher after ART in three overseas 
locations compared with naturally conceived babies. Researchers are looking for the 
mechanism underlying such relationships between ART, imprinting genes and the 
environment (Chang et al., 2011; Tierling et al., 2011). Batcheller, Cardozo, Maguire, de 
Cherney and Segars (2011) support epigenetic changes as ART-conceived children have 
an increased risk for cardiometabolic abnormalities and genomic wide changes in DNA 
methylation. Some researchers question these associations and further research is 
required to clarify any associations (Odom & Segars, 2011). 
Katari et al. (2009) found that conception in vitro is associated with small but statistically 
significant differences in methylation at CpG (cytosine-phosphate –guanine sites) sites 
compared to conception in vivo. This occurs when DNA methylation at CpG sites changes 
the cytosine to 5-methylcytosine (MeCpG). Handyside (2011) suggests that ovarian 
simulation in ART may disturb the process of embryonic development as the 
chromosomes are separating prematurely, in particular the smaller sized chromosomes 
from 11 to 22. Embryos with errors in meiosis II, result in premature segregation of 
chromatids and chromosomally abnormal embryos, and will either spontaneously miscarry 
or result in a chromosomally abnormal foetus. Maternal age is related to age-related 
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oocyte degeneration with potentially serious genetic implications for ART conceived babies 
(Lim & Tsakok, 1997). 
The long-term effects of infertility treatment are being studied longitudinally, but there is 
speculation that female children born to women who have received ovarian 
hyperstimulation might themselves have trouble with conception (Shelley, Venn, & Lumley, 
1999). The first ART-conceived baby in Queensland now has delivered her own healthy 
child (Keeping, 2010). A genetic theory of a correlation between maternal age at 
conception and the lifespan of offspring, although modified by epigenetic factors, proposes 
that the mtDNA (mitochondrial DNA) in oocytes from older intending mothers may be at 
increased risk of a reduced lifespan. The mechanism of inheritance of compromised 
mtDNA suggests that mitochondrial metabolism in offspring would start at a less than 
optimal level of efficiency (Wilding, 2015). Genetic effects on offspring due to maternal age 
would benefit from further investigation.  
Risk is evident for women having children in midlife, in particular for women aged over 40 
years, so accurate information on inherent risks allows prioritisation of risk versus benefits 
allows informed choice. However, identifying the lowest risk option is not always 
appealing, as the desire for a child can override concerns about medical risks (Smajdor, 
2011). 
4.7 Psychological Stressors Associated With Infertility And ART  
ART can be invasive, painful, expensive and time consuming, and hence have a profound 
and intense impact on people’s lives (Salvatore et al., 2001). It is well known that infertility 
treatment is for some women a time of anxiety and stress. Wang et al. (2015) found, of 
400 patients using ART, one-third had borderline or abnormal levels of anxiety and one-
fifth had borderline or abnormal levels of depression. Findings from a study of 427 patients 
in 29 Dutch fertility clinics highlighted the importance and association between the level of 
patient-centeredness, quality of life, and levels of anxiety and depression (Aarts et al., 
2011). Patients in two studies in Dutch infertility clinics expressed the need for more 
patient centred care, emotional support, continuity of care and access to their medical 
records to improve patient-centeredness (van Empel et al., 2010a; van Empel et al., 
2010b). Dancet et al.(2010) suggest that fertility staff comprehend that patients, in addition 
to medical care, want to be treated like human beings.  
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The stressors associated with infertility are physical, emotional and financial. Infertility in 
one partner can emotionally affect the other partner and their extended social network 
(Greil, Slauson-Blevins, & McQuillan, 2010). Infertile women exhibit greater levels of 
anxiety and depression than control populations of fertile women, however it is unclear if 
these levels are clinically significant (Conrad, 1992; Cook, Parsons, Mason, & Golombok, 
1989; Downey et al., 1992). Grief associated with infertility is compared with that 
experienced to the loss of a child, although it is the potential for loss of a wanted child 
rather than a physical loss (Lemeke, Pattison, Marshall, & Cowley, 2004:573). Heitman 
(1999) suggests that the profound despair after unsuccessful treatment is as 
overwhelming after initial hopes for success. There is a profound sense of loss when 
deciding to cease treatment so some women continue treatment to avoid grief (Tymstra, 
2007). Some women find the hope instilled in them from the clinics make the decision to 
stop treatment difficult (Cummings, 2005). 
The concept of psychogenic infertility treatment, in which infertility is caused by 
unconscious psychological factors, was thought to exist, although medical technology now 
disputes the notion that infertility arises from conscious thought (Wischmann, 2005). 
Facchinetti and Fazzo (2005) suggest that, as fertility is the norm, infertility is perceived as 
a failure of the couple, their friends, and family and is dependent on cultural norms. As 
noted earlier, many fertility treatment cycles may be unsuccessful with more than half of 
women using ART not having a baby and cycle failure an inescapable stress as women 
may anticipate cycle failure.  
People often suffer psychological distress when faced with a life crisis such as infertility, 
which affects their self-esteem, sense of control over their lives and their social stability 
(Fouad & Fahje, 1989; Greil et al., 2010). A life crisis is the occurrence of an unexpected 
event that may affect the individual in a negative way or the lack of an expected transition 
of a rite of life passage, such as parenthood (Gerrity, 2001; Menning, 1977). A Japanese 
study found infertility and ART treatment can be a life crisis and the fourth most dramatic 
life event in a woman’s life after the death of a parent or the infidelity of a life partner 
(Matsubayash et al., 2004).  
The psychological effects for women can be long-term and can manifest as depression, 
lower life satisfaction and lower self-esteem for many years (Australian Institute of Health 
and Welfare, 2011; Beaurepaire, Jones, Thiering, Saunders, & Tennant, 1994; Bryson , 
Sykes, & Traub, 2000; Dunkel-Schetter & Lobel, 1991). Verhaak et al. (2006) found in their 
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long-term study of psychological adjustment, that despite anxiety and depression 
commonly experienced during treatment, these reduced over time even for those who 
were unsuccessful. Psychological conditions, such as anxiety, may occur more frequently 
in midlife intending mothers, and higher levels of anxiety are found in pregnant women 
aged 40 or older (Bevilacqua, Barad, Youchah, & Witt, 2000). Bradow (2012) used the 
Post Traumatic Stress Disorder (PTSD) Checklist-Civilian to evaluate PTSD in women 
exhibiting either primary or secondary infertility. Findings combined with quantitative data 
found that women with primary and secondary infertility had a frequency of PTSD 
instances six times the population level. Infertility is a traumatic event for some women 
which can lead to experiencing PTSD symptoms. 
Women understandably experience positive emotions after a successful ART cycle and 
increased negative emotions after unsuccessful cycles. This can escalate after 
unsuccessful cycles leading to subclinical emotional problems in some women (Verhaak et 
al., 2006). Greil, McQuliian, Lowry and Screffer (2011) undertook a telephone study of 
4,787 women aged 25–45 years of age and found that the treatment was associated with 
fertility-specific stress in addition to the stress of the infertility alone. Infertile women who 
do not undertake ART had lower levels of distress than did treated women. Treatment 
causes distress over and above that associated with being infertile, and this is not 
dependant on the length of treatment time or if a live birth was achieved (Anderson, Sharp, 
Rattray, & Irvine, 2003; Greil et al., 2011).   
Psychological stressors can be accentuated for some women if they experience “victim 
blaming”. Van Balen (2002) suggests that victim-blaming is a psychogenic concept that 
increases the distress for women having ART because it places the cause and blame for 
infertility in the mind of the infertile woman, despite failure of the technology and not the 
woman. Victim blaming is a socially constructed belief system which seeks to make victims 
of others who are outside the social norm to maintain the social norms (Ryan, 1972). 
Victims are blamed for their situation, such as older women seeking infertility treatment 
(Sandelowski, 1986). The community may shame women for delaying childbearing by 
victim blaming, as women are solely blamed for the choice they made and partially 
responsible for the harm they experience (Pennings, 2001). Women may ask themselves if 
they have done enough to have a child. 
Psychological emotions can also influence women’s decisions to have ART treatment or to 
discontinue treatment and remain childless. ART cycles can induce stress because of the 
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hormonal fluctuations during superovulation, cancelled cycles due to poor ovarian follicle 
development, failure of oocytes to fertilise, embryo implantation failure, early pregnancy 
failure, OHSS, and stress about the affordability of the ART. Stimulation cycles are 
cancelled more frequently for midlife intending mothers (often due failure to respond) and 
delays can be stressful as the chance to have a baby declines with each lost month. 
Women can have a roller-coaster ride of hope, anticipation, fantasy, elation, anxiety, 
disappointment, despair, and grief if a cycle is cancelled or unsuccessful. Repeated failed 
cycles become difficult for women to cope with, and grief can develop into depressive 
symptoms (Alesi, 2005). Between 2009 and 2011 of the over 44,000 Australian women 
who used ART, 264 women had 10 or more initiated cycles ART (Macaldowie et al., 2013). 
Treatment is difficult for women who do not have a successful outcome. Couples having 
their first cycle reported that their marital relationship improved as the couples supported 
each other (Holter et al., 2006), however other research found some women had 
depression or anxiety six months after unsuccessful treatment (Verhaak, Smeenk, van 
Minnen, Kremer, & Kraaimaat, 2005). Some women with involuntary childlessness 
experience long-term grief and feelings of social isolation (Ferland & Caron, 2013; 
Kirkman, 2001b). Zoll’s (2013) book describes women depending on science to help them 
become mothers and some had to come to terms with their belief that women can have it 
all.  
4.8 The Marketing Of Hope Despite Risks 
ART is depicted as a mainstream medical procedure that is helpful for infertility despite the 
emotional, physical and financial costs involved (Diepenbrock, 2000). Lisa Jardine, the 
former chair of the Human Fertilisation and Embryology Authority, states that the world of 
IVF is a market of hope where users should be fully informed of its potential to deliver grief 
as well as success (BBC News, 2013). Health and illness provide the media with stories of 
technological miracles, magic and mystique. Media plays a major role in demystifying 
medical issues and has a pivotal role in the shaping of public opinion on medical problem 
and health risks. It can manipulate public opinion, educate the public and supply news 
items for the medical consumer market (Williams & Calnan, 1996b) (Williams & Calnan, 
1996b)   
Dramatisation and oversimplification of health issues by the media, may leave the 
individual with a distorted version of the facts (Lupton, 2005). In the case of infertility and 
ART, media gives a perception of tension between a biological imperative for children and 
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women’s socio-cultural aspirations (MacDougall et al., 2013). Hurley (2013) suggests that 
this may be, in part, due to journalistic enthusiasm where promising new developments in 
ART are portrayed as proven without undergoing clinical trials. In the Australian print 
media, childless women are constructed as requiring sympathy and as career women first, 
and motherhood is depicted as a valued role. Thus, childless women may be portrayed 
negatively (Graham & Rich, 2014). Media welcomes the notion of a women’s childless 
state being rectified by ART as generates public interest.  
Media is a source of information for many individuals and interest groups and about social 
issues involving new technologies and scientific discoveries. Media releases are designed 
and promoted by professional public relations agencies (Raymond, 1990; Valiverronen, 
2004). An integral part of such media promotions through media is “creating the need” for 
of a new drug or technology (Moynihan & Henry, 2006). Media is one of the main sites 
where cultural images of biotechnology and genetics evolve and are circulated 
(Valiverronen, 2004). Through newspapers, magazines, television and other sources, 
media can influence ideas, decisions and perception and advance social change through 
successful marketing (Kotler & Zaltman, 1971).  
ART offers more promise than performance as depicted in the language, images and 
themes of success as conveyed in the media, and highlights the miracles stories and the 
technical abilities of ART. The media is a popular source of information regarding ART, 
and there is widespread public acceptance of ART as a routine medical procedure (Cline & 
Haynes, 2001). ART as a fall-back option is normalised through the media portrayal of 
medical specialists and successful patients. Newspapers and women’s magazines give 
women encouragement despite the fact that many older patients are not successful (BBC 
News, 2013). Shanahan (2012) highlights the marketing for some Canberra IVF clinics, 
which have advertised on daytime television using attractive young ART participants, when 
in reality most women who use ART aged in the middle 30s, in soap-opera type scenarios 
to promote the use of ART. Zoll (2013) discusses a culture of hope and success reinforced 
by the fertility clinics, in which women do not discuss failed cycles and the inability of ART 
to solve reproductive problems, and there is an absence of truth. Zoll agues that such a 
culture of hope and success is misleading.  
Media influences community attitudes about reproductive choices, such as childbearing 
and contraception. A study that provided online educational information to a group of 
undergraduates on fertility, ART, and delaying childbearing resulted in an increase in 
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knowledge on fertility and a change in intention to have children at an earlier age 
(Wojcieszek & Thompson, 2013). Despite the benefits and availability of online resources, 
Daniluk (2015) found in a study of 199 men and women aged 18–35 years that fertility 
knowledge and ART initially improved after viewing online sources, but decreased to pre-
intervention levels after six months, particularly for male participants. Online education 
may be beneficial however the extent of retention of that information over the longer term 
is unknown. Holton et al.(Holton et al., 2016) found Facebook an effective media tool for 
young women to discuss reproductive health issues.  
Media has been accused of playing on the desire for easy technological solutions to 
problems of infertility (Nelkin, 1995). Media portrayal of success stories has been in the 
public domain since the early years of ART in Australia. Nobel and Bell (1992:25) analysed 
Australian press articles about ART for six months in 1988, and found numerous sources 
in the articles about women who had been successful, medical miracles, and little 
coverage of risks or psychological issues. Analysis of British print media in 2009 found 
little discussion of the risks of pregnancy and birth in older women and reinforced the 
notion that ART could solve fertility problems including ageing (Mills, Lavender, & 
Lavender, 2015). On the other hand, a Canadian study found that 63% of newspaper 
articles in the Canadian press from 2005 to 2011 discussed the risks of ART (King et al., 
2014). The aforementioned Canadian study found almost half of the newspaper articles 
depicted a medical miracle with stories of women bearing children aged in their 60’s and 
70’s depicted positively, but there was limited criticism of the technology. Technological 
advances in ART, as depicted in the media, helping to compensate for age-related fertility 
decline, may influence women to delay their childbearing (Leader, 2006). There is often 
scarce coverage of the many women who have not had successful cycles. The anecdotal 
personalisation of ART success stories contains minimal scientific empirical data and often 
omits the personal and financial costs, the risks of the technology, or the success rate 
versus the failure rate. ANZARD data indicate that, that for older women, inability to 
conceive rather than success is the most likely scenario contrary to the media stories of 
older mothers or celebrity mothers (Firth, 2005; Fitzmaurice & Wood, 2004; Gosse, 2006; 
Macaldowie et al., 2014; Wildman, 2006). 
The normalisation of reproductive medicine also occurs through women’s magazines. The 
discourse of women and their ART success in these magazines appears to follow a 
number of formulae (Diepenbrock, 2000). Having a baby is thus normalised, and infertility 
is portrayed as a devastating experience. One of these constructs is that normal women 
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want to have babies. Media has depicted medical technology as normalising ART 
treatment for the ordinary woman who endures pain and discomfort to gain her goal of a 
perfect child and who is assisted by a benevolent and humble medical specialist 
(Diepenbrock, 2000; Gibson, 2004; McLean, 2004). Consequently, women may have 
unrealistic perceptions of ART specialists, procedures, abilities and limitations (Bell, 2006; 
Peddie, van Teijlingen, & Bhattacharya, 2005). 
As the knowledge gap between doctor and patient lessens, medical practitioners become 
challenged as holders of expert knowledge (Kirkman, 2001a). Medical information in the 
media is often written as a sales pitch promoting the expertise and the success rates of 
clinics and is portrayed as in the public interest rather than as an advertisement (Halpern, 
1989). Such information provided by a professional, even if they have a vested interest, 
will create more interest and creditability than from a member of the public (Lupton, 2005), 
as illustrated in Canadian newspapers where almost half of the articles were cited by ART 
experts (King et al., 2014). A move to use social media to disseminate medical information 
on the limits of women’s fertility, and the capabilities and limitations of ART, could provide 
healthcare information which is effective and efficient provided the source is authoritative 
and without industry direction (Lupton, 2005), and counteracts the unrealistic portrayal of 
ART in the media. The difficulty in determining the level of engagement with health-care 
information and the effectiveness of social media, as a health-promotion tool is yet to be 
determined (Noble & McDonagh, 2014) .Primary health providers should guide their 
patients to online sites that provide expert information (Fahy, Hardiker, Fox, & Mackay, 
2014; King et al., 2014). 
Kimberley-Smith’s (2003) research showed that female undergraduate students have an 
unrealistic sense of security of delayed motherhood and the success of ART and that the 
media portrayal of images of celebrity births to older parents contributes to this lack of 
awareness of age-related fertility. Media coverage of celebrities having miracle babies 
after the age of 40 years gives women the impression that there are no age barriers for 
conception and that ART can extend the age at which women can be fertile (Caplan & 
Patrizio, 2010). 
Another false assumption of the success of ART is the portrayal of the technology by 
doctors and infertility clinics. As Haussenger (2005) suggests, women could have 
unfounded expectations of ART because marketing campaigns of infertility clinics tend to 
hide the discouraging facts of ART and to promote pregnancy at any cost. Media may 
   70 
influence decisions on the timing of childbearing and success of ART, and individuals may 
have trouble understanding statistical information and medical technology so the 
communication of information in an easily understandable format is vital. However, some 
unwise decisions do not originate from misinformation or incorrectly interpreted information 
and should not always be attributed to these factors (Smajdor, 2011). Education and 
information implemented by government agencies could improve community knowledge 
(Lemoine & Ravitsky, 2013). 
4.9 Accreditation And Governance Of ART In Australia 
Most states have some form of regulation to govern the use of ART except Queensland, 
which had no legislation specifically relating to ART (Cohen et al., 2005; Dawson, 1994). 
Currently, three Australian states have legislation relating to ART; Assisted Reproductive 
Treatment Act (2008) in Victoria, the Assisted Reproductive Treatment Act (1988) South 
Australian, and the Human Reproductive Technology Act (1991) in Western Australian 
(Bell, 2006). The National Health and Medical Research Council (NHMRC) operates under 
the guidelines of the Commonwealth legislations the Prohibition of Human Cloning for 
Reproduction Act 2002 and the Research Involving Human Embryos Act 2002 (National 
Health and Medical Research Council, 2007). Clinics can practice ART without being 
accredited; however, any procedures using embryos have to be accredited by the 
Reproductive Technology Accreditation Committee (RTAC) under their guidelines. In 1986 
the FSA introduced a Code of Practice for Assisted Reproductive Technology Units with 
the role of RTAC to develop program standards for ART clinics in Australia and New 
Zealand and to carry out the accreditation of ART units under FSA guidelines (Assisted 
Reproductive Technologies Review Committee, 2006). The guidelines for RTAC were 
consistent with the Ethical Guidelines on Assisted Reproductive Technology 1996 and 
2004 produced by the NHMRC (Assisted Reproductive Technologies Review Committee, 
2006). This Code of Practice was revised in 2008 and introduced compulsory actions and 
requirements to improve the standard of care, and to ensure minimum standards were met 
by ART clinics and to compel the clinics to function within a documented Quality 
Management System (Fertility Society of Australia, 2009).   
The NPESU was supported by the FSA to establish a register of, and the outcome of, ART 
cycles. This register is the only credible source of information on ART cycles and success 
rates in Australian and New Zealand. The initial report collected data from 12 units in 
Australia and one in New Zealand, and now reports on all ART units in Australasia (Ford, 
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Nassar, Sullivan, Chambers, & Lancaster, 2003). The FSA initiated a self-regulated 
process with the RTAC, which was formulated with the support of the federal health 
minister (Saunders, 2005). Shanahan (2012) suggests that this industry self-regulation 
confers a special ethical status to itself and the industry moves the ethical goalposts when 
a new technique is proposed. Kamphius (2014) suggests that the ART industry may be 
overused, and the industry should evaluate offering early ART intervention, which may 
have risks, instead of pursuing a natural conception. Kersten (2015a) found evidence of 
overtreatment within the Dutch population with intervention occurred in 36% of couples, 
who were mainly older primagravidas who may have conceived naturally within 1 year of 
trying to conceive, or started ART treatment earlier than the six-month management plan, 
which was considered to be overtreatment. It was suggested that a treatment plan is 
initiated for patients who may be able to conceive with minimal intervention. 
4.10 The History Of Public Funding Of ART In Australia  
In Australia, health expenditure consumes around 9.1% of the gross domestic product 
(GDP), which is lower than other comparable OECD countries (9.6%) and significantly 
lower than the USA (17%) (Duckett, 2007, :37; OECD, 2011). In 2005, the Australian ART 
industry was valued at $170 million; this is estimated to be growing at the rate of 8-10% 
annually in Australia as in other high-income countries (Chambers, Sullivan, Ishihara, 
Chapman, & Adamson, 2009). There is a growing need to make healthcare expenditure 
more sustainable, and as Medicare funds ART, expenditure should be under constant 
review (Chambers et al., 2012a). Australia provides public funding for an unlimited number 
of ART cycles for women who are eligible for Medicare funding. Many other developed 
countries place a limit on public funding for ART, so Australia bears a greater burden for 
this health funding compared to other countries (Assisted Reproductive Technologies 
Review Committee, 2006).  
The Medical Benefits Scheme (MBS) and the Pharmaceutical Benefit Scheme (PBS) 
subsidise infertility treatments and hormonal drugs for ART treatment, and thus permit 
greater equity for all Australian citizens wishing to access ART. The Health Insurance 
Commission, as Medicare, provides funding for ART for certain Medicare item numbers 
(13200 to 13221), which pertain to assisted reproductive services (Australian Government 
Department of Health and Aging, 2009). ART services were included in the Medicare 
Schedule as an initiative of the Hawke Labor government in 1990; before that, all 
treatment costs were born by the consumer.   
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The MBS was costed at $108.6 billion in the year 2004 and ART accounted for 0.25% of 
total health expenditure in Australia (Chambers et al., 2009). In 2006, the total cost of a 
standard ART cycle was estimated to be 14% of the per capita Gross National Income 
(GNI), which equated to 6% for an Australian individual after Medicare and the PBS 
subsidy (Chambers et al., 2009). MBS costing for a single ART cycle including the PBS, 
rose from $5768 in 2006 to $7488 in 2010 (Chambers et al., 2011). A report to the 
Australian Parliament in 2015 showed that ART services are funded under Section 100 of 
the Schedule of the Pharmaceutical Benefits and during reporting year 2013-2014, $85.5M 
funded ART, which is 4.2% of the annual PBS expenditure. ART expenditure averages a 
3.3% annual growth rate (Harvey & de Boer, 2015).  
It is understandable that in the early days of ART, success rates were significantly lower 
than current success rates and Medicare covered a lifetime funding of six stimulated 
cycles per woman. Once the lifetime limit was reached, women had to fund the treatment 
costs themselves and could have an unlimited number of self-funded cycles (Kovacs et al., 
2003; Smith, 2006). The figure of six funded cycles was initially proposed, as 90% of 
women would conceive within four or fewer stimulated cycles. However, this figure was 
challenged as only 50% of women were achieving conception after four to five cycles 
(Kovacs et al., 2003; Saunders & Satchwell, 1995).  
A concerted public campaign by infertility clinicians, consumers and ART support groups 
such as Access Australia challenged the federal government to abolish the capped six-
cycle limit. The campaign was successful and in 2000, this limit was abolished and 
unlimited government reimbursement was provided for ART with no limitations on the 
number of stimulated cycles (Nogrady, 2008). Australia is the only country in the world with 
unlimited publically funded ART cycles. Sweden and Britain have a three-cycle limit with 
an age limit of 39 years and New Zealand a two-cycle limit. Limited funding for ART in 
Britain has resulted in a greater scrutiny on spending on ART services. Shanahan (2012) 
suggests Australians have a unique sense of entitlement for unrestricted public funding for 
ART as demonstrated when proposals to limit Medicare funding for ART is strongly 
challenged by interest groups. 
The next major change to Medicare rebates for ART was the introduction of the Medicare 
Safety Net (MSN) in March 2000, proposed by Tony Abbott, the Health Minister in the 
Howard Liberal government (van Gool, 2004). The EMSN was introduced in March 2004 
and allowed the government to meet 80% of the out-of-pocket expenses (i.e., not covered 
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by Medicare) in a stimulated cycle once the threshold of $700 was spent in a year by non-
concession card holders (Assisted Reproductive Technologies Review Committee, 2007; 
Australian Government Department of Health and Aging, 2005; Smith, 2006). The scheme 
was originally designed to help the elderly, chronically sick and disabled to fund medical 
treatment (Dunlevy, 2007) by covering the out-of-pocket expenses by refunding 80% of 
medical costs above the threshold.  
The Extended Medicare Safety Net (EMSN) was designed to allow higher costing medical 
claims to be better compensated and to improve equity for medical services. The EMSN 
was expanded in 2004 and increased the subsidies for claims above the threshold, such 
as $300 for concession cardholders (Australian Government Department of Health and 
Aging, 2014). However, this was not achieved as clinicians increased their fees which 
permitted patients to reach the threshold earlier, so the patients out-of-pocket costs did not 
change and the clinicians revenue increased and Scott (2015) suggests that this was 
especially lucrative for infertility clinics. Van Gool (2009) describes that the EMSN, which 
aspired to improve equity in medical care, in reality created greater inequality as EMSN is 
related to income, so higher earning individuals users of ART and obstetric services were 
the greatest beneficiaries of the scheme.  
The nominated out-of-pocket expenditure to qualify for the EMSN for ART recipients was 
reached after one ART cycle, enabling 80% of cycle costs refunded for the remainder of 
that calendar year (Chambers et al., 2012a). Those qualifying for the EMSN had their out-
of-pocket expenses for a fresh IVF cycle reduced from $4000 to $1500. Due to reduced 
out-of-pocket expenses, attendance at ART clinics increased by 72% over 5 years from 
31,200 cycles in 2003 to 53,600 in 2008, and Medicare benefits for ART increased 300% 
from $50 M to $202.2 M under the EMSN scheme (Chambers et al., 2012b).  
One Queensland clinic encouraged women to engage in further ART cycles, which they 
may have not been able to afford previously, as Medicare would cover the majority of their 
out of pocket expense (Harris, 2007). Undeniably, the EMSN allowed some women to 
continue having ART cycles when it was evident that they had little chance of conception. 
Overall, the EMSN had not made Medicare services more accessible for Australians living 
in the lower socio-economic quintile (Chambers et al., 2013b). The cessation of the EMSN 
and the capping of the Medicare rebates for ART resulted in a 13% decrease in the 
number of treatment cycles in 2008 (Macaldowie et al., 2010). It appears that the EMSN 
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was a boom to the fiscal running of infertility clinics and was, at times, not in the best 
interests of women. 
Infertility clinician Dr. Richard Henshaw claims that underperforming preforming clinics are 
costing Medicare, private health funds, and individuals more than the best clinics. There 
was a seven-fold difference in the success rates between the best and poorest performing 
clinics. The clinics in the top 25 percentile cost around $2 million of Medicare funding to 
produce 100 babies, whereas the clinic in the lowest 25 percentile costs $6 million dollars 
for 100 babies. Women would benefit from accessing ANZARD data to find clinics with the 
highest success rates, however the Fertility Society of Australia will not release such data 
to consumers (Swan, 2015). This stance is under review by the ACCC (Australian 
Competition and Consumer Commission, 2015). 
4.11 Summary 
The number of cycles of ART in Australia has increased at a rate of around 2% from 2012 
to 2013. One in four autologous cycles were undertaken by women aged 40 years or 
older, and for this age group, age-related oocytes degeneration will be an impediment to 
conception and a live delivery (Macaldowie et al., 2015). On average, older women have 
fewer and poorer quality embryos available for transfer and a higher miscarriage rate 
compared to younger women. They have a higher probability of having a child with a 
chromosomal abnormality due to age-related chromosomal abnormalities than younger 
women.  
Midlife intending mothers using ART can have a higher risk of health problems because of 
their age, a greater risk of having a low birth weight baby due to female factor infertility, 
and a greater chance of needing neonatal intervention than younger women. There are 
more adverse perinatal outcomes for ART-conceived babies than from babies born from 
spontaneous conception. 
In addition to medical risks associated with ART, the frequency and the scope of 
psychological risks are increased for women using ART. Anxiety, depression, and lowered 
self-esteem are emotions associated with ART, regardless of whether the cycle is 
successful or not. The normalisation of ART through the media and medical marketing 
depicts ART as a successful medical procedure and consequently, the failure to conceive 
after ART compounds psychological distress.  
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Media stories of older mothers and the marketing of ART stories of achievements may be 
responsible for unrealistic belief in the success of ART. Stories about medical 
breakthroughs can give a false sense of security about delaying childbearing and using 
ART to rectify the problem (Glover, Gannon, Sherr, & Abel, 1996; Kimberley-Smith 2003; 
Maheshwari, Porter, Shetty, & Bhattacharya, 2007; O'Connor & Johnson, 2005). Media 
accounts can also report a biased view of ART behind glamorous stories, which may be 
misleading for infertile women (Condit, 1996). 
Costs for ART services are continually rising as expectations of ART increase. Since the 
corporatisation of many Australian infertility clinics, there appears to be a push for 
advanced and expensive scientific technology and more invasive and costly ART 
treatments. Rising costs in the health sector are of concern to governments.  
Research indicates that if a pregnancy does not occur within five stimulated cycles, the 
chance of success with further cycles is limited. Unrestricted Medicare rebates for ART, 
particularly for women aged 40 and older with a lowered success rate, warrants scrutiny of 
Medicare funding guidelines. Women who can afford the out-of-pocket treatment costs of 
ART have greater opportunities for conception than those less financially secure. 
4.12 Research Questions 
The review of the literature in Chapters 2 to 4 encompassing this research topic 
shapes the research questions. These are as follows: 
The following eight questions were investigated in this research.  
1 What are the views of women who have engaged with ART about their clinic 
experience? 
2 What were women’s expectations of the success of ART?  
3 What are the views of women involved with ART on women’s age-related 
fertility decline, childbearing decisions, the success of ART, and impact of 
media and marketing on childbearing decisions? 
4 What are the beliefs of the community towards women’s age-related fertility 
decline, childbearing decisions, success of ART,and impact of media and 
marketing on childbearing decisions? 
5 Do social factors such as; career and work, educational attainment, financial 
security, health or partnering relationship influence women’s childbearing 
intentions? 
6 Is there a perception among the general population and consumers of ART 
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that infertility is medicalised and its treatment commodified? 
7 What are the social and psychological impacts for women using ART? 
8 Do women who have engaged with ART have recommendations for women 
in the community regarding the timing of childbearing and ART? 
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Chapter 5: Research Methodology 
5.1 Introduction 
This exploratory research aims to contribute to the existing knowledge of women’s 
experiences of ART, expectations of the technology, factors influencing both the decisions 
to have children in midlife and to use ART. Chapter 5 outlines the sampling and methods 
of data collection used to explore these issues with women who have engaged in ART and 
a community group of men and women who may have little or no experience of ART.  
The investigative procedure of the research is shown in Figure 5.1. A pilot study (Group A) 
was initiated in 2007 while the researcher was employed at one of the research sites, an 
infertility clinic in Queensland. The pilot study was informed by a review of the literature 
and informal discussions with midlife intending mothers attending an infertility clinic. 
Responses from the pilot study guided the research for the two surveys for Groups B and 
C and the interviews for Group D. 
5.2 Methodology 
Initially it was anticipated that sufficient data for the research would be sourced from the 
surveys. However, after reviewing the findings, the researcher decided that the survey 
data could be enriched by interviews with women who had used ART. The qualitative 
findings were supported by the interviews and allowed the research questions to be 
discussed in greater depth (Cameron, 2009; Cresswell & Plano Clark, 2011; Cresswell, 
Plano Clark, Gutmann, & Hanson, 2003; Cresswell & Tashakkori, 2007).  
A mixed-methods approach was adopted as the most appropriate design to address the 
research questions. The rationale for using this method was to better understand the 
research problem by converging both the statistical trends from quantitative data with the 
insightful details of qualitative research (Cresswell & Tashakkori, 2007; Greene, 2008; 
Johnson, Onwuegbuzie, & Turner, 2007). A sequential mixed-methods approach was 
deemed to be appropriate. This method uses one method of data collection (quantitative) 
and builds on those data with the second method of data collection (qualitative) (Cresswell 
& Plano Clark, 2011; Cresswell et al., 2003). This design allowed survey data to be 
collected and analyses and, informed and guided by these findings, qualitative research 
was undertaken through in-depth interviews.  
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A study based solely on quantitative methods risks overlooking critical features of human 
phenomena so that results are sometimes of limited value (depending on the area of 
research) (Hathaway, 1995). One weakness of quantitative research is that it may de-
contextualise human behaviour in a way that removes it from the real-world setting and 
ignores the variables not included in the model being used. In this study, the quantitative 
research does not intensely question participants on their experience of ART but has the 
advantage of being able to analyse responses from a larger number of participants over a 
large geographical area and to identify any statistically significant results (Cresswell & 
Tashakkori, 2007).   
A solely qualitative study risks the criticism of being too subjective and without rigour, as 
no reproducible empirical data can be obtained by this method (as per the scientific 
method paradigm) (Schultze, 2003). However, the rich, in-depth responses from a small 
number of interview participants gives greater insight into the research question and can 
enrich the data obtained from the quantitative study (Crotty, 1998). The combination of 
these two methods was deemed to be an effective way to explore the research questions. 
Central themes were established with the survey data and then studied more deeply via 
interviews.  
Johnson, Onwuegbuzie and Turner (2007) suggest that mixed-methods research 
combines qualitative and quantitative research in viewpoints, data collection, analysis and 
inferences. Only by using both methods can the breadth, depth and richness of the 
research be fully realised (Palton, 1990; Schultze, 2003). Haynes (2012) discusses that 
the concept that reflexivity can allow the researcher to influence the research design and 
its interpretation, which was recognised by the investigator. 
The researcher did not have any personal reasons such as personal engagement with 
ART, delaying childbearing or involuntary childlessness for undertaking the research. The 
researcher has worked within an infertility clinic for 17 years, but was not employed by an 
clinic for most of the duration of the study. 
5.2.1 Study design 
The mixed methods approach is outlined in Figure 5.1. Purposive sampling was used in 
the pilot (Group A), support group survey (Groups B) and the interviews (Group D) to 
ensure that participants provided greater insight into the research questions (Devers & 
Frankel, 2000). Purposive sampling allowed the researcher to use their experience and 
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knowledge of the intricacies of the samples to devise the surveys and interviews (Ritchie, 
Lewis, Elam, Tennant, & Rahim, 2013). Participants were selected because they had 
unifying characteristics related to the research such as having experienced ART treatment, 
which allowed more in-depth analysis (Patton, 1990). For some responses, results were 
also analysed according to gender and age because these have been identified as 
significant factors in the literature (Bianco, 1996; Bornstein et al., 2006; Damario et al., 
1999). These groups were aged; 35–39 years and 40 years of age, and categorised as 
such in ANZARD data (Macaldowie et al., 2015). Chapter 9 reports data separately from 
the open-ended questions in Group B and the interview data from Group D as 
recommended by Foddy (1993).  
5.2.2 Study Groups: 
The study design comprised; Group A: a survey (pilot survey) of midlife intending mothers 
attending a Queensland infertility clinic who had not undertaken ART treatment but 
consulted a clinician and an infertility nurse (N=33). This study was used solely to refine 
the methodology and research questions. 
Group B: a quantitative study comprising an online survey of women, aged 35 years and 
older, who were members of a Queensland infertility clinic's support group and had 
engaged in ART treatment. There was also a qualitative component with an option to leave 
comments (N=68); 
Group C: a quantitative study comprising a telephone survey of a sample of male and 
female Queensland community members (N=1243); 
Group D: a qualitative study involving face-to-face interviews with midlife intending 
mothers attending a different Queensland infertility clinic who had engaged with ART 
(N=6). 
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Figure 5-1 Research Plan for Groups A, B ,C & D 
5.3 Group A: Pilot Study 
Women who were newly registered patients of a Queensland infertility clinic were invited to 
participate in the pilot study. Constraints of the recruitment process only permitted access 
to women aged 38 years or older. The purpose was to determine if participants would be 
willing to respond to such a survey due to sensitivity of the issues; this would inform the 
methods for a longer study. The pilot study was not intended to provide data for analysis. 
These women had registered with the program but had not commenced any ART 
treatment. Women in the pilot survey (Group A) attended their clinic between May 2006 
and July 2008 as registered patients and ranged in age from 38 to 45 years. They were 
invited to participate by a fertility nurse who gave participants a brief outline of the 
research, an information sheet, consent form, survey form and a stamped addressed 
envelope for return of their completed survey. Participants were informed that participation 
in this research would in no way influence their treatment at their clinic. 100 surveys were 
distributed, and 33 surveys were completed and returned to the researcher, representing a 
33% response rate. Comments on question flow and survey design were noted and used 
to design the questionnaire for Group B. The researcher encountered problems with 
survey distribution that may have contributed to the response rate. An analysis determined 
that sample size was small and using participants aged from 38 years of age was not 
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entirely appropriate for this research, for instance, as age restrictions led to lower 
response rates and fewer participants. The pilot determined that women were 
uncomfortable discussing the aetiology of their infertility or were uncertain of the aetiology. 
For those reasons, and as access to infertility patient’s clinical data was unavailable, it was 
proposed to survey women through the support group to improve the response rate and to 
survey women who accessed ART from the age of 35 years.  
5.4 Group B: Support Group Study  
5.4.1 Participants. 
Women who had engaged with ART and were registered patients of a Queensland 
infertility clinic were invited to participate in an online survey by the coordinator of their 
support group. The committee of the support group approved the survey. Members of the 
support group (N = 200) were sent an email inviting them to participate in the study. Those 
who agreed to participate were emailed a link to the Survey Monkey online survey. 
Seventy-seven initially completed the questionnaire but only sixty-six women aged 35 
years and older who had used ART when aged 35 or older fitted the survey criteria. Over 
half the women were aged 40 years or older. Data from nine participants was excluded 
from the analysis as participants were younger than 35 when they had accessed ART. 
Most women were at an age when fertility is likely to be compromised, as the mean age 
was 40.74 years, and represent a cross section of older women accessing ART (Hughes 
et al., 2005; Leader, 2006; Menken, Trussell, & Larsen, 1986; Prysak et al., 1995; van 
Noord-Zaadstra et al., 1991). Women in the support group had engaged with ART after 
their 32nd birthday. Taking into consideration that some researchers consider that fertility 
declines from the age of 32 years, all were potentially in the range of some fertility decline.  
5.4.2 Instrument. 
The survey questions investigated women’s experiences while undertaking ART and their 
expectations of the technology (see Appendix 1). Some participants had achieved a 
pregnancy, and some had given birth and some had not achieved either of these goals at 
the time of the survey. Some women had completed their treatment, some were still 
involved in treatment, and some were planning further cycles. The number of cycles 
undertaken was not available, as ethical clearance did not cover clinical data on the 
aetiology of infertility and data on cycle outcomes. Participants were not asked about 
clinical information as it could not be verified and participants may have an inaccurate 
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recall of their ART treatment (Kessels, 2003). Responses reflected the medical, emotional 
and psychological aspects surrounding engagement with ART. 
The survey contained either multiple-choice format or Likert scale questions (N = 31) with 
two open-ended questions. Open questions allowed participants to describe their own 
experiences and to provide a greater depth of information than permitted by the 
questionnaire, (Carr, Chadwick, Eardley, & Page, 2012). Questions were framed around 
established and peer-reviewed theoretical frameworks that are used widely and have been 
reviewed in the literature on health topics similar to those explored in this research 
(Davidson & Goldenberg, 2003; O'Connor et al., 1999; Siminoff, Ravdin, & Colabianchi, 
2000). A small group of women (N = 36) chose to expand their story on the last page of 
the survey where a section for further comments was provided. Additional comments were 
optional, and these are discussed in Chapter 9. 
The following peer-reviewed instruments were initially intended for inclusion in Survey B; 
however not all items for the instruments for the Fertility Problem Inventory (FPI) and 
Decisional Conflict Scale (DCS) instrument were used as the response number was 
statistically low and psychometric properties could not be properly determined. However, 
some questions from the FPI and DCS were included as they related intimately to the 
research questions. Questions from the following instruments were included in Survey B: 
a) The Fertility Problem Inventory (FPI) 
b) The Decision Regret Scale (DRS) 
c) The Decisional Conflict Scale (DCS) 
a) The FPI provides a reliable measure of perceived infertility-related stress. ART 
treatment and the desire for parenthood reflect social concerns, which are central to 
distress (Newton, Sherrard, & Glavac, 1999). The scale provides validity, measurement 
and structural invariance (Moura-Ramos, Gameiro, Canavarro, & Soares, 2012). This 
research included the ten questions regarding social concerns from the 46 questions in the 
instrument. The remaining 36 questions exploring sexual concerns and concerns about 
relationship stability which were not applicable to the research questions. The responses 
to the ten issues relating to social concerns were analysed and compared and contrasted 
with the qualitative data from Group B and Group D. 
b) The DRS comprises six items that explore healthcare decision regret at a given point in 
time (O'Connor, 1993). The DRS is a 5-item scale that asks subjects to reflect on a 
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particular decision and then rate each item on a 5 point scale from 1 (strongly agree) to 5 
(strongly disagree). A total DRS score is derived from reverse scoring items 2 and 4, 
calculating a mean score, and transforming the average scores by subtracting 1 and then 
multiplying by 25. The total DRS scores range from 0 to 100 and higher scores indicate a 
greater appraisal of decision regret (O'Connor, 1993). The scale is measured using a self-
reported Likert scale with 0 equating to no regret and 100 equating to highest regret  
(Davidson & Goldenberg, 2003]. The DRS {Brehaut, 2003) was used to measure ART 
decision regret and to assess which decisions result in regret if the outcome is not what 
the individual envisaged. This scale has been used previously to assess decisions made 
by cancer patients about whether to access treatment after diagnosis (Davidson & 
Goldenberg, 2003). The DRS was used to evaluate fertility-related decisions in young 
women diagnosed with early stage breast cancer (Peate et al., 2012). The DRS has a high 
internal reliability consistency with a measure of Cronbachs coefficient α of 0.81-0.92 
(Brehaut et al., 2003; O'Connor, 1993). 
c) The DCS (O'Connor, 1995) is a conflict scale to measure what the participant feels it is 
like to live with the consequences of choice concerning health decisions. This scale 
examines choices perceptions of risks and benefits, decision-making and levels of 
emotional stress. The DCS comprises 16 items that measure decisional conflict regarding 
uncertainty about medical action and healthcare users’ perceptions about their decisions. 
The scale quantifies factors that contribute to uncertainty during deliberation before and 
after an ART cycle of treatment. This research used 13 items covering the informed, 
support, uncertainty and effective decision subscales (O'Connor, 1993).  Katapodi, 
Munro,Pierce and Williams (2011) tested the validity of the DCS and demonstrated that all 
16 validated questions are necessary and Tabachnick and Fidell (Tabachnick & Fidell, 
2007) suggest at least 300 respondents are required for factor analysis. However, 13 of 
the 16 questions were analysed with descriptive statistics. 
Study specific questions were also used to assess social capital by exploring linkages 
between individuals, social relationships, environment and social networks to which they 
feel connected (Germov, 2005). This was evaluated using features from the socio-
ecological framework of Bronfenbrenner, which is conceptual in nature, and is not 
operationalized into specific instruments and scales (Bronfenbrenner, 1977, 1979, 1986). 
The ecological systems theory suggests that different levels of social exposure influence 
human development. Social connections closer to the individual, such as immediate family 
and peers, would have greater influences than those more distant such as media, social 
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institutions or neighbours. This framework is used to examine the proximity of personal 
relationships to women’s decisions regarding childbearing and their knowledge of fertility 
and ART.  
The following five key questions were asked of the participants. These questions were also 
asked of participants in Group C.  
Question 1) Would you choose either; women's career and work, educational attainment, 
financial security, health or partnering relationship as the primary reason women delay 
motherhood until they are older? 
Question 2) Which age range; younger than 35 years, 35–39 years of age, or 40 years or 
older, signals a significant drop in a woman’s fertility and ability to conceive?  
Question 3) Are women aged 35 years or older likely or unlikely to get pregnant using 
ART? 
Question 4) Are women aged 35 years or older likely or unlikely to have a healthy baby 
using ART? 
Question 5) Do you feel that media, including magazines and current affairs programmes, 
does or does not portray IVF as being successful for older women? 
5.4.3 Data Analysis. 
Responses to the online survey were recorded on the password-protected Survey Monkey 
site (www.surveymonkey.com) and deleted from the web server after downloading; these 
anonymous responses were saved as a CSV file. Quantitative data were coded then 
analysed using Version 19 of the Statistical Package for the Social Sciences (SPSS)(IBM, 
2010). SPSS excluded missing data from the analysis as not all participants completed 
every single item. Missing data reduces the available sample size and consequently data 
becomes less powerful (de Vaus, 1995). Responses were broken down into two groups; 
aged 35-39 years and 40 years of age or older (Bianco, 1996; Bornstein et al., 2006; 
Damario et al., 1999; Gilbert et al., 1999).   
The responses for Questions 3 (What is the likelihood of women aged 35 years or older to 
get pregnancy using ART?) and 4 (What is the likelihood of women aged 35 years or older 
to have a healthy baby using ART?) were condensed with response “not likely” and 2 
collated to “not likely”, 3 and 4 to “unlikely”, 5 and 6 to “neither unlikely nor likely”, 7 and 8 
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to ‘”likely” and 9 and “very likely”. Where appropriate, categories were collapsed due to the 
small sample size to improve the accuracy of the reporting, which did not affect the 
integrity of the data. As Burton (2004) suggests, collapsing categories for a small number 
of respondents will allow a more accurate and robust analysis. Collapsing the data allows 
patterns in the data to be highlighted which otherwise would not stand out (de Vaus, 
1995). 
Pearson’s chi-squared variance and frequency were used predominantly to analyse 
relationships in the data. Ordinal data were examined using the chi-squared test of 
variance. A chi-square analysis requires the count in the cells of the contingency tables to 
exceed five. Some of the analysis, when broken down by age, had cells that had a count 
of less than five, and if 80% of the expected frequencies did not exceed five a chi-squared 
analysis for trend was used. In addition to the research questions, relationships between 
demographics, childbearing decisions, social and psychological factors and women’s 
expectations of ART were examined.  
5.5 Group C: Community Group Study  
5.5.1 Participants. 
The Queensland Social Survey Community Survey (QSSCS) in 2008 (Survey C), included 
1243 adults (aged 18–83 years) residing in Queensland. The 2008 Queensland Social 
Survey (QSS08) was the fourth annual state wide survey administered by the Institute for 
Health and Social Science Research (IHSS) at Central Queensland University in 
Rockhampton, Australia (Population Research Laboratory for Social Science Research, 
2008). The Population Research Laboratory (PRL) within the IHSS, holds databases of 
Queensland phone numbers, which are merged and checked for duplications or deletions 
before each survey sample.  
The study was conducted using computer-assisted telephone interviewing (CATI) by the 
PRL testing laboratory using trained telephone interviewers. The PRL limited the number 
of questions for this research to five questions as part of a collaborative survey with other 
researchers also submitting questions in their area of interest. The 2008 QSS sampling, of 
which the survey was a part, was drawn from the telephone database by a computer 
program designed to select, with replacement, a simple random sample of phone 
numbers. The target population designated for telephone interviewing was persons 18 
years or older who at the time of the survey were living in a dwelling in Queensland that 
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could be contacted by direct-dialled, land-based telephone service, which was the 
accepted laboratory control for conducting the research. One adult member of each 
household was interviewed. 
The opportunity to be part of this larger CATI study allowed data to be gathered from over 
1243 individuals within Queensland and produced substantial data from a broad cross-
section of the community. The response rate was 37.07%, cooperation rate was 38.19%, 
contact rate was 97.78%, and the refusal rate was 55.82% as per the QSS08 data. Data 
were gathered from individuals who ranged in age from 18 to 83 years with a mean age of 
51.6 years. Males comprised 50.1 % of respondents; 80% of the participants were 
Australian born. Most (64.9%) had up to 14 years of education, and 34.5% had 15 years or 
more of education.  Due to financial limitations of the CATI study, the researcher was 
limited to five questions as outlined in 5.5.2.  
5.5.2 Questions. 
The QSS08 survey consisted of three components relevant to this research, and 
responses to sections (b) and (c) were used in this study: 
(a) A standardised introduction  
(b)  Standard demographic questions  
(c) Five questions relating to the this research as outlined below: 
 
Five research questions that were posed to the participants .The questions related to 
reasons for delaying childbearing, beliefs of the age of women’s fertility decline, hopes of 
the success rate for women aged 35 years and older and ideas about the media’s 
influence on success rates for ART.  
The questions were: 
Question 1) Would you choose either; women's career and work, educational 
attainment, financial security, health or partnering relationship as the primary reason 
women delay motherhood until they are older? 
Question 2) Which age range; younger than 35 years, 35–39 years of age, or 40 
years or older, signals a significant drop in a woman’s fertility and ability to conceive? 
Question 3) Are women aged 35 years or older likely or unlikely to get pregnant 
using ART? 
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Question 4) Are women aged 35 years or older likely or unlikely to have a healthy 
baby using ART? 
Question 5) Do you feel that media, including magazines and current affairs 
programs, does or does not portray IVF as being successful for older women? 
Data were analysed with SPSS as described in 5.2.3. Responses to Questions 3 and 4 
were condensed for reporting as outlined earlier. Data were further analysed according to 
gender because men and women may have different perceptions of technology and a 
different level of trust in new technology (Wajcman, 2004) and they may have different 
understandings of female reproduction and fertility (Daniluk & Koert, 2013).  
5.6 Group D: Interview Study  
The researcher formulated a recommended question script for the semi-structured 
interviews and prompts for the interview facilitator. This interview script guide ensured 
maximum use of the interview time and helped to keep interviews focused, while allowing 
the systematic interviewing of the participants (Loftland & Loftland, 1984). The average 
duration of the interviews was one hour. A semi-structured interview gave control and 
structure to the conversation, and flexibility to develop rapport and empathy with the 
participant, resulting in richer data (Smith & Osborn, 2008).  
An experienced and neutral facilitator rather than the researcher conducted the interviews 
for three reasons. Firstly, a neutral facilitator limits the possibility that the interviewer could 
be biased because qualitative data are less structured and can be criticised on the basis of 
interviewer bias (Johnson, 1997). Secondly, as individuals may attend a number of 
infertility clinics, there was a chance that the researcher, when employed at a Queensland 
infertility clinic, may have had previous contact with an interviewee, which could be 
perceived as a potential bias. Panucci and Williams (2010) point out that interviewer bias 
is more likely when the interviewer knows the interviewee’s disease status. Thirdly, the 
researcher wished to avoid any assumption that they may have unknowingly led the 
interview in a predetermined direction.  
The researcher was concerned that the effect of the researcher’s presence may have had 
on the participant’s responses. Researchers, focusing on their hypothesis, may send out 
unwanted signals to interviewees, whereas independent interviewers are not subject to 
subconscious tendencies (Clarke, Sprostan, & Thomas, 2003). An independent interviewer 
was viewed as a necessity as the researcher was required to provide a reliable reflection 
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of participant views without the participant perceiving that the questions were leading the 
interviewee to a pre-determined end (Neuman, 2003b). Despite being aware of reflexivity 
to oppose researcher bias, the researcher did not wish to be seen as steering the 
interviewees towards the researchers preferred outcomes as interviewers should not 
reveal their opinions, either verbally or non-verbally (Neuman, 2003a).  
Through constant comparison, thematic categories were identified and evaluated and build 
into a coherent model of the women’s stories (Lincoln & Guba, 2000). The validity of 
interviews was monitored by external audit and triangulation of the interviews by the 
researcher and a neutral supervisor to ensure an unbiased assessment (Cresswell & 
Miller, 2000). Triangulation also permitted convergence of the interview data and the short 
answer responses from Group B by merging these in the overall interpretations of 
responses in the discussion (Cresswell, Fetters, & Ivankova, 2004). Validity was also 
established by the researcher through a rigorous review of the data to ensure that the 
“constricts, categories, explanations and interpretations make sense” (Patton, 1990: 239). 
5.6.1 Participants 
Face-to-face interview participants were women aged 35 years and older. Participants 
were registered patients of another Brisbane infertility clinic and were invited to participate 
in the study by a flyer distributed to patients. Infertility nurses offered flyers to patients and 
flyers were displayed at the clinic reception desk for one month. Six women agreed to 
participate in the research: five in a face-to-face interview and one woman (located in 
Central Queensland) by telephone.  
5.6.2 Interview Questions 
The 12 interview questions followed the five standard questions used in the 
QSS08 survey. The interviews were audiotaped, transcribed and analysed for 
themes: 
1) Tell me who you are, and your position in your IVF journey: started or 
not, how many cycles undertaken, any pregnancies or births, and how 
many years of trying for a natural conception before ART. 
2) What are some personal reasons why you are having a family at this 
stage of your life? What do you think about women looking to 
childbearing when aged 35 or older? 
3) When do you believe a woman’s fertility start to decline? 
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4) How would you rate the chance for a woman aged 35 or older to have 
a pregnancy? 
5) How would you rate the chance for woman aged 35 or older to have a 
live birth? 
6) What perception do you think the media gives women of the success 
of ART? Do you think media stories influence women’s timing of 
childbearing? 
7) Do you think the marketing information supplied from infertility clinics 
shape women’s impression of IVF technology and success rates? 
8) Your expectation of ART technology, and have your expectations been 
reached? 
9) Your experiences of going through ART treatment; was that different to 
your expectation before you started ART? 
10) What do you think the success rates of ART were before you 
accessed the clinic and has that changed now? 
11) Taking your experiences into account, do you have advice for other 
women about the ideal age to have a child? 
12) Do you think it is difficult for women to stop IVF cycles if they have not 
had a baby? What factors could influence their decision to stop? 
5.6.3 Data analysis 
5.7 Ethical clearance for the research 
Ethical clearance for Group A and Group B research was gained from the Central 
Queensland Ethics Committee (Ethics Approval No H06/07-137) and the Infertility Clinic’s 
Humanities and Ethics Committee (See Appendix 2). The University of Queensland and 
the Central Queensland University, due to the highly emotional subject matter of the 
research, required ethical approval for the surveys and interviews. Studies in this area, 
and in particular for women whose ART treatment was unsuccessful, can be 
psychologically difficult for some participants and may have adverse consequences for 
some women. 
Ethical clearance for Survey C was granted by the Human Ethics Research Review Panel 
at CQUniversity Project: H08/05-020, Queensland Social Survey 2008.  Group D 
interviews received ethical approval by the Behavioural & Social Sciences Ethical Review 
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Committee at the University of Queensland (Project: 2011000456) (see Appendix 2). The 
design and conduct of the research was heavily influenced by the sensitivity surrounding 
issues of infertility and the personal stress that ART can place on individuals, particularly if 
no conception or live birth resulted. Participants had the option not to participate or to 
discontinue participation at any stage. Counselling support for participants was freely 
available from the infertility clinics psychologists if requested. Contact information for 
Lifeline and the infertility clinic was supplied in the participant information sheet. No 
requests for counselling support were received by the researcher or research supervisor 
over the duration of the research.  
5.8 Data Management 
Hard copy data were kept in a locked filing cabinet in the office of the investigator. Data on 
the principle researcher’s computer were password protected following the requirements of 
the NHMRC Ethical Guidelines for Human Research (NHMRC, 2014). Data will be 
retained for five years in keeping with NHMRC guidelines. After this period, hard copy data 
will be shredded, and the computer files deleted. 
 
 
Chapter 6: Group B Data – Support Group  
6.1 Introduction 
This chapter reports data from Group B collected from participants in the Support Group. 
The method of data collection and the methodology are described in Chapter 5. Women 
were asked about influences, beliefs, experiences and expectations relating to starting, 
continuing and stopping ART. For the purpose of more meaningful analysis, some 
responses were further divided into two categories based on age groups; 35–39 years of 
age and 40 years or older. Although 77 responses were received, the responses from nine 
participants were excluded as either their age at the time of the survey was younger than 
35 years, or their engagement with ART occurred when younger than 35 years.  
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6.2 Demographics 
 The participants (N = 68) were registered female patients of a Queensland infertility clinic. 
As shown in Figure 6.1, participants ranged in age from 35 to 52 years with a mean age of 
40.7 years. (SD=3.93) 
 
 
Figure 6-1 Group B Participant Ages 
 
Most participants 94% (45/48) were or had been in a partnered relationship including two 
women who were separated, divorced or widowed, and seven women were not in a 
currently partnered relationship. Three women were in a same-sex relationship. Most 
participants (41/53) were in a relationship for longer than five years. Half the women 
agreed that women should be in a stable relationship when having children. Two-thirds of 
women were currently in the same relationship as when they had undertaken treatment. 
As anticipated, three-quarters (49/68) of participants were Australian born.  
Table 6.2 shows that the educational attainment of participants was higher and more 
women had tertiary qualifications than their mothers. Similarly, the participants were more 
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likely to be in employment and less likely to primarily work in the home than their mothers. 
Ninety-three percent of the women’s mothers had their first child when aged younger than 
30 years and 7% when aged 31–39 years of age. 35% of women (22/62) had naturally 
conceived a baby before using ART for another child. For around one-fifth of these 
(12/62), a baby was born using ART.  
Table 6-1 Group B and Mother’s Education and Employment 
Education and 
Employment/Activity 
Participants 
 
Participant’s 
mothers 
Secondary level education 11 
(14.4) 
44  
(61.1) 
Trade/Diploma qualification 21 
(27.6) 
15  
(20.9) 
Tertiary Education 26  
(34.2)  
9   
(12.5) 
Postgraduate education 18  
(23.7) 
4   
(5.6) 
Full-time employment 27  
(36.0) 
17  
(22.4) 
Part-time employment 22  
(29.3) 
14 
(18.4) 
Household duties 20 
(26.7) 
44  
(57.9) 
Carer 4  
(5.3) 
0 
Student 2   
(2.7) 
0 
Retired from paid work 0 1   
(1.3) 
Other 3   
(4.0) 
0 
Note. Number (%) 
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6.3 Treatment Status 
As discussed in Chapter 4, participants were predominantly of an age associated with 
declining fertility due to age-related infertility. Responses were sought from women aged 
35 and older. The age distribution at time of survey was: 35–39 years (39.7%), and 40 
years and older (62.3%). Of the 64 respondents, 25% of participants were currently having 
ART treatment, 30% had used ART within the last 12 months, 25% had ART treatment 
within two to three years of the survey, 18.5% had ART treatment within three or more 
years and one participant was intending to start ART as shown in Table 6.2. Some of the 
participants had conceived a pregnancy unassisted by ART but over half of these had 
spontaneously miscarried. The participants were asked about the outcome of their 
treatment as women may have had multiple treatment cycles with more than one outcome. 
Tables 6.3.1 to 6.3.7 details the treatment outcomes. 
Table 6-2 Group B: Treatment Status 
Engagement with ART 35-39  
years of 
age 
40 years 
and 
older  
Total 
 
Currently using ART 9 
(56.3) 
7 
(43.7) 
16 
(100.0) 
Used ART within the last 12 
months 
8 
(42) 
11 
(58) 
19 
(100.0) 
Used ART within 2–3 years 7 
(44) 
9 
(56) 
16 
(100.0) 
Used ART over 3 years ago  3 
(25) 
9 
(75) 
12 
(100.0) 
Intending to use ART 0 1 
(100) 
1 
(100.0) 
Total for age groups 27 
(42) 
37 
(58) 
64 
(100.0) 
Note. Number (%) 
6.3.1 Group B treatment outcome – pregnancies. 
Table 6.3 shows that 67% of participants had at least one pregnancy with 71.4% of those 
aged 35–39 years and 62.9% of those aged 40 years and older. The percentage of women 
   94 
who had a pregnancy did not significantly differ between age groups, χ2 (1, N = 55) 
=0.266, p = 0.606.  
Table 6-3 Group B: At Least One Pregnancy 
At least one pregnancy Yes No Total 
35–39 years 15 
(71.4) 
6 
(28.6) 
21 
(100.0) 
40 years or older 22 
(62.9) 
12 
(34.3) 
34  
(100.0) 
Total 37 
(67.3) 
18 
(32.7) 
55 
(100.0) 
Note. Number (%) 
6.3.2 Group B treatment outcome – births. 
Table 6.4 shows over half of participants in both age groups had at least one live birth. The 
percentage of women who had a birth did not significantly differ between age groups, χ2 (1 
N = 50) =0.127, p = 0.721.  
Table 6-4 Group B: At Least One Birth 
At least one birth Yes No Total 
35–39 years 12 
(63.1) 
7 
(36.9) 
19 
(100.0) 
40 years or older 18 
(58.1) 
13 
(41.9) 
31  
(100.0) 
Total 30 
(60.0) 
20 
(40.0) 
50 
(100.0) 
Note. Number (%) 
6.3.3 Group B treatment outcome – pregnancy loss. 
Table 6.5 shows half of the participants in both groups had a pregnancy that did not 
continue. The percentage of women who had a pregnancy loss did not significantly differ 
between age groups, χ2 (1, N = 47) =0.013, p = 0.909.  
   95 
Table 6-5 Group B: Pregnancy Loss 
Pregnancy loss Yes No Total 
35–39 years 9 
(50.0) 
9 
(50.0) 
18 
(100.0) 
40 years or older 15 
(51.7) 
14 
(48.3) 
29  
(100.0) 
Total 24 
(51.1) 
23 
(48.9) 
47 
(100.0) 
Note. Number (%) 
6.3.4 Group B treatment outcome – women undertaking ART. 
Table 6.6 shows around half of applicable participants, more aged 35–39 years than aged 
40 years or older, were still using ART to have a child. The percentage of women who 
were still using ART did not significantly differ between age groups, χ2 (1, N = 42) =1.14, p 
= 0.286.  
Table 6-6 Group B: Still Undertaking ART 
Still trying for a child Yes No Total 
 35–39 years 13 
(68.4) 
6 
(31.6) 
19 
(100.0) 
 40 years or older 12 
(46.2) 
11 
(42.3) 
23  
(100.0) 
Total 25 
(59.5) 
17 
(40.5) 
42 
(100.0) 
Note. Number (%) 
6.3.5 Group B treatment outcome – still undertaking ART until successful.  
One-half of the 38 participants were continuing ART with until they had a baby as shown in 
Table 6.7. Chi-square analysis between still undertaking ART until successful and the two 
age groups was not significant, χ2 (2, N = 38) =0.217, p = 0.897. One-third were unsure of 
their decision to stop ART.  
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Table 6-7 Survey Group B: Keep Trying Until Have a Child 
Keep trying for a child Yes No Unsure Total 
 35–39 years 3 
(21.4) 
6 
(42.9) 
5 
(35.7) 
14 
(100.0) 
40 years or older 5 
(16.1) 
12 
(38.7) 
7 
(22.6) 
34  
(100.0) 
Total 8 
(21.0) 
18 
(47.4) 
12 
(31.6) 
38 
(100.0) 
Note. Number (%) 
6.3.6 Group B treatment outcome – stopped ART and successful birth. 
Table 6.8 shows 32.6% of applicable participants of all ages had stopped ART as they had 
a live birth, and around half had stopped without having a baby. The relation between 
these variables was not significant, χ2 (2, N = 46) =2.895, p = 0.235. One-fifth were unsure 
of their decision to stop ART. 
Table 6-8 Group B: Stopped ART and Successful Birth 
Stopped ART and have child Yes No Unsure Total 
35–39 years 7 
(41.2) 
5 
(29.4) 
5 
(29.4) 
17 
(100.0) 
 40 years or older 8 
(27.6) 
16 
(55.2) 
5 
(17.2) 
29  
(100.0) 
Total 15 
(32.6) 
21 
(45.6) 
10 
(21.8) 
46 
(100.0) 
Note. Number (%) 
6.3.7 Group B treatment outcome – stopped ART as unsuccessful. 
One-fifth of participants had stopped ART and did not conceive, as shown in Table 6.9. 
Chi-square analysis for trend between stopped ART and did not have a baby and the two 
age groups was not significant, χ2 (1, N = 33) =2.584, p = 0.108, the decision to stop ART 
was not dependent on age group. One-sixth were unsure of their decision to stop ART. 
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Table 6-9 Group B: Stopped ART as Unsuccessful 
Stopped ART and do not have 
child 
Yes No Unsure Total 
35–39 years 2 
(20.0) 
8 
(80.0) 
0 10 
(100.0) 
40 years or older 4 
(17.4) 
14 
(60.9) 
5 
(21.7) 
23  
(100.0) 
Total 6 
(18.1) 
22 
(66.7) 
5 
(15.2) 
33 
(100.0) 
Note. Number (%) 
6.4 Beliefs and Decisions on ART and Childbearing 
6.4.1 Decisions surrounding ART. 
The Decision Regret Scale (O'Connor, 2003) as discussed in Chapter 5.4.2 measures 
distress or remorse after a health care decision, as shown in Table 6.10. Participants were 
asked five questions of the instrument regarding their decision to delay childbearing. The 
scale has five items and is scored from 0–100, and a higher score indicates less regret 
about the decision to delay childbearing. As described in Chapter 5, the scale comprised 
five questions that are scored. Questions one, three and five are scored with a result of 0 
indicating high regret and 100 indicating no regret. Questions two and four are reverse 
scored with a score of 0 scoring no regret and 100 high regret. The women were 
somewhat divided whether delaying childbearing was; the right decision, if they regretted 
their decision, if they would make the same decision again, if it had done them harm and if 
it was a wise decision.  
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Table 6-10 Group B: Decision Regret Scale on Decision to Delay Childbearing 
Decision Agree Disagree Unsure Strongly 
Agree 
Strongly  
Disagree 
Total 
Score 
It was the right 
decision 
6 
 
7 
 
7 11 
 
8 39 
(42.3)  
I regret the 
decision that 
was made 
  
4 
10 
 
7 11 4 36  
(44.3) 
I would go for the 
same choice if 
I had to do it 
over again 
4  11 5 6 9 35  
(49) 
The choice did me 
a lot of harm 
4 9 8 7 8 36 
(53.3) 
The decision was 
wise  
2 12 5 7 7 33 
(57.5) 
  Note. Number ( Score) 
Questions about decisions to use ART were modelled on the Decisional Conflict Scale. As 
not all the questions from the instrument were used, the instrument cannot be reported, 
however responses follow in Table 6.11–6.13. Table 6.11 shows that most participants did 
not find the decision to use ART hard, most were sure of their decision and ART was the 
best choice for them.  
Table 6-11 Group B: Decision to use ART 
Decision to use ART Yes  No Unsure Total  
Decision was hard to make 15 
(27.8) 
39  
(72.2) 
0  54 
(100.0) 
Not sure what to do in this decision  12 
(23.1) 
35  
(67.3) 
5   
(9.6) 
52 
(100.0) 
Clear what choice is best  35  
(67.3)  
13  
(25.0) 
4   
(7.7) 
52  
(100.0) 
 Note. Number (%) 
Table 6.12 shows that most participants were aware of the choices they had in ART, and 
they were aware of risks and benefits. 
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Table 6-12 Group B: Risks and Benefits of ART 
Choice to use ART Yes No Unsure Total  
Aware of choices in ART 41  
(75.9) 
10  
(18.5) 
3   
(5.6)  
54 
(100.0) 
Know the benefits of ART  44  
(81.5) 
8   
(14.8) 
2   
(3.7) 
54  
(100.0) 
Know the risks of ART 40  
(74.1)  
10  
(18.5) 
4   
(7.4) 
54  
(100.0) 
Note. Number (%) 
Table 6.13 shows most participants felt they had made an informed choice to use ART, 
would stick to their decision, the decision was important to them, and they were satisfied 
with their decision.  
Table 6-13 Group B: Effective Decision Making 
Decision satisfaction Yes No Unsure Total  
Feel made informed choice  45  
(83.3) 
6  
(11.1) 
3   
(5.6)  
54 
(100.0) 
Decision important  48  
(94.1) 
2 
(3.9) 
1  
(2.0) 
51  
(100.0) 
Stick with decision 44  
(86.3)  
2  
(3.9) 
5   
(9.8) 
51  
(100.0) 
Satisfied with decision 47 
(88.7) 
2  
(3.8) 
4 
(7.5) 
53  
(100.0) 
Note. Number (%) 
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6.4.2 Beliefs about ART.  
Table 6.14 shows chi-square test between pregnancy confidence and two age groupings 
and was significant, χ2 (2, N = 64) =7.78, p = .020. Women aged 35–39 years had a 
stronger belief they would get pregnant than the women aged 40 years or older. 
Table 6-14 Group B: Beliefs about Getting Pregnant by Age Group Response 
Belief about getting Pregnant Disagree Unsure Agree Total 
35–39 years 0 6   
(24.0) 
19 
(76.0) 
25  
(100.0) 
 40 years or older 9 
(23.1) 
11  
(28.2) 
19 
(48.7) 
39 
(100.0) 
Total 9 
(14.0) 
17 
(26.5) 
38 
(59.5) 
64 
(100.0) 
Note. Number (%) 
Table 6.15 shows there was no difference between the two age groups on the assumption 
that the quality of their oocytes was problematic. Chi-square test for trend was not 
significant, χ2 (1, N = 61) =0.1699, p = .680.  
Table 6-15 Group B: Oocyte Quality 
Belief oocyte problem Disagree Unsure Agree Total 
 35–39 years 10 
(38.5) 
2   
(7.7) 
14 
(53.8) 
26  
(100.0) 
 40 years or older 18 
(51.4) 
3  
(8.6) 
14 
(40.0) 
35  
(100.0) 
Total 28 
(45.9) 
5 
(8.2) 
28 
(45.9) 
61 
(100.0) 
Note. Number (%)  
Participants were asked to reflect on the beliefs they held about ART. Responses are 
shown in Table 6.16. Most participants agreed that media success stories of ART do not 
depict the experiences for most women, they were confident of a pregnancy, women need 
to be in a stable relationship before children, and ART does not guarantee a baby. The 
majority of women disagreed that ART allows women to delay childbearing, having regular 
menstrual cycles allows pregnancy regardless of age, having a child later in life is trying to 
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have the best of everything, and it is not possible to have a successful career and a family. 
They were equally divided whether mixing motherhood and career is a result of social 
pressure. 
Table 6-16 Group B: Beliefs regarding ART Before Starting Treatment 
Beliefs Disagree Unsure Agree Total  
ART success media stories not 
representative of ART users 
15 
(25.0) 
7  
(11.7) 
38 
(63.3)  
60   
(100.0) 
Confident that ART will ensure 
pregnancy 
5  
(9.8) 
2 
(3.9) 
44 
(86.3) 
51  
(100.0) 
ART allows women aged 35 and 
older to have children  
36 
(60.0) 
2  
(3.3) 
22 
(36.7) 
60  
(100.0) 
Women need to be in a stable 
relationship before children 
24 
(40.0) 
4 
(6.7) 
32 
(53.3) 
60 
(100.0) 
Regular menstrual cycles allow 
childbearing regardless of age 
46 
(76.7) 
3 
(5.0) 
11 
(18.3) 
60 
(100.0) 
Mixing motherhood and career due 
to social pressure 
27 
(45.8) 
6 
(10.1) 
26 
(44.1) 
59 
(100.0) 
Child in midlife trying for best of 
everything 
50 
(84.7) 
2 
(3.3) 
7 
(11.9) 
59 
(100.0) 
Not possible for successful career 
and family life 
49 
(84.5) 
2 
(3.4) 
7 
(12.1) 
58 
(100.0) 
ART no guarantee of a baby 5 
(8.3) 
2 
(3.3) 
53 
(88.4) 
60 
(100.0) 
Note. Number (%) 
Women’s obstetrician or gynaecologist and self-education were strong sources of 
information on ART. Some information was sourced from public health information, 
internet sites, television, newspapers, friends, family, colleagues and community 
knowledge on ART as shown in Table 6.17. Educational institutions were the least 
informative source. 
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Table 6-17 Group B: Sources of Information regarding ART 
Sources of information Strong  
Influence 
Some 
Influence 
No  
Influence 
Total 
 
Education from school 
/university 
2 
(9.5) 
1 
(4.8) 
18 
(85.7) 
21   
(100.0) 
Self education 17  
(77.4) 
4 
(18.1) 
1 
(4.5) 
22  
(100.0) 
Public Health Information  3 
(18.8) 
12  
(75.0) 
1 
(6.2) 
16  
(100.0) 
Family  3 
(16.7) 
10 
(55.5) 
5 
(27.8) 
18 
(100.0) 
Friends  6 
(27.2) 
13 
(59.1) 
3 
(13.7) 
22 
(100.0) 
Work colleagues 2 
(18.2) 
9 
(81.8) 
0 11 
(100.0) 
Obstetrician/ 
Gynaecologist 
43 
(100.0) 
0 0 43 
(100.0) 
Newspapers 3 
(33.3) 
6 
(66.7) 
0 9 
(100.0) 
Women’s magazines 5 
(8.3) 
30 
(50.0) 
25 
(41.7) 
60 
(100.0) 
Television 0 8 
(80.0) 
2 
(20.0) 
10 
(100.0) 
Internet sites 4 
(33.3) 
5 
(41.7) 
3 
(25.0) 
12 
(100.0) 
Community knowledge 4 
(33.3) 
7 
(58.4) 
1 
(8.3) 
12 
(100.0) 
Note. Number (%) 
Table 6.18 shows views of media portrayal of ART for two age groups. Chi-square 
analysis for trend between media portrayal of ART and the two age groupings was not 
significant, χ2 (1, N = 54) = 0.138, p = .709, the groups were in agreement that the media 
portrays ART as successful for older women. 
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Table 6-18 Group B: Media Influence 
Age  Yes No  Unsure Total   
 35–39 years 19 
(90.4) 
1   
(4.8) 
1   
(4.8) 
21  
(100.0 
40 years or older 30  
(90.9) 
2  
(6.1) 
1  
(3.0) 
33  
(100.0) 
Total 49 
(90.7) 
3 
(5.6) 
2 
(3.7) 
54 
(100.0) 
Note. Number (%) 
Table 6.19 shows chi-square test for trend between beliefs about fertility decline and the 
two age groupings and was not significant, χ2 (1, N = 56) = 1.981, p =.159.  
Table 6-19 Group B: Beliefs on Age of Fertility Decline by Age Response 
Age  Declines from 
34 years or  
younger  
Declines  
from 35– 
39years  
Declines from 
 40 years or 
 older 
Total  
 
 35–39 years 14   
(51.8) 
13  
(48.2) 
0 27  
(100.0) 
 40 years or 
older 
0 25  
(86.2) 
4  
(13.8) 
29 
(100.0) 
Total 14 
(25.0) 
38 
(67.9) 
4 
(7.1) 
56 
(100.0) 
Note. Number (%)   
Table 6.20 shows beliefs on the chance of pregnancy for women aged 35 years or older 
using ART for the two age groups. Chi-square analysis between chance of a pregnancy 
and the two age groupings was not significant, χ2 (2, N = 56) = 0.373, p = .829.  
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Table 6-20 Group B: Likelihood of Pregnancy for Women aged 35 and older using 
ART 
Age  Not Likely  
 
Neither not 
 likely or  
likely 
Likely   
 
Total  
 
35–39 years 5 
(23.8) 
10  
(47.6) 
6 
(28.6) 
21  
(100.0) 
40 years or older 11 
(31.4) 
15  
(42.9) 
9  
(25.7) 
35 
(100.0) 
Total 16 
(28.6) 
25 
(44.6) 
15 
(26.8) 
56 
(100.0) 
Note. Number (%) 
Table 6.21 shows beliefs on the chance of a healthy baby for women aged 35 years or 
older using ART between the age groups. Chi-square analysis between beliefs and the 
age groupings was not significant, χ2 (4, N = 56) = 0.533, p = .766.  
Table 6-21 Group B: Likelihood of a Live Birth for Women aged 35 and older using 
ART 
Age  Not Likely  
 
Neither not 
 likely or 
 likely 
Likely   
 
Total  
 
35–39 years 5 
(23.8) 
9  
(42.9) 
7 
(33.3) 
21  
(100.0) 
40 years or older 11 
(31.4) 
15  
(42.9) 
9  
(25.7) 
35 
(100.0) 
Total 16 
(28.6) 
24 
(42.8) 
16 
(28.6) 
56 
(100.0) 
Note. Number (%) 
Table 6.22 shows beliefs on their personal chance of pregnancy using ART between the 
two age groups. Chi-square analysis between expectations and the age groupings was not 
significant, χ2 (4, N = 62) = 0.982, p = .612.  
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Table 6-22 Group B: Personal Belief on a Pregnancy 
Belief of a 
pregnancy 
Not Likely  
 
Neither not 
 likely or  
likely 
Likely   
 
Total 
 
35–39 years 3 
(11.1) 
6 
(22.2) 
18   
(66.7) 
27  
(100.0) 
40 years or older 5 
(14.3) 
11 
(31.4) 
19 
(54.3) 
35  
(100.0) 
Total 8 
(12.9) 
17 
(27.4) 
37 
(59.7) 
62 
(100.0) 
Note. Number (%) 
Participants were asked to estimate their personal chance of a pregnancy between the two 
age groups, as shown in Table 6.23. Most women rated their chance of pregnancy at 40–
60% or less. 
Table 6-23 Group B: Personal Beliefs on Chance of a Pregnancy 
Age  0–20% 20–40%  40–60%  60–80%  80– 
100%  
Total 
 35–39 
years 
3   
(23.1) 
5   
(38.4) 
3  
(23.1) 
1   
(7.7) 
1   
(7.7) 
13 
 (100.0) 
40 years or 
older 
11   
(61.1) 
4   
(22.2) 
3  
 (16.7) 
0 0 18  
(100.0) 
Total 14 
(45.2) 
9 
(29.0) 
6 
(19.4) 
1 
(3.2) 
1 
(3.2) 
31 
(100.0) 
Note. Number (%) 
6.4.3 Timing of childbearing. 
Participants were asked why women delay, childbearing until midlife. Five possible 
options, as suggested by the literature, were given to the participants and they were asked 
to choose one option, which they believed was the main reason for delaying childbearing. 
Results are shown in Table 6.24. Most participants selected the option of 'lack of a partner' 
as the main reason women are delaying childbearing until midlife. 
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Table 6-24 Group B: Main Reason why Women Delay Childbearing 
Reasons for delaying childbearing Response 
Lack of a relationship partner 35  
(63.6) 
Career or work   12  
(21.8) 
Financial security  5  
(9.1) 
Health issues 3   
(5.5) 
Furthering Education  0 
 
Total 55  
(100.0) 
Note. Number (%) 
Table 6.25 shows chi-square test for trend between reasons for delaying and the two age 
groupings, and was not significant, χ2 (1, N = 55) = 0.004, p =.949.  
Table 6-25 Group B: Delaying Childbearing by Age 
Age  Lack of 
partner 
Career 
or work 
Financial 
Security 
Health 
 
Education Total 
 
35–39 
years 
12  
(57.1) 
5 
(23.9) 
2   
(9.5) 
2   
(9.5) 
0 21  
(100.0) 
40 years  
or older 
23   
(67.6) 
7 
(20.6) 
3   
(8.9) 
1 
(2.9) 
 
0 34 
(100.0) 
Total 35 
(63.6) 
12 
(21.8) 
5 
(9.1) 
3 
(5.5) 
0 55 
(100.0) 
Note. Number (%) 
Table 6.26 shows current views on having a child. One-third of the women suggested that 
they were trying ART to do all they could to have a child and they would have had a child 
earlier but they were not in a supported partnered relationship.  
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Table 6-26 Group B: Current Decision to have a Child 
Current Decision to have a Child Response 
Tried IVF to do everything possible to have a child 19 
(35.2) 
Would have had children earlier but not in a supported 
partnered relationship 
14 
(30.0) 
Difficult to find a partner to share a family  7 
(13.0) 
Having a child is the current life focus 6 
(11.1) 
Waiting for financial security  6 
(11.1) 
Pursuing a career 1 
(1.8) 
Children not a life focus five years ago 1 
(1.8) 
Total 54 
(100.0) 
Note. Number (%) 
Table 6.27 shows women’s responses if, hypothetically, they would make the same 
decision to delay their childbearing for both age groups. Chi-square analysis between 
decision to delay childbearing and the two age groupings was not significant, χ2(1, N =19) 
= 0.693, p =.405. Both groups disagreed that they would, hypothetically, make the decision 
to delay childbearing again. 
Table 6-27 Group B: Decision to Delay Childbearing by Age 
Age  Disagree Agree Total 
35–39 years 6  
(60.0) 
4 
(40.0) 
10 
(100.0) 
40 years or older 7  
(77.8) 
2 
(22.2) 
9 
(100.0) 
Total 13 
(68.4) 
6 
(31.6) 
19 
(100.0) 
Note. Number (%) 
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6.4.4 Heartache along the way.   
As discussed in Chapter 4.7, ART treatment has been extensively documented in the 
literature as being a deeply emotional and stressful experience. Participants were asked 
whether the clinic provided sufficient social support for them. The Fertility Society of 
Australia requires ART clinics to offer psychological counselling for individuals before their 
first ART cycle. Some clinics offer continuous counselling, and 71% of women found the 
amount of counselling provided was adequate. 
Women were asked if the clinic offered sufficient emotional support during their treatment, 
as shown in Table 6.28. Chi-square analysis for trend between emotional support and the 
two age groups was significant, χ2(1, N =58) = 9.9351, p =.001. Women who conceived 
felt they had better emotional support than women who did not get pregnant. 
Table 6-28 Group B: Clinic Offered Adequate Emotional Support 
Pregnant after ART Not 
offered 
 emotional 
 support  
Offered 
 emotional 
 support  
 
Unsure if  
offered 
 emotional 
 support  
Total  
 
No 6   
(35.3) 
8   
(47.1) 
3   
(17.6) 
17  
(100.0) 
Yes 7   
(17.1) 
34   
(82.9) 
0 41  
(100.0) 
Total 13 
(22.4) 
42 
(72.4) 
3 
(5.2) 
58 
(100.0) 
Note. Number (%)    
Chi-square analysis for trend between a live birth and the clinic offering adequate 
emotional support was significant, χ2 (1, N = 58) = 5.6105, p =.0179. As expected, most 
women who had a birth and half of those who did not have a birth agreed that they 
received emotional support, as shown in Table 6.29.  
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Table 6-29 Group B: Had Birth and Clinic Offered Adequate Emotional Support 
Live Birth 
 after ART 
Not offered 
emotional 
 support  
Offered 
emotional  
support  
Unsure if  
offered 
 emotional 
 support  
Total  
 
No 7   
(31.8) 
12 
(54.6) 
3   
(13.6) 
22  
(100.0) 
Yes 6   
(18.7) 
26   
(81.3) 
0 32  
(100.0) 
Total 13 
(24.1) 
38 
(70.3) 
3 
(5.6) 
54 
(100.0) 
Note. Number (%) 
Additional questions were modelled on the Fertility Problem Inventory (Newton et al., 
1999) as described in Chapter 5.4.2. The ten Social Concerns questions addressed the 
respondents’ sensitivity to comments, reminders of infertility, feeling of social isolation and 
alienation from family or peers. Table 6.30 shows participants were mostly in agreement 
that they found holidays and celebrations difficult, they couldn’t help comparing 
themselves with friends who had children, they had lots in common with friends who had 
children, and they felt like family and friends were leaving them out. Participants mostly 
disagreed that it did not bother them when asked questions about children, that family 
members didn’t treat them differently, that family gatherings were difficult and that it was 
hard to spend time with friends who had children. Participants were equally divided when 
asked if they felt left behind by family and friends and feeling bothered when others talk 
about children. 
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Table 6-30 Group B: Emotions Surrounding Children 
Emotions involving children  Agree Disagree Unsure  Total  
     
Doesn’t bother me when asked 
about children  
20 
(35.7) 
33  
(58.9) 
3   
(5.4) 
56  
(100.0) 
Family members don’t treat us 
differently 
24  
(42.9) 
31   
(55.3) 
1  
(1.8) 
56  
(100.0) 
Celebrations and holidays difficult 33  
(58.9)  
19  
(34.0) 
4   
(7.1) 
56  
(100.0) 
Family get-togethers difficult 26   
(46.4) 
28 
(50.0) 
2   
(3.6) 
56  
(100.0) 
Can’t help comparing myself to 
others with children  
43 
(76.8) 
11  
(19.6) 
2   
(3.6) 
56  
(100.0) 
Lots in common with friends with 
children 
31  
(55.4) 
22  
(39.2) 
3  
(5.4) 
56  
(100.0) 
Hard when with friends with children 24  
(42.9) 
30  
(53.5) 
2   
(3.6) 
56 
(100.0) 
Families with children make me feel 
left out 
33  
(58.9) 
21  
(37.5) 
2   
(3.6) 
56  
(100.0) 
Feel left behind by family and 
friends 
28  
(50.0) 
28  
(50.0) 
0 56 
(100.0) 
Not bothered if others talk about 
children 
27  
(48.2) 
27 
(48.2) 
2   
(3.6) 
56  
(100.0) 
Note. Number (%) 
6.5 Experiences of ART 
All the women who were still trying for a pregnancy and 92% of women who were not 
trying for a pregnancy believed their clinician had explained the medical procedures in 
detail. Participants were asked about their emotional and psychological experiences while 
attending the infertility clinic by the provision of caring and supportive service. Table 6.31 
shows most participants indicated that the clinic offered them emotional (91%) and 
psychological (67%) support and that they did not feel out of control during treatment 
(85%). They believed their clinician explained the medical procedures in sufficient detail 
(90%), explained all the treatment options (85%), informed them of drug side effects 
(76%), and the risks of, and options in, ART (75%). 
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Table 6-31 Group B: Psychological Support during ART 
Psychological Support Agree  Disagree Unsure N/A Total 
Clinician explained ART 51 
(91.2) 
4   
(7.1) 
1   
(1.7) 
0 56 
(100.0) 
Treatment options 
explained 
49  
(86.0) 
5   
(8.8) 
3   
(5.2) 
0  57 
(100.0) 
Clinician gave ART options 49 
(90.7) 
4  
(7.4) 
1   
(1.9) 
0 54  
(100.0) 
Risks of ART explained 47  
(83.9) 
5   
(8.9) 
4   
(7.2) 
0 56  
(100.0) 
Drug effects explained 40 
(75.5) 
10  
(18.9) 
3  
(5.6) 
0 53  
(100.0) 
Clinic gave emotional 
support 
50  
(91.0) 
4  
(7.0) 
1   
(2.0) 
0 55  
(100.0) 
Psychological support 
adequate 
37 
(67.3) 
11  
(20.0) 
5   
(9.1) 
2  
(3.6) 
55  
(100.0) 
I felt out of control during 
treatment 
9  
(16.1) 
47  
(83.9) 
0 0 56 
(100.0) 
Tried IVF to avoid future  
regret 
33 
(60.0) 
13 
(23.7) 
2 
(3.6) 
7 
(12.7) 
5 
(100) 
Note. Number (%) N/A. Not applicable 
Participants did not feel that they needed more advice and information on ART, did not feel 
pressure from other people when making the decision to use ART, and were supported 
when making their choice, as shown in Table 6.32. 
Table 6-32 Group B: Decision Support 
Support Subscale Yes No Unsure Total 
Need more advice and information on 
choices  
15  
(28.9) 
33 
(63.4) 
4   
(7.7)  
52 
(100.0) 
Feel pressure from others making 
decision using ART  
9  
(17.3) 
42  
(80.8) 
1   
(1.9) 
52  
(100.0) 
Support from others in making choice of 
ART 
36  
(69.2)  
10  
(19.3) 
6   
(11.5) 
52  
(100.0) 
Note. Number (%) 
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Women who stopped ART when they had a child were asked if they had experienced 
emotional support. Table 6.33 shows chi-square analysis for trend between stopped ART 
with a live birth and the clinic offering emotional support was significant, χ2 (1, N = 29) = 
6.947, p =.008. Women who did not have a baby did feel supported but for those who had 
a baby, only one-quarter felt supported. 
Table 6-33 Group B: Comparing Stopped ART had Birth and Clinic Offered Emotional 
Support 
Stopped ART and birth Not 
 supported 
Yes 
 supported 
Unsure if 
 supported 
Total 
No 5   
(25.0) 
14  
(70.0) 
1  
 (5.0) 
20  
(100.0) 
Yes 4   
(57.1) 
2   
(28.6) 
1   
(14.3) 
7   
(100.0) 
Unsure 1   
(50.0) 
0 1   
(50.0) 
2   
(100.0) 
Total 10   
(34.4) 
16  
(55.2) 
3 
(10.4) 
29 
(100.0) 
Note. Number (%) 
Table 6.34 shows whether women felt assured by their clinicians that they would get 
pregnant, between the two age groups. Chi-square analysis between a decision to 
continue with ART after assurances and the two age groupings was significant, χ2(2, N 
=59) = 9.444, p =.008. More women aged 35–39 years agreed their clinician assured them 
they were likely to get pregnant compared to women aged 40 years or older. 
Table 6-34 Group B: Doctor Assured Pregnancy by Age 
Age  Agree Disagree Total 
35–39 years 18 
(81.8) 
4 
(18.2) 
22  
(100.0) 
40 years or older 12 
(41.4) 
17 
(58.6) 
29 
(100.0) 
Total 30 
(58.8) 
21 
(41.2) 
51 
(100.0) 
Note. Number (%) 
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Table 6.35 shows a series of questions to reflect on the participant’s experiences and 
expectations of ART. Most participants found their expectations of ART were met, were 
realistic, sympathetic service was provided, and their doctor understood their expectations. 
Most found their experiences with infertility challenging and half did find their experiences 
as difficult as they had expected. Overall most participants found their experiences to be 
‘worth it.’  
Table 6-35 Group B: Expectations and Experiences 
Experiences and expectation Response 
The experience was worth it  51 
(80.4) 
My expectations of the technology were realistic 52 
(78.9) 
My expectations of the technology were met  51 
(78.4) 
My doctor understood my expectations  52 
(77) 
My expectations of sympathetic service were met 52 
(77) 
The experience was difficult 39 
(66.7) 
The experience as not as difficult as I expected 42 
(42.9) 
Note. Number (%) 
6.6 Stopping ART 
Table 6.36 shows that for participants who had ceased treatment, the main reasons for 
stopping ART was a birth or not conceiving. Emotional, financial and personal costs were 
selected by one-third of participants. Other than stopping as they had a baby, there is no 
dominant reason for discontinuing treatment. Clinics may not be aware that a woman has 
discontinued treatment, as patients leave clinics without notifying their clinicians.  
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Table 6-36 Group B: Reasons for Stopping ART Treatment Response 
Reasons for stopping ART Yes No Unsure Total 
I am pregnant 5   
(20.8) 
19  
(79.2) 
0 24  
(100.0)  
I have a baby 21  
(70.0) 
9  
(30.0) 
0 30 
(100.0) 
I have adopted a child 0  22  
(100.0) 
0 40  
(100.0) 
The emotional cost was too high 8   
(36.4) 
14  
(63.6) 
0 41  
(100.0) 
The financial cost was too high 11  
(44.0) 
14   
(56.0) 
0 42 
(100.0) 
I have decided to move to a 
childfree life 
2   
(9.6) 
15   
(71.4) 
4   
(19.0) 
41 
(100.0) 
The treatment placed stress on 
personal relationships 
8   
(33.3) 
15   
(62.5) 
1   
(4.2) 
43  
(100.0) 
I have had enough treatment 8   
(34.8) 
13   
(56.5) 
2  
 (8.7) 
41  
(100.0) 
Note. Number (%) 
As shown treatment costs may not be a major reason for stopping ART but may control 
the number of cycles. Table 6.38 demonstrates the relationship between cost limitations 
and pregnancy. Chi-square analysis between a pregnancy and treatment costs and was 
significant, χ2 (1, N = 57) = 10.729, p =.001. Women who were not pregnant found the 
treatment costs limiting but those who were pregnant did not, clearly as they did not 
require a further cycle of ART. 
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Table 6-37 Group B: Pregnancy and the Treatment Costs Limited the Number of 
Cycles 
Pregnant Not limited by 
 cost 
Yes limited by 
 cost 
Total 
No 6   
(35.3) 
11  
(64.7) 
17  
(100.0) 
Yes 32  
(80.0) 
8   
(20.0) 
40  
(100.0) 
Total 38 
(66.7) 
19 
(33.3) 
57 
(100.0) 
Note. Number (%) 
As discussed in Chapter 2.8, the decision to continue or discontinue treatment is difficult 
for some women. Some women do not wish to experience regret after they discontinue 
treatment and for some, external factors may not allow them to continue ART cycles. The 
theory of anticipated decision regret (Tymstra, 1989, 2007) suggests that women will 
undertake ART to ensure they have done all possible to have a baby. This was supported 
by 68.8% (33/48) of the participants. Table 6.38 shows the relationship between decision 
regret and pregnancy. More women who were pregnant than not, supported avoiding 
disappointment.  
Table 6-38 Group B: Pregnancy and Regret Avoidance Response 
Pregnant after ART Yes tried ART to avoid 
regret  
Total 
No 11   
(35.5) 
11  
(100.0) 
Yes 20   
(64.5) 
20  
(100.0) 
Total 31   
(100.0) 
31 
 (100.0) 
Note. Number (%) 
Table 6.39 shows whether the decision to continue ART was influenced by clinician’s 
assurances. Chi-square analysis between their clinician encouraging them to continue 
treatment and the two age groups and was not significant, χ2 (1, N = 43) = 1.1, p = .294.  
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Table 6-39 Group B: Doctor Influenced Continuation of ART by Age 
Age  Yes No Total 
35–39 years 7   
(38.9) 
11  
(61.1) 
18  
(100.0) 
40 years or older 6  
(24.0) 
19  
(76.0) 
25  
(100.0) 
Total 13 
(30.2) 
30 
(69.8) 
43 
(100.0) 
 Note. Number (%) 
Table 6.40 shows possible limitations to continuing ART. One-third of the participants aged 
35–39 years responded that time and for one-third aged 40 years or older, oocyte quality 
were limitations for them. Younger women were more concerned about time constraints, 
and the older group were most concerned about their oocyte quality. 
Table 6-40 Group B: Personal Limitations to Continuing with ART Response 
Age  Time   Cost  Egg 
Quality  
No 
 Limits 
Unsure if 
 Limits 
No 
 Plans  
Total 
 35–39 
year
s 
7   
(35.0) 
2   
(10.0) 
4  
(20.0) 
1   
(5.0) 
1   
(5.0) 
5 
(25.0) 
20 
(100.0) 
 40 years 
or 
older 
7   
(27.0) 
4  
(15.4) 
10  
(38.4) 
0 0 5 
(19.2) 
26 
(100.0) 
  
Total 14 
(30.4) 
6 
(13.0) 
14 
(30.4) 
1 
(2.2) 
1 
(2.2) 
10 
(21.8) 
46 
(100.0) 
 
 
Note. Number (%) 
6.7 Summary 
Data were collected from a small cohort of women (N=68), with an average age of 40.7 
years, who had engaged with ART. Participants used ART because they were unable to 
conceive naturally and most women had, at least, one pregnancy that proceeded to a live 
birth. Of the pregnancies that were lost, there was no difference between the age groups 
on the rate of loss.  
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Most were in a stable relationship and educated to tertiary level and were in the workforce. 
Participants were mainly of an age where their fertility would be declining. 
As they had some knowledge and experience of ART, most women suggested that fertility 
declined from the age of 35–39 years, and women aged 40 years or older were more 
knowledgeable of fertility decline. Some in the older age group suggested that fertility did 
not wane until women were older than 40 years. Women aged younger than 40 years were 
more confident of success than those aged over 40 years. Infertility clinicians boosted the 
confidence of a pregnancy and encouraged more women aged 35–39 years to continue 
with ART than those aged 40 years or older.  
Most agreed that the lack of a relationship partner was the primary reason for women 
delaying childbearing, more so than career or work, financial security, health or furthering 
their education. There was a no significant difference between both age groups for this 
item. 
Both age groups were equally unsure of the likelihood of pregnancy or birth for women 35 
years or older. Half of the women were unsure if a birth was likely or not. However, they 
believed that they were likely to get pregnant, which is contrary to their uncertainty about 
the likelihood of a women aged 35 or older to be successful. Even though personally they 
were confident of a conception, few rated their chance of success at greater than 60%. 
Many women who had stopped treatment either had a pregnancy or a baby, but some had 
stopped ART without having a baby. Women who were pregnant did not agree that 
financial reasons were limiting, but clearly those who were still trying, found costs to be a 
limiting factor. 
Women thought their expectations of ART were realised. Their knowledge of ART was 
acquired primarily from their gynaecologist, media, and friends. Women aged 40 or older 
were more likely to be encouraged to try ART by their friends than younger women. Most 
agreed that the media reporting on the success of ART for women in midlife was 
misleading and failed to realistic depict experiences. 
Upon reflection, the women felt they knew the risks and benefits of ART; they had made 
an informed choice, and were satisfied with their decision. They were clear about their 
decision to use ART, which had not been a hard decision. Women aged 40 years, and 
older did not agree that their decision to delay childbearing was wise. Most found ART 
challenging, and as difficult as they had anticipated, yet worthwhile, regardless of the 
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outcome. They were informed of their ART choices and felt supported but not pressured. 
More women aged 40 and older would hypothetically not make that decision again to delay 
childbearing compared to younger women.  
Most found the clinic to be sympathetic towards them, and those who had favourable 
outcomes were more likely to say they had adequate emotional support. As their clinic 
offered them emotional and psychological support, they did not feel out of control. The 
procedures of treatment, drugs and the risks of ART were adequately explained. They did 
not seem influenced by their clinicians to continue ART and had developed awareness that 
ART was no guarantee of a baby. 
Many women found social situations involving children difficult despite being emotionally 
supported by their family. Women who were childless found it difficult to be with friends 
who had children, particularly at family gatherings as they felt left out and compared 
themselves to others with children. Some women felt their friends and relatives with 
children were leaving them behind.  
Women who had favourable outcomes did not agree that treatment costs limited the 
number of treatment cycles. All women, whether they had successfully conceived, decided 
that they tried ART so they would not regret that they had not tried all their options. As 
expected, particularly when analysing the data into age groupings, issues with small 
sample size arose. A larger sample size would be beneficial for more in-depth statistical 
significance. 
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Chapter 7: Group C - Community Survey 
This phone survey was undertaken on behalf of the researcher under strict 
guidelines for this form of research, as discussed in detail in Chapter 5. The PRI allowed 
the researcher five questions which are outlined in Chapter 5.5.2, and the effects of 
gender and age demographics were analysed.  
The respondents of Group C with an age range of 18 to 82 years numbered 1243. 
50.1% of respondents were male. The mean age of the male participants was 52.35 
(SD=16.00) as shown in Figure 7.1. and the mean age of the female participants was 
49.57 (SD=15.31) as shown in Figure 7.2. The response rate was 37.1%, cooperation rate 
was 38.2%, contact rate was 97.8% and the refusal rate was 55.8%. 
 
 
Figure 7-1 Group C: Male Participant Ages 
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Figure 7-2 Group C: Female Participant Ages 
Almost 52% had up to 12 years of education, 47.7% had more than 12 years, and 
0.6% did not respond. Data were initially analysed by total responses then for some 
questions, responses were broken down into gender and age groups. As for Group B the 
age groups chosen were: 35–39 years and 40 years of age and older.  
The five questions each had six analyses undertaken: 
a) All participants of all ages, 
b) Participants aged 35–39 years compared to participants aged 40 years and 
older, 
c) Men compared to women,  
d) Men aged 35 years or older compared to women aged 35 years or older. 
e) Women aged 35–39 years compared to women aged 40 years or older, and 
f) Men aged 35–39 years compared to men aged 40 years or older. 
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7.1 Main Reason for Delaying Childbearing 
The first question inquired about primary reason for women delaying childbearing. The 
most common reasons are; career aspirations, furthering education, financial reasons, 
relationship partnering and health. 
7.1.1 Main reason for delaying childbearing – all ages. 
As shown in Table 7.1, the most frequent response was that career or work were the 
primary reason for women having children later in life. Participants selected financial 
reasons as the next most common response. The option of lack of a partner was selected 
by only a small number of respondents, where it rated as a minor response along with the 
options of health issues and education.  
Table 7-1 Group C: Main Reason for Women Delaying Childbearing  
Main reason for women  
delaying childbearing 
 Response 
Career or Work 589 
(53.6) 
Financial  440 
(40.1) 
Lack of partner 46 
(4.2)  
Education 14 
(1.3) 
Health 9 
(0.8) 
Total 1098 
(100.0)  
Note. Number (%) 
 
7.1.2 Main reason for delaying childbearing–men and women aged 35–39 years 
compared to 40 years and older. 
Table 7.2 shows the beliefs about the main reason women delay childbearing. Chi-square 
analysis for trend between reasons for delaying childbearing and the two age groupings 
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was significant, χ2 (1, N = 994) = 12.704, p =.004. Career or work was the most common 
response for both genders aged 35–39 years and 40 years or older. Participants aged 40 
years or older believed that career or work were more influential than did participants aged 
35–39 years.  
Table 7-2 Group C: Main Reason for Women Delaying Childbearing Responses between 
Men and Women aged 35–39 years and 40 years and older 
Age  Career 
or work 
Financial 
 
Lack of  
partner 
Education 
 
Health  Total 
35–39 
 years 
58 
(48.4) 
39 
(32.5) 
19 
(15.8) 
1 
(0.8) 
3 
(2.5) 
120 
(100.0) 
40 or 
 older 
449   
(51.4) 
356 
(40.7) 
59   
(6.7) 
6 
(0.7) 
4 
(0.5) 
874  
(100.0) 
Total 507 
(51.0) 
395 
(39.7) 
78 
(7.9) 
7 
(0.7) 
7 
(0.7) 
994 
(100.0) 
     Note. Number (%) 
7.1.3 Main reason for delaying childbearing–men compared to women all ages.  
Views on the main reasons for women to delay childbearing between men and women of 
all ages are shown in Table 7.3. Chi-square analysis between the reasons for delaying 
childbearing and gender was significant, χ2 (4, N = 1098) = 11.028, p =.026. Around half of 
men and women selected career or work as the main reason. More men selected career 
or work than women, and more women than men selected a lack of partner. 
Table 7-3 Group C: Main Reason for Women Delaying Childbearing by Gender for all ages 
Gender Career 
or work 
Financial 
 
Lack  
of  
partner  
Education 
 
Health 
 
Total 
 
Men 299   
(55.8) 
212 
(39.6) 
12   
(2.2) 
8 
(1.5) 
5 
(0.9) 
536   
(100.0) 
Women 290  
(51.6) 
228 
(40.6) 
34   
(6.0) 
6   
(1.1) 
4 
(0.7) 
562 
(100.0) 
Total 589 
(53.6) 
440 
(40.1) 
46 
(4.2) 
14 
(1.3) 
9 
(0.8) 
1098 
(100.0) 
     Note. Number (%) 
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7.1.4 Main reason for delaying childbearing–men aged 35 years and older 
compared to women aged 35 years and older.  
Table 7.4 shows beliefs about the main reason for women to delay childbearing for both 
genders in the 35 years or older age group. Chi-square analysis between the reasons for 
delayed childbearing and the two age groups was significant, χ2 (4, N = 1016) = 10.111, p 
=.038. More men than women selected career or work, and more women than men 
selected lack of a partner.  
Table 7-4 Group C: Main Reason for Women Delaying Childbearing between Men and 
Women Aged 35 years and Older  
Gender Career 
or work 
Financial 
 
Lack of 
 partner  
Education 
 
Health 
 
Total 
 
Men 
35 years 
and 
older 
252   
(51.5) 
212 
(43.4) 
12   
(2.5) 
8 
(1.6) 
5 
(1.0) 
489  
(100.0) 
Women 
35 years 
and 
older 
255  
(48.4) 
228 
(43.3) 
34   
(6.4) 
6   
(1.2) 
4 
(0.7) 
527 
(100.0) 
Total 507 
(49.9) 
440 
(43.3) 
46 
(4.5) 
14 
(1.4) 
9 
(0.9) 
1016 
(100.0) 
Note. Number (%) 
7.1.5 Main reason for delaying childbearing– women aged 35–39 years compared to 
women aged 40 years and older. 
A comparison between women aged 35–39 years and those aged 40 years or older about 
the main reason for delaying childbearing is shown in Table 7.5. Chi-square analysis for 
trend between the reasons and the two age groups was significant, χ2 (1, N = 539) = 
7.016, p =.008. More women aged 40 years and older selected career or work than 
younger women.  
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Table 7-5 Group C: Reason for Women Delaying Childbearing between Women aged 35–
39 years and 40 years and older 
Age  Career 
or work 
Financial 
 
Lack of 
 partner 
Education 
 
Health  Total  
Women 
Aged 
35–39 
 years 
37 
(44.1) 
27 
(32.1) 
18 
(21.4) 
0 
 
2 
(2.4) 
84 
(100.0) 
Women 
aged 
40 or 
older 
218  
(47.9) 
183 
(40.3) 
50   
(11.0) 
2 
(0.4) 
2 
(0.4) 
455 
(100
.0) 
Total 255 
(47.3) 
210 
(39.0) 
68 
(12.6) 
2 
(0.4) 
4 
(0.7) 
539 
(100.0) 
        Note. Number (%) 
7.1.6 Main reason for delaying childbearing– men aged 35–39 years compared to 
men aged 40 years and older. 
Table 7.6 shows a comparison between men ages 35–39 years and men aged 40 years or 
older on the main reason why women delay childbearing. Over half the men in both age 
groups selected career or work as the main reason. Chi-square analysis for trend between 
men’s views gave and the two age groups was not significant, χ2 (1, N = 455) = 0.188, p 
=.664.  
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Table 7-6 Group C: Reason for Women Delaying Childbearing between Men aged 35–39 
years and 40 years and older 
Age  Career 
or work 
Financial 
 
Lack of 
 partner 
Education 
 
Health  Total  
Men 
aged 
35–39 
years 
21 
(58.3) 
12 
(33.3) 
1 
(2.8) 
1 
(2.8) 
1 
(2.8) 
36 
(100.0) 
Men  
aged 40 
 years or 
 older 
231  
(55.1) 
173 
(41.3) 
9   
(2.1) 
4 
(1.0) 
2 
(0.5) 
419 
(100.0) 
Total 252 
(55.4) 
185 
(40.6) 
10 
(2.2) 
5 
(1.1) 
3 
(0.7) 
455 
(100.0) 
    Note. Number (%) 
7.2 Age of Fertility Decline 
This question relates to community knowledge on the age range of women’s fertility. 
7.2.1 Age of fertility decline –all participants.  
Table 7.7 shows the responses on fertility decline for the age ranges: 34 years or younger, 
35–39 years, and 40 years of age or older. Respondents chose the age range of 35–39 
years followed by 40–44 years as the most likely age. 
Table 7-7 Group C: Age of Women’s Fertility Decline all Ages 
Age range of fertility decline  Response 
34 years or younger 299  
(25.3) 
35–39 years 543 
(45.9) 
40 years or older 340 
(28.8) 
Total 1182 
(100.0) 
Note. Number (%) 
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7.2.2 Age of fertility decline–participants aged 35–39 years and older compared to 
participants aged 40 years and older.  
Table 7.8 shows differences between perceptions of the age of fertility decline between 
participants aged 35–39 years and those 40 years or more. Around half of the participants 
in both age groups selected the age of decline as 35–39 years. Chi-square analysis 
between age of fertility decline and the two age groups was significant, χ2 (2, N = 1061) = 
12.087, p =.002. More community participants aged 35–39 years of age selected the age 
of 35–39 years as the age of fertility decline compared to the younger group. 
Table 7-8 Group C: Age of Women’s Fertility Decline between Age Groups 35–39 years 
and 40 years and older 
Age 
 
34 years or 
younger 
35–39 years 
 
40 years or 
older  
Total 
 
35–39 years 32 
(23.7) 
80 
(59.3) 
23 
(17.0) 
135 
(100.0) 
40 years or 
 older 
232 
(25.0) 
417 
(45.0) 
227 
(30.0) 
926 
(100.0) 
Total 264 
(24.9) 
497 
(46.8) 
300 
(28.3) 
1061 
(100.0) 
Note. Number (%) 
7.2.3 Age of fertility decline–men compared to women for all ages.  
A gender comparison on the age of women’s fertility decline is presented in Table 7.9. Chi-
square analysis between age of fertility decline and gender was significant, χ2 (2, N = 
1181) = 24.633, p =.000. Significantly more women believed that fertility decline started 
between 35–39 years than men, Whereas more men believed that fertility declined for 
women in their 40s.   
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Table 7-9 Group C: Age of Women’s Fertility Decline by Gender for all Ages 
Gender 34 years or 
younger 
35–39 years 
 
40 years or 
older 
Total 
 
Men 129 
(22.3) 
244 
(42.3) 
204 
(35.4) 
577  
(100.0) 
Women 170 
(28.1) 
299 
(49.5) 
135 
(22.4) 
604 
(100.0) 
Total 299 
(25.3) 
543 
(46.0) 
339 
(28.7) 
1181 
(100.0) 
Note. Number (%) 
7.2.4 Age of fertility decline–men aged 35 years and older compared to women 
aged 35 years and older. 
Table 7.10 shows a gender comparison between participants aged 35 years or older on 
the age of fertility decline. Chi-square analysis between age of fertility decline and gender 
was significant, χ2 (2, N = 1061) = 31.908, p =.000. Significantly more women in this age 
range believed that a woman’s fertility started declining between the ages of 35–39 years 
than men, and over a third of men of this age believed that fertility declined when women 
were aged in their 40s.   
Table 7-10 Group C: Age of Women’s Fertility Decline by Gender between Men aged 35 
years and older and Women aged 35 years and older 
Gender 34 years or 
younger 
35–39 years 
 
40 years or  
older 
Total 
 
Men 109 
(22.5) 
197 
(40.7) 
178 
(36.8) 
484  
(100.0) 
Women 155 
(26.8) 
300 
(52.0) 
122 
(21.2) 
577 
(100.0) 
Total 264 
(24.9) 
497 
(46.8) 
300 
(28.4) 
1061 
(100.0) 
Note. Number (%) 
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7.2.5 Age of fertility decline – women aged 35–39 years compared to women aged 
40 years and older. 
Table 7.11 shows the age group differences in women’s perceptions of the age of fertility 
decline. Chi-square analysis between age of fertility decline and the two age groups was 
significant, χ2  (2, N = 577) = 6.832 p =.032. Within the female community more 
participants aged 35–39 years believed women’s fertility started to decline between the 
ages of 35 to 39 years than those aged 40 years or older. More women aged 40 years or 
older had a stronger belief that fertility declined at an older age than the younger cohort. 
Table 7-11 Group C: Age of Women’s Fertility Decline Responses Between Women aged 
35–39 years and Women Aged 40 years and older   
Age  34 years or 
 younger 
35–39 years 
 
40 years or  
older 
Total 
 
Women 
35–39 years 
24 
(27.0) 
55 
(61.8) 
10  
(11.2) 
89 
(100.0) 
Women 
40 or older 
131 
(26.8) 
245 
(50.2) 
112   
(23.0) 
488 
(100.0) 
Total 155 
(26.9) 
300 
(52.0) 
122 
(21.1) 
577 
(100.0) 
Note. Number (%) 
7.2.6 Age of fertility decline- men aged 35–39 years compared to men aged 40 
years or older. 
Age group difference in men’s perceptions of the age of women’s fertility decline is 
presented in Table 7.12. Chi-square analysis between age of fertility decline and the two 
age groups for males was significant, χ2  (2, N = 501) = 12.687, p =.002. More men aged 
35–39 years than aged 40 years or older supported fertility decline from 35–39 years.  
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Table 7-12 Group C: Age of Women’s Fertility Decline between Men aged 35–39 years and 
Men Aged 40 years and older   
Age  34 years or 
younger 
35–39 years 
 
40 years or 
older 
Total 
 
Men 
35–39 years 
2 
(5.0) 
25 
(62.5) 
13 
(32.5) 
40 
(100.0) 
Men 
40 or older 
101 
(21.9) 
172 
(37.3) 
188 
(40.8) 
461 
(100.0) 
Total 103 
(20.6) 
197 
(39.3) 
201 
(40.1) 
501 
(100.0) 
Note. Number (%) 
7.3 Likelihood of a pregnancy 
This question explores community beliefs of the chance of a conception for women aged 
35 years or older using ART.  
7.3.1 Likelihood of a pregnancy – participants all ages. 
Table 7.13 shows the belief of the community of the chance of a woman aged 35 
years and older to get pregnant after ART. Half of the respondents believed women aged 
35 years or older were likely to get pregnant after ART, and one third were unsure. 
 
Table 7-13 Survey C: Beliefs on Likelihood of a Pregnancy Response 
Likelihood of a pregnancy Response 
Not likely 201 
(17.5) 
Neither not likely or likely 373 
(32.5) 
Likely 574 
(50.0) 
Total 1148 
(100.0) 
Note. Number (%) 
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7.3.2 Likelihood of a pregnancy–participants aged 35–39 years and older compared 
to participants aged 40 years or older. 
Table 7.14 shows a comparison between participants aged 35–39 years and 40 years or 
older on the chance of a pregnancy for women aged 35 years or older after ART. Around 
half of participants believed a pregnancy was likely. Chi-square analysis between age of 
fertility decline and the two age groups was not significant, χ2 (2, N = 1034) = 3.972, p 
=.137. 
Table 7-14 Group C: Chance of a Pregnancy responses between Age Groups 35–39 years 
and 40 years and older 
Age  Pregnancy 
 not likely 
 
Pregnancy 
neither not 
 likely or likely 
Pregnancy 
likely 
 
Total 
 
35–39 years 17 
(12.7) 
45 
(33.6) 
72  
(53.7) 
134 
(100.0) 
40 or older 177   
(19.7) 
295 
(32.7) 
428  
(47.6) 
900 
(100.0) 
Total 194 
(18.7) 
340 
(32.9) 
500 
(48.4) 
1034 
(100.0) 
Note. Number (%) 
7.3.3 Likelihood of a pregnancy–men compared to women for all ages. 
Table 7.15 shows a comparison between men and women of all ages on the chance of a 
pregnancy for women aged 35 years or older after ART. Chi-square analysis between 
beliefs about pregnancy chances and gender was not significant, χ2 (2, N = 1148) = 0.337, 
p =.845.  
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Table 7-15 Group C: Likelihood of a Pregnancy by Gender Response all Ages 
Gender Pregnancy 
 not likely 
Pregnancy 
 neither not 
 likely or likely 
Pregnancy  
likely 
Total 
 
Men 
all ages 
101  
(18.1) 
178 
(31.8) 
280 
(50.1) 
559  
(100.0) 
Women 
all ages 
100 
(17.0) 
195 
(33.1) 
294  
(49.9) 
589 
(100.0) 
Total 201 
(17.5) 
373 
(32.5) 
574 
(50.0) 
1148 
(100.0) 
Note. Number (%) 
7.3.4 Likelihood of a pregnancy–men aged 35 years or older compared to women 
aged 35 years or older. 
Table 7.16 shows a gender comparison for those aged 35 years or older on the chance of 
a pregnancy for women aged 35 years or older after ART. Chi-square analysis between 
age of fertility decline and gender was not significant, χ2 (2, N = 1059) = 0.666, p =.716. 
Table 7-16 Group C: Chance of a Pregnancy between Men aged 35 years or older and 
Women aged 35 years or older 
Gender Pregnancy 
 not likely 
 
Pregnancy 
neither not 
 likely or likely 
Pregnancy  
likely 
 
Total 
Men 
35 years or 
older 
85  
(18.1) 
145 
(30.9) 
240 
(51.0) 
470 
(100.0) 
Women 35 
years or 
older 
100 
(17.0) 
195 
(33.1) 
294 
(49.9) 
589 
(100.0) 
Total 201 
(17.5) 
373 
(32.5) 
574 
(50.0) 
1059 
(100.0) 
Note. Number (%) 
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7.3.5 Likelihood of a pregnancy– women aged 35–39 years compared to women 
aged 40 years or older. 
A comparison between women aged 35–39 years and those aged 40 years or older on the 
chance of a pregnancy after ART is shown in Table 7.17. Chi-square analysis between 
belief in a pregnancy and the age groups was undertaken on the responses and was not 
significant, χ2 (2, N = 564) = 3.312, p=.190.  
Table 7-17 Group C: Likelihood of a Pregnancy Women aged 35–39years and 40 years or 
older 
Age  Pregnancy 
 not likely 
 
Pregnancy 
neither not 
 likely or likely 
Pregnancy 
likely 
 
Total 
 
Women 
35–39 years 
11 
(12.4) 
34 
(38.2) 
44 
(49.4) 
89 
(100.0) 
Women  
40 or older 
98 
(20.6) 
161 
(33.9) 
216  
(45.5) 
475 
(100.0) 
Total 109 
(19.3) 
195 
(34.6) 
260 
(46.1) 
564 
(100.0) 
Note. Number (%) 
7.3.6 Likelihood of a pregnancy - men aged 35–39 years compared to men aged 40 
years or older. 
Table 7.18 shows age group differences in men’s perceptions of the chance of a woman 
aged 35 years or older getting pregnant after ART. Chi-square analysis between age of 
pregnancy chance and the two age groups for males was not significant, χ2  (2, N = 470) = 
2.497, p =.286. 
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Table 7-18 Group C: Likelihood of a Pregnancy between Men aged 35–39 years and Men 
Aged 40 years or older   
Age  Pregnancy not 
likely 
 
Pregnancy 
neither not 
likely or likely 
Pregnancy 
likely 
 
Total 
 
Men  
35–39 years 
6 
(13.3) 
11 
(24.5) 
28 
(62.2) 
45 
(100.0) 
Men  
40 or older 
79 
(18.5) 
134 
(31.5) 
212  
(50.0) 
425 
(100.0) 
Total 85 
(18.1) 
145 
(30.9) 
240 
(51.0) 
470 
(100.0) 
Note. Number (%) 
7.4 Likelihood of a healthy baby  
Chances of having a live birth after an ART-conceived pregnancy is lower for midlife 
intending mothers, and the lower success rate can be attributed to physiological factors, as 
discussed in Chapter 4. Most participants (66.1%) believed that women aged over 35 
years who conceived after ART would go on to have a healthy baby.  
 
7.4.1 Likelihood of a healthy baby for all participants. 
Table 7.19 shows the age group differences in participant’s beliefs of the chance of a 
woman aged 35 years having a healthy baby after ART. Most participants believed that 
women of this age who conceived via ART would give birth to a health baby. 
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Table 7-19 Group C: Likelihood of a Healthy Baby  
Likelihood of a baby Response 
Not Likely 96 
(8.3) 
Neither likely or not likely 296 
(25.6)  
Likely 764 
(66.1)  
Total 1156 
(100.0) 
Note. Number (%) 
7.4.2 Likelihood of a healthy baby- participants aged 35–39 years and older 
compared to participants aged 40 years or older. 
Table 7.20 shows the differences between participants aged 35–39 years and 40 years or 
older on the likelihood of a birth after ART. Chi-square analysis between likelihood of a 
birth and the two age groups was not significant, χ2 (2, N = 1043) = 1.809, p =.405.  
Table 7-20 Group C: Likelihood of a Healthy Baby between Men aged 35 years or older and 
Women aged 35 years or older 
Age  
 
Healthy baby 
 not likely 
 
Healthy baby 
neither not 
 likely or likely 
Healthy baby 
likely 
 
Total 
 
35–39 years 14 
(10.5) 
39 
(29.3) 
80 
(60.2) 
133 
(100.0) 
40 years or 
older 
76 
(8.3) 
234 
(25.7) 
600 
(66.0) 
910 
(100.0) 
Total 90 
(8.6) 
273 
(26.2) 
680 
(65.2) 
1043 
(100.0) 
Note. Number (%) 
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7.4.3 Likelihood of a healthy baby- men compared to women for all ages. 
Table 7.21 shows the differences between men and women of all ages on the likelihood of 
a healthy baby after ART. Chi-square analysis between belief in a birth after ART and 
gender was not significant, χ2  (2, N = 1156) = .934, p =.630.  
Table 7-21 Group C: Likelihood of a Baby by Gender 
Gender Live birth not 
 likely 
 
Live birth 
neither not 
 likely or likely 
Live birth 
likely 
 
Total 
 
Male 44  
(7.7) 
151 
(26.7) 
371 
(65.6) 
566 
(100.0) 
Female 52 
(8.8) 
145 
(24.5) 
393 
(66.7) 
590 
(100.0) 
Total 96 
(8.3) 
296 
(25.6) 
764 
(66.1) 
1156 
(100.0) 
Note. Number (%) 
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7.4.4 Likelihood of a health baby- men aged 35 years and older compared to 
women aged 35 years and older. 
Table 7.22 shows the differences between men and women all aged 35 years or older on 
the likelihood of a healthy baby after ART. Chi-square analysis between chance of a 
healthy baby and gender was not significant, χ2 (2, N = 1043) = 3.959, p =.138.  
Table 7-22 Group C: Likelihood of a Healthy Baby by Gender between Men aged 35 years 
and older and Women aged 35 years and older 
Gender Healthy baby 
 not likely 
 
Healthy baby 
 neither not 
 likely or likely 
Healthy baby 
likely 
 
Total 
 
Men 
35 years or 
older 
34  
(7.1) 
119 
(24.9) 
325 
(68.0) 
478 
(100.0) 
Women 35 
years or 
older 
56 
(9.9) 
154 
(27.3) 
355 
(62.8) 
565 
(100.0) 
Total 90 
(8.6) 
273 
(26.2) 
680 
(65.2) 
1043 
(100.0) 
Note. Number (%) 
7.4.5 Likelihood of a healthy baby – women aged 35–39 years compared to women 
aged 40 years and older. 
Differences between women aged 35 –39 years and those aged 40 years or older on the 
likelihood of a healthy baby after ART are shown in Table 7.23. Chi-square analysis 
between belief in a birth and age group was not significant, χ2 (2, N = 565) = 1.016, 
p=.602.  
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Table 7-23 Group C: Likelihood of a Healthy Baby between Women aged 35–39years and 
Women 40 years or older 
Age  Healthy baby 
not likely 
 
Healthy baby 
neither not 
 likely or likely 
Healthy baby 
likely 
 
Total 
 
Women  
35–39 years 
9 
(10.1) 
28 
(31.5) 
52 
(58.4) 
89 
(100.0) 
Women  
40 or older 
47 
(9.9) 
126 
(26.5) 
303  
(63.6) 
476 
(100.0) 
Total 56 
(9.9) 
154 
(27.3) 
355 
(62.8) 
565 
(100.0) 
Note. Number (%) 
7.4.6 Likelihood of a healthy baby - men aged 35–39 years compared to men aged 
40 years and older. 
Table 7.24 shows age group comparisons between men aged 35–39 years and those 
aged 40 years or older about a birth after ART. Chi-square analysis between likelihood and 
two age groups was not significant, χ2  (2, N = 478) = 1.366, p =.505.  
Table 7-24 Group C:  Likelihood of a Pregnancy between Men aged 35–39 years and Men 
Aged 40 years and older   
Age  Healthy baby 
not likely 
 
Healthy baby 
neither not 
 likely or likely 
Healthy baby 
likely 
 
Total 
 
Men 35–39 
years 
5 
(11.4) 
11 
(25.0) 
28 
(63.6) 
44 
(100.0) 
Men 40 or 
older 
29 
(6.7) 
108 
(24.9) 
297  
(68.4) 
434 
(100.0) 
Total 34 
(7.1) 
119 
(24.9) 
325 
(68.0) 
478 
(100.0) 
Note. Number (%) 
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7.5 Media portrayal 
As discussed in Chapter 4.8, media plays an important role in demystifying medical issues 
and a pivotal role in shaping of public opinion on medical issues and health risks. This 
question explores whether community members believe that media portrays ART as 
successful for older women.  
7.5.1 Media Influence– Participants all Ages. 
Table 7.25 shows most community members (73.5%) agreed that the media portrays ART 
as a successful way for older women to get pregnant. 
Table 7-25 Group C: Media Portrayal of ART Response-Participants all Ages 
Media positively portrays IVF as 
successful for older women 
Response 
Yes 904 
(73.5)  
No 212 
(17.2)  
Unsure 114 
(9.3)  
Total 1230 
(100.0)  
Note. Number (%) 
7.5.2 Media Influence - participants aged 35–39 years and older compared to 
participants aged 40 years and older. 
Table 7.26 shows a comparison for those aged 35-39 years and 40 and older on their 
perceptions of media portrayal of ART. Chi-square analysis between media influence and 
the two groups was not significant, χ2 (2, N = 1104) = 2.296, p =.317.  
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Table 7-26 Group C: Media Portrayal of ART Participants aged 35–39 years and Older 
Compared to age 40 years or Older 
Age  Media 
portrays ART 
as successful 
Media does 
not portray 
 ART as 
 successful 
Unsure if 
 Media 
 portrays ART 
 as 
 successful 
Total 
 
35–39 years 110 
(79.8) 
18 
(13.0) 
10 
(7.2) 
138 
(100.0) 
40 years or 
older 
712 
(73.7) 
161 
(16.7) 
93 
(9.6) 
966 
(100.0) 
Total 822 
(74.5) 
179 
(16.2) 
103 
(9.3) 
1104 
(100.0) 
Note. Number (%) 
7.5.3 Media influence- men compared to women for all ages. 
Table 7.27 shows a gender comparison for all ages. Chi-square analysis between media 
portrayal and gender was close to significance, χ2 (2, N = 1230) = 5.907, p =.052. More 
women believed that the media portrays ART as successful. 
Table 7-27 Group C: Beliefs on the Media Portrayal of ART by Gender  
Gender Media 
 portrays ART 
as successful 
Media not  
portrays ART 
 as 
successful  
Unsure if 
 Media 
 portrays ART 
 as 
 successful 
Total 
 
Men 438  
(71.4) 
106 
(17.3) 
69 
(11.3) 
613 
(100.0) 
Women 466 
(75.5) 
106 
(17.2) 
45 
(7.3) 
617 
(100.0) 
Total 904 
(73.5) 
212 
(17.2) 
114 
(9.3) 
1230 
(100.0) 
Note. Number (%) 
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7.5.4 Media influence-men aged 35 years or older compared to women aged 35 
years or older. 
Table 7.28 shows a comparison between men and women aged 35 years or older.  Chi-
square analysis between media portrayal and these groups was close to significance, χ2 
(2, N = 1104) = 5.854, p =.054.  
 
Table 7-28 Group C: Beliefs on the Media Portrayal of ART by Gender Men and Women 
aged 35 years or Older 
Gender Media 
portrays ART 
as successful 
Media not 
 portrays ART 
 as 
 successful  
Unsure if  
Media 
 portrays ART 
 as 
 successful 
Total 
 
Men 371 
(71.6) 
88 
(17.0) 
59 
(11.4) 
518 
(100.0) 
Women 451 
(77.0) 
91 
(15.5) 
44 
(7.5) 
586 
(100.0) 
Total 822 
(74.5) 
179 
(16.2) 
103 
(9.3) 
1104 
(100.0) 
Note. Number (%) 
7.5.5 Media Influence- women aged 35–39 years compared to women aged 40 years 
or older. 
A comparison between women aged 35–39 years of age and those aged 40 years or older 
is shown in Table 7.29. Chi-square analysis between media portrayal and the two groups 
was not significant, χ2 (2, N = 586) = 4.186, p =.123. 
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Table 7-29 Group C: Media Portrayal of ART Women aged 35–39 years Compared to 
Women aged 40 years or older 
 
7.5.6 Media Influence- men aged 35–39 years compared to men aged 40 years and 
older. 
Table 7.30 shows a comparison between men aged 35–39 years of age and those aged 
40 years or older. Chi-square analysis between media portrayal across the groups was not 
significant, χ2 (2, N = 586) = 4.186, p =.123.  
Table 7-30 Group C: Media Portrayal of ART Men aged 35–39 years compared to Men 
aged 40 years or Older 
Age  Media 
portrays 
ART 
as 
successful 
Media does 
not 
 portray ART 
 as  
 successful  
Unsure if Media 
portrays 
ART as 
successful 
Total 
 
35–39  
years of age 
33 
(70.2) 
7 
(14.9) 
7 
(14.9) 
47 
(100.0) 
40  
years or older 
338 
(71.8) 
81 
(17.2) 
52 
(11.0) 
471 
(100.0) 
Total 371 
(71.6) 
88 
(17.0) 
59 
(11.4) 
518 
(100.0) 
Note. Number (%) 
 
Age  
 
Media 
 portrays ART 
 as 
 successful 
Media not 
 portrays ART 
as successful 
 
Unsure if 
 Media 
 portrays ART 
as successful 
Total 
 
35–39  
years of age 
77 
(84.6) 
11 
(12.1) 
3 
(3.3) 
91 
(100.0) 
40  
years or older 
374 
(75.5) 
80 
(16.2) 
41 
(8.3) 
495 
(100.0) 
Total 451 
(77.0) 
91 
(15.5) 
44 
(7.5) 
586 
(100.0) 
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7.6 Summary 
Community members (N=1243) provided valuable data regarding fertility perceptions and 
beliefs. Career or work was perceived as the primary reason for women delaying having 
children for all age groups and gender. Financial security was the second most common 
response, and lack of a partner not a frequent response.  
The age ranges 35–39 years was the most commonly selected response as the age of 
fertility decline; this is consistent with the medical literature. However, around a quarter of 
the community decided the age of 40 years and older as the age at which fertility declines. 
Those aged 35–39 years were more likely to choose the ages of 35–39 years as the age 
of decline while the older respondents believed fertility declined for women over the age of 
40 years. Women, particularly those over 35 years, were more likely to correctly select the 
age of 35 years as when fertility significantly declines. 
Almost half of the respondents believed women aged 35 years or older were likely to get 
pregnant and deliver a healthy baby after ART. Men (all ages) and community members 
aged 40 years or older were more confident of a healthy baby. There was no significant 
difference between the beliefs across age groups and genders. In general, community 
members had faith in the success of ART for women aged 35 years or older. 
A large proportion of the surveyed community believed that media portrays ART as a 
successful way for older women to become pregnant, with some strongly holding this view. 
Data also showed that some community members are unsure about fertility and ART. In 
particular, one-quarter to one-third of respondents were confused about the likelihood of 
pregnancy or live birth for women aged 35 years and older. Chapter 8 presents results of a 
comparison of data for these five questions for Groups B and C. 
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Chapter 8: Comparison between Groups B and C 
This chapter presents the comparison between women in Groups B and C. Survey 
responses from participants in Group B (68 women in a support group who had used ART) 
and Group C (1243 men and women in the general community) were compared. Five 
questions were asked of participants in these two surveys as discussed in Chapter 5. 
Responses were further divided into two age groups: 35–39 years and 40 years of age or 
older, and comparisons made between women in each group.  
8.1 Main Reason for Delaying Childbearing 
The most common reasons for women delaying childbearing, as discussed in Chapter 3.4, 
were compared cross the two groups of participants. 
8.1.1 Main Reason for Delaying Childbearing- Groups B and C all ages. 
Table 8.1 shows the main reason women delay childbearing for Groups B and C. Chi-
square analysis for trend between reasons for delay and the two groups was significant, χ2 
(1, N = 1161) = 172.783, p =.001. More support group members believed lack of a partner 
was the major reason while more community members believed career or work was the 
main reason for women delaying childbearing. 
Table 8-1 Groups B and C: Main Reason for Women Delaying Childbearing all Ages 
Group Career 
or work 
Financial 
 
Lack of 
 partner 
Education Health 
 
Total 
 
Group B 15   
(23.8) 
8 
(12.7) 
39   
(61.9) 
0 
 
1 
(1.6) 
 
63   
(100.0) 
Group C 589  
(53.6) 
440 
(40.1) 
46   
(4.2) 
14   
(1.3) 
9 
(0.8) 
1098 
(100.0) 
Total 604 
(52.0) 
448 
(38.6) 
85 
(7.3) 
14 
(1.2) 
10 
(0.9) 
1161 
(100.0) 
Note. Number (%) 
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8.1.2 Main Reason for Delaying Childbearing- Groups B and C aged 35 years or 
older. 
Beliefs about the main reason for women to delay childbearing between men and women 
in Groups B and C aged 35 years or older is shown in Table 8.2. Chi-square analysis for 
trend between beliefs across the two groups was significant, χ2 (1, N = 1161) = 656.689, p 
=.000. Most in the support group aged 35 years or older believed lack of a partner, while 
half of the community in this age group believed career or work was the main reason for 
women delaying childbearing. 
Table 8-2 Groups B and Group C: Main Reason for Women Delaying Childbearing 
aged 35 years or Older 
Group Career 
or work 
Finance 
 
Lack of 
 partner 
Education Health 
 
Total 
Group B 
All aged 35 
years or 
older 
14   
(23.7) 
7 
(11.9) 
397  
(62.7) 
0 
 
1 
(1.7) 
 
59   
(100.0) 
Group C 
All aged 35 
years or 
older 
493 
(52.7) 
388 
(41.5) 
41   
(4.5) 
7   
(0.7) 
6 
(0.6) 
935 
(100.0) 
Total 507 
(51.1) 
395 
(39.7) 
78 
(7.8) 
7 
(0.7) 
7 
(0.7) 
994 
(100.0) 
Note. Number (%) 
8.1.3 Main reason for delaying childbearing- Groups B and C Women aged 35–39 
years.  
Table 8.3 shows the beliefs about the main reason for women to delay childbearing for 
women in Groups B and C aged 35–39 years of age. Chi-square analysis for trend 
between reasons across the two groups was significant, χ2 (1,N = 84) = 15.142, p =.000. 
Half of women in the support group aged 35–39 years of age believed lack of a partner 
and half of females in the community of this age believed career or work was the main 
reason for women delaying childbearing. 
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Table 8-3 Groups B and C: Women aged 35–39 years of age on Reason for Women 
Delaying Childbearing 
Group Career 
or work 
Finance Lack of 
 partner 
Education Health Total 
Group B 
Women 
aged 35–
39 years 
6  
(25.0) 
4 
(16.6) 
13  
(54.2) 
0 
 
1 
(4.2) 
 
24   
(100.0) 
Group C 
Women aged 
35–39 
years 
31 
(51.7) 
23 
(38.3) 
5   
(8.3) 
0 
 
1 
(1.7) 
60 
(100.0) 
Total 37 
(44.1) 
27 
(32.1) 
18 
(21.4) 
0 
 
2 
(2.4) 
84 
(100.0) 
Note. Number (%) 
8.1.4 Main reason for delaying childbearing- Groups B and C women aged 40 years 
or older  
Table 8.4 shows the main reason for women to delay childbearing between women in 
Groups B and C in the 40 or older category. Chi-square analysis for trend between 
reasons across the two groups was significant, χ2 (1, N = 455) = 82.384, p=.000. Most 
women in the support group aged 40 years or older believed lack of a partner and half the 
participants in the community in this age group believed career or work was the main 
reason for women delaying childbearing. 
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Table 8-4 Groups B and C: Women aged 40 years or older on Reason for Women 
Delaying Childbearing 
Group Career 
 or work 
Financial Lack of  
partner 
Education Health Total 
Group B 
Women 
aged 40 
and older  
8 
(22.8) 
3 
(8.6) 
24  
(68.6) 
0 
 
0 
 
35   
(100.0) 
Group C 
Women aged 
40 and 
older  
210 
(50.0) 
180 
(42.8.) 
26  
(6.2) 
2 
(0.5) 
2 
(0.5) 
420 
(100.0) 
Total 218 
(47.9) 
183 
(40.3) 
50 
(11.0) 
2 
(0.4) 
2 
(0.4) 
455 
(100.0) 
Note. Number (%) 
8.2 Age of fertility decline 
As discussed in Chapter 4.2, female fertility declines with increasing maternal age. 
Participants were asked about their beliefs about the age when fertility begins to 
significantly decline for women. 
8.2.1 Age of fertility decline – Groups B and C all ages. 
Table 8.5 shows beliefs on the age of fertility decline in Groups B and C. Chi-square 
analysis between age of decline and the two groups was significant, χ2 (2, N = 1244) = 
16.568, p =.000. Over half of participants in both groups believed fertility declined between 
35–39 years.  A quarter of community members believed that fertility declined at 40 years 
or older whereas only a small number of Group B held the same belief. 
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Table 8-5 Groups B and C: Age of Fertility Decline all Ages 
Group 34 years or 
 younger 
35-39 years 40 years or 
 older 
Total 
 
Group B  16 
(25.8) 
42 
(67.7) 
4 
(6.5) 
62 
(100.0) 
Group C 
 
299 
(25.3) 
543 
(45.9) 
340 
(28.8) 
1182 
(100.0) 
Total 315 
(25.3) 
585 
(47.0) 
344 
(27.7) 
1244 
(100.0) 
Note. Number (%) 
8.2.2 Age of fertility decline- Groups B and C aged 35 years or older. 
Table 8.6 shows beliefs of participants aged 35 years or older on the age of female fertility 
decline in Groups B and C. Chi-square analysis between age of decline and the two 
groups was significant, χ2 (2, N = 1061) = 15.558, p =.000. Two thirds of the support group 
compared to less than half of the community believed fertility declined between the 35–39 
years. A third of community members believed that fertility declined at 40 years or older 
compared to a small number of support group members. 
Table 8-6 Groups B and C: Age of Fertility Decline aged 35 years or Older 
Group 34 years 
 or younger 
35–39 years 40 years 
 or older 
Total 
Group B  
aged 35 years or older 
16 
(27.1) 
39 
(66.1) 
4 
(6.8) 
59 
(100.0) 
Group C 
aged 35 years or older 
248 
(24.8) 
458 
(45.7) 
296 
(29.5) 
1002 
(100.0) 
Total 264 
(24.9) 
497 
(46.8) 
300 
(28.3) 
1061 
(100.0) 
Note. Number (%) 
8.2.3 Age of fertility decline –Groups B and C females aged 35–39 years. 
Beliefs of female participants in Groups B and C aged 35–39 years on the age of women’s 
fertility decline is shown in Table 8.7. Chi-square analysis for trend between age of decline 
and the two groups was not significant, χ2 (1, N = 89) = 3.545, p =.059. . 
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Table 8-7 Groups B and C: Women on Age of Fertility Decline aged 35–39 years 
Group 34  
years or 
 younger 
35–39 
 years 
40  
years or 
 older 
Total 
Group B  
Women aged 35–39 years 
9 
(37.5) 
15 
(62.5) 
0 24  
(100.0) 
Group C 
Women aged 35–39 years 
15 
(23.1) 
40 
(61.5) 
10 
(15.4) 
65 
(100.0) 
Total 24 
(27.0) 
55 
(61.8) 
10 
(11.2) 
89 
(100.0) 
Note. Number (%) 
8.2.4 Age of fertility decline –Groups B and C females aged 40 years or older. 
Table 8.8 shows beliefs of women aged 40 years or older on age of fertility decline in 
Groups B and C. A chi-square test between the age of decline and the two groups was not 
significant, χ2 (2, N = 488) = 5.372, p =.068.  
Table 8-8 Groups B and C: Women on Age of Fertility Decline aged 40 years and 
older 
Group 34 years 
or younger 
35–39 
 years 
40 years 
 or older 
Total 
 
Group B Women 
aged 40 years or older 
7 
(20.0) 
24 
(68.6) 
4 
(11.4) 
35  
(100.0) 
Group C 
Women aged 40 years or older 
124 
(27.4) 
221 
(48.8) 
108 
(23.8) 
453 
(100.0) 
Total 131 
(26.8) 
245 
(50.2) 
112 
(23.0) 
488 
(100.0) 
Note. Number (%) 
8.3 Likelihood of a pregnancy 
Participants were asked about their beliefs in an ART-conceived pregnancy for women 
aged 35 years or older. 
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8.3.1 Likelihood of a pregnancy- Groups B and C all ages. 
Table 8.9 shows the beliefs of Groups B and C on the likelihood of pregnancy after ART. 
Chi-square analysis between likelihood and the two groups was significant, χ2 (2, N = 
1210) = 13.88, p =.000. Half of community members compared to a quarter of the support 
group believed a pregnancy was likely after ART. 
Table 8-9 Groups B and C: Likelihood of a Pregnancy all Ages 
Group Pregnancy 
 not Likely 
 
Pregnancy 
 neither not 
 Likely or Likely 
Pregnancy  
Likely 
 
Total 
 
Group B 17  
(27.4) 
29 
(46.8) 
16 
(25.8) 
62 
(100.0) 
Group C 201 
(17.5) 
373 
(32.5) 
574 
(50.0) 
1148 
(100.0) 
Total 218 
(18.1) 
402 
(33.2) 
590 
(48.7) 
1210 
(100.0) 
Note. Number (%) 
8.3.2 Likelihood of a pregnancy- Groups B and C aged 35 years or older. 
Table 8.10 shows the beliefs of Groups B and C aged 35 years or older on the likelihood of 
a pregnancy after ART. Chi-square analysis between likelihood across the two groups was 
significant, χ2 (2, N = 1034) = 13.331, p =.001. In this age range, half of the community 
compared to a quarter of the support group believed a pregnancy was likely after ART. 
Table 8-10 Groups B and C: Likelihood of Pregnancy aged 35 years or older 
Group Pregnancy 
 not Likely 
Pregnancy 
 Neither 
 not Likely 
 or Likely 
Pregnancy  
Likely 
Total 
 
Group B 
All aged 35–39 years 
17 
(28.8) 
27 
(45.8) 
15 
(25.4) 
24 
(100.0) 
Group C 
All aged 35–39 years 
177 
(18.2) 
313 
(32.1) 
485 
(49.7) 
65 
(100.0) 
Total 194 
(18.8) 
340 
(32.9) 
500 
(48.3) 
1034 
(100.0) 
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Note. Number (%)  
8.3.3 Likelihood of a pregnancy- Groups B and C females aged 35–39 years. 
Beliefs of women aged 35-39 years in Groups B and C on the likelihood of a pregnancy 
after ART is shown in Table 8.11. Chi-square analysis between likelihood and the two 
groups was significant, χ2 (2, N = 89) = 9.415, p = .009. For women in this age group, half 
of community members compared to a quarter of the support group believed a pregnancy 
was likely. 
Table 8-11 Group B and C: Likelihood of Pregnancy Women aged 35–39 years 
Group Pregnancy 
 not likely 
Pregnancy 
 neither not 
 likely or 
 likely 
Pregnancy  
likely 
Total 
 
Group B 
Women aged 35–39 
 years 
6 
(25.0) 
12 
(50.0) 
6 
(25.0) 
24 
(100.0) 
Group C 
Women aged 35–39 
 years 
5 
(7.7) 
22 
(33.8) 
38 
(58.5) 
65 
(100.0) 
Total 11 
(12.4) 
34 
(38.2) 
44 
(49.4) 
89 
(100.0) 
Note. Number (%) 
8.3.4 Likelihood of a pregnancy- Groups B and C females aged 40 years or older. 
Table 8.12 shows the beliefs of females aged 40 years or older in Groups B and C on 
likelihood of a pregnancy after ART. Chi-square analysis between likelihood and the two 
groups was significant, χ2 (2, N = 475) = 6.274, p =.043. For women in this older age 
group, half of the community compared to a quarter of the support group believed a 
pregnancy was likely.  
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Table 8-12 Groups B and C: Likelihood of Pregnancy Women aged 40 years or older 
 
Note. Number (%) 
8.4  Group C: Likelihood of a Healthy Baby for Women aged 35 years 
Participants were asked about their beliefs for an ART-conceived pregnancy progressing 
to the birth of a healthy baby for women aged 35 years or older. 
8.4.1 Likelihood of a healthy baby – Groups B and C all ages. 
Beliefs of both groups about likelihood of a birth after ART are shown in Table 8.13. Chi-
square analysis between likelihood of a birth and the two groups was significant,χ2 (2, N = 
1218) = 27.463, p =.000. A third of the support group compared to two-thirds of the 
community group had expectations of a healthy baby. 
 
 
 
 
Group Pregnancy  
not likely 
Pregnancy 
 neither 
 not likely 
 or likely 
Pregnancy  
likely 
Total 
 
Group B 
Women aged 40 years or 
older 
11 
(31.4) 
15 
(42.9) 
9 
(25.7) 
35 
(100.0) 
Group C 
Women aged 40 years or 
older 
87 
(19.8) 
146 
(33.2) 
207 
(47.0) 
440 
(100.0) 
Total 98 
(20.6) 
161 
(33.9) 
216 
(45.5) 
475 
(100.0) 
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Table 8-13 Groups B and C: Likelihood of a Healthy Baby all Ages 
Group Healthy 
 baby 
 not likely 
Healthy 
 baby 
 not likely 
 or likely 
Healthy 
 baby 
likely 
Total 
 
Group B 12  
(19.3) 
29 
(46.8) 
21 
(33.9) 
62 
(100.0) 
Group C 96 
(8.3) 
296 
(25.6) 
764 
(66.1) 
1156 
(100.0) 
Total 108 
(8.9) 
325 
(26.7) 
785 
(64.4) 
1218 
(100.0) 
Note. Number (%) 
8.4.2 Likelihood of a healthy baby – Groups B and C aged 35 years or older. 
Table 8.14 shows beliefs of Groups B and C members aged 35 years or older 
on the likelihood of a healthy baby after ART.  Chi-square analysis between 
likelihood across the two groups was significant, χ2 (2, N = 1043) = 30.326, p =.000. 
A third of the support group compared to two-thirds of the community group of this 
age had expectations of a healthy baby. 
 
 
Table 8-14 Groups B and C: Likelihood of a Healthy Baby aged 35 years or older 
Group Healthy 
baby not 
 likely 
 
Healthy 
baby not 
 likely or 
 likely 
Healthy 
baby likely 
 
Total 
 
Group B 
aged 35 years or older 
11  
(18.6) 
29 
(49.2) 
19 
(32.2) 
59 
(100.0) 
Group C 
aged 35 years or older 
79 
(8.0) 
244 
(24.8) 
661 
(67.2) 
984 
(100.0) 
Total 90 
(8.6) 
273 
(26.2) 
680 
(65.2) 
1043 
(100.0) 
Note. Number (%) 
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8.4.3 Likelihood of a healthy baby- Groups B and C women aged 35–39 years. 
Table 8.15 shows beliefs of women aged 35-39 years of age in Groups B and C on the 
likelihood of a healthy baby after ART. Chi-square analysis between likelihood and the two 
groups was significant, χ2 (2, N = 89) = 19.227, p =.000. One-fifth of the support group 
women compared to three-quarters of women in the community group in this age group 
had expectations of a healthy baby after ART.    
Table 8-15 Groups B and C: Likelihood of a Birth Women aged 35 years or older 
Group Healthy 
 baby not 
 likely 
 
Healthy 
 baby 
neither not 
 likely or 
 likely 
Healthy 
baby 
likely 
 
Total 
 
Group B 
Women aged 35–39 years 
5 
(20.8) 
14 
(58.3) 
5 
(20.9) 
24 
(100.0) 
Group C 
Women aged 35–39 years 
4 
(6.2) 
14 
(21.5) 
47 
(72.3) 
65 
(100.0) 
Total 9 
(11.1) 
28 
(31.4) 
52 
(58.4) 
89 
(100.0) 
Note. Number (%) 
8.4.4 Likelihood of a healthy baby- Groups B and C women aged 40 years or older. 
Table 8.16 shows beliefs of women aged 40 years or older in Groups B and C on the 
likelihood of a healthy baby after ART. Chi-square analysis between likelihood and the two 
groups was significant, χ2 (2, N = 476) = 9.175, p =.010. About 40% of the support group 
women of this age compared to 65% of women in the community aged 40 years or older 
had expectations of a healthy baby after ART. 
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Table 8-16 Groups B and C: Likelihood of a Birth Women aged 40 years or older 
Group Healthy 
 baby not 
 likely 
 
Healthy 
 baby 
neither not 
 likely or 
 likely 
Healthy 
 baby 
likely 
 
Total 
 
Group B 
Women aged 40 years or 
older 
6 
(17.1) 
15 
(42.9) 
14 
(40.0) 
35 
(100.0) 
Group C 
Women aged 40 years or 
older 
41 
(9.3) 
111 
(25.2) 
289 
(65.5) 
441 
(100.0) 
Total 47 
(9.9) 
126 
(26.5) 
303 
(63.6) 
476 
(100.0) 
Note. Number (%) 
8.5    Media influence  
Participants were asked if they believed the media portrayed ART as a successful way for 
women aged 35 years or older to have a child. 
8.5.1 Media Influence- Groups B and C all ages. 
Table 8.17 shows the beliefs of Groups B and C regarding media portrayal of ART 
success. Chi-square analysis between media influence and the two groups was not 
significant, χ2 (2, N = 1291) = 4.182, p =.124. 
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Table 8-17 Groups B and C: Media Influence all Ages 
Group Yes  No Unsure Total 
Group B 52 
(85.3) 
6 
(9.8) 
3 
(4.9) 
61 
(100.0) 
Group C 904 
(73.5) 
212 
(17.2) 
114 
(9.3) 
1230 
(100.0) 
Total 956 
(74.1) 
218 
(16.8) 
117 
(9.1) 
1291 
(100.0) 
Note. Number (%) 
8.5.2 Media Influence- Groups B and C aged 35 years or older. 
Table 8.18 shows the beliefs of Groups B and C aged 35 years or older on media portrayal 
of ART success. Chi-square analysis between media influence and the two groups was 
significant, χ2 (2, N = 1104) = 7.636, p =.022. Support group members of this age have a 
stronger belief that the media portrays ART as successful. 
 
Table 8-18 Groups B and C: Media Influence aged 35 years or older 
Group Yes  No Unsure Total 
Group B 
All aged 35 years or older 
52 
(89.6) 
3 
(5.2) 
3 
(5.2) 
58 
(100.0) 
Group C 
All aged 35 years or older 
770 
(72.6) 
176 
(16.6) 
114 
(10.8) 
1060 
(100.0) 
Total 822 
(73.5) 
179 
(16.0) 
117 
(10.5) 
1118 
(100.0) 
Note. Number (%) 
8.5.3 Media influence- Groups B and C women aged 35–39 years. 
Beliefs of women aged 35–39 years in Groups B and C about media portrayal of success 
of ART are shown in Table 8.19. Chi-square analysis for trend between media influence 
and the two groups was not significant, χ2 (1, N = 91) = 1.131, p =.287.  
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Table 8-19 Groups B and C: Media Influence Women aged 35–39 years 
Group Yes  No Unsure Total 
Group B 
Women aged 35–39 years 
22 
(91.6) 
1 
(4.2) 
1 
(4.2) 
24 
(100.0) 
Group C 
Women aged 35–39 years 
55 
(82.1) 
10 
(14.9) 
2 
(3.0) 
67 
(100.0) 
Total 77 
(84.6) 
11 
(12.1) 
3 
(3.3) 
91 
(100.0) 
Note. Number (%) 
8.5.4 Media Influence- Groups B and C women aged 40 years or older. 
Table 8.20 shows beliefs of women aged 40 years or older in Groups B and C on media 
portrayal of ART success. Chi-square analysis between Surveys B and C on portrayal of 
ART was not significant, χ2 (2, N = 495) = 3.418, p =.181.  
Table 8-20 Groups B and C: Media Influence Women aged 40 years or older 
Group Yes No Unsure Total 
Group B  
Women 40 years or older 
30 
(88.2) 
2 
(5.9) 
2 
(5.9) 
34 
(100.0) 
Group C 
Women 40 years or older 
344 
(74.6) 
78 
(16.9) 
39 
(8.5) 
461 
(100.0) 
Total 374 
(75.5) 
80 
(16.2) 
41 
(8.3) 
495 
(100.0) 
Note. Number (%) 
8.6    Summary 
Support group members who had engaged with ART had significantly different responses 
to the community group across the five key questions. They believed the primary reason 
for women approaching motherhood at a later age was that a relationship partner was 
desirable before starting a family. Conversely, community members believed that women’s 
career or work commitments were the primary reasons for delayed motherhood.  
The most common response from both the support group and the community was that 
female fertility starts to decline from the age of 35–39 years. One-quarter of the support 
group believed fertility started declining from the age of 25 years while a quarter of the 
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community believed fertility declines from 40 years of age. There was no significant 
difference between the beliefs of women in both groups in the age groups 35-39 years and 
40 and older. 
There was a significant difference between beliefs of the two groups for an ART-conceived 
pregnancy for women aged 35 or older. Only one-quarter of the support group believed 
women aged 35 years or older were likely to get pregnant compared to half the of the 
community. 
Similarly, there was a significant difference between the two groups on their beliefs of the 
chance of a healthy baby after ART for women aged 35 or older. The community were 
more confident of a healthy baby than those in the support group. More of the support 
group were unsure than the community on likelihood of a baby.  
Both groups, and for all ages, were in agreement that media portrays ART as a successful 
way for older women to conceive. There was a significant difference between those aged 
35 –39 years in both groups, with the support group having a stronger belief than the 
community that media portrays ART as successful. Women who had experienced ART 
had a more realistic understanding of these matters than the community. Chapter 9 
contains qualitative data from the support and focus groups.to expand upon the 
quantitative findings. 
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Chapter 9: Qualitative Results 
 
“I just can’t see life without having children” (TO). 
9.1 Introduction 
Qualitative data were gathered in this study to triangulate findings from the quantitative 
surveys and to gain a better insight into the perceptions and experiences of women who 
had used ART. Results are detailed in this chapter.  
9.2 Participants 
Participants were aged 35 years or older when they engaged with ART. Qualitative data 
were gathered from two groups of women who were undertaking or had recently 
undertaken ART; Group D involved six women in lengthy face-to-face interviews with a 
neutral facilitator while Survey B responses arose from open written comments from 23 
participants. These 29 women had a mix of ART history and success – some were still 
undertaking treatment while others had disengaged from ART. Some women who were 
successful initially had previous of subsequent unsuccessful cycles, enabling a broad 
experience with ART treatment to be reflected in comments and discussion. 
9.2.1 Group D Interviews 
All six participants in Group D were either recently or currently using ART. They were 
asked to tell the story of their ART journey with the outline of the interview script shown in 
Appendix 1. Each participated in a one-hour interview; five interviews were held in face-to-
face sessions in Brisbane and one interview was conducted via telephone as the 
participant lived in regional Queensland 
 These face-to-face interviews were audiotaped, transcribed and data were de-identified. 
The responses were pooled and coded by two independent researchers. The researchers 
immersed themselves in the data before common themes became evident. Responses 
were organised into 13 sections and outlined in this chapter.  
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9.2.2 Group D Participant Profiles 
Six participants took part in focus group interviews; their details and codes for 
analysis are as follows: 
1) AN is aged 40 years, has a daughter and had undertaken ART for three 
years. She started ART at the age of 37 and got pregnant on her fifth IVF 
cycle. 
2) JA is aged 44 years and is starting her 12th IVF cycle within three years. JA 
has now chosen to access donor egg and sperm because of her diminished 
oocyte quality and her partner’s poor semen parameters. 
3) LL is aged 42 years and had her first ART cycle when aged 41.  
4) SH is aged 41 and is 14 weeks pregnant after ART and has a daughter from 
ART.  
5) SJ is aged 37 years and completed her 17th ART cycle. She has now 
chosen to use donor oocytes rather than autologous oocytes. In total, she 
has experienced one miscarriage, has a son born in 2006 and had two 
ectopic pregnancies resulting in the removal of both fallopian tubes. 
6) TO is aged 38 years. She had several miscarriages, a triplet pregnancy 
leading to a birth at 24 weeks gestation with the neonatal death of the 
triplets, and a live birth after seven cycles of ART. She was nine weeks 
pregnant at the time of the interview. Nine cycles had been undertaken at the 
date of the interview. 
9.2.3 Interview Questions Group D 
Participants were asked 12 questions that covered their experiences and expectations of 
ART as detailed in Chapter 5.7.2. The interviewer asked the participants about: their 
experience at the infertility clinic; outcomes of their ART treatment; their understanding of 
women’s fertility decline; social reasons why women may postpone childbearing; their 
belief of the probability for a woman in midlife to have a baby using ART; whether media 
and marketing framed their expectations of success; decisions to stop treatment and 
whether they had recommendations for other women on age of childbearing or 
engagement with ART. 
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9.2.4 Data Analysis 
Responses from both interviews and survey comments were not combined as, although 
participants had been asked about similar key themes, responses were obtained in 
different formats. The issues arising from the analysis are outlined as subsections 9.3.1 to 
9.3.13 for Group D and 9.4.1 to 9.4.13 for Survey B.  
9.3 Results Group D 
9.3.1 Understanding of Fertility Decline. 
Participants were asked about their personal opinions on the optimal age to start a family. 
As they had used ART, their knowledge of the period of fertility decline could have 
changed from their original perception. 
I suppose before we went and started to look at it, I just don’t 
know, I knew eventually that your fertility declines but I didn’t 
realise it was at 35 and they had already put me in the problem 
category because I was 37. But the obvious impact on fertility is 
that 35 is the tipping point where it really starts to drop. And 
then once you get past 40 that’s the real grey danger zone. 
(AN) 
I guess as a young child my idea was that by the time I was 30 
I would have finished having my children and that probably just 
came from hearing aunties and older women talking. Now I 
understand through IVF is that 35 is the tipping point. (SJ) 
Some women were unaware of their “biological clock ticking” and the optimum age for 
childbearing. ART was their only chance for a conception.  
But from what I understand through IVF is that 35 is a tipping 
point where if you look at a child I guess the slope of the 
decline becomes a lot stronger, so it declines a lot more rapidly 
and a lot quicker after the age of 35. (SJ) 
No, I never thought about it. And I don’t know why I didn’t think 
about it. When you get to your late 30s you don’t remember 
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what your next goal is but maybe it was so I just didn’t look into 
all that. I do not know. (JA)  
At the age of 35 years, a relationship partner informed LL about the midlife decline in 
fertility, but she had dismissed the suggestion. She started ART at age 41. 
And I remember boo-hooing him, just sort of in my own mind 
like thinking - 35?  I was like, don’t be ridiculous, and now he is 
absolutely right. But I think I just sort of decided – there’s plenty 
of time, 35 is so young. (LL)   
 
SJ assumed that she had plenty of time to have a family. 
“There’s plenty of time — 35 is so young” (SJ). 
 
9.3.2 Social Factors Influencing the Timing of Childbearing. 
There are various socially based reasons why women approach motherhood in midlife and 
the literature highlights reasons of career, partnering relationships, financial security or 
educational aspirations.  
 
“So, I guess I was quite focused on study and then building 
careers and things like that” (LL). 
“The expectation for lot of women is to work until the mid-
thirties and then you think about children because you have 
that work pathway you must fill” (SH). 
 
Career and work commitments influenced some women to postpone childbearing until 
their late 30s and older. Nevertheless, some women found their priorities shifted with 
increasing age and their desire to have children surpassed their career aspirations.  
Once I sort of started trying to have a family my interest in 
having a career just sort of left - I think I realised that it’s just 
not a priority. I was working really long hours because I felt like 
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I just had to keep going up, up, up, you know, whereas now it’s 
like, I’m not interested, not in the slightest. You are made to 
feel like you have to make yourself powerful and break the 
glass ceiling. (TO) 
 
Some women intentionally delayed childbearing until they were financially secure.  
I would try full time to have a child whereas when you’re 30 you 
can’t afford to do that – 40 you have your money so I think 
ideally, financially it’s a better time. Unfortunately your body 
doesn’t always think that. (JA) 
 
Participants discussed how the absence of the right partnering relationship or the lack of a 
partner was a factor for them delaying childbearing. 
 “I travelled around the state every 3–4 weeks and didn’t have a 
chance to form a relationship of any sort” (SH). 
Well, my thing was that I hadn’t found anyone worth having 
children with, if you know what I mean. So I think having a 
husband 15 years ago probably means that I wouldn’t be here 
today, what I mean, I wouldn’t be telling a story. (JA) 
“I knew it was something I wanted to do, but something to do 
with someone else. We didn’t meet each other until later in life 
at the age of 35” (AN). 
 
Some women thought, upon reflection, that their search for a partner did not coincide with 
their most fertile years. 
I think I always imagined I would meet Mr. Right and all that 
stuff would happen and it just didn’t happen probably within 
those ideal childbearing years. The decision was reached and 
now that I do have a partner and he is supportive of trying and 
giving it a go, but, yeah, it’s probably not too late. (LL)  
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I was really lost leading up to where I found my partner in life, I 
just didn’t fit in anywhere anymore, and you are too tired to go 
out clubbing all the time, I couldn’t figure out where to meet 
people. (TO) 
 
Some participants were not focused on having a child in their prime reproductive years, as 
motherhood, at that time, was not imperative.    
I was never interested in having kids. I don’t remember really 
anyone that I would consider even having a family with, you 
know, it wasn’t at that point in my head. It was never really a 
decision that I must have children and I must, I am getting 
really old and I must have them. It sort of moved from an idea 
into reality as I didn’t have that huge expectation that I am 
going to have children. (SH) 
“I was never one of these women who wanted to necessarily 
now—wasn’t family, baby, husband focused. I sort of had other 
things going on” (LL). 
“Having a career and not finding the right person until into later 
life and believing you can have everything done with a career 
and have a family. But I do think from a societal point of view 
we have shifted that balance a bit further than it should have 
done” (AN). 
 
For some participants delaying motherhood was a conscious decision as it was not the 
right time for them to have a baby.  
“Well, I had already discussed it a couple of years prior and 
decided no, and I had always wanted children badly. I knew 
that I wasn’t ready to have them” (JA). 
… and I don’t know, I was consciously making a choice not to 
have a family, but people assume that you don’t, that you are 
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making that choice. They ask you why you haven’t and that’s 
quite a complicated question and really personal I think. (LL) 
 
9.3.3 Regrets about Postponing Childbearing.  
Some women expressed a range of regrets about lost time and opportunities to have 
children naturally and then engaging with ART and regretting their decision to delay 
childbearing.  
“I think more than anything else I wish I had known more about 
the possibilities maybe 5 years ago. I think once the window 
closes and those options are gone, then they are gone” (LL). 
 If you could just rethink your life and not place so much 
importance on something that you’re later going to regret, I 
really believe they’ll regret it and they might say that they don’t 
but deep down they will. (TO) 
“…they had already put me in a problem category because I 
was 37. I wished someone had said something to me earlier on 
that as a problem point” (AN). 
 
One participant suggested that even her family doctor of 20 years, did not initiate a 
conversation around fertility; rather, a past boyfriend informed her that she should have a 
child by the age of 35 years. 
“It might have actually rung some bells or something, but no 
one talks about it” (LL). 
9.3.4 Experiences at the Infertility Clinic. 
Some participants described the effects of medical intervention.  Some women described 
their experiences in philosophical terms and the lasting impact ART had on them.  
“I keep asking myself all the time you know, what have I ever 
done to deserve this — not being able to have children” (JA). 
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“…perhaps it’s kind of changed me in nice kinds of ways. I 
wouldn’t have thought that way had I not gone through the 
experiences I had” (SJ). 
I am probably more appreciative with my friends like the true 
friends. As I say, it’s robbed me of my confidence as a person. 
So definitely it has changed me. But I am hoping in the end it 
will be for the better. (TO) 
One participant, who was a health professional, commented on her interaction with 
counselling provided at the at the infertility clinic. 
All clinics need better and more focused counselling 
support. As a mental health professional the level of 
psychological support was out of date and tokenistic at all 
stages. 
 
9.3.5 Expectations of ART. 
Women would naturally have an expectation and hope that their treatment cycles would be 
successful. However, data showed that, for some women, their hopes were not realised. 
Several participants reflected on the changes in their expectations of success over time. 
Expectations may be heightened before the start of their treatment, but expectations of a 
live birth may decline if repeated cycles unsuccessful. Many midlife intending mothers will 
not conceive despite having expectations that they would conceive on the first few cycles 
of ART. Women may rely on ART as a fall-back option if they cannot naturally conceive.  
 
“…the expectations, are incredibly different to what I started to 
what they are now. My expectations are now that I guess the 
reality of this that we probably come to accept that this may not 
happen” (SJ). 
“People don’t realise when those ones are saying there’s 
always IVF, okay, that’s the last resort” (JA). 
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“We didn’t have a lot of knowledge of anything then and so we 
obviously had it in our heads that this is going to be a really, 
really quick process” (SJ). 
 
Success for many women would be having a baby, but for AN, it was just getting pregnant. 
“My feeling would be that for a success in IVF my hurdle is that 
19, 20-week morphology scan. Having gone through it I would 
draw my successes back a little earlier” (AN). 
 
Some women had unrealistic expectations that ART would be able to help them conceive. 
Some women had hopes that they would quickly fall pregnant, but for some this was 
unrealistic. 
Well for me, I think it’s got a bit to do with that you can do 
anything, you can do anything anytime, and science and 
technology is on your side; if you wake up and you are 40 and 
you don’t have a baby, someone will help you. You just went to 
a fertility specialist and a few months later walk out pregnant. I 
think I assumed it was that simple. I always assumed I think 
because I’ve achieved everything else I wanted to achieve. 
Sadly, it is not. (LL) 
Look, beforehand I really thought that I would walk up to IVF 
and it will just happen. I just trusted that it was just going to 
work. So I probably thought, 95% chance I was going to fall 
pregnant. I thought you walk in, walk out. But I did expect it to 
be sooner; I wouldn’t have expected it to be so this many years 
ago. (TO) 
I think it’s one of those things that once you make up your mind 
to give it a try and there is certainly a level of determination and 
well, I’m going to be different to everyone else and prove 
everyone else wrong. I assumed that if you achieved a 
pregnancy and all things were going well, again that science 
   167 
and the medical profession would step in and you would 
achieve a live birth. (LL) 
My expectation at the outset was basically the same before and 
the specialist’s opinion largely that was we were going to get 
pregnant in no time. So if you are a woman under 35 and going 
to seek fertility treatment, you know they’re going to be saying, 
you will be pregnant in no time and so I guess at the end of the 
day that was something I learnt really early on. (SJ) 
 
Several participants said they were not given realistic information on their chances of 
pregnancy and that infertility clinicians should give an honest indication of the chance of a 
successful pregnancy. 
No fertility doctor should ever tell you that you will be pregnant 
in no time, because they can never really know — that just 
causes a lot of trauma for the person. It would be nice for a 
specialist to be able to say, ‘I actually don’t think your chances 
are very good.’ I have never once heard anyone say that to me. 
(SJ) 
At the end of that first consultation, he [clinician] was so sure 
that it would all be OK. I was given the impression that all 
would be quite easy and so his parting words were ‘Let’s get a 
baby on board and have like that sticker at the back of cars.’ So 
it seemed to me to be really positive and sort of like it’s going to 
be a snap, let’s just get this started. I can make things happen 
when I want to, so if I want a baby, I’ll have a baby. (LL) 
 
A diagnosis of idiopathic infertility can be frustrating for women who need a clinical 
explanation of why they are unable to conceive. SJ had an expectation that not only would 
she have a baby but also the clinicians would be able to provide her with a medical 
diagnosis for her infertility. Her expectation had not been realised. 
My expectations haven’t been met because my expectations 
are that I should have a reason why I am not able to get 
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pregnant. I still can’t understand that given all the technology 
we have today around IVF that people don’t have diagnosis of 
unexplained fertility. So, all of that hasn’t really met my 
expectation I guess. (SJ)  
 
Some women’s expectations of a healthy baby were not realised, and this was a bitter 
disappointment even for women such as TO, who had her first child through IVF and 
experienced secondary infertility.  
I seem to always have such high expectations of myself. So, 
when I started the journey of trying to have a family, for it not to 
happen as I had planned it to happen, it was all a big shock for 
me. (TO) 
Even though you try to be logical and measure your own 
expectations, we’ll keep them realistic. I had created, obviously, 
an expectation of a positive outcome, so when there is a 
negative outcome the disappointment is quite strong. (LL) 
9.3.6 Impact of the media on women’s perceptions of ART. 
Expectations of a live birth could be influenced by personal preconceptions or by images 
portrayed in media or marketing campaigns. Participants agreed that media gave an 
affirmation of success rates which may elevate expectations for a baby. Furthermore, 
participants decided that the negative aspects of ART for older women were not frequently 
discussed in the mainstream media thus giving the perception that ART is successful for 
older women.  
“So I think the media does give women incorrect information of 
the success of IVF for the general public” (SJ). 
But for women like 40, I think the media creates a very positive 
spin on them. You don’t really hear the downside. The positive 
is always reported in the media. No one expects them to go 
into the gory details, but maybe that is not the type of content 
that women’s magazines want to portray because they are 
trying to sell a certain dream or a lifestyle or whatever. (LL) 
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I see things in the media that might create a false expectation 
of a woman’s ability to actually conceive a child whether it’s her 
own, got through her own egg or even a donor egg at a certain 
age. (LL) 
“I haven’t heard a lot of stories in the media for IVF, and what 
I’ve have it’s always been positive. You don’t hear anything 
negative about this sort of thing” (JA). 
“The one thing I remember hearing on the radio is [that] 99% 
developed a pregnancy in one in three cycles. It catches my 
ear every time, so I think, are you kidding yourself” (TO). 
I think, for people who don’t know very much about IVF, the 
media gives women the completely wrong picture and, again, 
what you will see in the media is probably all of the successful 
stories and they’re probably based on celebrities and so forth. 
What they don’t put in there is a person’s individual 
circumstances. (SJ) 
“I said the media does give women a perception of IVF, I think 
often they publish the good stories and the good outcomes” 
(SJ). 
“But the media does also show a lot of older women actually 
having babies quite later in life. Again, they’re obviously not 
reporting on all of the women who are unable to have children 
later in life” (SJ). 
“The impact that those media stories have on me is that I have 
often felt quite devastated by those stories” (AN). 
“I heard that you are susceptible to cancers, ovarian and breast 
cancer because of chemicals and hormones. But my desire to 
have a baby was stronger than the fear of getting cancer” (TO). 
 
Women’s perceptions of the success of ART may be influenced by media depiction of 
older celebrities who have a baby. Celebrities may appear as role models giving the 
impression that older women do not have difficulty with conception. However, it is often 
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unclear whether older celebrities have conceived with their oocytes, or donated oocytes 
from younger women, or used ART.  
 I think that if there is a celebrity who actually has an IVF baby, 
it looks as if that person has undergone IVF and done one 
cycle and they have a child, but it is very possibly they may 
have done 10. Those other previous cycles are probably not 
going to be mentioned. (SJ) 
You think if she can do it and I am only 35, then I can do it too 
or I am only 40 and all the personalities overseas like actresses 
that are 42 and having a baby… that probably gives off the 
message that that’s OK too. (TO) 
Some of the women had read an article in the Australian media about a woman who had 
given birth at the age of 50 years. However, the article failed to declare that the mother 
was hypertensive, an insulin dependent diabetic who required a LSCS at 35 weeks 
gestation due to concerns of preeclampsia (Rani et al., 2015). One woman, in particular, 
was disappointed in the content of the article. 
It was just a very glossy article about how happy she was, but it 
did not mention anything about her journey or what she’d gone 
through or whether it’s her own egg or a donor egg or anything 
like that. So I think it’s just very one-dimensional…it’s all about 
the outcome. (LL) 
 
SJ suggested that media focus on younger women delaying their childbearing with the 
assurance that frozen oocytes may lead them to future disappointment, as there is no 
certainty of success. 
In the media, I think they were just newspapers saying that 
people may perhaps be advocating for women to freeze their 
eggs at a young age with, obviously, the promise that later you 
can then have your career and do whatever you want to do, 
travel, and have your children later. And my understanding 
from the whole idea is that it doesn’t quite work like that and 
there is no great statistical evidence that egg freezing is any 
   171 
benefit. Stories like that in the media could make somebody 
think, well, I might just freeze my eggs and then I have got 
another 10–15 years or something like that. (SJ) 
“With young women, you know, when you think about the 
media as well, it is something reporting what the average time 
— what are the average ages that women are now having 
children” (SJ).  
 
Participant JA did not agree that media portrayal of ART influenced her childbearing 
intentions. 
AN was undecided as to the influence of the media compared 
to the influence of peer group. 
I think the media has an involvement in that sort of cultural 
influence of when it is a good time for people to have children. I 
feel like the people I was around and the communities I was in 
had a much bigger impact on me deciding when to have 
children rather than in the media. (AN) 
9.3.7 Understanding the Risks 
Some participants had great faith in the ability of science and technology to deliver them a 
healthy baby and were unaware of possible medical complications in conception and birth, 
and the risk of congenital anomalies. 
“The publicity about IVF never shows you the failure associated 
with it and I certainly haven’t seen about side effects 
beforehand” (AN). 
Midlife intending mothers may be unaware of the health risks to themselves and offspring 
when having children later in life. LL suggested that this lack of information opened women 
to potential unknown risks of ART. 
Just providing that information or some more reality in reporting 
so that women actually understand the possibilities, percentage 
wise; I think that’s not really discussed, some of that potential 
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health and sort of issues for the child. I don’t think that’s widely 
discussed or mentioned in the media. (LL) 
9.3.8 Commodification and Marketing of Motherhood and ART 
Expectations of a successful outcome can be elevated by promotional material supplied by 
infertility clinics and pharmaceutical companies that manufacture ovulatory drugs. Such 
information may not communicate the realistic success rates of ART or women may 
misunderstand the information from their clinician.  
“Sometimes when you first go to a clinic, you’re given 
enormous odds, positive odds over 90%” (JA). 
“I think they are very evasive about answering specific 
questions about success rates.” (AN) 
I think it’s a bit biased towards positives of IVF and they 
sometimes overstate success. If you read everything, it does 
say the success rate is about 30 percent, I think that it’s a bit 
biased towards the positive, bit it is business. (SH) 
 
One support group member had undergone eight years of ART from the age of 32 years 
without success. She felt she had no psychological support from the clinic, especially 
when she and her partner decided to remain childless. She expressed her concerns about 
the business of ART and profit making. 
They are more interested in the couples who have babies than 
the ones who fail! It has become a moneymaking business; 
they implied that all couples will take a baby home! When you 
are no longer a paying customer, they don’t want to know you. 
(SG) 
 
SJ also felt that the pictures of young mothers in marketing campaigns supported her 
belief that she would have a successful cycle. 
…even the pictures they use, I mean they’ve all got beautiful 
brand-new babies on there. Not all of them publish, I believe, 
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the actual success rates, I know some clinics do and some 
clinics don’t. But, definitely, the marketing information — it does 
change a person’s impression of IVF technology and success 
rates, particularly success rates. (SJ) 
I think it’s tilted more towards the possibilities and the positive 
outcome than the reality of the impacts of it, the journey, and 
the possible outcomes or the lack of outcome. So I felt they had 
a bit of a sales spin to it that was, you know, what can we do 
for you. It is obviously from the pharmaceutical suppliers, you 
know, look what we can do for you. (LL) 
Some participants felt that the clinic and the clinic staff elevated their hopes. Media or 
promotional material from infertility clinics could raise their expectations of success. SJ 
started ART when younger than 35 years and had undertaken 17 cycles.  
If I look back at even us in the early days, I mean we didn’t 
think we would be at the point of having 17 cycles later. We 
were always under the impression that we were going to be 
pregnant rather quickly, and all of that information and while we 
were reading, that the success rate was good and the fact that I 
was under 35 and so forth. It would be nice for a specialist to 
be able to say, I actually don’t think your chances are very 
good and I have never heard anyone say that to me. (SJ) 
The promotional material from fertility clinics can shape women’s perceptions of the 
success of ART.  
They [infertility clinics] talk about how many IVF babies have 
been born in Australia, but what about the bit of information 
they don’t give you is that they don’t tell you how many IVF 
cycles did it take to have that number of babies born (SJ). 
“The publicity about IVF never shows you the failure associated 
with it, and I certainly haven’t seen information on side effects 
before ”(AN).  
Once I decided I was going, I probably didn’t read a lot of their 
information. I would have seen was that I think it was a 95% 
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success rate that they were going to get you pregnant within, a 
certain number of cycles. That’s like all I caught on to and that’s 
all I believed in — all the other stuff behind the scenes saying 
no. (TO) 
 
TO suggested that no one told her that it would take more than one cycle to have a child. 
However, TO felt that her doctor maintained a positive outlook which was also for his 
benefit.   
They are so positive — their job is to keep you optimistic, I 
think. I don’t think it’s a sell job that he is optimistic, I think it’s 
just that he needs to maintain that, otherwise he probably has a 
crushed life, you know his job is to try and maintain his own 
sanity, he needs to be optimistic to people. (TO) 
 
9.3.9  ‘Calling it a day’: When and How to stop ART. 
The financial, emotional, social and relationship aspects of infertility treatment impacted on 
some participants. The decision to stop ART without having a child can be difficult. For 
such women, there is no hope of children and they must rethink their life plan and 
aspirations. Of the women who stop ART without having conceived, most do this because 
of emotional stress or poor prognosis' (Brandes et al., 2009).  
One respondent who had had nine ART cycles agreed that the cost of ART 
would be a factor in her continuing treatment.  
You really don’t get a lot of support from the government I 
think. The Medicare thing, they changed it. It was quite good 
before that, well, it didn’t feel as taxing on your savings until 
they changed that and then that really hurt. (TO) 
 
Financial constraints can be a reason for women stopping treatment as the out-of-pocket 
expenses for a cycle and options such as preimplantation screening can be expensive.  
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“I am sure for a lot of people financing would have to be up at 
the top of the list somewhere” (SJ). 
“Finance would be a big one. Someone was telling me they 
were in debt because of IVF” (JA). 
“There is a lot of outlay, which you have to fund for quite a 
while before you get money back as well” (LL). 
 
Women spoke of the emotional impact of ART being a reason for stopping treatment.  
“…he (partner) was struggling with the emotional impact of it 
(IVF) had on me. We were coming to a point where we were 
going to say this isn’t worth it” (AN). 
“I think the emotional cost to someone having those highs and 
lows constantly could definitely influence a person’s decision to 
stop” (SJ). 
That depends on age I think and the reality around whether or 
not continuing is going to pep up the potentials of positive 
outcomes. So I think it’s quite age dependent and depending 
on your circumstances to why you are there. Desperation, well, 
desperation I guess or the ability to adopt or something, so 
other choices. So I think that once the decision has been made 
that people want a baby. If they can have a baby in other ways 
through adoption or something like that, then that’s obviously 
going to be the trigger for them not continuing to peruse IVF. 
(LL) 
 
“For me, I want to sort of reach a point where I say, okay, 
you’ve got to let it go and I sort of want to get on. If it’s no then 
that’s okay, unless you’ve sort of at least made the decision to 
get on with other things” (LL). 
After a miscarriage and six back-to-back ART cycles TO said, 
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I just couldn’t give up. Finished one cycle and it didn’t work, I 
cried my eyes out, went on the next cycle. I don’t know how to 
say when I am going to say enough is enough. I am hoping, I 
guess, in my heart of hearts that this one, you know. I see 
myself with the two children — I feel I could be happy with that. 
But you know, I don’t know how I’m going to cope if it’s the only 
one. I have a baby and I still can’t stop. We are in debt but we 
are still going. (TO) 
One respondent discussed how the three years of ART had taken a toll on her partnering 
relationship and this was a factor in her discontinuing treatment. Wollett  (1996) suggests 
that when the decision is made to stop treatment, rather than blaming treatment, the blame 
can shift to blaming the woman for a lack of perseverance. 
Emotionally and relationship wise it was taking its toll and we 
realised we were coming to a point where we are going to have 
to say that this isn’t worth it as we are the most important thing 
in this relationship. We got to a point where we were almost 
getting a separation. (AN) 
 
SJ cited her reasons for stopping after 17 cycles of ART as financial and emotional. 
However, concerns about the potential health risk of another cycle were her main 
deterrent.  
“And I just kind of think how he would feel if something 
happened to me or I got sick because of trying to have another 
child when we actually have got him so I mean that is a factor 
that kind of influences my decision” (SJ). 
 
JA felt that her expectations of the technology had not been fulfilled, as she had not had a 
baby. However, she had personal reasons for not continuing with further cycles. 
No I haven’t got a baby yet, it’s got to happen soon. I’m not 
prepared to give up yet. Finance would be one thing, I think 
maybe the disappointment the constant no’s and my husband 
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is 10 years older than me, he is saying I don’t want to be an old 
dad. (JA) 
 
Some participants found it hard to stop treatment and hoped that the next cycle would be 
successful. Some had done everything possible for pregnancy but felt there was no clear 
endpoint to treatment. These women had anticipated decision regret, as they did not want 
to stop ART in case their next cycle was successful.  
“Because I achieved the blastocyst I sort of feel like I’ve 
got a step closer so now I think that probably we’ll have one 
more try” (LL). 
9.3.10 Emotional Roller Coaster. 
‘Emotional roller coaster’ was a term used by some participants to describe the swings of 
emotions from hope to despair if the cycle was unsuccessful and the hormonal effects of 
the ovulatory drugs. 
I think I didn’t expect the emotional stuff, although I’ve been 
warned. Oh it was bad. Because there was one drug they put 
me on the very first time and I sort of became wimpy. I have 
been crazy and said I’ll never do that again and then with this 
new clinic that I tried hasn’t sent me wimpy this time. It must 
have been stresses in my life at the time as well. I didn’t realise 
at first it was ever so much of an emotional a roller coaster. 
(JA) 
“Emotionally the brain is just not prepared – you still expect it to 
work. Mentally consuming and it’s really hard not to think about 
that every minute of the day. I just couldn’t have even 
anticipated the emotional toll associated with it” (AN). 
 
Some suggested that the waiting time after the embryo transfer until a pregnancy test was 
a time of heightened emotions eventuating in either joy or despair. TO was anxious after 
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oocyte collection procedure, as she had lost ART-conceived triplets at 24 weeks gestation. 
She found unsuccessful cycles were difficult when her oocytes failed to fertilise.  
 
Then you get the negative result and you hang up the phone 
and burst into tears. I was always crying at the clinic as I am 
really emotional. I just want more, you know, the journey is not 
done for me.  (TO) 
9.3.11 Taboos and Secrecy. 
Some women do not freely discuss their decision to have a child or their ART journey. 
Some women considered that ART is often a taboo subject with their friends and family. 
Women may be unaware of the low success rates for midlife intending mothers as shown 
by some of the responses. Zoll (2013, 2014) suggests that taboos are reinforced by 
infertility clinics as they do not wish patients to discuss their infertility or the failure of ART 
to solve their infertility.  The absence of accurate information makes the success stories in 
media misleading. 
 “I don’t think that’s talked about, and I think it probably should 
be. And I think friends should be more honest with each other 
around things like that” (LL). 
I think there is a bit of a taboo, people don’t want to talk about it 
with their friends or with their family and certainly wouldn’t want 
to participate in something like this because they might as well 
talk about things that are personal — I’m not sure why I think 
there is a taboo around this subject. I think women’s ability to 
have a child, to be fertile is not something that women feel 
comfortable talking about with their friends necessarily even 
with their health professionals. (LL)  
“Girlfriends don’t ask each other about when they are having 
like why they don’t like having a baby, none of mine do. I 
cannot even remember one friend of mine who has talked 
about her fertility” (LL). 
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“My friends hear my story. But other than that, when you are 
going through the process of IVF most people don’t know your 
story” (SJ). 
I didn’t even know that my cousin had a problem until she 
found out that I had a problem and that’s probably because my 
parents are both from huge families — it’s not a dirty secret that 
I am doing IVF. (TO) 
“It’s, to them, like a taboo subject, and I know women in their 
fertility and their ability to mother and all that type of thing is 
very deeply engrained in literature and art history and the 
feminine psyche” (LL). 
 
AN found an important emotional support tool through an online 
support group with other women undertaking ART. 
I didn’t have to talk to people in my normal world, I had people 
who understood all the stresses of IVF and that we could post 
and chat to each other. It helped me understand a lot more 
about the drugs… and how you deal with failure and how you 
deal with moving into the next one. (AN) 
 
It was mentioned that women are reluctant to discuss issues with other clinic patients who 
might be empathetic. Women were secretive about the outcomes of their oocyte transfers 
and the results of their cycles.  
IVF is, sort of like, it’s a secret fraternity. If you walk into a clinic 
and you see 10 other couples, not one of those couples will talk 
to you. Some would barely make eye contact. And I don’t know 
why. I don’t think it’s shame; I think it’s that’s people are afraid 
of the success of others in my opinion. (TO) 
“I didn’t want to be around other people who are doing IVF and 
didn’t want to be around other infertile people because I didn’t 
want to be faced with it” (AN). 
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9.3.12 The Journey. 
Whether the treatment was successful or not, women describe their journey as an often 
difficult and something they will not quickly forget, and AN and LL found aspects of their 
experience to be positive. 
I think it has made me a better person as well because it has 
made me look at how to deal with more hurdles and get over 
those. It has made me incredibly sensitive about not making 
judgement on childless couples…it has opened my eyes to the 
world of infertility because I never expected to be in that place. 
(AN) 
It’s probably made me more aware of the possibilities for other 
people who don’t appear to have made choices around 
childbearing. I think it’s actually been quite a good thing for our 
relationship because it sort of made us focus on what we want 
and it’s been quite good. (LL) 
9.3.13  “Don’t Wait for IVF”: Recommendations from Participants.  
Women who had used ART had the following recommendations for those who may be 
contemplating ART or midlife motherhood. Some of the women were clear that they hoped 
their recommendations would be available to other women as a result of this research. No 
woman in this study recommended ART or delaying childbearing; their recommendations 
were to the contrary. They advised other women, if possible, to have a natural conception 
when fertile and not to rely on ART as a fall-back option. Women’s recommendations for 
other women making decisions on timing of childbearing are detailed below and in direct 
quotation from the data, as their message is more poignant when in their words. 
“Women thinking they can wait until 35, I don’t know, it’s a 
dangerous game to play with your body” (TO). 
“Cut to the chase, do it by the time you’re 35 and do it naturally 
if you can” (LL). 
“Don’t rely on it [ART]…. some more information about the 
reality of how likely it is” (LL). 
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“Obviously, don’t leave it too late… if it’s an age-related issue 
that 12 months delay could have been precious time where 
perhaps your eggs were of better quality” (JA). 
The following recommendations were for women who were worried that taking time away 
from a career to have a baby could be disadvantageous for their careers.  
 I would never, even for my daughter, want her to wait as long 
as I did. I would really like for her to have her life in order that 
she has a good comfortable career, job, whatever that she 
understands that can be put on hold and you can come back to 
it, you’re not old and dead at 40. (SJ) 
You still may be 35, look at the time you have for a career from 
there. You are grounded; you are in a better position at 35 to 
have a career then you are having that career when you are 
young. I will be telling it to my step-daughter, I will be telling it to 
our daughter. (TO) 
“I would like to change people’s perception about having 
children in their late 20s, early 30s, that’s when I think we 
should be doing it” (AN). 
 
Women who had used ART had suggestions to disseminate warnings to their peers on the 
timing of motherhood. They suggested that these discussions should be initiated among 
young women during their educational years or whilst employed. Social media was 
suggested as one medium for public health education. 
“Maybe Facebook — it will probably catch you. I don’t know, 
there must be some sort of women’s network” (TO). 
“It’s an opportunity in their senior years to introduce it to the 
curriculum about the cycle of life, I mean, the real cycle of life” 
(LL). 
There could be some sort of information pack and there would 
be stories of women who of various ages or something like that 
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so that you actually know where you’re heading and then it 
might help you make your choices. (LL) 
“But I think more information, more balanced information would 
certainly assist in people if they decide to continue or give then 
a measure of reality around what the possible outcomes might 
be” (LL). 
…but for your average person to be looking in a reproductive 
journal isn’t going to actually get to the people that would have 
needed to see it at the right time. ..If you’re trying to get it to a 
mass amount of people I would say the newspaper would 
probably be the best bet…but the health section is probably 
read by a majority of people. (SJ) 
“TV advertisements” (JA). 
9.4 Results from Survey B 
Survey B comprised 68 women, and of these, around half the women chose to provide 
comments in an open question format provided as an optional question in the online 
survey. These participants were aged 35 years or older and had a range of engagement 
with ART and a mixture of success and failure to conceive. Survey B participants who left 
comments were coded SG. 
9.4.1 Understanding of Fertility Decline. 
As with Group D interviewees, some women did not intentionally delay childbearing and 
were midlife intending mothers due to personal circumstances. 
 “I did have some belief that it was still OK to have a child after 
40. I now believe this is truly not the case” (SG 4). 
“I have to admit that I never imagined that I would be 39, single, 
and having to rely on an anonymous sperm donor in order to 
have children. I want a man” (SG 11). 
I married at 28 and began trying to get pregnant. Altogether we 
had 10 attempts with two births at 37 and 42.  I did not choose 
to have children late in life; it was thrust upon me by infertility 
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issues beyond my control. …do not forget those of us who 
have children late in life not by choice. (SG 19) 
 
9.4.2 Social Factors Influencing the Timing of Childbearing. 
Participants supported the common theme of midlife mothering due to difficulties in finding 
a suitable relationship partner and waiting until they were financially secure. 
“Unfortunately I did not find my life partner until I was 40. That 
is the only reason I delayed having a baby” (SG 4). 
“If had found my sole mate and married earlier in life, then I 
would have attempted to have a family earlier” (SG 26). 
“We delayed starting a family until we felt we were in a secure 
financial position” (SG 34). 
9.4.3 Regrets about Postponing Childbearing. 
The theory of anticipated decision regret suggests that women try ART so they would not 
have regrets later in life that they had done not all they could to have a child. The wish to 
avoid regret was suggested by some participants. 
At least I could say that I tried everything and would have no 
possible regrets later in life. It was a difficult decision that I 
spent six months thinking about to make sure it was the right 
decision for me. (SG 11) 
“…so that at least I could say that I had tried everything and 
would have no possible regrets later in life” (SG 11). 
I have found going through IVF treatment the most difficult 
thing I have ever experienced. We had our daughter when I 
was 34 and have tried for the next five years to have another 
child. I feel I will never get over the emotional trauma of not 
being able to have more children. (SG 16) 
SG 33 expressed regret that health professionals did not advise her of the low statistical 
chance of a birth after she terminated a pregnancy conceived with an unwilling partner 
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when aged 41. It was suggested to her that there was no reason why she could not have a 
family when her partner was ready. 
“I’m struggling with the outcomes of ignorance and poor 
(but seemingly politically correct) advice (as in, You Can Have 
It All” (SG 33) 
9.4.4 Experiences at the Infertility Clinic 
Overall the participants found their experiences of ART to be a difficult and for some 
women a negative experience, however others found their experiences to be more 
positive. 
“The two-week wait was the most difficult part and felt that 
extra support would have been appreciated during this time” 
(SG 8). 
 
Some ART clinics display photographs of ART-conceived babies in clinicians’ and infertility 
clinic offices. For SG 9, this visual assault and her eight failed cycles exacerbated her 
distress and sense of personal failure. 
Every month that went by and I continued to be unsuccessful, 
these reminders were like someone sticking a knife into my 
heart and inflicting more pain and sadness than I was already 
enduring. This shows you how insensitive these health 
professionals can be. (SG 9) 
 
Many women had a positive experience at the fertility clinic.   
“Overall found it to be a positive experience despite having 
negative outcomes and a cancelled cycle (SG 13). 
“When I ended up being treated by the fertility professionals, I 
can only say good things about their assistance and support” 
(SG 33). 
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SG 15 suggested women should inform themselves about their fertility options rather than 
relying solely on their clinician.  
“Tell other people who are trying IVF to know what options are 
available; don’t just listen to your doctor — the QFG newsletter 
kept us informed of new technology” (SG 15). 
Participants suggested clinics should provide a greater level of psychological and nurse 
counsellor support.  
The clinic provided excellent support in terms of medical 
procedures, but the psychological support was limited. I had a 
good relationship with my fertility doctor but I was not able to 
talk to her directly about questions or the receipt of results. I 
was not at all happy about receiving results of my treatment 
from receptionists. (SG 17) 
“There was the lack of support from the nurse counsellors 
during my treatment in general as I hardly had any contact from 
them during my journey” (SG 20). 
“Once you have a pregnancy everything is great, however if 
you have a miscarriage there is very little emotional support for 
the couple, no one checks how you are going” (SG 30). 
9.4.5 Expectations of ART. 
Women reflected on their expectations of a baby through ART and some felt that their 
expectations were unrealistic. 
“I had treatment for eight years without success. I started when 
I was 32, I continued treatment as I was given (false) hope that 
I could still have a child” (SG 9). 
I probably did have unrealistic expectations of success from 
IVF, mostly because two of my best friends had success first 
go. I remember being reading or being quoted a 40-50% 
success rate for ‘fresh’ cycles and 30% for ‘frozen’ cycles. (SG 
17)  
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“We were very naïve — I think we didn’t really believe the 
statistics would apply to us” (SG 33). 
9.4.6 Impact of the Media on Women’s Perceptions of ART. 
Some participants believed that the portrayal of ART success in media was not a balanced 
view for women of all age groups. 
I thought my fertileness [sic] might reduce but I never did I 
imagine that it would become almost non-existent, particularly 
with all the media hype about women having babies in their 40s 
with friends backing this up with you’ll be right, women have 
babies at 40. (SG20) 
“If I hear one more story about these 40-something celebrities 
having babies ‘naturally’, I will scream” (SG 22). 
The media and other publications focus on the positive 
outcomes of ART and women over 35 years having babies. It is 
not a balanced and objective approach in accurately portraying 
the facts, but then the negative stories wouldn’t generate 
revenue return. (SG 24) 
9.4.7 Understanding the Risks.  
Risks of undertaking ART include risks from the ovulatory drugs and for women aged over 
35 years there is an increased risk of a child with an abnormal karyotype compared with 
younger women.  
“I wish the stats had been explained more often. It’s hard to 
take in all the information about the drugs and side effects, as 
well as stats about your chances” (SG 27). 
9.4.8 Commodification and Marketing of Motherhood and ART. 
Some women felt a lack of support after they registered with the clinic and felt that having 
a baby had become commodified.  
They are more interested in the couples who have babies than 
the ones who fail! It has become a money-making business 
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that implied all couples will take a baby home! When you are 
no longer a paying customer they don’t want to know you. (SG 
9) 
“My fertility doctor’s response to a failed cycle was to ask when 
I wanted to start the next one” (SG 17). 
9.4.9 “Calling it a day”: When and How to Stop ART. 
Deciding to stop ART was mentioned as a difficult decision as women may believe that 
another cycle will be successful. One participant suggests that psychological support was 
not available when making the decision whether to continue or stop treatment.  
“Due to the latest poor outcome from my IVF treatment, I am 
hugely undecided if I will have another attempt. The 
disappointment is also very hard to bear” (SG 4). 
“After many years of heartache we decided that our life was to 
sadly be childless! There was no psychological support from 
the clinic; we had to face this decision alone” (SG 9). 
“I am not ready for that conversation yet although I am starting 
to feel we may need to do so soon” (SG 12). 
“I feel it can also become quite an addictive treatment, i.e. 
knowing when to stop…maybe this cycle will be the one” (SG 
13). 
SG 5 used ART as her relationship partner chose to leave the relationship rather than go 
through the expense and stress of ART. Despite these impediments she chose to continue 
until she was successful. 
“I would never have stopped til I’d had at least two 
children”. (SG 5)  
One woman was advised to stop autologous cycles but felt her doctor supported her 
decision to continue treatment despite a having negligible chance of success. 
“..he kept going as long as I needed him to and that was 
hugely important, because I needed to make the decision to 
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stop rather than have someone make that decision for me”. 
(SG34) 
9.4.10 Emotional Roller Coaster. 
As SG31 described, the decision to stop after four ART cycles was averted when she 
conceived. She understood the difficulty when making the decision whether to stop ART or 
continue. SG 19, SG20 and SG 31 described their ART experience as like being on a 
‘roller coaster’.  
“…when you are on an emotional roller coaster most of the 
time. I do have times when I am still quite affected by the 
childless that I must now endure (SG19). 
“… you are on an emotional roller coaster most of the time 
(SG20).   
“It is an all-consuming process and, once on the roller coaster, 
state very hard to make the decision to jump off!” (SG31). 
Women described the emotional toll of ART treatments. 
“I found IVF treatment very difficult at times however the 
emotional side of things was far more difficult than the 
treatments (SG 1). 
“I know of so many who are heartbroken through constant 
failure (SG 2). 
“The pubic don’t realise the huge correlation between marriage 
breakdown associated with infertility and single women trying to 
conceive” (SG 5). 
“I believe we are very realistic about our chances and find each 
cycle of IVF difficult when you get a negative result but we are 
strong enough to try again” (SG 17). 
 
SG 24, who had five full cycles and five frozen transfers with no success, commented on 
the emotional toll on her marriage. 
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“…my marriage broke up and I believe this had something to 
do with it “(SG 24). 
9.4.11 Taboos and Secrecy. 
SG 11 supported the belief that some women found discussing their engagement with 
ART was not something they openly discussed. 
“My closest friends know how I came to have a baby, but I don’t 
go around telling everybody because I don’t want to be judged 
(SG 11). 
9.4.12 The Journey. 
Whether the treatment was successful or not, women describe their journey as an often 
difficult and something they will not easily forget. 
They told me I had a 10% chance of it working. I gave birth at 
the age of 41 and a half. There isn’t a day that goes by that I 
don’t thank God for my opportunities and the baby I’ve been 
given. It was the right decision for me (SG 11). 
“I know many families have had more traumatic experiences 
with infertility than myself, and I feel blessed to have my 
daughter, but I do feel the experience of infertility has 
dominated my life for the past six years” (SG 17). 
As a result of my journey, I find it very difficult to go anywhere 
near Watkins Medical Centre these days and whilst I am 
getting much better, I do have times when I am quite affected 
by the childless state that I now endure (SG 20). 
“I am now pregnant…it seems worth all the stress and 
heartache however, I haven’t forgotten how hard it was and 
everyday I am grateful” (SG 36). 
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9.4.13 “Don’t wait for IVF”: Recommendations from participants. 
Women’s recommendations for other women making decisions on timing of childbearing 
are detailed below and in direct quotation from data, as their message is more poignant 
when in their words. The views of these women were similar to those of Group D. 
“I tell any young women I meet not to leave their babies till later 
in their lives. The possible complications and emotional pain 
associated with that are not worth the wait” (SG 4). 
“I did have some belief that it was OK to have a child after 40. I 
now believe this is truly not the case” (SG 4). 
“Women need to be warned to start trying to conceive before 
age 30 so they can complete their families, not given the 
impression they can wait until closer to 33 or so” (SG 5). 
“I think there needs to be more public awareness about ART” 
(SG 10). 
“If you can do it now, don’t wait for IVF” (SG 13). 
“I tell any young women I meet not to leave their babies until 
later in life. The possible complications and emotional pain 
associated with that are not worth the wait” (SG 16). 
“ART is no guarantee of a child, and young women should not 
have the attitude of delaying a child because they think they 
can always have IVF. Definitely a misconception” (SG 29).  
9.5 Summary 
Responses from both participant groups revealed a complicated emotional journey for 
women undertaking ART. There lies an undercurrent that highlights the difficulty of trying 
to have a child and the far-reaching impacts of the ART process. Women who had a baby 
considered themselves lucky. Despite their success, these women, as did their less 
fortunate peers, found the process financially, physically and emotionally challenging. 
Women had various reasons for delaying childbearing and lack of a relationship was a 
typical response. Some women found they had bypassed their fertile years by trying to be 
financially secured before having children. Others believed they were not emotionally 
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ready for motherhood until later in life, and when they tried for a natural conception they 
were unsuccessful. Many women felt they could have children in their late 30s and early 
40s, and expressed regret that they were not aware of the limits to their fertility or chose to 
ignore warnings from friends.  
The expectation that they would conceive was high and many participants were surprised 
to find they were unsuccessful. Infertility clinicians who were enthusiastic about their 
chances of success heightened women’s expectations. The assumption of ART success 
was reinforced by information from the fertility clinic and the media’s depiction of babies 
born to older women, particularly older celebrity mothers. 
Some women expressed the view that the marketing of ART bypassed some critical 
information for older women as they were given an impression of high success rates. 
Some were not made aware of potential risks to the health of mother and baby and the 
higher-than-population risk of a genetic abnormality in ART-conceived infants evidenced in 
some studies. Some women felt that ART was commodified and they had become part of 
a money-making business. On the other hand, many women were satisfied with the 
infertility clinic and did not discuss such feelings.  
Some participants discussed a lack of emotional support during treatment and when 
contemplating whether to cease treatment. Some women did not want to experience regret 
that they had not done all they could to have a child. 
These women felt this research could facilitate an improvement in community knowledge 
of the age of fertility decline and realistic success rates of ART. After having used ART, 
their recommendations detail the messages they believe should be passed on to younger 
women. Women think the medical profession and media can improve the understanding of 
these issues in women of childbearing age. 
Women found ART to be an arduous journey that consumed their lives. These findings are 
juxtaposed in Chapter 10 with the quantitative results from Chapters 6, 7 and 8. 
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Chapter 10: Discussion 
The discussion reports on responses from women who had used ART from the support 
group, the interview group, and males and females in the community who may not have 
used ART. The findings are reported as a generalised view of ART in Australia. Women 
who had used ART had significantly different views to the general community regarding 
older women accessing assisted fertility services and fertility decline. The findings indicate 
that this is a complex issue and it would be simplistic to imagine an easy solution. Many 
factors determine women’s decision making however, accurate information is required for 
informed decisions to be made. This chapter outlines the key findings and responses to 
the research questions, and recommendations to young women from those who used 
ART. 
10.1 Introduction 
This research aimed to ascertain the beliefs, expectations, and experiences of a cohort of 
women undergoing ART in Australia as well as community understanding of fertility and 
ART. Two groups were statistically compared: a group of men and women in the 
community (N=1243; Group C) and women who had engaged with ART (N=68; Group B). 
Qualitative data were gathered from interviews with Group D (N=6). A broad range of data 
collection methods was utilised and allowed in-depth analysis of the research topic. 
Qualitative and quantitative data were analysed and the findings reported in Chapters 6–9. 
The concepts described in this research are of interest because they challenge the 
depiction of women intent on delaying childbearing for career or financial enhancement. 
ART promotional information and media representation may give some women the 
impression that medical technology can override age-related infertility. The dominant 
image is that ART is a successful technology. So when ART fails women have limited 
resources to understand and manage that situation (Throsby, 2004). 
ART does not cure infertility and, in the case of age-related infertility in older women, it 
cannot reverse age-related chromosomal changes in their oocytes. The consequences of 
such genetic changes are to reduce the chance of fertilisation and increase the risk of 
miscarriage. The previous chapters describe a somewhat challenging journey for women 
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who undertake ART. Whatever the outcome, ART treatment can be intensely emotional 
and challenging. 
10.2 Research Questions 
The following eight research questions are addressed within sub-sections 10.2.2 to 10.2.7.  
1. What are the views of women who have engaged with ART about their clinic 
experience? 
2. What were women’s expectations of the success of ART?  
3. What are the views of women involved with ART on women’s age-related 
fertility decline, childbearing decisions, the success of ART, and impact of 
media and marketing on childbearing decisions? 
4. What are the beliefs of the community towards women’s age-related fertility 
decline, childbearing decisions, success of ART, and impact of media and 
marketing on childbearing decisions? 
5. Do social factors such as career and work, educational attainment, financial 
security, health or partnering relationship influence women’s childbearing 
intentions? 
6. Is there a perception among the general population and consumers of ART that 
infertility is medicalised and its treatment commodified? 
7. What are the social and psychological impacts for women using ART? 
8. Do women who have engaged with ART have recommendations for women 
in the community regarding the timing of childbearing and ART? 
10.2.1 Age and Education: the IVF Support Group 
The support group comprised women who ranged in age from 32 to 54 years and had 
experienced ART; many were still undertaking treatment. Education levels of the support 
group participants and their mothers were compared. Participants were mostly educated to 
a graduate or postgraduate level and were mostly in full-time employment. By contrast, 
most mothers’ of the participants had a secondary-level education and fewer were 
employed outside the home. Women with higher levels of education and who are 
employed are more likely to delay childbearing and marriage (Rindfuss & St.John, 1983; 
Stolka & Barnett, 1969; Summers, 2003; Weston et al., 2004) and have a greater level of 
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childlessness compared with non-tertiary educated women in Australia (Miranti et al., 
2009). Most participants were conceived when their mothers were aged 21 to 30 years of 
age, whereas all the participants were trying to get pregnant at least 8 and up to 17 years 
later than their mothers, a noticeable delay within one generation. Women today, are in a 
new context for mothering and it appears that they are not following the childbearing 
patterns of their mothers and grandmothers due to recent demographic changes.  
Older mothers tend to be in stable relationships, educated, and have stable careers (Billari 
et al., 2011). The age at which women start their families is a factor in smaller family size 
(Australian Bureau of Statistics, 2006b), and comes with a greater chance of age-related 
infertility, and consequently higher demand for ART (de Graaff, Land, Kessels, & Evers, 
2011). Women in the support group had more opportunities for education and career than 
their mothers.  
10.2.2 Expectations of ART 
People perceive having children as a fundamental aspect of life’s journey, and the 
research queries if women had these expectations. The expectations and definitions of 
normal patterns of reproduction have changed, and women are more likely to seek 
medical intervention if they cannot get pregnant; they are also more likely to consider 
medical intervention as a standard procedure (Karpf, 1988). Many in the support and the 
interview group initially had expectations that medical technology would result in a baby.  
Notwithstanding their outcomes from ART, only a quarter of the support group believed 
women aged 35 and older were likely to get pregnant using ART, compared to the general 
community who thought half of such a group would conceive. Half of all women in the 
community thought women aged 35 and older likely to conceive via ART. Around half the 
support group were unsure if a pregnancy or a live birth was likely or unlikely, indicating a 
lack of confidence in answering the question or a lack of knowledge enabling an answer. 
The community had double the expectation that ART will result in conception compared to 
women who had used ART. Women are likely to have modified their expectations they 
held before treatment, after having ART. In our society women may approach ART, or 
delay their childbearing, with the false belief that they have a good chance of a birth.  
Nearly two-thirds in the support group gained fuller awareness of the facts and success 
rates of ART after seeking assistance from an infertility specialist. Women in MacDougall’s 
study (2013) were highly educated but were not appropriately aware of age-related 
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infertility and had “age shock”. They were shocked to find that their knowledge of the 
period of fertility decline was incorrect, which had consequences for their decisions 
regarding pregnancy. Some interview participants responded that they were not given 
realistic indications of their chance of a live birth, which suggests a dichotomy between 
information provided by the clinic and what information is understood and retained. 
Following on from beliefs of a pregnancy, subjects were asked if they believed an ART-
conceived pregnancy would proceed to a healthy baby. This question intends to determine 
the knowledge of miscarriage rates especially among older females. Responses were 
similar to the likelihood of pregnancy as discussed above, with one-third of the support 
group believing in the high chance of a live birth compared to two-thirds of the community. 
Community’s expectations were higher, regardless of age group or gender, indicating 
inflated faith in this technology. Women should not consider ART as a fall back option or 
they risk unintentional childlessness (Weston & Qu, 2005). 
Expectations of pregnancy may change once women engage with treatment and their 
hopes of success can be tempered. As one woman said “the expectations are incredibly 
different to when I started to what they are now”. Some women expressed the prevailing 
opinion that “you just went to a fertility specialist and walked out pregnant a few months 
later”. The support group was asked if they were confident that they would conceive before 
they started ART, and most women were sure of a pregnancy. Younger women were more 
confident of success than those aged 40 and older. Peddie’s et al (2005) research 
participants also felt they had commenced treatment with unrealistic expectations of 
success and required improved psychological assistance if their expectations were not 
met. Such unrealistic expectations may be prevalent, in part, as the procedures are 
described as routine and the risks of failure of the technology are downplayed (Sharp, 
2000).  
Expectations of success are also dependent on an understanding of medical impediments 
to conception such as advancing biological age. Maheshwari et al. (2007) demonstrated 
that 85% of their study’s infertile group expected ART to overcome the effects of their age-
related infertility. Expectations can be shaped from women’s sources of information about 
ART. The support group suggested that their gynaecologist or obstetrician was a source of 
information on ART and its capacity to achieve pregnancy. Self-education on fertility and 
ART through sources such as newspapers, magazines, and the Internet was most 
influential for the support group. However, non-peer reviewed information on the Internet 
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can be misleading. Dougherty and Stovall (2010), for instance, found most women in the 
USA accessing the Internet for information before their first consultation had a significant 
misunderstanding of the number of clinic visits they may require and cost of treatment. 
Most support group participants aged younger than 40 years perceived that clinicians gave 
them confidence that they had a good chance of pregnancy, and most felt the risks and 
options were clearly outlined. Physician optimism may result in underestimation of the 
risks and costs, and women may undergo invasive procedures that have little chance of 
success. Clinicians should ensure that complicated information on risks and treatment 
options are understood; Mourad (2009) suggests that as many patients perceive treatment 
as positive and a solution to their problem and may ignore warnings or negative 
information on the treatment. Some participants suggested the myth that women ‘can have 
it all’ indicated that family, career, and relationships were all possible. Sauer (2015) 
suggests this myth be condemned and women should not delay their childbearing until a 
convenient time.  
Overall, women felt they were not pressured into deciding to use ART and were more 
influenced in making the decision to seek treatment from their primary health provider or 
relationship partner. Bronfenbrenner and Qu (1994; Qu & Weston, 2005) suggest that 
individuals in a relationship with close proximity most influence decision-making. Data did 
not totally support Bronfenbrenner’s theory, as individuals close to women such as family 
and friends, were suggested as influences for less than half of the group. Public health 
information, including that shared by clinicians, was a source for three-quarters of the 
women. A primary health provider did not provide information for one woman who 
expressed regret that her family doctor of 20 years had never mentioned her declining 
fertility, and she suggested: “no-one talks about it.” Findings suggest that the primary 
health provider should be a mindful source of information on fertility, infertility, and ART 
(Mazza, Cannold, Nagle, McKay , & Brijnath, 2012). Health resources from the Internet 
vary significantly in quality and accuracy, and patients need guidance from their clinician 
on evaluating accurate sources (Fahy et al., 2014). However, sourcing information from 
the Internet may place tension between the patient and their doctor (Henwood, Wyatt, 
Hart, & Smith, 2003). The choices women make on the timing of childbearing are only as 
good as the information provided to, or sourced by them. 
Most of the support group had expectations that ART was the only way for them to have a 
baby and initially believed they would conceive after a minimal number of cycles. After 
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treatment, the majority of this group agreed that their current expectations of ART had 
been met and that their expectations were now realistic. They had tempered their 
expectations, as they were now aware of the limitations of the technology. It was also 
apparent after using ART that it did not allow women to ameliorate the consequences of 
delayed childbearing. Two-thirds of the support group were mindful of the fact that their 
fertility declined from the age of 35 years, and half the women were aware that oocyte 
quality could limit their chances of success. It is likely they garnered this level of 
knowledge from their infertility specialists, but that cannot be determined from the data. 
Potential users of ART may commence with unrealistic and uninformed expectations. 
Many women seeking treatment mostly believed their decision to use ART was not hard to 
make and were clear that they had made a good choice. Findings also show that they 
were aware, at this point in their treatment, of their choices as well as the risks and 
benefits of ART. Having a child was not a life focus for most of these women earlier in their 
lives. Impediments to risk-taking and decision-making involve not only medical or scientific 
factors but also cultural, economic and political influences (Becker & Nachtigall, 1994). A 
laypersons perception of risk differs from those of health professionals, and may vary 
between different segments of the community due to individual priorities (Williams & 
Calnan, 1996a). Women were aware of the risks of ART, however this understanding may 
be more fully realised after stopping treatment. 
It is possible that some women have unrealistic expectations of the success of ART, as the 
potential for the technology to fail to deliver a live birth are downplayed (Sharp, 2000). 
Data shows that some women initially had hopes which exceeded the reality of success. 
Richard Kennedy of the British Fertility Society stated: “there is an incredible amount of 
false and unreasonable expectation about fertility treatment and what it can do.” Further, 
that “doctors are partly to blame because of the way in which IVF is talked about”. He 
suggested that stories in the media about older and even post-menopausal women giving 
birth contributed to this increase in expectations (Firth, 2005).  
10.2.3 Social issues around ART and timing of childbearing 
Western women are perceived to have considerable control over events in their lives. 
However, social factors that influence childbearing decisions may be difficult to manage. 
An understanding of fertility decline and timing of childbearing can originate from social 
connections. As an extension of Bronfenbrenner’s framework, individuals close to women 
are often influential with childbearing decisions and treatment (Bronfenbrenner, 1972, 
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1994). This research showed that the media and medical practitioners had a greater 
influence than family and friends on childbearing decisions. 
The primary reason the support group selected for delaying childbearing was lack of a 
relationship partner. Career or work, financial security, education, and health issues were 
less significant. Some in the support group may have been able, when younger, to 
conceive spontaneously, however they did not have a supporting relationship partner. 
Two-thirds of the support group selected lack of a partner as the primary reason compared 
to just 4% of community members, particularly those aged 40 years or age or older. 
Interviewees noted that they “hadn’t found anyone worth having children with” or they 
simply did not meet a suitable partner. Holton (2011a; Holton et al., 2011b) suggests that 
health is a major issue for women delaying childbearing for women aged 35 years of age. 
However, only a small number of the support group thought health was a factor in women 
having children after the age of 35. Lack of relationship stability, multiple partners, and 
partnering relationships later in life are shown to influence women considering motherhood 
later in their reproductive life (Australian Bureau of Statistics, 2003a; Birrell, 2004; Gray et 
al., 2008; Weston et al., 2001). However, an acknowledgement must be made to the 
unknown complex social forces that shape the environment for decisions on timing of 
childbearing.  
This study supports the work of Cannold (2000 ) who found, while interviewing Australian 
and North American women on their reasons for childlessness, that lack of relationship 
partner was the primary reason for women to be childless or to have fewer children than 
they aspired to have. A Canadian study found independence and a stable relationship 
influenced women’s fertility intentions, with the readiness of the partner to have children 
with lesser determinant in decision-making (Benzies et al., 2006). These findings were at 
odds with the responses of the community members in this study who perceive delayed 
childbearing as due mostly to career or work commitments. 
Indeed, for some women they believed there existed an expectation for women to work 
until their mid-thirties and then consider pregnancy, and there was a desire for women to 
work and to “make yourself powerful and break the glass ceiling.” This type of perception 
was evident even among the younger members of the community. The public perception 
of women pursuing careers ahead of childbearing is not supported by data from the IVF 
support group whose circumstances have lead to the need for ART. 
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The general community, particularly those aged 40 years and older, noted that women 
also wanted financial security before having children, which was not strongly supported by 
the support group. One woman who had used ART agreed that for women at 40 years of 
age  “financially it’s a better time.” Qu (2000) argues that the high economic cost of raising 
children also contributes to Australian women delaying childbearing.  
Childlessness can leave women with a feeling of social isolation and alienation when their 
family and friends have children. Most in the support group found holidays and 
celebrations difficult, and felt left out when they saw families with children as supported by 
Kirkman’s research (Kirkman, 2001b). Women with involuntary childlessness can 
experience a lack of social support and life-long grief (Ferland & Caron, 2013). Qualitative 
data supported feelings of exclusion, as some women were reluctant to discuss their 
fertility issues with family and friends. Baker (2003) concludes that social exclusion due to 
childlessness made some people feel excluded from normal adult life while childless 
women may have less life satisfaction than women with children (Callan & Hennessey, 
1988). Some support group members reflected on their feelings of isolation; Redshaw et 
al. (2007) recommend that health professionals should look at the individual’s experience 
of ART as many women found diagnosis and treatment an isolating and depersonalised 
experience.  
Despite the availability of ART and social oocyte freezing, there are no guarantees these 
will avail women of a child. As a medical procedure, they pose a potential risk to mother 
and baby.  
10.2.4 Experiences of ART   
ART places physical and emotional stress on many women which has been widely 
documented in literature (Benyamini, Gozlan, & Kokai, 2005; Kopitzke & Wilson, 2000). 
The experience of ART for each woman will be an individual one, based on their history, 
expectations of the treatment, and outcome. Most women in the support group who had 
conceived believed the clinic offered them adequate emotional support during their 
treatment and looked back more positively on the experience. Women felt their clinician 
and clinic offered them treatment options and explained the IVF procedures.  
Literature supports the findings that a caring and supportive clinic makes the experience of 
ART less severe than it otherwise would be (Hammarberg et al., 2001; Malin, Hemminki, 
Raikkonen, Sihvo, & Perala, 2001; Parry, 2004; Peddie et al., 2005; Redshaw et al., 2007). 
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Most in the support group found their ART experience difficult, and it would be expected 
that women who had a baby found the experience less stressful, or forgot how challenging 
the experience was for them. This finding aligns with Malin’s et al. (2001) study showed 
women who were successful after ART exhibit a higher degree of satisfaction than women 
who do not. 
The experience of ART was difficult for the majority of women over age 35 years, 
particularly for women aged 40 and older. Women aged 44 and older have only a 1:100 
chance of a live birth (Lotz, 2012). This older group was less confident they would 
conceive again and gave a negative response when asked if that they would delay 
childbearing if given the choice. They also had the strongest belief that women delayed 
childbearing due to relationship issues. 
Half of women in the support group agreed that the clinic offered them emotional and 
psychological support. Alesi (2005) suggests that psychological acceptance and resolution 
of the emotional roller coaster of ART may not occur until conception or treatment end. 
Psychological support and a sympathetic approach from the infertility clinic can make ART 
treatment easier for women (Malin et al., 2001). Women who are well-supported 
psychologically in the early stages of treatment and who are informed of the stress they 
may experience if their treatment is unsuccessful may be able to control these negative 
emotions (Hammarberg et al., 2001).  
This study found there were taboos and secrecy associated with undertaking ART, for 
some participants and women were not always supportive of each other. Although ART is 
becoming accepted as a standard medical procedure, some women are secretive about 
using ART even in neutral research settings (Van Balen & Inhorn, 2002), ..”it’s like to them 
a taboo subject.” One woman participant dispelled the notion that those undertaking ART 
would be fully supportive of each other, and suggested it is like a secret fraternity, ..”if you 
walk into a clinic and you see ten other couples, not one of those couples will talk to you. I 
don’t think it’s shame, I think it’s that’s people are afraid of the success of others in my 
opinion.”  Zoll (2013) suggests that taboos are reinforced by infertility clinics that do not 
wish patients to discuss their infertility or the failure of ART; this absence of truth-telling 
may make success stories in the media even more misleading. 
Some women in the study chose not to openly discuss their decision to use ART with 
family or friends: “I think there is a bit of a taboo, people don’t want to talk about it with 
their friends or with their family and certainly wouldn’t want to participate in something like 
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this because they might as well talk about things that are personal”. Research shows that 
couples pregnant after ART feel different from their fertile peers and are reluctant to share 
their excitement or concerns with their infertile friends of clinic support group for fear of 
hurting them or appearing insensitive (Glazer, 1998). 
The hope of success in the next treatment cycle can make the decision to discontinue 
treatment a difficult step. Making the decision to stop treatment without having a baby 
forces some women to come to terms with their unresolved infertility and involuntary 
childlessness. However, it may help to relieve them of the emotional stress associated with 
ART (Peddie et al., 2005). One woman said “…I want to reach a point where I say you’ve 
got to let go…”. The ever-growing number of medical treatments offered by infertility clinics 
can pressure women to keep trying (Greil, 1991b). Treatment costs were not a factor in 
women stopping treatment. However, it was a limiting factor in the number of IVF cycles 
women could undertake. 
Women were divided about whether the clinic had given them adequate support when 
deciding to stop treatment. Some clinics may be unaware of women stopping treatment as 
some may have long breaks between cycles, and are unable to offer timely support, as 
they are unaware that ceasing treatment is being considered. Ending ART moves women 
from hoping for a child to a childless state and women may require social support to 
develop new life goals (Verhaak, Smeenk, Evers, & Kremer, 2007). Women can be 
unprepared for making that decision and for recognising when that point has come: ”I want 
to sort of reach a point where I say, okay, you’ve got to let it go and I sort of want to get 
on.” Peddie et al. (2005) found women were unprepared for making that heart-wrenching 
decision and wished a timeframe for stopping ART had been initially discussed with them. 
Women who are overwhelmed with their desire for a child can have a limited capacity to 
make that final decision (Rauprich, Berns, & Vollman, 2011). One participant reflected that 
“I feel it can also become quite an addictive treatment...maybe this next cycle will be the 
one”. Individuals may not be able to move to acceptance and resolution until there is a 
definite end to their ART experience by either having a baby or stopping treatment (Alesi, 
2005). 
Social and financial factors can be the catalyst in stopping treatment. Stress on partnering 
relationships may also be a trigger: “Emotionally and relationship wise it was taking its 
toll…we got to a point when we were almost having a separation”. Psychological stress is 
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attributed to the majority of couples who discontinue ART without a child (Olivius, Friden, 
Borg, & Bergh, 2004).  
ART can either be a positive or a negative experience. For many women the ART 
experience is hard, emotionally and financially demanding, and for some women their 
experiences at the clinic impact on their decision to end treatment (Peddie et al., 2005). 
Women undertaking ART can experience anticipated decision regret where they are 
reluctant to stop in case their next cycle is successful. In this study, women who conceived 
suggested they wanted to avoid decision regret, whereas the women who did not conceive 
did not support this. In the event of infertility, women who wish to avoid regret about their 
decision to pursue ART may be motivated to make decisions which will lessen their 
chance of regret that they had not taken every opportunity available (O’Connor, et al 1999; 
Zoeten M.J et al 1987). In this study, two-thirds of women tried ART to ensure they had 
done everything possible to have a child which correlates with Tymstra’s and others (de 
Zoeten et al., 1987; Tufan & Durmusoglu, 2004; Tymstra, 1989; Zeelenberg, 1999) 
discussion on the theory of anticipated regret. Stopping ART without a child involves the 
loss of a parenthood experience, loss of conceiving a child with one’s partner, and the loss 
of the continuation of a family history (Cooper & Glazer, 1998). 
A person may feel regret when the realisation that good outcomes of a certain decision are 
no longer possible before those consequences are experienced (Connolly, Edelmann, & 
Cooke, 1992; Zeelenberg, 1999). Currently, there are no limitations on the number of ART 
cycles undertaken by women in Australia and the decision to stop treatment must be 
owned entirely by the individual. This study found the cost of treatment could restrict the 
number of cycles undertaken for some couples. Legislation to limit the number of 
Medicare-funded cycles available to older women is a recommendation of this research. 
10.2.5 Community attitudes towards ART 
Attitudes to ART will arise, in part, from knowledge and understanding of fertility and 
infertility. There was a lack of awareness about women’s age-related fertility decline 
among some members of the community group in this study, with males showing less 
accurate knowledge compared to females. Daniluk and Koert (2015) suggest that as men 
have a longer fertility lifespan they are less aware of fertility issues.  
The general community unrealistically had high expectations of a pregnancy and a live 
birth after ART. This was also apparent when comparing women who had used ART and 
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women in the community group. Hammarberg’s (2013) community survey confirmed that 
Australian men and women have varying assumptions of the age of fertility decline. 
Wajcman (2004) showed that men and women have different perceptions of technology.  
Community attitudes towards infertile married couples using ART have been surveyed; 
77% of Australians surveyed between 1981 and 1994 supported the use of IVF by infertile 
couples (Cohen et al., 2005). By 2001, community approval increased to 86% (Kovacs et 
al., 2003), and to 91% in 2011(Kovacs, Morgan, Levine, & McCrann, 2012). An Australian 
infertility clinic commissioned this survey. Questions were limited, and the responses 
interpreted favourably towards the infertility clinic to show widespread approval of ART and 
Medicare funding of ART. However, no success rates or treatment costs or cycle 
information was supplied to participants. Women are more influenced in their childbearing 
decisions by physical and emotional factors, and men more by economic factors 
(Newman, 2004). The community seems to support ART, but they have elevated 
expectations of the success rate of this technology. 
10.2.6 Medicalisation, marketing, and commodification of ART 
One research question proposed that women might have unrealistic expectations of the 
success of ART. Findings support this, and align with previous Australian research (as 
discussed in Chapter 1). The question regarding age-related infertility due to social factors 
is medicalised and that ART has become commodified is also supported by the findings. 
These show that many in the community sample had an understanding of age-related 
infertility which overestimates the age of fertility decline and the success of ART, perhaps 
influenced by media and marketing 
Women attending an ART clinic are not ill; they are not able to conceive. Whether this is 
due to a biological impediment or age-related infertility, they require medical resources. As 
Sandelowski et al. (1990) intimates, infertility becomes an illness only by the virtue of one 
symptom that is the lack of a desired child. The question arises whether ART is a medical 
necessity and could be treated with less invasive and less expensive technology 
(Mladovsky & Sorenson, 2010) taking into account that there is a question as to the 
efficacy of ART for older women.  
Within the context of a medical condition, the IVF support group felt the infertility clinic 
informed them about ART, options for treatment and risks of treatment. The expectations 
of women instigating and accepting ART treatment depends on an individual’s beliefs 
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(Kamphuis et al., 2014). Australians have a high level of trust in science and consequently 
new technologies (Farquharson & Critchley, 2004). Women can trust an infertility clinic due 
to its reputation or marketing perception, which gives them the expectation that an 
infertility clinic has the processes in place to perform its tasks in a predictable and 
particular way (Farquharson & Critchley, 2004). This may have impacted on the 
acceptance of the clinic by some women in this study. 
For some women who had used ART, this trust was tested when the clinician or clinic 
inappropriately elevated hopes of pregnancy by providing them with unrealistic 
expectations of success particularly in the early stages of treatment. This was illustrated 
when one woman’s clinician told her “that all would be OK and I was given the impression 
that all would be quite easy” and the participant who was not pregnant after 17 cycles was 
“under the impression that we were going to be pregnant rather quickly.” This research 
shows that some women were given the impression by infertility clinics that ART was very 
successful. Heitman (1999) suggests that infertile couples are vulnerable to the 
technology’s seductive promises of parenthood. Most service providers over-estimate the 
success rate of ART (Hammer Burns, 1999; Peddie et al., 2005).  
Commodification occurs when a medical procedure generates an item for sale. This may 
be evident for women when they are given inappropriate success rates and then sold ART 
- which comes with an uncertain outcome. In this study, one woman who had 12 
unsuccessful cycles was told when she first attended the clinic that she was “given 
enormous odds, positive odds over 90%”. Their clinician had assured most support group 
participants that they had a high likelihood of a conception, but not as frequently for 
women aged 40 and older. This study reveals clinicians encouraged half the women 
younger than age 40 years to continue treatment when they were unsure if they wished to 
stop, which delayed their decision to discontinue ART treatment.  
Marketing by infertility clinics of the cumulative success rate rather than a live birth rate for 
each cycle is likely to be confusing to non-experts; it gives the impression of a higher 
success rate. One woman expressed her confusion:. “I think it was a 95% success rate 
that they were going to get you pregnant in within a certain number of cycles - that’s all I 
caught on to and that’s all I believed in”. Daya (Daya, 2005) suggests that the use of 
cumulative success rates for ART is not appropriate due to the passage of time and lack of 
informative censoring which may lead to an overestimation of the success rate and biased 
decision-making. In order to give better and comparable information between clinics, 
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Recommendation 10 in the Independent Review of ART in 2006, which was approved by 
the Department of Health and Aging, asks that clinics provide standardised outcome 
measures with the primary outcome presented being the live birth rate per initiated cycle 
(Department of Health and Aging, 2006); which has not been implemented by clinics. It is 
postulated that this may not been executed by some clinics as the real success rates 
would not be as favourable. Women cannot make informed decisions on the success of 
ART if success rates published by infertility clinics are overestimated. Promotion of 
pregnancy rates data rather than live birth rates is misleading, as not all pregnancies will 
proceed to term (Napoli, 1999).  
Findings showed that over three-quarters of the support and community group felt that 
ART was portrayed in the media as a successful way for older women to have a child. The 
media often depicts misleading stereotypes of health conditions (King et al., 2014), so 
women may have false assurances based on the impact of the press and marketing of 
ART and make decisions on childbearing based on this premise. Lupton  (2005) suggests 
that the media can overdramatise or simplify health issues that may distort understanding 
of them. There was little difference in attitudes in the community, between age groups or 
gender, in support of media influence. The implication of this finding is that the community, 
with their lowered awareness and knowledge of infertility and ART, believe that ART is 
successful for older women and be influenced by the positive media depiction.  
The mass media has been shown to influence beliefs and perceptions and to manipulate 
public opinion (Kotler & Zaltman, 1971; Williams & Calnan, 1996a). It can portray ART as a 
standard medical procedure and give a positive view, which could encourage women to 
use ART. This reassurance of success may influence women to postpone their 
childbearing, especially as women in this study felt that the depiction of ART in the media 
was accurate, and the marketing of infertility clinics through the press is increasingly used 
to influence the public perceptions of medical technology (Karpf, 1988). It appears from the 
data that some older women who have engaged with the technology believed the success 
stories of IVF in the media, and had delayed childbearing with the belief that ART would 
enable then to have a baby. Unfortunately, the live birth rates for older women as shown in 
the literature do not support this assumption.   
Published stories about women’s experiences with infertility through television, women’s 
magazines and newspapers are readily accessible. The Internet has become a reference 
source and a supporting body for women as blogs help to renegotiate women’s 
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experiences when motherhood is hard to achieve (Harrison, 2014). Some women in this 
study felt that media stories were not an accurate representation of the experiences of the 
majority of midlife intending mothers who access ART.  
A review of Canadian media showed nearly half of the stories mentioned positive 
outcomes (King et al., 2014). Stories in the media of miracle babies do not relate to the 
experiences of women who do conceive after using ART as one support group participant 
stated: “the publicity on IVF never shows the failure associated with it.” Several women 
said the depiction of older female celebrities as pregnant or with babies as ‘sensational’ 
and gave authority to the premise that pregnancy is achievable for older women. However, 
disclosure of such pregnancies lacks disclosure if donor gametes, donor embryos, or if 
autologous oocytes were required. One woman summarised the feeling of many women: 
“If I hear one more story about these 40 something celebrity’s having babies “naturally” I 
will scream.” Stories of miracle births for older women have contributed to an increase in 
expectations of success (Firth, 2005) for young women looking towards celebrities who are 
older parents (Kimberley-Smith 2003). 
The history of the development of the ART industry shows a change from small business 
models that were clinician based, to clinics owned by venture capital companies. These 
acquire smaller Australian and international infertility clinics and tend to dominate the 
infertility market. Shareholders of ASX listed companies expect a dividend for their 
investment, as businesses need to grow and make a profit. Some women interviewed felt 
that they were part of a moneymaking business. It would be disappointing if those large 
companies used unsubstantiated information to market ART success rates and new 
procedures for profit.  
It was anticipated that women would reflect more overtly on the business model of ART 
and commodification of infertility services and treatment. Few comments in this area were 
noted; it may be that, only after disengaging completely from ART and association with a 
support group, can women adequately reflect and analyse their experience. It is also 
possible that only the most highly educated participants consider this type of critical 
reflection. 
10.2.7 Public health and policy implications  
Australia’s centrally-funded healthcare system, Medicare, provides financial assistance for 
eligible Australian citizens for services registered for treatment by registered medical and 
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allied health professionals. Many factors that influence childbearing are regulated by 
government policy (Gray et al., 2008). Some of these policies include childcare access, 
financial support, and birth and financial bonuses.  
Policy discussions have focused on workforce participation and economic incentives to 
stem fertility decline. Within the Australian healthcare system, there is a constant struggle 
of justification as to distribution of available funds. Australia’s aging population will require 
increasing medical services for conditions such as cardiovascular disease and joint 
replacement surgery. Health spending comprises one of the largest components of 
government expenditure and justification for the allocation of funds is in the public interest. 
Within the context of limited healthcare resources, the cost-effectiveness of ART needs to 
be justified.  
ART is available via only privately owned clinics with high overheads and expensive fee 
structures. Mladovsky (2010) suggests that cost-effectiveness needs to take into 
consideration whether the outcome is focussed on quality or quantity. Based on the 
desires of women undertaking ART, the desired outcome is for a singleton pregnancy and 
a healthy mother and baby circumventing the need for expensive and challenging neonatal 
care (Schieve & Reynolds, 2004). 
Medical conditions such as infertility can be socially constructed in that, rather than looking 
at the medical environment of the time, women are individually focused on their own 
circumstance. Policy issues need to consider the underlying social problems and 
complexities of women in their childbearing years and to understand there are no quick 
fixes for these complex challenges (Conrad & Barker, 2010). Social stigma towards 
involuntary childlessness and taboos towards infertility are a public health issue to note 
(Lemoine & Ravitsky, 2013).  
The public funding of ART by Medicare has a policy history of a continual challenge from 
pressure groups, either medical or consumer, who have vested interests in the outcome. 
Public funding for ART will most likely steadily increase for two reasons. Firstly, women 
are having children later in life and consequently may require ART, as they cannot 
conceive naturally. Secondly, ART is becoming acceptable as a way to have children and 
public funding for ART is expected (Shannon, 2013). However, there are no controls about 
the potential inequity regarding who can claim a rebate from Medicare services. Women 
aged 40 years and older likely to be more financially secure than younger women as they 
have been in the workforce for longer. Unlimited and non-means tested ART cycles are 
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available to all women aged 40 and older and these women have the lowest success 
rates. Younger or less affluent women have reduced access to ART if they are unable to 
fund the out-of-pocket component of cycle costs (Lotz, 2012). Public policy needs to reflect 
changes in community and childbearing intentions of women. Consideration should be 
made to limiting the number of Medicare-funded autologous cycles available for women 
aged 40 years and older due to their diminished chance of a live birth compared to 
younger women (Macaldowie et al., 2014). This is supported by findings of this study in 
which older women, even knowing their slight chance of success, struggle to make the 
decision to stop ART. Once the funded cycle limit is reached for women aged over 40 
years of age or older, it is recommended that treatment costs should be funded entirely by 
the patient.  
Australia’s protocol for single-embryo transfer has reduced the rate of multiple births, as 
multiple births have increased risks for mother and child as discussed in Chapter 4. 
However, this is not the situation in overseas countries such as the USA, where ART is 
self-funded or paid through health insurance. Consequently, the USA has a high rate of 
multiple births (26.6%) as women try to maximise the chance of a conception by multiple 
embryo transfers (Centers for Disease Control, 2013). Australia’s multiple birth-rate in 
2013 for ART-conceived pregnancies was 5.6% (Macaldowie et al., 2015). Australia’s 
funding and regulation of ART is unique compared to other countries in the developed 
world.  
Overall, women who used ART did not gain knowledge on fertility and ART from an 
educational institution such as a school or tertiary institution. The potential exists for many 
people without access to reliable and accurate information to trust their clinician for 
information (Kahlor & Mackert, 2009). Henwood et al.(2003) found the search strategies of 
consumers were dependent on their ability to access accurate information with some 
constraints due to the patient’s requests for information from their GP being dismissed or 
rejected. Information may not be sourced from a GP and an easily accessible source of 
information is provided by infertility clinic marketing campaigns, which have not been 
demonstrated to give an entirely accurate portrayal of ART (Chan, Schon, O'Neill, & 
Masson, 2014). Hammarberg and Clarke (2005) suggest that women may resent not being 
informed of age-related fertility decline and scientists, journalists and primary health 
providers need to ensure that this information is in the public domain. Accurate and easily 
accessible information could be provided through the Royal College of General 
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Practitioners in Australia, circumventing the need for GPs or other primary health providers 
to rely on infertility clinics to provide such information. 
Analysis shows there to be three groups of women highlighted in this research. Firstly, 
there are women who believe they are informed but they may not be (including many in 
the general community); secondly, there are those who are not informed and who become 
aware of risks along the treatment journey. Thirdly there are those who are informed but 
choose to delay childbearing anyway (Cooke, 2010). Pre-conception education could 
assist the first two groups, and the third group could make a more fully informed choice. 
Governments have the power to initiate a preventive health approach focused on young 
adults in educational facilities (Lemoine & Ravitsky, 2013). Government funding could be 
made available to encourage couples to develop a reproductive life plan with their GP, 
family planning clinic, or gynaecologist to assist development of a timeline for childbearing. 
Health professionals need to provide easily accessible and accurate information on 
reliable websites to provide unbiased information; this may help to avoid involuntary 
childlessness (O'Connor & Johnson, 2005). Specific information from ART clinicians is 
required for effective decision-making on commencement, treatment options, and 
decisions to end treatment if necessary (Mounce, 2013). 
Lupton (2005) suggests that individuals have the option to avoid lifestyle risk behaviour. 
Ignoring information about risks to health places the individual in danger of illness or 
disability and to incur costs to the tax funded medical system. Extrapolating this to women 
who are aware of age-related fertility decline and delay childbearing for social reasons. 
This places their health and the health of a future baby at risk and adds to the demands on 
the taxpayer funded health system. Guidelines and predictive models should be developed 
to ascertain if women unable to conceive after 12 months should initiate ART at that stage 
or if, recommendations to continue trying for a spontaneous conception for a period should 
be implemented as it would be preferable if younger women did not have to undertake 
medical intervention if possible (Herbert et al., 2012; McLernon, te Velde, Steyerberg, Mol, 
& Bhattacharya). In the case of intentionally delaying childbearing, questions arise whether 
treatment should be publically or self-funded if treatment is due to social or lifestyle factors 
(2006). 
Bronfenbrenner’s (1977, 2005) theories surrounding social ecology propose that there are 
multiple layers of factors which influence health behaviour. Women were influenced by 
their beliefs on the age of childbearing and success of ART by people close to them such 
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as their partner, to more indirect influences such as media and marketing. Health 
information could be aimed at influences proximal to women making childbearing 
decisions. Mills et al (Mills et al., 2015) suggests health professionals and public policy 
needs to expand the current paradigm of advanced maternal age and childbearing 
Government health policy aims to provide equitable health care, but this is a difficult 
balance to achieve as there is an insatiable need for services and technology which 
challenges government budgets (Haines, 2008). New policy initiatives that seek to reward 
fertility, such as financial bonuses for babies, will not be enough to encourage and support 
childbearing. Improvements to women’s workplace options and accessible childcare are 
essential for women planning childbearing (Mahon et al., 2016). If governments are 
concerned about fertility levels, then policy should be coordinated across employment, 
health, education, and family services. Society needs to consider the impact our attitudes 
and expectations about parenting are having on women (Maher et al., 2004). Evaluating 
the cost-effectiveness of medical treatments is a challenge in medicine when health costs 
are rising and are one of the main areas of expense for many governments (Mastenbroek 
& Repping, 2014). Accurate information on costing of ART and success rates for women of 
all ages allows women to make an informed choice and potentially decrease the need for 
ART in the future. 
10.3 Key Findings 
1. The clinical process of infertility treatment can be a stressful event. Social 
isolation and secrecy were evident. 
2. Women in the support group were aware of age-related fertility decline. They 
felt that lack of a relationship partner was a key problem for timing of 
childbearing.  
3. Women who had engaged with ART believed that lack of a relationship 
partner was the primary reason women delaying childbearing. The generally 
community believed that women focusing on career and work were the main 
reasons. 
4. Community members, both males and females, have elevated expectations of 
the success of ART and perceive ART to be successful for women aged over 
35 years. Women who used ART had more realistic expectations of the 
success of treatment once they started treatment. 
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5.  Some women had high expectations of success and these were lowered 
once they started their treatment as they discovered they had less chance of 
success than they first believed. 
6. Most participants perceived media portrayed ART as a successful way for 
women aged 35 years and older to have a baby. Some women were 
frustrated by an unrealistic media portrayal of older women and older 
celebrities having children later in life. 
7. Several women felt discomfort with the level of the commodification of their 
ART experience.  
8. Women wish to avoid decision regret which may occur if they stop treatment 
before they are successful. Those who had been unsuccessful struggled with 
the decision to stop treatment, particularly as some believed help was not 
available to them when they required counselling .  
9. Recommendations from the support group to women in the community are 
discussed in Chapter 11.  
10.4 Significance of the Findings 
The study was important to voice the concerns of women who had experience of ART. For 
such a group, their ability to discuss their experiences with women in the community is 
limited. These findings are significant as they compare the beliefs of women who have 
used ART with views of the community who generally would not have previous experience. 
Findings indicate that the community has exaggerated expectations of the success of 
ART, incorrect opinions of the age when women’s fertility declines, and false assumptions 
for women’s reasons for delaying childbearing. Consequently, it is not surprising that 
women are delaying their childbearing and relying on ART as a fall-back option. They held 
similar opinions when they were making these life-altering decisions. This study has the 
advantage of examining views of women by an independent researcher who has no ties to 
infertility clinics. 
The study’s strengths lie in the mixed methods approach. Information obtained from 
surveys supplies statistical data to give an overview of the perceptions, expectations and 
attitudes of two major participant groups: women who have engaged with ART and the 
community who may not have had direct knowledge or engagement. However, it is the 
extended interview data which enrich and expand upon the quantitative data and which 
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reflection of women’s engagement with ART. The research findings indicate a lack of 
knowledge of fertility decline and the danger of relying on ART as a fall-back option. 
Findings suggest the initiation of an educational programme for the general community 
and primary health providers. Findings provide an overview of ART at the current time 
which could be used as the basis for a larger or longitudinal study of ART.  
10.5 Limitations 
This study has several limitations. The size of the study is a limitation, but the specificity of 
the study limited its size and the sampling strategy. As Patton suggests (2002: 120) all 
research contains some imperfections, personal judgements, limitation of resources, and 
creativity. Responses obtained from only 68 women in the support group represent a 
restriction of the research, and a larger cohort of women would have given a stronger 
statistical result (Button et al., 2013). Not all the questions were answered and responses 
from all participants would have strengthened the findings. However, this can be difficult 
without the full cooperation of an infertility clinic, which was not forthcoming in this study. 
However, trends certainly emerged from statistical analysis and were further explored in 
depth in the interviews and across the breadth of the community. 
As Yusen and Littenberg (2005) note, selective sampling may enroll subjects with certain 
characteristics. This may result in sampling bias that leads to a non-representative sample 
of the population. Within the support group and the interview group, were women with 
varied experiences of ART and different reasons for using ART, which would reduce the 
selection bias of the sample. A larger sample size would help to eliminate the possibility of 
selection bias. The online survey findings raised some issues of concern which were 
explored in depth within the interviews. Responses from participants attending a cross-
section of clinics would be enlightening, as the participants in this research may have had 
a better or worse experience than women attending other clinics. As participants were self-
selected volunteers, they may possess certain characteristics that have the potential to 
impact upon the general nature of the findings. 
As infertility is a private issue and emotionally challenging to discuss in the context of an 
investigative survey or interview, non-compliance is not unexpected (Van Balen, 2002). 
Many women found their experience with ART to be a painful emotional and physical 
experience that may have resulted in some women considering the research questions 
challenging. Clearly for women who had a successful outcome, they may be more 
comfortable to relating their experiences compared to women who were unsuccessful.  
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Kessels (2003) suggests participants have subjective perceptions and assessments that 
may impair recall of events. In this research, women’s perceptions of their experiences 
and beliefs may be influenced by factors such as continued engagement with ART, length 
of treatment, and previous success. Personal views of ART experiences could be made 
clear upon reflection once disengaged from treatment or after some time embedded in the 
treatment experience; the length of time the members of the support group had 
undertaken treatment was not obtained. However, women in the support group had not 
completely removed themselves as many were supporting other women currently 
undergoing treatment.  
Most of the support group women had at least one pregnancy and most had, at least, one 
live birth during their treatment time. Data does not indicate how many cycles these 
women undertook or stage of embryo transfers. This is a potential limitation, as the data 
was not able be linked to clinical cycle records. It is well documented that after five cycles 
of ART, there is little chance of pregnancy regardless of a woman’s age, and the sixth 
cycle only increases the chance by 0.7% (Macaldowie et al., 2013). Within the qualitative 
research group, some women had a baby but many women did not get pregnant after 
multiple cycles of ART, as shown by an interview participant who had completed 17 cycles 
of ART.  
10.6 Directions for future research 
A robust analysis by an independent body should be conducted into the cost-effectiveness 
of ART. There is no limit on Medicare rebate for ART cycles, and as discussed, there is 
little likelihood of conception after five or six cycles. Research should be undertaken into 
whether a limitation in the funding level would encourage women to start childbearing 
earlier in life or to make easier the decision to end treatment. Currently, some analysis had 
been undertaken in this area; however, an infertility company financially supported the 
research and it cannot be deemed independent research. 
Further research into the social reasons surrounding partnering relationships and women’s 
childbearing decisions could be initiated on the basis of this study. This research could 
discuss with women who have delayed childbearing socially constructed reasons for this 
trend. Strategies are required to mitigate this trend or to inform females of age-related 
fertility limits and ART to counteract fertility decline. However, Dr. Jane Fisher suggested 
that since Australian clinics became commercial entities they are less supportive of 
psychosocial research (Cohen, 2015). 
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Further in-depth research on best practice in disseminating information to women and girls 
about their fertility could be undertaken. This would enable information on the actual 
success rate of ART for all age groups of women made available. Simplified information on 
the success rate per cycle pertaining to women’s age for ART and PGD is recommended. 
This information needs to be gained from ANZARD rather than from individual clinics to 
provide some consistency and reliability to clinic marketing.  
The quantitative aspect of the study could be repeated with a larger sample size to 
examine, with greater statistical power, relationships between the main variables. A 
longitudinal study of women’s beliefs of ART and timing of childbearing would be very 
valuable. Further investigation could commence with young women and follow them over 
time during their childbearing years. 
Further research into the understanding of the success rates of ART by primary health 
providers such as GP’s, sexual health clinics, and gynaecologists is needed. Marketing 
information supplied by infertility clinics may be the only source of information for primary 
health providers and may impart an unrealistic view of ART. A survey of the knowledge of 
primary health providers and their sources of up to date information on ART would give an 
indication of deficiencies and strengths. If required, a strategy to improve the knowledge of 
these front line professionals could be implemented through the Australian Medical 
Association. 
Clearly the concept of women struggling to make the decision to stop ART treatment is of 
concern and deserves further investigation. Findings support the theory of anticipated 
decision regret when women would continue treatment, even if there were a slim chance 
for pregnancy, as ART offered the only avenue to avoid regret  
10.7 Summary 
The research questions explored women’s expectations and experiences of ART, factors 
influencing the decision to delay childbearing, and the medicalisation and marketing of 
ART. A mixed methods approach was adopted to explore these questions. Several 
limitations to the research are acknowledged. 
Findings indicate that lack of accurate knowledge of fertility, infertility, and its treatment are 
widespread in the community. Community expectations of the success of ART and the 
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reasons for women delaying pregnancy are not realistic. Media misrepresentation may 
influence this. 
Women who had used ART were influenced when making decisions by IVF clinic 
marketing, sometimes their GP, and the media. Realistic expectations only developed over 
time and with experience. These women overwhelmingly reported lack of a partner as the 
key reason for delaying childbearing. 
The emotional side of the unending desire to be a parent must be balanced against 
practicalities. This applies to women who have delayed childbearing for personal reasons 
with the intention that they can use ART if necessary. Delaying childbearing can only be 
considered as risk behaviour if women are aware of the decline in fertility related to 
maternal age. Some women have chosen to accept the risk in delaying childbearing. 
Delayed childbearing has a personal, financial and psychological cost for the woman, as 
well as society and public healthcare funding. Policy discussions have focused on 
workforce participation and economic incentives to stem the fertility decline; however, 
financial incentives cannot help women establishing partnering relationships that support 
families. 
Although ART has assisted many women, there is no guarantee of a baby. Having children 
before fertility wanes increases women’s chances of having a technology free conception, 
the number of children they aspire to have, and to avoid involuntary childlessness. Women 
can choose to have control over this part of their lives if they overcome social impediments 
to having children at the most opportune time.  
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Chapter 11: Recommendations 
Recommendations arising from this study are outlined below. Some women in the 
support group and the interview group were keen that their recommendations be acted 
upon to effectively educate younger women and to prevent others from suffering infertility 
as detailed in Chapter 9.3.12. 
1. A coherent body of knowledge is required in the public domain to educate 
the community on success rates, physical and psychological challenges and 
the medical procedures of ART. A greater public awareness of age-related 
fertility should be implemented to the community and adolescents through 
school-based education programs. Knowledge of age-related fertility decline 
and limitations of ART can be improved in primary health providers such as 
GPs so they can inform their female patients of childbearing age. This 
information should be independent and accurate.  
2. An independent regulator should monitor and censor information marketed to 
GPs, in the media, and from infertility clinics. The regulator should be 
managed by an Australian government body and should remain independent 
of agencies who have a vested commercial interest such as infertility clinics, 
pharmaceutical companies and support groups such as Access Australia.  
3. Cumulative success rates need to be reviewed to avoid unrealistic 
expectations of ART success. More realistic success rates allowing a fair 
comparison between infertility clinics should be in the public domain. 
Publication of live birth rates per cycle for each age group is recommended 
by the Department of Health and Aging (Department of Health and Aging, 
2006).  
4. There is a need for a debate on the distribution of publically funded 
healthcare in ART. A discussion in the public domain should be initiated on 
the public funding for unlimited ART cycles, particularly when there is a very 
low success rate for women aged 40 years.  
5. Less invasive techniques for treating infertility and the need to promote lower 
dose stimulation cycles should be encouraged to give women with simple 
solutions to the aetiology of their infertility the option of low-cost treatment. 
6. Infertility clinics should provide women with realistic expectations of success 
before they start their first treatment cycle and free psychological counselling 
   217 
for women who are struggling with treatment, have repeated failed cycles 
and who have difficulty stopping treatment.  
7. Women who do not have a baby after ART and are ending treatment need to 
find new role models who can help them move ahead into a future life 
without children and infertility support groups can provide empathy and 
understanding. Not all women will seek help and need to be aware of the 
availability of specialised psychological counselling for themselves and their 
partner if required. At the end of fertility treatment support staff should be 
able to discuss the future with patients. 
8. Public health information should be aimed at younger members of the 
community using technology such as social media and informed media sites.  
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Project Title: 
Women aged 35 and older: Their expectations, experiences, and decisions 
regarding Assisted Reproductive Technology (ART) 
 
Draft question outline 
 
• Please tell me who you are and where you are in your IVF journey  ….. 
 
 
• What are your personal reasons for having a family at this stage of your life?  
 
 
• What do you think about women looking to childbearing when aged 35 or older ? 
 
 
• What is your understanding of when women’s fertility starts to decline? 
 
 
• How would you rate the chance for a women aged 35 or older to have a pregnancy through IVF in a 
range  of 1 to 10  where 10 = most successful)? 
 
 
• How would you rate the chance for a women aged 35 or older to have a live birth (in a range  of 1 
to 10  where 10 = most successful)? 
 
 
• What perception do you think the media gives women of the success of IVF?  
 
 
• Do you think media stories influence women’s timing of childbearing? 
 
 
• Do you think the marketing information supplied from infertility clinics shapes women’s impression 
of IVF technology and success rates? 
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• Have your expectations of the IVF technology been met? 
 
• What are/were your  experiences of going through IVF treatment? 
Was that different to the expectation before you started IVF? 
 
 
• What did you think the success rate of IVF was before you accessed the clinic? 
 Has your perception changed now? 
 
• Taking your experiences into account, do you have advice for other women about the best age to 
have a child?  
  
• Do you think it is difficult for women to stop IVF cycles if they have not had a baby ?  
What factors could influence their decision to stop? 
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Project title:   
Women aged 35 and older: Their experiences, expectations and 
influences on decisions regarding Assisted Reproductive Technology 
for age-related infertility 
Researcher:   Andrea Hayward, PhD student, School of Science, Engineering 
and Health, Central Queensland University 
Research supervisor: Associate Professor Sandy Taylor, Head of the School of 
Science, Engineering and Health, Central Queensland University 
Informed consent 
 
I, ____________________________________voluntarily consent to take part in this 
research project, which has been explained to me by 
____________________________________________________________ 
 
Ø I have received an Information Sheet to keep which provides full details of this 
research project. 
Ø I understand that participation in the research involves filling in two questionnaires 
(one when first attending the clinic and another 6 months later).  
Ø I understand that I may be invited also to be interviewed for the study but that I am 
free to accept or decline the invitation without penalty 
Ø I understand the participation in this research is entirely voluntary and that I am free 
to withdraw from the study at any time without prejudice, or to withdraw permission 
to use any information that I have provided.   
Ø I understand that the information I provide in the questionnaires and interviews will 
be kept in confidence and I will not be identifiable in any reports or publications 
which emerge from this research. 
 
I have read the above statement and the Participant Information Sheet and give my 
consent to participate in the study 
Signature__________________________________________ 
Name (please print)_________________________________ 
Date  ____/____/___ 
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Project Title: 
Women aged 35 and older: Their expectations, experiences, and decisions regarding 
Assisted Reproductive Technology (ART) 
Research Team Contacts 
Principal Researcher 
Andrea Hayward 
PhD Student UQ School of Medicine 
Phone: 0428163031  Email: andreajh@uqconnect.net 
 
Principal Supervisor 
Dr. Tracey Papinczak         Email: tapapinczak@gmail.com 
Associate Supervisor: 
Dr. David King 
UQ School of Medicine     Phone: 07 3365 5382 Email: d.king@uq.edu.au 
 
Description of the research: 
The purpose of this study is to explore the experiences and expectations of women who are having 
treatment at an infertility clinic.  Women who are aged 35 or older, and participating in Assisted 
Reproductive Technology, are asked to participate in a focus group session.   
 
The research will focus on your expectations of IVF technology, your beliefs on the success of IVF, 
whether your expectations have changed after having IVF treatment, whether you believe your 
expectations were realistic, whether the media had a role in shaping your expectations of IVF, and 
whether marketing information of IVF shaped your expectations of IVF. The focus group will also 
explore your knowledge of women’s fertility declining with age and the concept of the ‘biological 
clock’.  
 
The research will also focus on your experience of IVF treatment.  These questions will not discuss 
your opinions of Life Fertility, but your general experience of the medical, emotional and 
psychological aspects of having IVF treatment. Other topics open to discussion will include: the 
social influences or impediments for having children when aged 35 or older, whether relationship 
issues, career, education, or economic reasons have influenced having children at this time.  
 
Participation: 
Your participation in this project is voluntary.  If you do agree to participate, you may withdraw at 
any time during the project without comment.  Your decision to participate will in no way impact 
on your involvement with Life Fertility. 
The interview format will be a semi-structured discussion based on the topics as described above.  
The setting will be informal and it is hoped that you chat freely about your IVF experience under 
the guidance of the facilitator.  There will not be any financial reimbursement for participating in 
the focus groups. The session will be audio recorded.  Your first names only will be used in the 
Participant Information sheet 
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tapes, and each participant will be given a pseudonym when the tapes are transcribed to preserve 
your anonymity.  No identifying information will be recorded in the focus groups. 
 
Expected benefits: 
It is expected that this study will provide benefits to the knowledge of women having IVF 
treatment. Many medical studies have discussed treatments and technology but very few studies 
have explored the issues for Australian women who have experienced IVF treatment. 
 
Risks: 
This project may result in some emotional discomfort or anxiety during the focus group session.  
Conversely, you may find the discussion beneficial to you.  Should you become distressed at any 
time during the focus group the focus group will be halted and you may choose to leave the 
discussion – please let the facilitator know. Free independent counseling is available through 
Lifeline on 13 11 14. Counselling and support services are available through Life Fertility. 	
Confidentiality: 
You will be asked to sign a consent form before participating in the focus group. All comments and 
responses will be confidential and viewed only by members of the research team.  Your name will 
be replaced by a pseudonym for the transcription of the focus group session and in the research 
document.  No study or published document will identify you personally. 
 
Questions or Further information on this project: 
Please contact the principal researcher for information on this focus group research. 
Concerns or complaints regarding the conduct of this research: 
This study has been cleared by one of the human ethics committees of the University of Queensland 
in accordance with the National Health and Medical Research Council's guidelines. The University 
of Queensland is committed to researcher integrity and the ethical conduct of research projects.  
However, if you have any concerns or complaints about the ethical conduct of this research please 
contact the School of Medicine Research Ethics Unit on 07 3365 3924 on or email 
humanethics@research.uq.edu.au.  The Research Ethics Unit is not connected with the research 
project and can facilitate a resolution to your concern in an impartial manner. 
Thank you for your assistance in this research,  
 
Andrea Hayward MSc(Hons) 
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Informed Consent Form 
Women aged 38 and older: Their experiences, expectations and influences on 
decisions regarding Assisted Reproductive Technology for age-related infertility 
 
Researcher:   Andrea Hayward, PhD student, School of Medicine, University 
of Queensland 
Research supervisor: Dr. Tracey Papinczak, University of QLD 
   Dr. David King, School of Medicine, University of QLD 
 
I, ____________________________________voluntarily consent to take part in this  
research project, which has been explained to me by  
____________________________________________________________ 
Ø I have received an Information Sheet to keep which provides full details of this 
research project. 
Ø I understand that participation in the research involves a phone interview or a face 
to face interview with Dr. Suzie King. 
Ø I understand the participation in this research is entirely voluntary and that I am free 
to withdraw from the study at any time without prejudice, or to withdraw permission 
to use any information that I have provided.   
Ø I understand that the information I provide in the interviews will be kept in 
confidence and I will not be identifiable in any reports or publications which emerge 
from this research. 
 
I have read the above statement and the Participant Information Sheet and give my 
consent to participate in the study. 
 
Name (please print)_________________________________ 
Signature__________________________________________ 
Date    ________/__________/__________ 
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